{"2021-12-27": {"status": "ok", "totalResults": 5, "articles": [{"source": {"id": null, "name": "Sputnik International"}, "author": "Elizabeth Blade", "title": "Israel is Set to Offer 4th Dose of Pfizer Vaccine; Expert Says It Should Not Be Mandatory", "description": "The decision to start mass vaccination yet again hasn't been taken yet, but the Jewish state is already encouraging its medical staff, people above 60 and those at risk to get the jab.", "url": "https://sputniknews.com/20211227/israel-is-set-to-offer-4th-dose-of-pfizer-vaccine-expert-says-it-should-not-be-mandatory--1091828138.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091828138.jpg?10825952661640590707", "publishedAt": "2021-12-27T07:38:26Z", "content": "We know that there will be an added value if a person chooses to get a fourth dose. We don't know how much it will be but we know for a fact that it exists. Plus, the vaccine is totally safe,\" he rea\u2026 [+6 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Vishwam Sankaran", "title": "Pfizer antiviral pills for Covid may be risky when taken with other medications, experts warn", "description": "FDA says drug combination is not recommended for people with severe kidney and liver disease", "url": "https://www.independent.co.uk/news/health/pfizer-covid-antiviral-pill-medications-b1982690.html", "urlToImage": "https://static.independent.co.uk/2021/12/26/14/Virus_Outbreak_Treatment_Explainer_55362.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-27T05:40:49Z", "content": "Pfizers new antiviral pills against Covid-19 may not be safe for everyone, experts have cautioned, adding that the new drug could be life-threatening when taken with other medications.\r\nThe US Food a\u2026 [+3578 chars]"}, {"source": {"id": null, "name": "AllAfrica - Top Africa News"}, "author": "GhanaToday", "title": "U.S. Donates 1.7 Million Doses of Pfizer Vaccines to Ghana", "description": "[GhanaToday] Mr Kwaku Agyemang Manu, Minister for Health (Right) receiving the vaccines from US Ambassador to Ghana, Stephanie Sullivan", "url": "https://allafrica.com/stories/202112270097.html", "urlToImage": "https://cdn08.allafrica.com/static/images/structure/aa-logo-rgba-no-text-square.png", "publishedAt": "2021-12-27T08:22:51Z", "content": "Mr Kwaku Agyemang Manu, Minister for Health (Right) receiving the vaccines from US Ambassador to Ghana, Stephanie Sullivan\r\nGhana has received another 1.7 million doses of Pfizer Covid-19 vaccines fr\u2026 [+1124 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer antiviral pill could be risky with other widely used medications | TheHill - The Hill", "description": "Pfizer antiviral pill could be risky with other widely used medications | TheHillThe Hill EXPLAINER: New easy-to-use COVID-19 pills come with a catchYahoo News S. Korea to announce decision on whether to authorize antiviral COVID-19 pills for emergency useAri\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156893609", "urlToImage": null, "publishedAt": "2021-12-27T04:52:53Z", "content": "If A = B and B = C, then A = C, except where void or prohibited by law.\r\n-- Roy Santoro"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer Covid pills for Covid symptoms may be risky with other drugs. - NBC News", "description": "Pfizer Covid pills for Covid symptoms may be risky with other drugs.NBC News EXPLAINER: New easy-to-use COVID-19 pills come with a catchYahoo News S. Korea to announce decision on whether to authorize antiviral COVID-19 pills for emergency useArirang News Edi\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156890505", "urlToImage": null, "publishedAt": "2021-12-27T02:32:25Z", "content": "It was pity stayed his hand.\r\n\"Pity I don't have any more bullets,\" thought Frito.\r\n-- _Bored_of_the_Rings_, a Harvard Lampoon parody of Tolkein"}]}, "2021-12-26": {"status": "ok", "totalResults": 10, "articles": [{"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-covid-vaccine-booster-pfizer-moderna-astrazeneca-b1982448.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-26T10:10:32Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": "nbc-news", "name": "NBC News"}, "author": "Benjamin Ryan", "title": "Pfizer Covid pills may be risky with other medications", "description": "Pfizer Covid pills for symptoms may cause harmful reactions if taken with other prescription medications.", "url": "https://www.nbcnews.com/health/health-news/pfizer-covid-pills-covid-symptoms-may-risky-drugs-rcna9683", "urlToImage": "https://media-cldnry.s-nbcnews.com/image/upload/t_nbcnews-fp-1200-630,f_auto,q_auto:best/rockcms/2021-12/211222-stack-pills-stock-se-158p-39616a.jpg", "publishedAt": "2021-12-26T09:30:36Z", "content": "As the omicron surge pummels a pandemic-weary nation, the first antiviral pills for Covid-19 promise desperately needed protection for people at\u00a0risk of severe disease. However, many people prescribe\u2026 [+5979 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "ANI", "title": "US donates 5 million doses of Pfizer coronavirus vaccine to Pakistan", "description": "The United States has announced shipping an additional five million doses of Pfizer's coronavirus vaccine to Pakistan through the COVAX facility.", "url": "https://www.business-standard.com/article/current-affairs/us-donates-5-million-doses-of-pfizer-coronavirus-vaccine-to-pakistan-121122600032_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2020-11/10/full/1604952252-2271.jpg", "publishedAt": "2021-12-26T02:08:00Z", "content": "The United States has announced shipping an additional five million doses of Pfizer's coronavirus vaccine to Pakistan through the COVAX facility.\r\n\"The United States asked Santa to bring an additiona\u2026 [+2938 chars]"}, {"source": {"id": "the-hill", "name": "The Hill"}, "author": "Sarakshi Rai", "title": "Pfizer antiviral pill could be risky with other widely used medications", "description": "The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for\u00a0COVID-19\u00a0that\u00a0has been touted as e a game-changer in the figh...", "url": "https://thehill.com/policy/healthcare/public-global-health/587334-pfizer-antiviral-pill-could-be-risky-with-other-widely", "urlToImage": "https://thehill.com/sites/default/files/pfizer_010721ap_lead.jpg", "publishedAt": "2021-12-26T18:10:13Z", "content": "The Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the first at-home treatment for\u00a0COVID-19\u00a0that\u00a0has been touted as e a ga\u2026 [+1984 chars]"}, {"source": {"id": null, "name": "Ynetnews"}, "author": "i24NEWS", "title": "Israel to receive first shipment of Pfizer anti-COVID pills in coming week", "description": "PM spoke with pharma giant's CEO Bourla over the weekend to finalize purchase of some 100,000 doses, which will be available free of charge to Israelis in high-risk groups", "url": "https://www.ynetnews.com/health_science/article/s1bx00wijy", "urlToImage": "https://ynet-images1.yit.co.il/picserver5/crop_images/2021/12/22/S1MWXkWoF/S1MWXkWoF_0_0_2000_1334_0_large.jpg", "publishedAt": "2021-12-26T16:42:09Z", "content": "<ul><li>facebook</li><li>print</li><li>send to friend</li><li>comment</li></ul>\r\n<ul><li>comment</li><li>send to friend</li><li>share</li><li>share</li></ul>"}, {"source": {"id": null, "name": "Haaretz"}, "author": "Ido Efrati \u05d5Reuters", "title": "Israel authorizes use of Pfizer antiviral COVID pill Paxlovid", "description": "Paxlovid, the first at-home treatment for the coronavirus, is expected to arrive in Israel in the next few days", "url": "https://www.haaretz.com/israel-news/israel-authorizes-use-of-pfizer-antiviral-covid-pill-paxlovid-1.10495082", "urlToImage": "https://www.haaretz.com/polopoly_fs/1.10495091.1640537313!/image/3302704606.jpg_gen/derivatives/headline_1200x630/3302704606.jpg", "publishedAt": "2021-12-26T16:40:42Z", "content": "Israel's Health Ministry authorized on Sunday the use of Pfizer's antiviral COVID-19 pill, Paxlovid,\u00a0the first at-home treatment for coronavirus that is expected to become an important tool in the fi\u2026 [+1351 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "UK agency: Pfizer booster\u2019s ability to prevent symptomatic COVID wanes within weeks - The Times of Israel", "description": "UK agency: Pfizer booster\u2019s ability to prevent symptomatic COVID wanes within weeksThe Times of Israel Why an Omicron wave may not be as severe as DeltaTimes of India Individuals Affected by Omicron are 50-70% Less Likely to Need Hospital Care in Comparison t\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156877925", "urlToImage": null, "publishedAt": "2021-12-26T16:32:11Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Protection From Pfizer Booster Drops Significantly After 10 Weeks: Study - The Daily Wire", "description": "Protection From Pfizer Booster Drops Significantly After 10 Weeks: StudyThe Daily Wire Why an Omicron wave may not be as severe as DeltaTimes of India Individuals Affected by Omicron are 50-70% Less Likely to Need Hospital Care in Comparison to Other Variants\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156872403", "urlToImage": null, "publishedAt": "2021-12-26T13:12:04Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Israel to receive first shipment of Pfizer anti-COVID pills in coming week \u2014 report - The Times of Israel", "description": "Israel to receive first shipment of Pfizer anti-COVID pills in coming week \u2014 reportThe Times of Israel Approval of new pills for COVID-19 treatment gives stocks a boostDetroit Free Press SC to receive 800 sets of COVID-19 pillLive 5 News WCSC Editorial: Waiti\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156856777", "urlToImage": null, "publishedAt": "2021-12-26T00:32:33Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "CNN Philippines"}, "author": "Paul R.", "title": "Albert Bourla of Pfizer is the CNN Business CEO of the Year", "description": "Albert Bourla of Pfizer is the CNN Business CEO of the Yearcnnphilippines.com", "url": "http://cnnphilippines.com/business/2021/12/26/Albert-Bourla-CNN-Business-CEO-of-the-Year.htmlhttps://cnnphilippines.com/business/2021/12/26/Albert-Bourla-CNN-Business-CEO-of-the-Year.html", "urlToImage": "http://cnnphilippines.com/.imaging/mte/demo-cnn-new/750x450/dam/cnn/2021/12/26/Albert-Bourla_CNNPH.jpg/jcr:content/Albert-Bourla_CNNPH.jpg", "publishedAt": "2021-12-26T14:38:33Z", "content": "(CNN) -- The COVID-19 pandemic is far from over. But life in many ways has returned to something resembling normal for many. That's in large part because there are now multiple coronavirus vaccines, \u2026 [+7066 chars]"}]}, "2021-12-25": {"status": "ok", "totalResults": 6, "articles": [{"source": {"id": "cnn", "name": "CNN"}, "author": "Paul R. La Monica, CNN Business", "title": "Albert Bourla of Pfizer is the CNN Business CEO of the Year - CNN", "description": "The Covid-19 pandemic is far from over. But life in many ways has returned to something resembling normal for many. That's in large part because there are now multiple coronavirus vaccines, including one from Pfizer.", "url": "https://www.cnn.com/2021/12/25/investing/ceo-of-the-year-2021/index.html", "urlToImage": "https://cdn.cnn.com/cnnnext/dam/assets/211220170142-pfizer-ceo-albert-bourla-0423-super-tease.jpg", "publishedAt": "2021-12-25T15:20:00Z", "content": "New York (CNN Business)The Covid-19 pandemic is far from over. But life in many ways has returned to something resembling normal for many. That's in large part because there are now multiple coronavi\u2026 [+7053 chars]"}, {"source": {"id": null, "name": "The Daily Wire"}, "author": "Joseph Curl", "title": "Protection From Pfizer Booster Drops Significantly After 10 Weeks: Study - The Daily Wire", "description": "<ol><li>Protection From Pfizer Booster Drops Significantly After 10 Weeks: Study\u00a0\u00a0The Daily Wire\r\n</li><li>COVID-19 vaccine booster protection against Omicron fades within 10 weeks, says new study\u00a0\u00a0Republic World\r\n</li><li>Pfizer booster's efficacy to prevent\u2026", "url": "https://www.dailywire.com/news/protection-from-pfizer-booster-drops-significantly-after-10-weeks-study", "urlToImage": "https://dw-wp-production.imgix.net/2021/09/Vaccine.jpg?w=1200&h=800&ixlib=react-9.3.0", "publishedAt": "2021-12-25T18:30:15Z", "content": "The protection that a Pfizer booster shot gives against the new coronavirus variant Omicron, following a Pfizer primary course, drops to just 45% after 10-plus weeks, according to a new study.\r\nA boo\u2026 [+3187 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/covid-vaccine-omicron-pfizer-moderna-astrazeneca-b1982240.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-25T09:49:34Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": null, "name": "The Times of Israel"}, "author": null, "title": "Israel to receive 100,000 Pfizer anti-COVID pills in coming week \u2014 report", "description": "PM Naftali Bennett speaks to Pfizer CEO over weekend to finalize deal for at-home treatment shown to reduce risk of hospitalization, death in high-risk groups by 90%", "url": "https://www.timesofisrael.com/israel-to-receive-100000-pfizer-anti-covid-pills-in-coming-week-report/", "urlToImage": "https://static.timesofisrael.com/www/uploads/2021/11/AP21320681843352-1024x640.jpg", "publishedAt": "2021-12-25T21:00:54Z", "content": "Israel has finalized an agreement to purchase about 100,000 of Pfizer\u2019s antiviral COVID-19 pills and is set to receive the first shipment in about a week, Channel 12 reported Saturday.\r\nThe network s\u2026 [+4074 chars]"}, {"source": {"id": "cnn", "name": "CNN"}, "author": null, "title": "Pfizer CEO shares thoughts on boosters and the future of Covid - CNN Video", "description": "Pfizer CEO Albert Bourla spoke with CNN Business' Paul R. La Monica about annual Covid-19 vaccines, the future of the virus, and getting the vaccine to low-income countries.", "url": "https://www.cnn.com/videos/business/2021/12/19/albert-bourla-pfizer-ceo-interview-mc-orig.cnn-business", "urlToImage": "https://cdn.cnn.com/cnnnext/dam/assets/211207174111-omicron-news-042321-super-tease.jpg", "publishedAt": "2021-12-25T12:54:49Z", "content": ""}, {"source": {"id": null, "name": "Justthenews.com"}, "author": "Aaron Kliegman", "title": "Pfizer to continue distributing version of COVID-19 vaccine not fully approved by FDA", "description": "Pharma giant says no medical difference between the two; others point to major legal distinctions affecting vaccine mandates", "url": "https://justthenews.com/politics-policy/health/pfizer-continue-distributing-version-covid-19-vaccine-not-fully-approved-fda", "urlToImage": "https://justthenews.com/sites/default/files/styles/social_media_share/public/2021-12/pfizer%20vaccine.jpg?h=58c8a5e7&itok=CjeKx4RO", "publishedAt": "2021-12-25T08:19:50Z", "content": "Pfizer's vaccine against COVID-19 has been fully approved by the Food and Drug Administration, yet the pharmaceutical giant is still providing distributors across the country with an earlier version \u2026 [+6348 chars]"}]}, "2021-12-24": {"status": "ok", "totalResults": 13, "articles": [{"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-pfizer-moderna-astrazeneca-b1982064.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-24T15:11:40Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": null, "name": "Childrenshealthdefense.org"}, "author": "Mike Rivero", "title": "Pfizer, FDA Dodge Media Questions About Pfizer Comirnaty Vaccine", "description": "Two media outlets last week requested, but failed to obtain, clarity from Pfizer on whether its fully licensed Comirnaty COVID vaccine is available in the U.S.\nReporting by The Ohio Star and National File highlighted the ongoing debate over whether the vaccin\u2026", "url": "https://childrenshealthdefense.org/defender/pfizer-fda-media-pfizer-comirnaty-vaccine/", "urlToImage": "https://childrenshealthdefense.org/wp-content/uploads/Pfizer-FDA-dodge-comments-Comirnaty-feature-1.jpg", "publishedAt": "2021-12-24T13:40:34Z", "content": "Miss a day, miss a lot.Subscribe to The Defender's Top News of the Day. It's free.\r\nTwo media outlets last week requested, but failed to obtain, clarity from Pfizer on whether its fully licensed Comi\u2026 [+9513 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Two Doses of Pfizer or Moderna Fail to Protect Against Omicron After 6 Months, Scientists Say", "description": "MOSCOW (Sputnik) - A study by a group of scientists from the United States has found that two doses of COVID-19 vaccines from Pfizer or Moderna do not provide protection against the Omicron strain six months after the second vaccination.", "url": "https://sputniknews.com/20211224/two-doses-of-pfizer-or-moderna-fail-to-protect-against-omicron-after-6-months-scientists-say-1091777362.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091777362.jpg?10910565181640352859", "publishedAt": "2021-12-24T13:34:17Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nThe new COVID variant was initially detected in South Africa and Botswana and sparked major concerns due to its high number\u2026 [+3002 chars]"}, {"source": {"id": null, "name": "The Times of Israel"}, "author": null, "title": "UK agency: Pfizer booster\u2019s ability to prevent symptomatic COVID wanes within weeks", "description": "Data shows 3rd shot 70% effective in preventing illness after 2 weeks but only 45% after 10 weeks; Moderna seems to offer more durable protection, staying at 70% after 10 weeks", "url": "https://www.timesofisrael.com/uk-agency-pfizer-boosters-ability-to-prevent-symptomatic-covid-wanes-within-weeks/", "urlToImage": "https://static.timesofisrael.com/www/uploads/2021/12/iStock-1355780408-1024x640.jpg", "publishedAt": "2021-12-24T15:23:30Z", "content": "New data from the UK indicates that the effectiveness of Pfizer vaccine booster shots in preventing symptomatic COVID-19 as a result of the Omicron variant drops considerably within 10 weeks of recei\u2026 [+1959 chars]"}, {"source": {"id": null, "name": "Uniindia.com"}, "author": "Uniindia News Service", "title": "Two doses of Pfizer or Moderna fail to protect against Omicron after 6 months: Scientists - United News of India", "description": "<ol><li>Two doses of Pfizer or Moderna fail to protect against Omicron after 6 months: Scientists\u00a0\u00a0United News of India\r\n</li><li>Vaccines, pills and data - Some good news in face of Omicron gloom\u00a0\u00a0Mint\r\n</li><li>Omicron can evade protection offered by Covid \u2026", "url": "http://www.uniindia.com/~/two-doses-of-pfizer-or-moderna-fail-to-protect-against-omicron-after-6-months-scientists/World/news/2602887.html", "urlToImage": "", "publishedAt": "2021-12-24T19:01:00Z", "content": "More News25 Dec 2021 | 2:18 AMWashington, Dec 24 (UNI/Sputnik) Tesla will modify features allowing people to play video games using a built-in touch screen during the ride following the US National H\u2026 [+1113 chars]"}, {"source": {"id": null, "name": "New York Post"}, "author": "Jackie Salo", "title": "Pfizer booster protection against Omicron drops in 10 weeks, study says", "description": "The effectiveness of Pfizer's booster shot against symptomatic Omicron significantly dwindles after 10 weeks.", "url": "https://nypost.com/2021/12/24/booster-protection-against-omicron-drops-within-10-weeks-study/", "urlToImage": "https://nypost.com/wp-content/uploads/sites/2/2021/12/pfizer-booster-00.jpg?quality=90&strip=all&w=1024", "publishedAt": "2021-12-24T18:35:54Z", "content": "The effectiveness of Pfizer\u2019s booster shot against symptomatic Omicron significantly wanes after 10 weeks, a new study said this week \u2014 as experts weigh whether fourth shots are necessary.\r\nThe\u00a0UK He\u2026 [+2061 chars]"}, {"source": {"id": null, "name": "NDTV News"}, "author": null, "title": "Merck, Pfizer Pills Cleared For Use, Now US To Focus On Rationing", "description": "The US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.", "url": "https://www.ndtv.com/world-news/merck-pfizer-pills-cleared-for-use-now-us-to-focus-on-rationing-2668779", "urlToImage": "https://c.ndtvimg.com/2021-12/4luj96r_pfizer-covid-pill-afp_625x300_22_December_21.jpg", "publishedAt": "2021-12-24T04:33:11Z", "content": "Pfizer Inc.'s Paxlovid was authorised earlier this week\r\nThe US has cleared its first two Covid-19 treatment pills, and now comes another hurdle -- deciding who should get which one.\r\nMerck &amp; Co.\u2026 [+5097 chars]"}, {"source": {"id": null, "name": "Womensystems.com"}, "author": "mayaleo", "title": "Will The US Consider A FOURTH COVID Vaccination? Speculation Mounts That Yet Another Shot Is On The Horizon To Deal With Soaring Omicron Cases After Pfizer CEO Backed Them, With Germany And Israel Both Preparing To Roll Them Out", "description": "Women Entertainment Sysytem", "url": "http://www.womensystems.com/2021/12/will-us-consider-fourth-covid.html", "urlToImage": "https://lh5.googleusercontent.com/proxy/ekzJEpFnHVIXLQXVGSap-Ccw0kUoipOj3dn-OQlgQ7F4A0UsK93wT6aYKjSVnTx5usD3GumT1DJ5Wy6TKztWqRdO8rMRS-E3ve8RTECu86pHy1CX2eWhpUellIFh_o377FuUDoEfCjnUgb71FA=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-24T13:52:38Z", "content": "Speculation is mounting that the United States could offer people a fourth COVID vaccine shot in the coming months as the Omicron variant surges.\u00a0\r\nIsrael and Germany are both on the verge of rolling\u2026 [+11870 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "Press Trust of India", "title": "United States donates 664,560 doses of Pfizer vaccines to Nepal", "description": "The United States has donated 664,560 new doses of Pfizer vaccine to Nepal to help it intensify its fight against the coronavirus, the US Embassy said here on Friday.\nThe new doses of Pfizer vaccine given to Nepal free of cost is in addition to the doses the \u2026", "url": "https://www.business-standard.com/article/international/united-states-donates-664-560-doses-of-pfizer-vaccines-to-nepal-121122400863_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-02/25/full/1614255646-8333.jpg", "publishedAt": "2021-12-24T13:21:00Z", "content": "The United States has donated 664,560 new doses of Pfizer vaccine to Nepal to help it intensify its fight against the coronavirus, the US Embassy said here on Friday.\r\nThe new doses of Pfizer vaccine\u2026 [+2798 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "dailyexpose.uk", "title": "Pfizer/BioNTech Covid Injections reprogram both adaptive and innate immune responses", "description": "A study posted on the preprint site medRxiv shows that Covid mRNA injections are causing immune system dysregulation, a breakdown of immune system processes. In other words, researchers are finding that the injections reprogram not only your adaptive immune s\u2026", "url": "https://freerepublic.com/focus/f-chat/4023939/posts", "urlToImage": null, "publishedAt": "2021-12-24T05:09:23Z", "content": "Skip to comments.\r\nPfizer/BioNTech Covid Injections reprogram both adaptive and innate immune responsesdailyexpose.uk ^\r\n | 12/23/2021\r\n | RHODA WILSON\r\nPosted on 12/23/2021 9:09:23 PM PST by ransomn\u2026 [+5282 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "dailyexpose.uk", "title": "Pfizer Injection Contents: La Quinta Columna Confirms Findings of Polish Scientist and Dr. Carrie Madej", "description": "Using optical microscopy, La Quinta Columna finds the famous \u201cnano-octopus\u201d that appeared in the Pfizer vaccine vial analysed by Dr. Campra, observed by Dr. Carrie Madej under the microscope, and also found by the Polish scientist Dr. Franc Zalewksi.\u201cIt looks\u2026", "url": "https://freerepublic.com/focus/f-chat/4023944/posts", "urlToImage": null, "publishedAt": "2021-12-24T05:49:33Z", "content": "Skip to comments.\r\nPfizer Injection Contents: La Quinta Columna Confirms Findings of Polish Scientist and Dr. Carrie Madejdailyexpose.uk ^\r\n | December 23, 2021\r\n | Rhoda WIlson\r\nPosted on 12/23/2021\u2026 [+5593 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Monit Khanna", "title": "After Pfizer, Merck\u2019s Anti-COVID-19 Pill Gets Emergency Use Approval In US", "description": "Yesterday we saw Pfizer\u2019s pill for COVID-19 treatment get approved by the FDA and today, Merck\u2019s pill dubbed 'Molnupiravir'\u00a0 for COVID-19 treatment gets emergency use authorization.                        APAlso Read:\u00a0United States Approves Use Of World's Fir\u2026", "url": "https://www.indiatimes.com/technology/science-and-future/merck-anti-covid-19-pill-approved-557589.html", "urlToImage": "https://im.indiatimes.in/content/2021/Dec/Facebook-Image---2021-12-24T130445601_61c57907b368a.jpg", "publishedAt": "2021-12-24T07:28:11Z", "content": "Yesterday we saw Pfizers pill for COVID-19 treatment get approved by the FDA and today, Mercks pill dubbed 'Molnupiravir'\u00a0 for COVID-19 treatment gets emergency use authorization.\r\nAP\r\nAlso Read:\u00a0Uni\u2026 [+1459 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer booster protection against Omicron drops in 10 weeks, study says - New York Post", "description": "Pfizer booster protection against Omicron drops in 10 weeks, study saysNew York Post COVID-19: Data suggests Omicron 'less severe'Sky News Omicron up to 70% less likely to need hospital careBBC News UK Omicron IS less severe studies show as ministers urged to\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156803301", "urlToImage": null, "publishedAt": "2021-12-24T20:12:36Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}]}, "2021-12-23": {"status": "ok", "totalResults": 41, "articles": [{"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "Pfizer (PFE) Gets FDA's Emergency Use Nod for COVID Pill", "description": "Pfizer's (PFE) COVID-19 pill Paxlovid is the first oral antiviral medicine, which can be prescribed as an at-home treatment for mild-to-moderate COVID-19.", "url": "http://www.zacks.com/stock/news/1842876/pfizer-pfe-gets-fda-s-emergency-use-nod-for-covid-pill?cid=CS-ENTREPRENEUR-FT-analyst_blog|company_news_-_medical_sector-1842876", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-404477.jpeg", "publishedAt": "2021-12-23T15:30:00Z", "content": "Pfizer PFE announced that the FDA has granted Emergency Use Authorization (EUA) to its promising oral antiviral candidate for COVID-19, Paxlovid, amid rising infection rates. The Omicron variant of t\u2026 [+6384 chars]"}, {"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "Moderna (MRNA) Down as Pfizer Paxlovid EUA May Fuel Competition", "description": "Moderna's (MRNA) COVID-19 vaccine may face stiffer competition following the FDA's emergency approval of an oral COVID-19 pill, Pfizer's Paxlovid, which may result in lower sales.", "url": "http://www.zacks.com/stock/news/1842878/moderna-mrna-down-as-pfizer-paxlovid-eua-may-fuel-competition?cid=CS-ENTREPRENEUR-FT-analyst_blog|company_news_-_medical_sector-1842878", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-404475.jpeg", "publishedAt": "2021-12-23T15:39:00Z", "content": "Shares of popular COVID-19 vaccine-maker, ModernaMRNA were down 6.3% on Wednesday, following the news of emergency use authorization (EUA) for Pfizers PFE promising oral COVID-19 pill, Paxlovid, in t\u2026 [+7367 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Merck and Pfizer COVID-19 pills effective against Omicron -U.S. FDA official - Reuters", "description": "Available data indicates that both Merck's <a href=\"https://www.reuters.com/companies/MRK.N\" target=\"_blank\">(MRK.N)</a> and Pfizer's <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> COVID-19 anti-viral treatments are effective ag\u2026", "url": "https://www.reuters.com/world/us/merck-pfizer-covid-19-pills-effective-against-omicron-us-fda-official-2021-12-23/", "urlToImage": "https://www.reuters.com/resizer/Ym2-lihEXiC1sjyMdF3KbAdpiLg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/TUAWFANQXJLVFM76ZJH5H7A4CM.jpg", "publishedAt": "2021-12-23T17:10:00Z", "content": "Vials labelled \"VACCINE Coronavirus COVID-19\" and a syringe are seen in front of a displayed U.S. flag in this illustration taken December 11, 2021. REUTERS/Dado RuvicWASHINGTON, Dec 23 (Reuters) - A\u2026 [+928 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "CBS News Videos", "title": "FDA authorizes Pfizer pill to treat COVID-19 as Omicron hits all 50 sates", "description": "The Food and Drug Administration announced Wednesday it has authorized Pfizer's antiviral pill to treat COVID-19 as the new Omicron variant hits all 50 U.S. ...", "url": "https://news.yahoo.com/fda-authorizes-pfizer-pill-treat-012154903.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/rBdcVmE03PRrGNQVdLNdBQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/23/61c3d484709d502188af5a14/61c3d484709d502188af5a15_o_U_v2.jpg", "publishedAt": "2021-12-23T01:21:54Z", "content": "Rep. Madison Cawthorn and his wife are divorcing after less than a year of marriage, with the North Carolina Republican citing his job in Congress as part of the reason for the split.\"When my wife Ch\u2026 [+252 chars]"}, {"source": {"id": null, "name": "Nature.com"}, "author": "Sandile Cele, Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally, James Emmanuel San, Deborah Cromer, Cathrine Scheepers, Daniel Amoako, Farina Karim, Mallory Bernstein, Gila Lustig, Derseree Archary, Muneerah Smith, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Shi-Hsia Hwa, Jennifer Giandhari, Jonathan M. Blackburn, Bernadett I. Gosnell, Salim S. Abdool Karim, Willem Hanekom, Network for Genomic Surveillance in South Africa, COMMIT-KZN Team, Anne von Gottberg, Jinal Bhiman, Richard J. Lessells, Mahomed-Yunus S. Moosa, Miles P. Davenport, Tulio de Oliveira, Penny L. Moore, Alex Sigal", "title": "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization", "description": "Discover the world\u2019s best science and medicine  | Nature.com", "url": "https://www.nature.com/articles/d41586-021-03824-5", "urlToImage": "https://media.nature.com/lw1024/magazine-assets/d41586-021-03824-5/d41586-021-03824-5_19974342.jpg", "publishedAt": "2021-12-23T00:00:00Z", "content": "National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa. MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Science\u2026 [+249 chars]"}, {"source": {"id": null, "name": "BNNBloomberg.ca"}, "author": "Bloomberg News", "title": "USA Weighs How To Ration PFIZER Pills...", "description": "USA Weighs How To Ration PFIZER Pills...\r\n\n \n \n \n (Top headline, 9th story, link)\r\n\n \r\n\n \r\n\n \n Related stories:HOPE: Omicron may bring record cases but fewer deaths, forecast says...\r\n60% of Americans infected by March?\r\nMarches Toward Endemic Status...\r\nIn h\u2026", "url": "http://www.bnnbloomberg.ca/u-s-weighs-how-to-ration-pfizer-pills-early-on-among-high-risk-1.1699825", "urlToImage": "http://www.bnnbloomberg.ca/img/tsn/logos/tsn-logo.png", "publishedAt": "2021-12-23T15:19:36Z", "content": "(Bloomberg) -- The U.S. has cleared Pfizer Inc.s Covid pill, and now comes another hurdle -- deciding who should get it.\r\nPfizers Paxlovid, authorized Wednesday by the Food and Drug Administration, h\u2026 [+1880 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Jim Halley)", "title": "The Worst Mistake Pfizer Investors Can Make in 2022", "description": "The company's share price and revenue have soared in 2021, and that's likely only the beginning.", "url": "https://www.fool.com/investing/2021/12/23/the-worst-mistake-pfizer-investors-can-make-in-202/", "urlToImage": "https://g.foolcdn.com/editorial/images/658089/pfizer.jpg", "publishedAt": "2021-12-23T12:23:00Z", "content": "It's been a great year for Pfizer(NYSE:PFE) and its investors as the company's share price is up more than 62% this year. Also, Pfizer has said it expects to record annual revenue of between $81 bill\u2026 [+4737 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": null, "title": "Pfizer Covid Pill Cleared for High-Risk Patients in US(Podcast)", "description": "Understand every aspect of the global economy \u2013 and know how to make your next move.", "url": "https://www.bloomberg.com/news/audio/2021-12-23/pfizer-covid-pill-cleared-for-high-risk-patients-in-us-podcast", "urlToImage": null, "publishedAt": "2021-12-23T02:37:12Z", "content": "Robert Langreth, Bloomberg Healthcare Reporter, discusses Pfizer's Covid pill with Bryan Curtis and Rishaad Salamat on Bloomberg Daybreak Asia.\r\nDec 23, 2021"}, {"source": {"id": null, "name": "TheStreet"}, "author": "Scott Rutt", "title": "Cramer's Mad Money Recap 12/23: Pfizer, Nvidia, Tesla", "description": "Jim Cramer's got a list of who's naughty, who's nice and which companies deserve a lump of coal.", "url": "https://www.thestreet.com/jim-cramer/cramers-mad-money-recap-dec-23-2021", "urlToImage": "https://www.thestreet.com/.image/t_share/MTg1NDg3NTI3ODUzOTU4MzA1/stocks-markets-holiday-lights-sh.jpg", "publishedAt": "2021-12-23T18:58:00Z", "content": "Santa took his time getting to Wall Street this year, but\u00a0Jim Cramer told his Mad Money viewers that it looks like the so-called Santa Claus Rally started on Monday and has been delivering gifts to i\u2026 [+7301 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "Pfizer pill becomes 1st US-authorised home COVID treatment", "description": "The long-awaited milestone comes as U.S. cases, hospitalisations and deaths are all rising and health officials warn of a tsunami of new infections from the omicron variant that could overwhelm hospitals.", "url": "https://www.moneycontrol.com/news/world/pfizer-pill-becomes-1st-us-authorised-home-covid-treatment-7856481.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/09/pfizer-770x433.jpg", "publishedAt": "2021-12-23T02:56:14Z", "content": "U.S. health regulators on Wednesday authorised the first pill against COVID-19, a\u00a0Pfizer\u00a0drug that Americans will be able to take at home to head off the worst effects of the virus.\r\nThe long-awaited\u2026 [+4511 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-pfizer-astrazeneca-moderna-b1981500.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-23T15:17:19Z", "content": "The more contagious Omicron Covid variant is spreading rapidly across the UK and is set to become the dominant strain in the UK.\r\nSo far more than deaths from the new variant have been recorded and t\u2026 [+7283 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "CBS News", "title": "FDA authorizes Pfizer pill to treat COVID-19 as Omicron hits all 50 sates", "description": "The Food and Drug Administration announced Wednesday it has authorized Pfizer's antiviral pill to treat COVID-19 as the new Omicron variant hits all 50 U.S. states. CBS News correspondent Nancy Chen reports on how the new strain is causing disruptions across \u2026", "url": "https://www.cbsnews.com/video/fda-authorizes-pfizer-pill-to-treat-covid-19-as-omicron-hits-all-50-sates/", "urlToImage": "https://cbsnews3.cbsistatic.com/hub/i/r/2021/12/23/cac15539-3030-4b53-a36f-3a9fc4a3a97e/thumbnail/1200x630/0c4cc6507e672d30f245c747bdc20138/cbsn-fusion-fda-authorizes-pfizer-pill-to-treat-covid-19-as-omicron-hits-all-50-sates-thumbnail-861641-640x360.jpg", "publishedAt": "2021-12-23T01:25:24Z", "content": "Watch CBSN Live\r\nCopyright \u00a9 2021 CBS Interactive Inc. All rights reserved.\r\nGet browser notifications for breaking news, live events, and exclusive reporting.\r\nNot NowTurn On"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Merck and Pfizer COVID-19 pills effective against Omicron -U.S. FDA official", "description": "Available data indicates that both Merck's and Pfizer's COVID-19 anti-viral treatments are effective against the Omicron variant of the coronavirus, a top...", "url": "https://news.yahoo.com/merck-pfizer-covid-19-pills-171022056.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/zud1gbh2kOslNaNAGDAHcA--~B/aD01MjI7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/2733226d78192706fa2e0f53f0ec0b7b", "publishedAt": "2021-12-23T17:10:22Z", "content": "WASHINGTON (Reuters) - Available data indicates that both Merck's and Pfizer's COVID-19 anti-viral treatments are effective against the Omicron variant of the coronavirus, a top U.S. Federal Drug Adm\u2026 [+629 chars]"}, {"source": {"id": "breitbart-news", "name": "Breitbart News"}, "author": "Ian Hanchett, \nIan Hanchett", "title": "Biden: If People Get Vaccinated and Boosted, They Won't Need Pfizer COVID Pill", "description": "During an interview aired on Wednesday\u2019s edition of ABC\u2019s \u201cWorld News Tonight,\u201d President Joe Biden stated that the government has ordered millions of the Pfizer coronavirus antiviral pills, but \u201cI hope we don\u2019t get there. Because if people get the", "url": "https://www.breitbart.com/clips/2021/12/22/biden-if-people-get-vaccinated-and-boosted-they-wont-need-pfizer-covid-pill/", "urlToImage": "https://media.breitbart.com/media/2021/11/GettyImages-1236914951-640x335.png", "publishedAt": "2021-12-23T00:49:43Z", "content": "During an interview aired on Wednesday\u2019s edition of ABC\u2019s \u201cWorld News Tonight,\u201d President Joe Biden stated that the government has ordered millions of the Pfizer coronavirus antiviral pills, but \u201cI h\u2026 [+610 chars]"}, {"source": {"id": "breitbart-news", "name": "Breitbart News"}, "author": "Ian Hanchett, \nIan Hanchett", "title": "Biden: It Will Be 'Weeks to a Month' Before Hospitals Get Pfizer COVID Pill", "description": "During an interview aired on Wednesday\u2019s edition of ABC\u2019s \u201cWorld News Tonight,\u201d President Joe Biden stated that it will take \u201cweeks to a month\u201d to get the Pfizer coronavirus pill to hospitals, but \u201cit won\u2019t be enough to get to", "url": "https://www.breitbart.com/clips/2021/12/22/biden-it-will-be-weeks-to-a-month-before-hospitals-get-pfizer-covid-pill/", "urlToImage": "https://media.breitbart.com/media/2021/11/Joe-Biden-Flubs-a-Joke-640x335.jpg", "publishedAt": "2021-12-23T00:49:46Z", "content": "During an interview aired on Wednesday\u2019s edition of ABC\u2019s \u201cWorld News Tonight,\u201d President Joe Biden stated that it will take \u201cweeks to a month\u201d to get the Pfizer coronavirus pill to hospitals, but \u201ci\u2026 [+552 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Hong Kong Scientists Say Pfizer/BioNTech Vaccine Effective Against Omicron Variant", "description": "MOSCOW (Sputnik) \u2013 Scientists from the University of Hong Kong said on Thursday that a booster dose of the Comirnaty vaccine against the coronavirus jointly developed by Pfizer and BioNTech companies provides a high level of protection from the Omicron strain\u2026", "url": "https://sputniknews.com/20211223/hong-kong-scientists-say-pfizerbiontech-vaccine-effective-against-omicron-variant-1091754189.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091754189.jpg?10910565181640271832", "publishedAt": "2021-12-23T15:03:51Z", "content": "\"A third dose of Comirnaty vaccine given to those who received two doses of either Comirnaty or CoronaVac provides protective levels of protective antibody against the Omicron variant\", the statement\u2026 [+33 chars]"}, {"source": {"id": null, "name": "Memeorandum.com"}, "author": null, "title": "Pfizer pill becomes 1st US-authorized home COVID treatment (Matthew Perrone/Associated Press)", "description": "Matthew Perrone / Associated Press:\nPfizer pill becomes 1st US-authorized home COVID treatment\u00a0 \u2014\u00a0 WASHINGTON (AP) \u2014 U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to h\u2026", "url": "https://www.memeorandum.com/211222/p118", "urlToImage": "https://storage.googleapis.com/afs-prod/media/9d9e826c49e24b1c933a1f5b43b266a1/1905.jpeg", "publishedAt": "2021-12-23T02:50:06Z", "content": "memeorandum is an auto-generated summary of the stories that US political commentators are discussing online right now.\r\nUnlike sister sites Techmeme and Mediagazer, it is not a human-edited news out\u2026 [+72 chars]"}, {"source": {"id": null, "name": "Memeorandum.com"}, "author": null, "title": "U.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use (Reuters)", "description": "Reuters:\nU.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use\u00a0 \u2014\u00a0 The United States on Wednesday authorized Pfizer Inc's (PFE.N) antiviral COVID-19 pill for people ages 12 and older at risk of severe illness, the first oral and at-home treatm\u2026", "url": "https://www.memeorandum.com/211223/p44", "urlToImage": "https://www.reuters.com/resizer/6ajCUtrS6UDOyJ4bG5tJuu6YRLg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/QDROFKF225L55I36I7TMPUEFZA.jpg", "publishedAt": "2021-12-23T16:00:55Z", "content": "memeorandum is an auto-generated summary of the stories that US political commentators are discussing online right now.\r\nUnlike sister sites Techmeme and Mediagazer, it is not a human-edited news out\u2026 [+72 chars]"}, {"source": {"id": null, "name": "Lewrockwell.com"}, "author": "Thomas DiLorenzo", "title": "Congressman James Clyburn (D-Pfizer) was \u201cVaccinated\u201d and \u201cBoosted\u201d", "description": "And he still got COVID, he announced today.\u00a0 He explained the obvious lesson he learned from this by saying:\u00a0 \u201cI urge anyone who has not done so to protect themselves by getting vaccinated and boosted.\u201d Maryland Governor Larry Hogan (R-Pfizer) did the exact s\u2026", "url": "https://www.lewrockwell.com/lrc-blog/congressman-james-clyburn-d-pfizer-was-vaccinated-and-boosted/", "urlToImage": "https://s3.amazonaws.com/lrc-cdn/assets/2021/02/LRC-share.jpg", "publishedAt": "2021-12-23T20:19:31Z", "content": "https://www.lewrockwell.com/lrc-blog/congressman-james-clyburn-d-pfizer-was-vaccinated-and-boosted/And he still got COVID, he announced today.\u00a0 He explained the obvious lesson he learned from this by\u2026 [+466 chars]"}, {"source": {"id": null, "name": "Womensystems.com"}, "author": "mayaleo", "title": "JUST IN: FDA Authorizes Pfizer Antiviral Pill For COVID-19 Home Treatment \u2026Sort Of Like Ivermectin", "description": "Women Entertainment Sysytem", "url": "http://www.womensystems.com/2021/12/just-in-fda-authorizes-pfizer-antiviral.html", "urlToImage": "https://lh6.googleusercontent.com/proxy/LG4fkrFZHnY4kuf18Y2D-KOCoDVV4VkYAHMfZAkgU13ghoQuUO8bvjOE9R6q2TAkH1QwXkjbbK-WQQfO7hsGOOj3pFEe-4gdPxAOba5M3EyeXHqCMjJspKWYCPneqgHH1H5KbcAXL8ur_7zyWHHuXg=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-23T16:57:47Z", "content": "The U.S. Food and Drug Administration issued an\u00a0emergency use authorization for Pfizer\u2019s antiviral pill for the treatment of mild-to-moderate COVID-19 infection\u00a0on Wednesday.\r\n\u201cToday\u2019s authorization \u2026 [+3646 chars]"}]}, "2021-12-22": {"status": "ok", "totalResults": 103, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Pfizer COVID pill gets US authorization - Reuters", "description": "Pfizer Inc said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is expected to become an important tool in the fight against the fast-spreading Omicron v\u2026", "url": "https://www.reuters.com/video/watch/idPBIk?now=true", "urlToImage": "https://ajo.prod.reuters.tv/api/v2/img/61c3a4dde4b09631b0e4480b-1640211677447?location=LANDSCAPE", "publishedAt": "2021-12-22T23:22:03Z", "content": "Posted \r\nPfizer Inc said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is expected to becom\u2026 [+75 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Britain approves Pfizer-BioNTech shot for younger children - Reuters", "description": "Britain's medicines regulator on Wednesday approved use of the COVID-19 vaccine from partners Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and BioNTech <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\u2026", "url": "https://www.reuters.com/world/uk/britain-approves-pfizer-biontech-shot-younger-children-2021-12-22/", "urlToImage": "https://www.reuters.com/resizer/_2y_4Zwvoz8kCxzNgLT7L-KHh7E=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/MHRGN3LT7VKTZF7XJCIYS2RBSI.jpg", "publishedAt": "2021-12-22T14:33:00Z", "content": "Nurse Christina McCavana prepares the vials of the Pfizer coronavirus disease (COVID-19) vaccine for use at a pop-up vaccination clinic in the Central Fire Station in Belfast, Northern Ireland, Decem\u2026 [+814 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer oral COVID-19 pill gets U.S. authorization for at-home use - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is expected\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-oral-covid-19-pill-gets-us-authorization-at-home-use-2021-12-22/", "urlToImage": "https://www.reuters.com/resizer/6ajCUtrS6UDOyJ4bG5tJuu6YRLg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/QDROFKF225L55I36I7TMPUEFZA.jpg", "publishedAt": "2021-12-22T17:26:00Z", "content": "Dec 22 (Reuters) - Pfizer Inc (PFE.N) said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is\u2026 [+2523 chars]"}, {"source": {"id": null, "name": "Castanet.net"}, "author": null, "title": "Pfizer pill becomes 1st US-authorized home COVID treatment - World News - Castanet.net", "description": "<ol><li>Pfizer pill becomes 1st US-authorized home COVID treatment - World News\u00a0\u00a0Castanet.net\r\n</li><li>Pfizer\u2019s oral COVID-19 pill approved by U.S. FDA for at-home use\u00a0\u00a0Global News\r\n</li><li>Antiviral pill for COVID-19 unlikely to be approved by Health Canad\u2026", "url": "https://www.castanet.net/news/World/355260/Pfizer-pill-becomes-1st-US-authorized-home-COVID-treatment", "urlToImage": "https://www.castanet.net/content/2021/12/20211222121228-61c36107874d33425336addfjpeg_p3568384.jpg", "publishedAt": "2021-12-22T17:36:00Z", "content": "U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.\r\nThe long-awaited\u2026 [+4521 chars]"}, {"source": {"id": null, "name": "CP24 Toronto's Breaking News"}, "author": "Matthew Perrone", "title": "Pfizer pill becomes 1st US-authorized home COVID treatment - CP24 Toronto's Breaking News", "description": "<ol><li>Pfizer pill becomes 1st US-authorized home COVID treatment\u00a0\u00a0CP24 Toronto's Breaking News\r\n</li><li>Pfizer\u2019s oral COVID-19 pill approved by U.S. FDA for at-home use\u00a0\u00a0Globalnews.ca\r\n</li><li>'Game changer': FDA authorizes first pill to treat Covid-19\u00a0\u00a0C\u2026", "url": "https://www.cp24.com/world/pfizer-pill-becomes-1st-us-authorized-home-covid-treatment-1.5717077", "urlToImage": "https://www.cp24.com/polopoly_fs/1.5717083.1640204942!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-22T20:31:10Z", "content": "WASHINGTON (AP) - U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.\u2026 [+4788 chars]"}, {"source": {"id": "time", "name": "Time"}, "author": "MATTHEW PERRONE / AP", "title": "The FDA Just Authorized the First COVID-19 Pill, a Pfizer Drug That Can Be Taken At Home", "description": "U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The long-awaited milestone comes as U.S. cases, hospitalizations and deaths a\u2026", "url": "https://time.com/6131058/pfizer-covid-19-pill-authorized/", "urlToImage": "https://api.time.com/wp-content/uploads/2021/12/pfizer-pill-covid-19.jpg?quality=85&w=1024&h=628&crop=1", "publishedAt": "2021-12-22T17:34:17Z", "content": "U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.\r\nThe long-awaited\u2026 [+4888 chars]"}, {"source": {"id": null, "name": "Nature.com"}, "author": "Sandile Cele, Laurelle Jackson, David S. Khoury, Khadija Khan, Thandeka Moyo-Gwete, Houriiyah Tegally, James Emmanuel San, Deborah Cromer, Cathrine Scheepers, Daniel Amoako, Farina Karim, Mallory Bernstein, Gila Lustig, Derseree Archary, Muneerah Smith, Yashica Ganga, Zesuliwe Jule, Kajal Reedoy, Shi-Hsia Hwa, Jennifer Giandhari, Jonathan M. Blackburn, Bernadett I. Gosnell, Salim S. Abdool Karim, Willem Hanekom, Network for Genomic Surveillance in South Africa, COMMIT-KZN Team, Anne von Gottberg, Jinal Bhiman, Richard J. Lessells, Mahomed-Yunus S. Moosa, Miles P. Davenport, Tulio de Oliveira, Penny L. Moore, Alex Sigal", "title": "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization", "description": "Discover the world\u2019s best science and medicine  | Nature.com", "url": "https://www.nature.com/articles/d41586-021-03824-5", "urlToImage": "https://media.nature.com/lw1024/magazine-assets/d41586-021-03824-5/d41586-021-03824-5_19974342.jpg", "publishedAt": "2021-12-23T00:00:00Z", "content": "National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa. MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Science\u2026 [+249 chars]"}, {"source": {"id": "associated-press", "name": "Associated Press"}, "author": "Matthew Perrone", "title": "PFIZER pill becomes 1st authorized home treatment...", "description": "PFIZER pill becomes 1st authorized home treatment...\r\n\n \n \n \n (Top headline, 11th story, link)\r\n\n \r\n\n \r\n\n \n Related stories:'21 on track to surpass '20 as nation's deadliest...\r\nHalf Call It Worst Year Of Lives!\r\nWill USA Be Open in January?\r\nHoliday travel p\u2026", "url": "https://apnews.com/article/coronavirus-pandemic-pfizer-medication-f5f65e7e61d6aa9c7dfa193053e8878a", "urlToImage": "https://storage.googleapis.com/afs-prod/media/9d9e826c49e24b1c933a1f5b43b266a1/1905.jpeg", "publishedAt": "2021-12-22T18:19:36Z", "content": "WASHINGTON (AP) U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.\r\n\u2026 [+4783 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Tara Patel", "title": "France Scraps Order for Merck Antiviral Pill, Looks to Pfizer", "description": "France canceled an order for Merck & Co.\u2019s antiviral pill on disappointing test results and is now counting on a treatment from Pfizer Inc., according to the country\u2019s health minister.", "url": "https://www.bloomberg.com/news/articles/2021-12-22/france-scraps-order-for-merck-antiviral-pill-looks-to-pfizer", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iA24OVvu_J.s/v1/1200x800.jpg", "publishedAt": "2021-12-22T15:22:13Z", "content": "France canceled an order for \r\nMerck &amp; Co.s antiviral pill on disappointing test results and is now counting on a treatment from \r\nPfizer Inc., according to the countrys health minister.\r\nWe had \u2026 [+1005 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "FDA Authorizes Pfizer Antiviral Pill for COVID-19", "description": "The FDA was also expected to authorize an antiviral pill from Merck, but as of Wednesday afternoon, only Pfizer's had been authorized for use.", "url": "https://www.webmd.com/lung/news/20211222/fda-authorizes-pfizer-pill", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/other/virus_3d_render_skeleton_01_other/1800x1200_virus_3d_render_skeleton_01_other.jpg", "publishedAt": "2021-12-22T17:45:55Z", "content": "Dec. 22, 2021 The FDA on Wednesday granted emergency use authorization of a new antiviral pills to treat people with symptomatic COVID-19.\r\nPfizers ritonavir, name brand Paxlovid, can now be taken by\u2026 [+1298 chars]"}, {"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Pfizer COVID-19 pill approved for at-home use by US", "description": "Trial data shows oral pill is 90 percent effective in preventing deaths and hospitalisations in high-risk patients.", "url": "https://www.aljazeera.com/news/2021/12/22/pfizer-covid-19-pill-approved-by-us-for-at-home-use", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2021/12/AP21355638154179.jpg?resize=1200%2C630", "publishedAt": "2021-12-22T18:49:31Z", "content": "Health regulators in the United States have authorised the first oral pill against COVID-19, a Pfizer drug that users will be able to take at home to head off the worst effects of the coronavirus.\r\nT\u2026 [+3604 chars]"}, {"source": {"id": "axios", "name": "Axios"}, "author": "Axios", "title": "FDA authorizes Pfizer COVID antiviral pill for high-risk individuals", "description": "The Food and Drug Administration on Wednesday authorized Pfizer's antiviral pill for the treatment of individuals at high risk of severe illness from COVID-19. Why it matters: At-home COVID-19 treatments, especially Pfizer's Paxlovid, are seen as possible gam\u2026", "url": "https://www.axios.com/fda-pfizer-covid-antiviral-pill-paxlovid-authorization-274ee4ed-3b4e-49c1-afbf-b5861dc2ef2c.html", "urlToImage": "https://images.axios.com/XoNFb_9PUdRdOchX3xTuZavKRrM=/0x209:2000x1334/1366x768/2021/12/21/1640118156101.jpg", "publishedAt": "2021-12-22T17:15:46Z", "content": "The Food and Drug Administration on Wednesday authorized Pfizer's antiviral pill for the treatment of individuals at high risk of severe illness from COVID-19. \r\nWhy it matters: At-home COVID-19 trea\u2026 [+2222 chars]"}, {"source": {"id": null, "name": "Snopes.com"}, "author": "AP News", "title": "Pfizer Pill Becomes 1st US-Authorized Home COVID Treatment", "description": "U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.", "url": "https://www.snopes.com/ap/2021/12/22/pfizer-pill-becomes-1st-us-authorized-home-covid-treatment/", "urlToImage": "https://www.snopes.com/tachyon/2021/12/Virus-Outbreak-Treatments_54179-c80e719f2-733x412.jpg", "publishedAt": "2021-12-22T18:43:37Z", "content": "This article is republished here with permission from The Associated Press. This content is shared here because the topic may interest Snopes readers; it does not, however, represent the work of Snop\u2026 [+4746 chars]"}, {"source": {"id": null, "name": "TheBlaze"}, "author": "Daniel Horowitz", "title": "Horowitz: The indefensible approval of Pfizer and Merck drugs compared to the snubbing of ivermectin", "description": "Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven drugs with a track record of no serious adverse events. The \u2026", "url": "https://www.theblaze.com/op-ed/horowitz-the-indefensible-approval-of-pfizer-and-merck-drugs-compared-to-the-snubbing-of-ivermectin", "urlToImage": "https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yODI3NzgzOS9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTY1NzE2NDY1MH0.OjXgRTnNSnmYWBx9BlWU6ggdWEMqPFg5CNeU7WQQEKs/img.jpg?width=1200&coordinates=0%2C113%2C0%2C58&height=600", "publishedAt": "2021-12-22T15:15:02Z", "content": "Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven \u2026 [+7479 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Britain approves Pfizer-BioNTech shot for younger children", "description": "Britain's medicines regulator on Wednesday approved use of the COVID-19 vaccine from partners Pfizer and BioNTech for children aged 5 to 11 years, after the ...", "url": "https://news.yahoo.com/britain-approves-pfizer-biontech-shot-143253326.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/9s9fxhxELGCBUul27XsZTg--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/3f4ff2178d642587415ecea5a5aeda03", "publishedAt": "2021-12-22T14:32:53Z", "content": "LONDON (Reuters) - Britain's medicines regulator on Wednesday approved use of the COVID-19 vaccine from partners Pfizer and BioNTech for children aged 5 to 11 years, after the watchdog found the shot\u2026 [+444 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "The Independent", "title": "FDA authorises use of Pfizer-made pill to treat Covid-19", "description": "The US Food and Drug Administration has issued an emergency use authorisation for a pill made by Pfizer that can be used to treat Covid-19.", "url": "https://www.independent.co.uk/news/world/americas/pfizer-covid-pill-fda-authorised-b1980963.html", "urlToImage": "https://static.independent.co.uk/2020/08/19/11/breaking-news.png?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-22T17:32:05Z", "content": "The US Food and Drug Administration has issued an emergency use authorisation for a pill made by Pfizer that can be used to treat Covid-19. \r\nThe agency issued the statement on Wednesday, announcing \u2026 [+915 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Nina Massey", "title": "Pfizer Covid jab approved for use in vulnerable primary school children", "description": "In response to the Omicron variant, the JCVI has also advised that some older children be offered a booster dose.", "url": "https://www.independent.co.uk/news/uk/omicron-pfizer-kevin-courtney-biontech-medicines-and-healthcare-products-regulatory-agency-b1980917.html", "urlToImage": "https://static.independent.co.uk/2021/12/22/16/34f9b5c868f929be97a7f968679ee451Y29udGVudHNlYXJjaGFwaSwxNjQwMjc1MDM2-2.61672331.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-22T18:21:51Z", "content": "The PfizerBioNTech coronavirus vaccine has been approved for use in vulnerable primary school children.\r\nThe Joint Committee on Vaccination and Immunisation (JCVI) updated its advice after the UKs Me\u2026 [+5748 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Nina Massey", "title": "Pfizer Covid jab approved for use in some five to 11-year-olds", "description": "Further advice regarding Covid vaccination for the age group will be issued in due course.", "url": "https://www.independent.co.uk/news/uk/pfizer-mhra-biontech-omicron-b1980808.html", "urlToImage": "https://static.independent.co.uk/2021/12/22/14/72a2469e44e15125456e3ad9e06b156eY29udGVudHNlYXJjaGFwaSwxNjQwMjY5MTAz-2.64454561.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-22T14:30:00Z", "content": "A new formulation of the PfizerBioNTech coronavirus vaccine has been approved for use in children aged five to 11.\r\nThe UKs Medicines and Healthcare products Regulatory Agency (MHRA) made the approva\u2026 [+2962 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer oral COVID-19 pill gets U.S. authorization for at-home use", "description": "Data from Pfizer's clinical trial showed its antiviral regimen was 90% effective in preventing hospitalizations and deaths in patients at high risk of severe...", "url": "https://news.yahoo.com/pfizer-oral-covid-19-pill-172151590.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/F76_37omlGhsJSZy1rPw9Q--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/767b46e09b00181bff6903de7e1becac", "publishedAt": "2021-12-22T17:21:51Z", "content": "(Reuters) -Pfizer Inc said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is expected to bec\u2026 [+2326 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "MATTHEW PERRONE", "title": "Pfizer pill becomes first FDA-authorized home COVID treatment", "description": "The drug, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited.", "url": "https://www.bostonglobe.com/2021/12/22/nation/pfizer-pill-becomes-first-us-authorized-home-covid-treatment/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/AAOhmk7Z5Oz4wgvDxOyXzGChxsI=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/O7RKABUQGVHLBUFUDP3P5PGPRY.jpg", "publishedAt": "2021-12-22T17:36:57Z", "content": "An antiviral pill from Merck also is expected to soon win authorization. But Pfizers drug is all but certain to be the preferred option because of its mild side effects and superior effectiveness, in\u2026 [+3913 chars]"}]}, "2021-12-21": {"status": "ok", "totalResults": 30, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "U.S. FDA set to authorize Pfizer, Merck COVID-19 pills this week - Bloomberg News - Reuters", "description": "The U.S. Food and Drug Administration is set to authorize COVID-19 treatment pills from both Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and Merck <a href=\"https://www.reuters.com/companies/MRK.N\" target=\"_blank\">(\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-set-authorize-pfizer-merck-covid-19-pills-this-week-bloomberg-news-2021-12-21/", "urlToImage": "https://www.reuters.com/resizer/6ajCUtrS6UDOyJ4bG5tJuu6YRLg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/QDROFKF225L55I36I7TMPUEFZA.jpg", "publishedAt": "2021-12-21T15:57:00Z", "content": "Dec 21 (Reuters) - The U.S. Food and Drug Administration is set to authorize COVID-19 treatment pills from both Pfizer Inc (PFE.N) and Merck (MRK.N) as early as Wednesday, Bloomberg News reported on \u2026 [+758 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights)", "title": "Why Pfizer Stock Is Sinking Today", "description": "The pharma stock is moving in the opposite direction of the overall market.", "url": "https://www.fool.com/investing/2021/12/21/why-pfizer-stock-is-sinking-today/", "urlToImage": "https://g.foolcdn.com/editorial/images/658400/omicron-variant.jpg", "publishedAt": "2021-12-21T16:44:09Z", "content": "What happened\r\nShares of Pfizer(NYSE:PFE) were sinking 4.4% as of 11:18 a.m. ET on Tuesday. The big drugmaker didn't report any new developments. Today's decline appears to be a by-product of the ove\u2026 [+1486 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-pfizer-astrazeneca-moderna-booster-b1980055.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-21T12:15:06Z", "content": "The Omicron variant of Covid-19 has begun to spread widely in the UK, with Boris Johnson warning of a tidal wave of infections hitting these shores if the public do not observe social restrictions an\u2026 [+7631 chars]"}, {"source": {"id": null, "name": "PJ Media"}, "author": "Glenn Reynolds", "title": "THE VACCINES SEEM TO BE UNDERPERFORMING: Study: Moderna, Pfizer COVID-19 vaccines less effective in\u2026", "description": "THE VACCINES SEEM TO BE UNDERPERFORMING: Study: Moderna, Pfizer COVID-19 vaccines less effective in seniors with chronic health woes.", "url": "https://pjmedia.com/instapundit/492539/", "urlToImage": null, "publishedAt": "2021-12-21T18:00:23Z", "content": "As an Amazon Associate,I earn from qualifying purchases."}, {"source": {"id": null, "name": "The Week Magazine"}, "author": "Brigid Kennedy", "title": "FDA reportedly could authorize Pfizer, Merck COVID pills this week: 'The biggest thing to happen in the pandemic after vaccines'", "description": "FDA reportedly could authorize Pfizer, Merck COVID pills this week: 'The biggest thing to happen in the pandemic after vaccines'", "url": "https://theweek.com/coronavirus/1008306/fda-reportedly-could-authorize-pfizer-merck-covid-pills-this-week-the-biggest", "urlToImage": "https://mediacloud.theweek.com/image/upload/s--X-WVjvBW--/f_auto,t_content-image-full-desktop@1/v1640103687/GettyImages-1237290895.jpg", "publishedAt": "2021-12-21T17:02:19Z", "content": "The U.S. Food and Drug Admnistration could authorize revolutionary COVID-19 antiviral pills from both Pfizer and Merck as soon as this week, Bloomberg reports, \"a milestone in the fight against the p\u2026 [+1414 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Clayton, Dubilier & Rice Appoints Jon Selib, former Pfizer Policy & Public Affairs Leader, as Global External Affairs Leader", "description": "Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing ...", "url": "https://finance.yahoo.com/news/clayton-dubilier-rice-appoints-jon-140000834.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/NhMzJqBYdftRA6XEHbUhAQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/74a228b886f044b7628f5fafb2f27077", "publishedAt": "2021-12-21T14:00:00Z", "content": "NEW YORK, Dec. 21, 2021 /PRNewswire/ -- Clayton, Dubilier &amp; Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy &amp; Public Affairs at Pfizer, as Man\u2026 [+3276 chars]"}, {"source": {"id": null, "name": "FierceBiotech"}, "author": "Annalee Armstrong", "title": "Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment", "description": "Pfizer reported the death of a young male patient who was participating in an an early-stage trial for the Big Pharma\u2019s Duchenne muscular dystrophy gene therapy. The company paused screening and dosing in the study while it works with the trial site investiga\u2026", "url": "https://www.fiercebiotech.com/biotech/pfizer-reports-death-patient-duchenne-trial-halts-enrolment", "urlToImage": "https://qtxasset.com/fiercebiotech/1640093978/PfizerHQsignone.jpg/PfizerHQsignone.jpg?VersionId=rP49e7awFiMyi_azFHqLhDaepKm8Iakr", "publishedAt": "2021-12-21T13:39:57Z", "content": "Pfizer reported the death of a young male patient who was participating in an an early-stage trial for the Big Pharmas Duchenne muscular dystrophy (DMD) gene therapy.\r\nThe company paused screening an\u2026 [+3240 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Josh Wingrove, Jennifer Jacobs, Robert Langreth", "title": "FDA expected to authorize Pfizer and Merck COVID pills this week", "description": "The US Food and Drug Administration is poised to authorize a pair of pills from Pfizer and Merck to treat COVID-19 as soon as this week, according to people familiar with the matter -- a milestone in the fight against the pandemic that will soon expand therap\u2026", "url": "https://www.bostonglobe.com/2021/12/21/nation/fda-expected-authorize-pfizer-merck-covid-pills-this-week/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/AAOhmk7Z5Oz4wgvDxOyXzGChxsI=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/O7RKABUQGVHLBUFUDP3P5PGPRY.jpg", "publishedAt": "2021-12-21T15:59:28Z", "content": "The U.S. Food and Drug Administration is poised to authorize a pair of pills from Pfizer Inc. and Merck &amp; Co. to treat Covid-19 as soon as this week, according to people familiar with the matter \u2026 [+1347 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Research and Markets", "title": "Global $3.11 Bn Erythropoietin (EPO) Markets, 2015-2020, 2020-2025F, 2030F Featuring Amgen, Johnson & Johnson, Roche Group, Pfizer Inc., Novartis, Celltrion, and LG Life Sciences", "description": "Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The \"Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth and Change to 2030\" report has been added to...", "url": "https://finance.yahoo.com/news/global-3-11-bn-erythropoietin-105300361.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/HP.E8HUfnyGeLtMAKwLgAQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "publishedAt": "2021-12-21T10:53:00Z", "content": "Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The \"Erythropoietin (EPO) Global Market Report 2021: COVID-19 Growth and Change to 2030\" report has been added to ResearchAndMarkets.com's offering.\r\nThe glo\u2026 [+4478 chars]"}, {"source": {"id": null, "name": "Investor's Business Daily"}, "author": "Investor's Business Daily", "title": "Pfizer Stock Falls As FDA Reportedly Nears Covid Pill Decision - Investor's Business Daily", "description": "<ol><li>Pfizer Stock Falls As FDA Reportedly Nears Covid Pill Decision\u00a0\u00a0Investor's Business Daily\r\n</li><li>US FDA to Authorize Covid Pills\u00a0\u00a0Bloomberg Markets and Finance\r\n</li><li>FDA reportedly could authorize Pfizer, Merck COVID pills this week: 'The bigge\u2026", "url": "https://www.investors.com/news/technology/pfizer-stock-falls-as-fda-reportedly-nears-covid-pill-decision/", "urlToImage": "https://www.investors.com/wp-content/uploads/2017/10/stock-Pfizer-01-shutter.jpg", "publishedAt": "2021-12-21T21:10:00Z", "content": "The Food and Drug Administration could authorize Covid pills from Pfizer (PFE) and Merck (MRK) this week, according to a Tuesday report. But Pfizer stock toppled while Merck shares also fell.\r\nXA dec\u2026 [+2624 chars]"}, {"source": {"id": null, "name": "Memeorandum.com"}, "author": null, "title": "FDA Expected to Authorize Pfizer and Merck Covid Pills This Week (Bloomberg)", "description": "Bloomberg:\nFDA Expected to Authorize Pfizer and Merck Covid Pills This Week\u00a0 \u2014 Two drugs would be first at-home treatments for Covid-19\u00a0 \u2014 U.S. has ordered 13 million courses of medicines so far\u00a0 \u2014\u00a0 The U.S. Food and Drug Administration is poised to authorize\u2026", "url": "https://www.memeorandum.com/211221/p43", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ilKMtjRgyIVY/v0/1200x800.jpg", "publishedAt": "2021-12-21T16:25:00Z", "content": "memeorandum is an auto-generated summary of the stories that US political commentators are discussing online right now.\r\nUnlike sister sites Techmeme and Mediagazer, it is not a human-edited news out\u2026 [+72 chars]"}, {"source": {"id": null, "name": "101morefm.ca"}, "author": "Linda Morgan", "title": "Canada Gets Over A Million Pediatric Pfizer COVID -19 Shots - 101.1 More FM", "description": "<ol><li>Canada Gets Over A Million Pediatric Pfizer COVID -19 Shots\u00a0\u00a0101.1 More FM\r\n</li><li>Vaccination rates rising in Prince George\u00a0\u00a0CKPGToday.ca\r\n</li><li>SA Health site crashes as slots open for kids\u2019 jabs\u00a0\u00a0The Advertiser\r\n</li><li>Pfizer COVID vaccine b\u2026", "url": "http://www.101morefm.ca/news/local-news/canada-gets-over-a-million-pediatric-pfizer-covid-19-shots/", "urlToImage": "https://mm.aiircdn.com/122/588027.jpg", "publishedAt": "2021-12-21T18:27:11Z", "content": "A shipment of 1.136 million doses of the pediatric Pfizer shot has arrived in Canada. \r\nOver a million more child-sized Pfizer COVID-19 doses have arrived in Canada.\u00a0\r\nProcurement Minister Filomena T\u2026 [+1061 chars]"}, {"source": {"id": null, "name": "Stationgossip.com"}, "author": "orraz", "title": "Government Panel: 26-Year-Old's Death 'Probably' Due to Pfizer COVID Vaccine", "description": "Your Daily Station of Entertainment !!", "url": "http://www.stationgossip.com/2021/12/government-panel-26-year-olds-death.html", "urlToImage": null, "publishedAt": "2021-12-21T14:21:42Z", "content": "A 26-year-old New Zealand man\u2019s death from myocarditis has been linked to the Pfizer/BioNTech vaccine by New Zealand officials.\r\n\u201cWith the current available information, the board has considered that\u2026 [+3107 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Pfizer, Merck could receive FDA OK for COVID-19 pills this week - Bloomberg", "description": "The FDA is set to authorize the COVID-19 pills developed by Merck (MRK)/ Ridgeback Biotherapeutics and Pfizer (PFE) as early as this week,\u00a0Bloomberg\u00a0reports, citing people familiar with...", "url": "https://seekingalpha.com/news/3782385-pfizer-merck-could-receive-fda-ok-for-covid-19-pills-this-week-bloomberg", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971249/large_image_1286971249.jpg", "publishedAt": "2021-12-21T15:55:18Z", "content": "Grandbrothers/iStock Editorial via Getty Images"}, {"source": {"id": null, "name": "Rumble.com"}, "author": "Mike Rivero", "title": "BREAKING: FOIA Confirms Jab is Deadly: Pfizer, FDA Caught Hiding Bioweapon Deaths", "description": "!function(r,u,m,b,l,e){r._Rumble=b,r[b]||(r[b]=function(){(r[b]._=r[b]._||[]).push(arguments);if(r[b]._.length==1){l=u.createElement(m),e=u.getElementsByTagName(m)[0],l.async=1,l.src=\"https://rumble.com/embedJS/u4\"+(arguments[1].video?'.'+arguments[1].video:'\u2026", "url": "https://rumble.com/vr4w8g-breaking-foia-confirms-jab-is-deadly-pfizer-fda-caught-hiding-bioweapon-dea.html", "urlToImage": "https://sp.rmbl.ws/s8/1/W/C/3/T/WC3Tc.qR4e-small-BREAKING-FOIA-Confirms-Jab-.jpg", "publishedAt": "2021-12-21T15:32:34Z", "content": "RumbleThank God for the Freedom of Information Act. Public Health and Medical Professionals for Transparency is a professional organization of scientists and doctors. They recently filed a FOIA reque\u2026 [+796 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "CLOWN WORLD! New Zealand links death (of 26 year old) to Pfizer COVID vaccine: 'it remains safer to be vaccinated'\"", "description": null, "url": "https://www.investmentwatchblog.com/clown-world-new-zealand-links-death-of-26-year-old-to-pfizer-covid-vaccine-it-remains-safer-to-be-vaccinated/", "urlToImage": null, "publishedAt": "2021-12-21T00:44:45Z", "content": "We have reached peak idiocracy.Health authorities in New Zealand have said they believe a 26-year-old man\u2019s death\u00a0is connected to a side effect\u00a0from\u00a0Pfizer\u2019s COVID-19 vaccine.\r\nA preliminary postmort\u2026 [+685 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Jim Hoft", "title": "New Zealand Health Authorities Link Death of 26-Year-Old Man Who Suffered Myocarditis to Pfizer COVID-19 Vaccine", "description": "New Zealand health authorities said on Monday that they had linked the death of a 26-year-old man who developed myocarditis after receiving his first dose of the Pfizer COVID-19 vaccine. The man, who was not identified, was believed to die with myocarditis tw\u2026", "url": "https://www.thegatewaypundit.com/2021/12/new-zealand-health-authorities-link-death-26-year-old-man-suffered-myocarditis-pfizer-covid-19-vaccine/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/6A0830C8-FB69-4650-B7A8-690B091821E8.jpeg", "publishedAt": "2021-12-21T03:53:08Z", "content": "New Zealand health authorities said on Monday that they had linked the death of a 26-year-old man to\u00a0Pfizer COVID-19 vaccine.\r\nThe man, who was not identified, was believed to die with myocarditis tw\u2026 [+1414 chars]"}, {"source": {"id": null, "name": "Womensystems.com"}, "author": "mayaleo", "title": "New Zealand Health Authorities Link Death Of 26-Year-Old Man Who Suffered Myocarditis To Pfizer COVID-19 Vaccine", "description": "Women Entertainment Sysytem", "url": "http://www.womensystems.com/2021/12/new-zealand-health-authorities-link.html", "urlToImage": "https://lh4.googleusercontent.com/proxy/V1A1ewtxGuwyUXb5pjKskDjFTym1IfbyGk19RxJSgCzyr5lMqoZ-uoZroyS0m6e4cu7KtFi_sDVmTNV3np_pLupy3gRif5Yi2C_GcOdiZRB7Sk6W23xiUypZTU9G7IxY30fhBAdkSYWCIuV9yUg9iFA=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-21T17:07:10Z", "content": "New Zealand health authorities said on Monday that they had linked the death of a 26-year-old man to\u00a0Pfizer COVID-19 vaccine.\r\nThe man, who was not identified, was believed to die with myocarditis tw\u2026 [+1273 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Mansur Shaheen U.S.", "title": "FDA to authorize the use of antiviral Covid pills developed by Pfizer and Merck later this week", "description": "Both molnupiravir and paxlovid are expected to receive authorization from the FDA at some point this week. The antiviral pills are believed to become important tools in the fight against Covid.", "url": "https://www.dailymail.co.uk/health/article-10333161/FDA-authorize-use-antiviral-Covid-pills-developed-Pfizer-Merck-later-week.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/21/19/52075469-0-image-a-13_1640115263094.jpg", "publishedAt": "2021-12-21T19:46:47Z", "content": "Two new weapons in America's fight against COVID-19 could be added to the arsenal later this week.\r\nBloomberg reports that authorization from the Food and Drug Administration (FDA)\u00a0 for two different\u2026 [+4185 chars]"}, {"source": {"id": null, "name": "City A.M."}, "author": "Amy O'Brien", "title": "FDA set to give both Pfizer and Merck Covid pills the green light this week", "description": "The US Food and Drug Administration is poised to authorise two pills developed by Pfizer and Merck for the treatment of Covid as early as Wednesday this week. Continuing a trend for rapid drugs innovation in the fight against Covid this year, the US watchdog \u2026", "url": "https://www.cityam.com/fda-set-to-give-both-pfizer-and-merck-covid-pills-the-green-light-this-week/", "urlToImage": "https://www.cityam.com/wp-content/uploads/2021/10/pills-getty-1024-57ff78e66dccb-57ff78e69deba.jpg", "publishedAt": "2021-12-21T17:34:18Z", "content": "Tuesday 21 December 2021 5:34 pm\r\nThe US Food and Drug Administration is poised to authorise two pills developed by Pfizer and Merck for the treatment of Covid as early as Wednesday this week. \r\nCont\u2026 [+2020 chars]"}]}, "2021-12-20": {"status": "ok", "totalResults": 57, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Biontech, Pfizer to provide EU with extra 200 mln COVID doses - Reuters", "description": "BioNTech SE <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> and Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> said on Monday that they would be providing the European Union with more t\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-pfizer-provide-eu-with-extra-200-mln-covid-doses-2021-12-20/", "urlToImage": "https://www.reuters.com/resizer/CNXruww6hVSpYJLQtdIWRtHNHKU=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/A6VBWB4WSVJOHB2MT633KD2D2Q.jpg", "publishedAt": "2021-12-20T12:23:00Z", "content": "Rodrigo Rojas Morilla, 11, reacts as he receives his first dose of the \"Comirnaty\" Pfizer BioNTech COVID-19 vaccine against coronavirus disease at the La Serrania de Ronda hospital as Spain continues\u2026 [+942 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "New Zealand links 26-year-old man's death to Pfizer COVID-19 vaccine - Reuters", "description": "New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> COVID-19 vaccine after the person suffered myocarditis, a rare inflammation of the h\u2026", "url": "https://www.reuters.com/world/asia-pacific/new-zealand-links-26-year-old-mans-death-pfizer-covid-19-vaccine-2021-12-20/", "urlToImage": "https://www.reuters.com/resizer/2--FEEmjzEwvdEaHLu0qIB6fJCY=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/WET7VB5NVZJT5CMFVWZMXAU5VE.jpg", "publishedAt": "2021-12-20T04:15:00Z", "content": "SYDNEY, Dec 20 (Reuters) - New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's (PFE.N) COVID-19 vaccine after the person suffered myocarditis, a rare infl\u2026 [+1423 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Jeannie Baumann", "title": "Pfizer, Moderna Vaccine Preference Applies to Boosters, CDC Says", "description": "", "url": "https://www.bloomberg.com/news/articles/2021-12-20/pfizer-moderna-vaccine-preference-applies-to-boosters-cdc-says", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ivk3OAiWZp5o/v0/1200x800.jpg", "publishedAt": "2021-12-20T17:48:42Z", "content": "People who got a \r\nJohnson &amp; Johnson Covid-19 vaccine in the U.S. should seek a messenger RNA booster shot, the Centers for Disease Control and Prevention clarified Monday to Bloomberg Law.\r\nThe \u2026 [+2219 chars]"}, {"source": {"id": null, "name": "National Post"}, "author": null, "title": "PFIZER-funded talks contained untrue information about rivals...", "description": "PFIZER-funded talks contained untrue information about rivals...\r\n\n \n \n \n (Top headline, 18th story, link)\r\n\n \r\n\n \r\n\n \n Related stories:JINGLE BELL LOCK!\r\nUK PROTESTS TURN VIOLENT...\r\nNew party allegations at Boris residence come to light...\r\nRIOTS ACROSS EUR\u2026", "url": "https://nationalpost.com/news/canada/pfizer-funded-talks-contained-untrue-negative-information-about-rival-covid-vaccines-experts-say", "urlToImage": "https://img-s-msn-com.akamaized.net/tenant/amp/entityid/AARZUBm.img?h=315&w=600&m=6&q=60&o=t&l=f&f=jpg", "publishedAt": "2021-12-20T21:07:37Z", "content": "\u00a9 Provided by National Post\r\n Experts told the National Post that the first two disadvantage statements in a Powerpoint slide shown to Canadian health professionals were untrue with respect to non-re\u2026 [+7757 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Matthew Brockett", "title": "New Zealand Says Man's Death May Be Linked to Pfizer Vaccine", "description": "New Zealand health authorities said they believe a man\u2019s death may be linked to the Pfizer Covid-19 vaccine.", "url": "https://www.bloomberg.com/news/articles/2021-12-20/new-zealand-says-man-s-death-may-be-linked-to-pfizer-vaccine", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i4P7BhPT9VbU/v0/1200x800.jpg", "publishedAt": "2021-12-20T02:34:44Z", "content": "New Zealand health authorities said they believe a mans death may be linked to the Pfizer Covid-19 vaccine.\r\nThe 26-year-old man died within two weeks of his first dose of Pfizer and preliminary post\u2026 [+1526 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Dario Sabaghi, Contributor, \n Dario Sabaghi, Contributor\n https://www.forbes.com/sites/dariosabaghi/", "title": "Pfizer To Enter The Medical Cannabis Industry With $6.7 Billion Acquisition", "description": "Pfizer is to enter the medical cannabis industry betting on a promising cannabinoid-based bowel disease treatment.", "url": "https://www.forbes.com/sites/dariosabaghi/2021/12/20/pfizer-to-enter-the-medical-cannabis-industry-with-67-billion-acquisition/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61c08499428b8b334890eb8d%2F0x0.jpg", "publishedAt": "2021-12-20T13:33:01Z", "content": "Brussels, Belgium. 21st December 2020. Exterior view of Pfizer Pharmaceutical company's offices.\r\ngetty\r\nPfizer is to enter the medical cannabis industry betting on a promising cannabinoid-based bowe\u2026 [+3923 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Trefis Team, Contributor, \n Trefis Team, Contributor\n https://www.forbes.com/sites/greatspeculations/people/trefis/", "title": "Pfizer, Merck, Regeneron: Covid Treatment Stocks Back In Focus As Infections Soar", "description": "Our indicative theme on Covid-19 Treatment Stocks \u2013 which includes biotech and pharma companies selling or developing treatments for the Covid-19 virus \u2013 is up by 25% year-to-date, compared to the S&P 500 which is up about 26% over the same period. Although w\u2026", "url": "https://www.forbes.com/sites/greatspeculations/2021/12/20/pfizer-merck-regeneron-covid-treatment-stocks-back-in-focus-as-infections-soar/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F5fc9f88165fd2c07cd02256e%2F0x0.jpg", "publishedAt": "2021-12-20T14:00:42Z", "content": "The logo of US multinational pharmaceutical company Pfizer, is pictured at a factory in Puurs, where ... [+] Covid-19 vaccines are being produced for Britain, on December 3, 2020. - Britain on Decemb\u2026 [+5228 chars]"}, {"source": {"id": null, "name": "NBC Chicago"}, "author": "NBC Chicago", "title": "Booster Shots and Omicron: Is Moderna or Pfizer Performing Better? Here's the Data So Far - NBC Chicago", "description": "<ol><li>Booster Shots and Omicron: Is Moderna or Pfizer Performing Better? Here's the Data So Far\u00a0\u00a0NBC Chicago\r\n</li><li>Moderna says COVID-19 booster appears to work against Omicron\u00a0\u00a0Reuters\r\n</li><li>Moderna Says Its Booster Significantly Raises Antibodies \u2026", "url": "https://www.nbcchicago.com/news/coronavirus/booster-shots-and-omicron-is-moderna-or-pfizer-performing-better-heres-the-data-so-far/2711734/", "urlToImage": "https://media.nbcchicago.com/2021/12/GettyImages-1237348301.jpg?quality=85&strip=all&resize=1200%2C675", "publishedAt": "2021-12-20T23:09:42Z", "content": "Both Moderna and Pfizer have released early data showing the effectiveness of their vaccines and booster doses as the new omicron variant begins to take hold and as COVID cases rise across the U.S. \r\u2026 [+8841 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Siladitya Ray, Forbes Staff, \n Siladitya Ray, Forbes Staff\n https://www.forbes.com/sites/siladityaray/", "title": "Death Of 26-Year-Old In New Zealand Likely Caused By Rare Heart Inflammation Linked To Pfizer Covid-19 Vaccine, Authorities Say", "description": "Health authorities say the person\u2019s death was likely caused by myocarditis\u2014inflammation of the heart muscle\u2014which is believed to be a rare side effect of the Pfizer vaccine.", "url": "https://www.forbes.com/sites/siladityaray/2021/12/20/death-of-26-year-old-in-new-zealand-likely-caused-by-rare-heart-inflammation-linked-to-pfizer-covid-19-vaccine-authorities-say/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61c077935dd81cb0bb1d3877%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D1820%26cropY1%3D92%26cropY2%3D1116", "publishedAt": "2021-12-20T12:33:01Z", "content": "Health authorities in New Zealand on Monday said that a 26-year-old mans death may be linked to a rare side effect of the Pfizer vaccine, a finding that does not however alter the authorities' view t\u2026 [+3165 chars]"}, {"source": {"id": null, "name": "ABC15 Arizona"}, "author": "Crystal Bedoya", "title": "ADHS: Johnson and Johnson vaccine recipients should get Pfizer, Moderna booster shot - ABC15 Arizona", "description": "<ol><li>ADHS: Johnson and Johnson vaccine recipients should get Pfizer, Moderna booster shot\u00a0\u00a0ABC15 Arizona\r\n</li><li>UPDATE: Virginia adopts CDC preferential recommendation to use mRNA COVID-19 vaccines\u00a0\u00a0The News Leader\r\n</li><li>Pfizer, Moderna Vaccine Pref\u2026", "url": "https://www.abc15.com/news/vaccine-in-arizona/adhs-johnson-and-johnson-vaccine-recipients-should-get-pfizer-moderna-booster-shot", "urlToImage": "https://ewscripps.brightspotcdn.com/dims4/default/2d3a612/2147483647/strip/true/crop/2636x1384+0+62/resize/1200x630!/quality/90/?url=https%3A%2F%2Fewscripps.brightspotcdn.com%2F7d%2F72%2F0890a0bd407a8b534e0978c6e642%2Fcovidvaccine.png", "publishedAt": "2021-12-20T22:07:00Z", "content": "PHOENIX State health officials are recommending Arizonans who received the Johnson and Johnson vaccine should get a Pfizer or Moderna booster shot.\r\nIn a blog post Monday, the Arizona Department of H\u2026 [+1290 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70 per cent protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-booster-pfizer-astrazeneca-moderna-b1979508.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-20T15:14:41Z", "content": "The Omicron variant of Covid-19 has begun to spread widely in the UK, with Boris Johnson warning of a tidal wave of infections hitting these shores if the public do not observe social restrictions an\u2026 [+7631 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "New Zealand links 26-year-old man's death to Pfizer COVID-19 vaccine", "description": "New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's COVID-19 vaccine after the person suffered myocarditis, a...", "url": "https://news.yahoo.com/zealand-links-26-old-mans-041523888.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/KR1DA9qCrEz5wx1wivddyw--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/e24148cb2c90d02a0573ece30583a1f5", "publishedAt": "2021-12-20T04:15:23Z", "content": "SYDNEY (Reuters) - New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's COVID-19 vaccine after the person suffered myocarditis, a rare inflammation of the \u2026 [+1234 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Thai agency approves Pfizer vaccine for use in children aged 5-11", "description": "Thailand's Food and Drug Administration said on Monday it has approved the use of the Pfizer-BioNTech COVID-19 vaccine for children between the age of five...", "url": "https://news.yahoo.com/thai-agency-approves-pfizer-vaccine-080254049.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/Jpq0vqSAw2BKlGP1lX.Flw--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/484b0065d216e70c20e43be72eedd279", "publishedAt": "2021-12-20T08:02:54Z", "content": "BANGKOK (Reuters) - Thailand's Food and Drug Administration said on Monday it has approved the use of the Pfizer-BioNTech COVID-19 vaccine for children between the age of five and 11.\r\nThe Comirnaty \u2026 [+267 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Biontech, Pfizer to provide EU with extra 200 million COVID doses", "description": "BioNTech SE and Pfizer said on Monday that they would be providing the European Union with more than 200 million additional doses of the COVID-19 vaccine...", "url": "https://news.yahoo.com/biontech-pfizer-eu-extra-200-122233396.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/gPyp9FqJrr.fH7mUn5pB4Q--~B/aD01MjY7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/02a97abf1fd551c7fefaf4fff0a6ab53", "publishedAt": "2021-12-20T12:22:33Z", "content": "BERLIN (Reuters) - BioNTech SE and Pfizer said on Monday that they would be providing the European Union with more than 200 million additional doses of the COVID-19 vaccine they produce.\r\nThe two vac\u2026 [+531 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "26-year-old dies after one dose of Pfizer Covid vaccine", "description": "New Zealand officials announced on Monday that a 26-year-old\u2019s death has been formally linked to the Pfizer-BioNTech vaccine after he suffered a rare heart inflammation following his first dose of the Covid jab. Read Full Article at RT.com", "url": "https://www.rt.com/news/543732-pfizer-covid-vaccine-death-myocarditis/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61c0518320302706b51c15cc.JPG", "publishedAt": "2021-12-20T10:29:50Z", "content": "In a statement, the country\u2019s Covid-19 Vaccine Independent Safety Monitoring Board, confirmed the myocarditis that had led to his death \u201cwas probably due to vaccination.\u201d\r\nThe man died within two wee\u2026 [+1530 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "New Zealand links 26-year-old man#39;s death to Pfizer COVID-19 vaccine", "description": "The death is New Zealand#39;s second linked to a known but rare side effect from the vaccine after health authorities in August reported a woman had died after taking her doses.", "url": "https://www.moneycontrol.com/news/trends/health-trends/new-zealand-links-26-year-old-mans-death-to-pfizer-covid-19-vaccine-7845221.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/10/Pfizer-_-covid-770x433.jpg", "publishedAt": "2021-12-20T09:44:39Z", "content": "New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer Inc's\u00a0COVID-19 vaccine after the person suffered myocarditis, a rare inflammation of the heart muscle, after\u2026 [+1335 chars]"}, {"source": {"id": null, "name": "Theepochtimes.com"}, "author": null, "title": "CDC Director: People Unable or Unwilling to Get Pfizer or Moderna Vaccines Should Get Johnson & Johnson\u2019s - The Epoch Times", "description": "<ol><li>CDC Director: People Unable or Unwilling to Get Pfizer or Moderna Vaccines Should Get Johnson & Johnson\u2019s\u00a0\u00a0The Epoch Times\r\n</li><li>JJ\u00a0\u00a0LOCAL 12\r\n</li><li>Advocate Aurora Pauses Johnson & Johnson COVID-19 Vaccine\u00a0\u00a0Patch.com\r\n</li><li>COVID-19 vaccine\u2026", "url": "https://www.theepochtimes.com/cdc-director-people-unable-or-unwilling-to-get-pfizer-or-moderna-vaccine-should-get-johnson-johnsons_4167126.html", "urlToImage": "https://img.theepochtimes.com/assets/uploads/2021/12/20/walensky-with-black-mask-1200x793-1200x793.jpg", "publishedAt": "2021-12-20T11:14:10Z", "content": "Americans who are not willing or able to get the Pfizer or Moderna COVID-19 vaccines should get Johnson &amp; Johnson\u2019s COVID-19 shot, according to the director of the Centers for Disease Control and\u2026 [+2560 chars]"}, {"source": {"id": null, "name": "Bangkok Post"}, "author": "Post Reporters", "title": "Kids 5-11 allowed Pfizer shot", "description": "The Food and Drug Administration (FDA) on Monday gave the green light to allow children aged 5 to 11 to receive Pfizer's Comirnaty vaccine so as to build body immunity against Covid-19.", "url": "https://www.bangkokpost.com/thailand/general/2235131/kids-5-11-allowed-pfizer-shot", "urlToImage": "https://static.bangkokpost.com/media/content/20211221/c1_2235131_211221062800_700.jpg", "publishedAt": "2021-12-20T23:00:00Z", "content": "The Food and Drug Administration (FDA) on Monday gave the green light to allow children aged 5 to 11 to receive Pfizer's Comirnaty vaccine so as to build body immunity against Covid-19.\r\nThe Comirnat\u2026 [+2096 chars]"}, {"source": {"id": null, "name": "BleepingComputer"}, "author": "Bill Toulas", "title": "Phishing attacks impersonate Pfizer in fake requests for quotation", "description": "Threat actors are conducting a highly targeted phishing campaign impersonating Pfizer to steal business and financial information from victims. [...]", "url": "https://www.bleepingcomputer.com/news/security/phishing-attacks-impersonate-pfizer-in-fake-requests-for-quotation/", "urlToImage": "pfizer", "publishedAt": "2021-12-20T11:00:00Z", "content": "Threat actors are conducting a highly targeted phishing campaign impersonating Pfizer to steal business and financial information from victims.\r\nPfizer is a well-known pharmaceutical company that enj\u2026 [+2957 chars]"}, {"source": {"id": null, "name": "Bangkok Post"}, "author": "Reuters", "title": "Thai FDA approves Pfizer vaccine for use in children aged 5-11", "description": "Thailand's Food and Drug Administration (FDA) said on Monday it has approved the use of the Pfizer-BioNTech Covid-19 vaccine for children between the age of five and 11.", "url": "https://www.bangkokpost.com/thailand/general/2234995/thai-fda-approves-pfizer-vaccine-for-use-in-children-aged-5-11", "urlToImage": "https://static.bangkokpost.com/media/content/20211220/c1_2234995_700.jpg", "publishedAt": "2021-12-20T08:34:00Z", "content": "Thailand's Food and Drug Administration (FDA) said on Monday it has approved the use of the Pfizer-BioNTech Covid-19 vaccine for children between the age of five and 11.\r\nThe Comirnaty vaccine, which\u2026 [+146 chars]"}]}, "2021-12-19": {"status": "ok", "totalResults": 16, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Adria Cimino and Keith Speights)", "title": "Better Buy: Ocugen vs. Pfizer", "description": "Can they both win in the coronavirus vaccine space?", "url": "https://www.fool.com/investing/2021/12/19/better-buy-ocugen-vs-pfizer/", "urlToImage": "https://g.foolcdn.com/editorial/images/658061/gettyimages-young-man-gets-vaccine.jpg", "publishedAt": "2021-12-19T11:00:00Z", "content": "There are plenty of options when it comes to vaccine stock investing these days. You can choose a player that's already generating billions of dollars in sales from the vaccine and other products. Or\u2026 [+4032 chars]"}, {"source": {"id": null, "name": "Deseret News"}, "author": "Herb Scribner", "title": "Will COVID end in 2024? Pfizer leaders predict the future - Deseret News", "description": "<ol><li>Will COVID end in 2024? Pfizer leaders predict the future\u00a0\u00a0Deseret News\r\n</li><li>Pfizer tests extra COVID shot for kids under 5 in setback\u00a0\u00a0KSL.com\r\n</li><li>Pfizer says vaccine data for younger children delayed\u00a0\u00a0Reuters\r\n</li><li>Pfizer says pandemi\u2026", "url": "https://www.deseret.com/coronavirus/2021/12/18/22843056/covid-19-end-2024-pfizer-president-predicts-future-coronavirus", "urlToImage": "https://cdn.vox-cdn.com/thumbor/Aees8UX0irdVhwxilyHKAqBptUc=/0x99:1024x635/fit-in/1200x630/cdn.vox-cdn.com/uploads/chorus_asset/file/23110277/AP21351696345359.jpg", "publishedAt": "2021-12-19T03:00:00Z", "content": "The novel coronavirus could become an endemic disease by 2024, Pfizer executives said Friday.\r\nPer CNBC, executives with the vaccine developer said the novel coronavirus could become a constant prese\u2026 [+1684 chars]"}, {"source": {"id": null, "name": "Kingstonist"}, "author": null, "title": "Shipping delays impact Pfizer vaccine supply in KFL&A \u2013 Kingston News - Kingstonist", "description": "<ol><li>Shipping delays impact Pfizer vaccine supply in KFL&A \u2013 Kingston News\u00a0\u00a0Kingstonist\r\n</li><li>Only Moderna vaccine available for adults 30+ in Waterloo Region\u00a0\u00a0CTV News Kitchener\r\n</li><li>Public health to substitute vaccines in some cases\u00a0\u00a0Chatham Dai\u2026", "url": "https://www.kingstonist.com/news/shipping-delays-impact-pfizer-vaccine-supply-in-kfla/", "urlToImage": "https://www.kingstonist.com/wp-content/uploads/2021/01/MM1_9548.jpg", "publishedAt": "2021-12-19T16:23:35Z", "content": "Nursing staff at Kingston Health Sciences Centre administer the first dose of the Pfizer-BioNTech COVID-19 vaccine in southeastern Ontario to Nanette Isaac, from Extendicare as part of the province-w\u2026 [+2308 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Pfizer is now testing THREE doses in kids under 5 since two shots don't work", "description": null, "url": "https://www.investmentwatchblog.com/pfizer-is-now-testing-three-doses-in-kids-under-5-since-two-shots-dont-work/", "urlToImage": null, "publishedAt": "2021-12-19T14:02:50Z", "content": "<ul><li>Pfizer said\u00a0two jabs failed to produce the expected immunity in babies and preschoolers\u00a0</li><li>A preliminary analysis found 2- to 4-year-olds\u2019 immune response wasn\u2019t as strong as expected t\u2026 [+1282 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Sara Marley", "title": "EU Orders Additional 20 Million BioNTech-Pfizer Vaccine Doses", "description": "", "url": "https://www.bloomberg.com/news/articles/2021-12-19/eu-orders-additional-20-million-biontech-pfizer-vaccine-doses", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iNBGbNziOyG8/v0/1200x800.jpg", "publishedAt": "2021-12-19T13:25:23Z", "content": "The European Commission said \r\nBioNTech-\r\nPfizer will deliver an additional 20 million vaccine doses in the first quarter, bringing the total number of deliveries in the first three months of 2022 to\u2026 [+273 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "The West News", "title": "Pfizer believes that the pandemic might last until 2024", "description": "Pfizer\u2019s Chief Scientific Officer Mikael Dolsten told investors that the company expects pandemic levels of COVID-19 cases in some locations for the next year or two. During the same time span, other countries will become \u201cendemic\u201d with low caseloads. The dis\u2026", "url": "https://freerepublic.com/focus/f-news/4022454/posts", "urlToImage": null, "publishedAt": "2021-12-19T01:57:37Z", "content": "Skip to comments.\r\nPfizer believes that the pandemic might last until 2024The West News ^\r\n | December 18, 2021\r\n | The West News\r\nPosted on 12/18/2021 5:57:37 PM PST by conservative98\r\nPfizers Chief\u2026 [+6015 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "US to send 1.78m more Pfizer doses to Bangladesh under COVAX", "description": "The US government has donated another 1.78 million doses of the Pfizer COVID-19 vaccine to Bangladesh through the global sharing platform COVAX.", "url": "https://bdnews24.com/bangladesh/2021/12/20/us-to-send-1.78m-more-pfizer-doses-to-bangladesh-under-covax", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/08/26/vial-pfizer-biontech-smr-230821-01.jpg/BINARY/vial-pfizer-biontech-smr-230821-01.jpg", "publishedAt": "2021-12-19T19:43:46Z", "content": "The new doses take the number of shots donated by the US to Bangladesh to 18.5. They will help Bangladesh expand vaccinations for young people ages 12 and up, reaching all 64 districts across the cou\u2026 [+604 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Red State", "title": "Pfizer Now Says Two Covid Vax Jabs in Six-Month-Olds Don't Produce Desired Results, Moves on to Third Dose", "description": "How can it be said objectively any other way?Drug companies and the Biden administration continue to use America\u2019s children as young as six months old as human guinea pigs by injecting them with COVID \u201cvaccinations,\u201d in response to which serious side effects \u2026", "url": "https://freerepublic.com/focus/f-bloggers/4022500/posts", "urlToImage": null, "publishedAt": "2021-12-19T06:14:17Z", "content": "Skip to comments.\r\nPfizer Now Says Two Covid Vax Jabs in Six-Month-Olds Don't Produce Desired Results, Moves on to Third DoseRed State ^\r\n | 12/18/2021\r\n | Mike Miller\r\nPosted on 12/18/2021 10:14:17 \u2026 [+5925 chars]"}, {"source": {"id": null, "name": "The Japan Times"}, "author": null, "title": "Japan\u2019s prime minister speaks with Pfizer CEO on speeding vaccine boosters", "description": "The Japanese government wants to speed up vaccine imports and shorten the time between the first two shots and the booster, from eight months to six months.", "url": "https://www.japantimes.co.jp/news/2021/12/19/national/science-health/fumio-kishida-pfizer-talks/", "urlToImage": "https://cdn-japantimes.com/wp-content/uploads/2021/12/np_file_130268-870x489.jpeg", "publishedAt": "2021-12-19T11:48:23Z", "content": "Japanese Prime Minister Fumio Kishida on Friday spoke with the country\u2019s biggest supplier of COVID-19 vaccines amid media reports he will seek to speed up the booster shot program.\r\nChief government \u2026 [+1229 chars]"}, {"source": {"id": null, "name": "Stuff.co.nz"}, "author": "OLIVIA CALDWELL", "title": "Covid-19: Coroner investigating after autopsy links Dunedin man's death to 'very rare' side effect of Pfizer vaccine", "description": "Ashleigh Wilson was ready to marry the love of her life in just a few months. But Dunedin plumber Rory Nairn suddenly dropped dead in their bathroom at 3am.", "url": "https://www.stuff.co.nz/national/health/coronavirus/127324992/covid19-coroner-investigating-after-autopsy-links-dunedin-mans-death-to-very-rare-side-effect-of-pfizer-vaccine", "urlToImage": "https://resources.stuff.co.nz/content/dam/images/4/y/w/1/i/e/image.related.StuffLandscapeSixteenByNine.1420x800.23t0lc.png/1639880715141.jpg", "publishedAt": "2021-12-19T02:25:14Z", "content": "Ashleigh Wilson was ready to marry the love of her life in just a few months.\r\n But last month, Dunedin plumber Rory Nairn dropped dead in their bathroom at 3am, likely due to vaccine-related myocard\u2026 [+4473 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "EditorDavid", "title": "Covid Vaccines Fight Serious Illness, But Only Pfizer and Moderna With a Booster Stop Omicron Infections", "description": "\"A growing body of preliminary research suggests the COVID vaccines used in most of the world offer almost no defense against becoming infected by the highly contagious omicron variant,\" reports the New York Times. (Emphasis added, because they stress that \"A\u2026", "url": "https://science.slashdot.org/story/21/12/19/1727237/covid-vaccines-fight-serious-illness-but-only-pfizer-and-moderna-with-a-booster-stop-omicron-infections", "urlToImage": "https://a.fsdn.com/sd/topics/medicine_64.png?refresh=now", "publishedAt": "2021-12-19T17:34:00Z", "content": "\"A growing body of preliminary research suggests the COVID vaccines used in most of the world offer almost no defense against becoming infected by the highly contagious omicron variant,\" reports the \u2026 [+2647 chars]"}, {"source": {"id": "fox-news", "name": "Fox News"}, "author": "Peter Aitken", "title": "Pfizer COVID-19 pill may not see approval for 'months' despite 'impressive' data", "description": "The Pfizer pill boast a 90% effectiveness at preventing serious illness and death from COVID-19.", "url": "https://www.foxnews.com/health/pfizer-covid-pill-approval-months-impressive-data", "urlToImage": "https://static.foxnews.com/foxnews.com/content/uploads/2021/12/Pfizer-COVID-Pills.jpg", "publishedAt": "2021-12-19T18:05:39Z", "content": "The new Pfizer COVID-19pill may not see Emergency Use Authorization for another month as health officials continue to highlight the promising effects it may bring.\u00a0\r\nDr. Anthony Fauci praised the dat\u2026 [+3309 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Will COVID end in 2024? Pfizer leaders predict the future - Deseret News", "description": "Will COVID end in 2024? Pfizer leaders predict the futureDeseret News Pfizer pushing back plans to request emergency use for vaccinations in kids under 5WFAA Pfizer tests extra COVID shot for kids under 5 in setbackKSL.com Pfizer says vaccine data for younger\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156629909", "urlToImage": null, "publishedAt": "2021-12-19T08:12:16Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer tests extra COVID shot for kids under 5 in setback - KSL.com", "description": "Pfizer tests extra COVID shot for kids under 5 in setbackKSL.com Pfizer says vaccine data for younger children delayedReuters Will COVID end in 2024? Pfizer leaders predict the futureDeseret News Parents bide time as Pfizer extends vaccine trial for young chi\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156626955", "urlToImage": null, "publishedAt": "2021-12-19T03:52:34Z", "content": "Never ask two questions in a business letter. The reply will discuss\r\nthe one you are least interested, and say nothing about the other."}, {"source": {"id": null, "name": "The Daily Star"}, "author": "The Daily Star", "title": "Bangladesh receives 1.78mn Pfizer vaccines from US", "description": "The United States government has contributed 1.78 million doses of the Pfizer Covid-19 vaccine to Bangladesh through the COVAX facility.", "url": "https://www.thedailystar.net/health/disease/coronavirus/fallouts-fightback/vaccine/news/bangladesh-receives-178mn-pfizer-vaccines-us-2921036", "urlToImage": "https://img.thedailystar.net/sites/default/files/styles/social_share/public/images/2021/10/04/pfizer_2.jpg?itok=pbJSauQq", "publishedAt": "2021-12-19T11:36:49Z", "content": "The United States government has contributed 1.78 million doses of the Pfizer Covid-19 vaccine to Bangladesh through the COVAX facility.\u00a0\r\nWith this consignment, the US has provided a total of 18.5 m\u2026 [+1167 chars]"}, {"source": {"id": null, "name": "Dailyutahchronicle.com"}, "author": "By Vanessa Hudson, News Writer", "title": "FDA Approves Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5-11", "description": "The Food and Drug Administration\u00a0approved the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 on Oct. 29, 2021. The vaccine gives children a way to protect themselves, their family and their friends from serious cases of COVID-19.\u00a0 According to the Ce\u2026", "url": "https://dailyutahchronicle.com/2021/12/19/fda-approves-pfizer-biontech-covid-19-vaccine-children-ages-5-11/", "urlToImage": "https://dailyutahchronicle.com/wp-content/uploads/2021/05/pexels-rfstudio-3825529.jpg", "publishedAt": "2021-12-19T14:00:40Z", "content": "The Food and Drug Administration\u00a0approved the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 on Oct. 29, 2021. The vaccine gives children a way to protect themselves, their family and their \u2026 [+2833 chars]"}]}, "2021-12-18": {"status": "ok", "totalResults": 39, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights and Brian Orelli, PhD)", "title": "What to Make of the FDA's Latest Warning to AbbVie and Pfizer", "description": "There's still a worst-case scenario that the FDA could unleash.", "url": "https://www.fool.com/investing/2021/12/18/what-to-make-of-the-fdas-latest-warning-to-abbvie/", "urlToImage": "https://g.foolcdn.com/editorial/images/657726/fda-blocks.jpg", "publishedAt": "2021-12-18T11:55:00Z", "content": "The U.S. Food and Drug Administration (FDA) has placed additional warnings on the labels for JAK inhibitors marketed by AbbVie(NYSE:ABBV) and Pfizer(NYSE:PFE).\u00a0In this Motley Fool Live video recorded\u2026 [+2469 chars]"}, {"source": {"id": null, "name": "KSL.com"}, "author": "Lauran Neergaard, Associated Press", "title": "Pfizer tests extra COVID shot for kids under 5 in setback - KSL.com", "description": "<ol><li>Pfizer tests extra COVID shot for kids under 5 in setback\u00a0\u00a0KSL.com\r\n</li><li>Pfizer says vaccine data for younger children delayed\u00a0\u00a0Reuters\r\n</li><li>Pfizer Announces Vaccine Provides Insufficient Protection for Young Children\u00a0\u00a0Yahoo! Voices\r\n</li><li\u2026", "url": "https://www.ksl.com/article/50314045/pfizer-tests-extra-covid-shot-for-kids-under-5-in-setback", "urlToImage": "https://img.ksl.com/slc/2856/285666/28566691.jpg?filter=kslv2/responsive_story_lg", "publishedAt": "2021-12-18T17:07:33Z", "content": "Estimated read time: 2-3 minutes\r\nWASHINGTON Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn't appea\u2026 [+2299 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Pfizer to test Covid booster dose on infants, young kids", "description": "Pfizer will start testing Covid-19 vaccine booster doses in children aged six months to five years old after finding that its lower-dose shot may not provide enough protection in one age group. Read Full Article at RT.com", "url": "https://www.rt.com/usa/543582-pfizer-booster-test-children/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61bd445985f540162f45751a.JPG", "publishedAt": "2021-12-18T02:17:15Z", "content": "The pharmaceutical giant announced on Thursday that it would start testing a third dose on young children \u201cat least two months after the second dose\u201d in an effort \u201cto provide high levels of protectio\u2026 [+1293 chars]"}, {"source": {"id": null, "name": "The Japan Times"}, "author": null, "title": "Pfizer says pandemic could extend through 2023, studies three-dose vaccine course for children", "description": "Pfizer executives said the company believed that by 2024, the disease should be endemic around the globe, meaning it would no longer be a pandemic.", "url": "https://www.japantimes.co.jp/news/2021/12/18/world/science-health-world/covid-omicron-vaccines-pfizer/", "urlToImage": "https://cdn-japantimes.com/wp-content/uploads/2021/12/np_file_130080-870x489.jpeg", "publishedAt": "2021-12-18T01:11:03Z", "content": "MADRID/DUBLIN \u2013 Pfizer Inc. said on Friday the COVID-19 pandemic could extend through next year and announced plans to develop a three-dose vaccine regimen for children ages 2 to 16, a move that coul\u2026 [+4887 chars]"}, {"source": {"id": null, "name": "VOA News"}, "author": "webdesk@voanews.com (Reuters)", "title": "Pandemic Could Extend To 2024, Pfizer Says", "description": "Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorization.\n\n\nPfizer Chief \u2026", "url": "https://www.voanews.com/a/pandemic-could-extend-to-2024-pfizer-says/6359993.html", "urlToImage": "https://gdb.voanews.com/1ABDB0C2-BA5E-479E-BFB8-EB10E81634C1_cx0_cy1_cw0_w1200_r1.jpg", "publishedAt": "2021-12-18T06:00:28Z", "content": "Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than e\u2026 [+3144 chars]"}, {"source": {"id": "usa-today", "name": "USA Today"}, "author": "Adrianna Rodriguez, USA TODAY", "title": "CDC says Moderna and Pfizer COVID-19 vaccines are preferred over Johnson & Johnson. What it means for you.", "description": "The CDC panel was persuaded by new data showing that blood clots linked to J&J\u2019s vaccine are not just in younger women as originally thought.", "url": "https://www.usatoday.com/story/news/health/2021/12/18/johnson-and-johnson-covid-vaccine-what-know-cdc-preference/8937706002/", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/fPTTEMy5CgqlUKU3JgQ9EA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03OTY-/https://s.yimg.com/uu/api/res/1.2/vpGS_yBpjJptxJgIj2Ay6A--~B/aD0yOTQxO3c9NDQzNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/usa_today_news_641/58f50a129a504854e02125271be8f4ac", "publishedAt": "2021-12-18T11:01:17Z", "content": "An advisory panel to the Centers for Disease Control and Prevention expressed their preference for Pfizer-BioNTech and Modernas mRNA COVID-19 vaccines over Johnson &amp; Johnsons jab.\r\nMembers of the\u2026 [+7718 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Study Shows Pfizer, AstraZeneca Vaccines Less Effective Against Omicron Strain, WHO Says", "description": "MOSCOW (Sputnik) - Preliminary results of a non-peer-reviewed study from the United Kingdom indicate reduced effectiveness of the Pfizer and AstraZeneca vaccines against the Omicron coronavirus variant, the World Health Organization (WHO) has said.", "url": "https://sputniknews.com/20211218/study-shows-pfizer-astrazeneca-vaccines-less-effective-against-omicron-strain-who-says-1091627507.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091627507.jpg?10913290751639833181", "publishedAt": "2021-12-18T13:12:58Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nThe new COVID variant was initially detected in South Africa and Botswana and sparked major concerns due to its high number\u2026 [+3192 chars]"}, {"source": {"id": null, "name": "Hindustan Times"}, "author": "Hindustantimes", "title": "Omicron detected in US returnee, who took 3 doses of Pfizer vaccine: BMC - Hindustan Times", "description": "<ol><li>Omicron detected in US returnee, who took 3 doses of Pfizer vaccine: BMC\u00a0\u00a0Hindustan Times\r\n</li><li>Man Back From US Positive For Omicron, Took 3 Jabs: Mumbai Civic Body\u00a0\u00a0NDTV\r\n</li><li>Mumbai News Live: Omicron patient from New York took 3 doses of P\u2026", "url": "https://www.hindustantimes.com/cities/mumbai-news/omicron-detected-in-us-returnee-who-took-3-doses-of-pfizer-vaccine-bmc-101639791054052.html", "urlToImage": "https://images.hindustantimes.com/img/2021/12/18/1600x900/BZRRXCZH75JSJCHVZ3NMAZMLJE_1639792528104_1639792539383.jpg", "publishedAt": "2021-12-18T01:58:02Z", "content": "One of the new patients in Mumbai who tested positive for the Omicron variant of the SARS-Cov-2 coronavirus after returning from New York had taken three doses of the Covid-19 vaccine, the Brihanmumb\u2026 [+2107 chars]"}, {"source": {"id": "news24", "name": "News24"}, "author": null, "title": "News24.com | Pfizer to test third vaccine shot for under-fives", "description": "Pfizer wants to test a third dose of the Covid-19 vaccine in the under-fives, as the low dosage such small children can handle may not offer the same protection that older children enjoy from just two shots.", "url": "https://www.news24.com/news24/World/News/pfizer-to-test-third-vaccine-shot-for-under-fives-20211218", "urlToImage": "https://cdn.24.co.za/files/Cms/General/d/516/8d733fb11fb94059b5f98048a676aacf.jpg", "publishedAt": "2021-12-18T07:08:44Z", "content": "<ul><li>Pfizer is set to test an extra dose of its Covid-19 for children under the age of five.</li><li>As part of its ongoing clinical trials, Pfizer has \r\nselected a dosage of three micrograms per \u2026 [+2103 chars]"}, {"source": {"id": null, "name": "Hurriyet Daily News"}, "author": "hurriyetdailynews.com", "title": "Pfizer tests extra COVID shot for kids under 5 in setback", "description": "Pfizer said on Dec. 17 it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn\u2019t appear strong enough for some of the children.", "url": "https://www.hurriyetdailynews.com/pfizer-tests-extra-covid-shot-for-kids-under-5-in-setback-170157", "urlToImage": "https://i.hurimg.com/i/hdn/75/200x200/61bd878e4e3fe115ac0cffdb.jpg", "publishedAt": "2021-12-18T07:01:00Z", "content": "WASHINGTON\r\nPfizer said on Dec. 17 it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didnt appear strong enough for some of th\u2026 [+2241 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "AP", "title": "Pfizer study tests extra covid-19 vaccine dose for kids under 5 in setback", "description": "Pfizer had expected data on how well the vaccines were working in children under 5 by year's end, and it's not clear how long the change will delay a final answer.", "url": "https://indianexpress.com/article/world/pfizer-study-tests-extra-covid-19-vaccine-dose-for-kids-under-5-in-setback-7678660/", "urlToImage": "https://images.indianexpress.com/2021/05/US-vaccine-2.jpg", "publishedAt": "2021-12-18T03:09:30Z", "content": "Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn\u2019t appear strong enough for some of the children.Pfiz\u2026 [+2237 chars]"}, {"source": {"id": null, "name": "Stationgossip.com"}, "author": "orraz", "title": "Pfizer Begins Testing Three-Dose COVID Vaccine for Babies and Toddlers", "description": "Your Daily Station of Entertainment !!", "url": "http://www.stationgossip.com/2021/12/pfizer-begins-testing-three-dose-covid.html", "urlToImage": null, "publishedAt": "2021-12-18T14:11:15Z", "content": "Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn\u2019t appear strong enough for some of the children.\r\nPf\u2026 [+2239 chars]"}, {"source": {"id": null, "name": "Jamaica Observer"}, "author": null, "title": "Pfizer tests extra COVID shot for kids under 5 in setback", "description": "Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn't appear strong enough for some of the children.Pfizer announced the change after a preliminary analysis found t\u2026", "url": "https://www.jamaicaobserver.com/international/pfizer-tests-extra-covid-shot-for-kids-under-5-in-setback_239230?profile=1470", "urlToImage": "https://www.jamaicaobserver.com/apps/pbcsi.dll/storyimage/JO/20211218/ARTICLE/312189992/AR/0/AR-312189992.jpg", "publishedAt": "2021-12-18T07:01:00Z", "content": "Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers after the usual two shots didn't appear strong enough for some of the children.\r\nPf\u2026 [+2269 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Jim Hoft", "title": "Naomi Wolf: NIAID Is Trying to Sideline the J&J Vaccines Because They Don\u2019t Have a Patent on and Aren\u2019t Making Money Off of Them like Pfizer and Moderna Vaccines (VIDEO)", "description": "Dr. Naomi Wolf, a Rhodes Scholar and former Clinton Administration advisor, joined Steve Bannon on The War Room on Saturday. Earlier this week the Centers for Disease Control and Prevention (CDC) expressed their preference for Pfizer-BioNTech and Moderna\u2019s mR\u2026", "url": "https://www.thegatewaypundit.com/2021/12/naomi-wolf-niaid-trying-sideline-jj-vaccines-dont-patent-arent-making-money-off-like-pfizer-moderna-vaccines-video/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/naomi-wolf-war-room.jpg", "publishedAt": "2021-12-18T16:30:48Z", "content": "Dr. Naomi Wolf, a Rhodes Scholar and former Clinton Administration advisor, joined Steve Bannon on The War Room on Saturday.\r\nEarlier this week the Centers for Disease Control and Prevention (CDC) ex\u2026 [+802 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?", "description": "Booster jabs provide up to 70% omicron protection, study finds", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-booster-pfizer-astrazeneca-moderna-b1978612.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-18T11:47:43Z", "content": "The Omicron variant of Covid-19 has begun to spread in the UK, with Boris Johnson warning of a tidal wave of infections hitting these shores if the public do not observe social restrictions and get t\u2026 [+7514 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Dailymail.com, Associated", "title": "Pfizer tests extra COVID shot for kids under 5 in setback", "description": "Pfizer said Friday it's going to test three doses of its COVID vaccine in young children under five years old, after two jabs failed to produce the expected immunity in babies and preschoolers.", "url": "https://www.dailymail.co.uk/news/article-10322175/Pfizer-study-tests-extra-COVID-vaccine-dose-kids-5.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/17/19/wire-51934761-1639770883-696_636x382.jpg", "publishedAt": "2021-12-18T05:21:57Z", "content": "Pfizer said Friday it's going to test three doses of its COVID vaccine in young children under five years old, after two jabs failed to produce the expected immunity in babies and preschoolers.\r\nTwo \u2026 [+2241 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Pfizer trial of low-dose shot fails for young children", "description": "A low dose of the Pfizer-BioNTech coronavirus vaccine did not produce a potent immune response in children aged 2 to just under 5 years of age, the companies announced Friday, a discouraging setback that threatens to keep the vaccine from younger children for\u2026", "url": "https://bdnews24.com/health/2021/12/18/pfizer-trial-of-low-dose-shot-fails-for-young-children", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/12/18/pfizer-vaccine-children-181221-01-smr.jpg/BINARY/pfizer-vaccine-children-181221-01-smr.jpg", "publishedAt": "2021-12-18T07:30:04Z", "content": "In ongoing clinical trials, the companies\r\ntested 3 micrograms of the vaccine one-tenth of the adult dose in children\r\n6 months to less than 5 years of age. After two doses, children between 6\r\nmonth\u2026 [+2693 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "BS Web Team", "title": "LIVE: India Omicron count crosses 100, Pfizer says Covid may stay till 2024", "description": "The Centre has advised people to avoid non-essential travel and mass gatherings and keep New Year celebrations at low intensity.", "url": "https://www.business-standard.com/article/current-affairs/live-india-omicron-count-crosses-100-pfizer-says-covid-may-stay-till-2024-121121800130_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-12/05/full/1638664968-8717.jpg", "publishedAt": "2021-12-18T01:45:00Z", "content": "Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the count\u2026 [+1029 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "IANS", "title": "Covid: Pfizer vax for 2 to 4 year-olds fails to produce expected immunity", "description": "The Covid vaccine developed for small children aged 2 to 4-year-olds by US drug maker Pfizer generates weaker immune response than expected, the company has announced", "url": "https://www.business-standard.com/article/current-affairs/covid-pfizer-vax-for-2-to-4-year-olds-fails-to-produce-expected-immunity-121121800718_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-05/24/full/1621857595-3349.jpg", "publishedAt": "2021-12-18T14:30:00Z", "content": "The Covid vaccine developed for small children aged 2 to 4-year-olds by US drug maker Pfizer generates weaker immune response than expected, the company has announced.\r\nThe company said a routine rev\u2026 [+3961 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Pfizer says pandemic could extend to 2024, vaccine data for younger children delayed", "description": "Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2- to 4-year-olds generated a weaker immune response than expected, potentially delaying authorisation.", "url": "https://bdnews24.com/coronavirus-pandemic/2021/12/18/pfizer-says-pandemic-could-extend-to-2024-vaccine-data-for-younger-children-delayed", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2020/11/09/pfizer-vaccine-091120-01.jpg/ALTERNATES/w640/pfizer-vaccine-091120-01.jpg", "publishedAt": "2021-12-18T04:48:52Z", "content": "Pfizer Chief Scientific Officer Mikael Dolsten\r\nsaid in a presentation to investors that the company expects some regions to\r\ncontinue to see pandemic levels of COVID-19 cases over the next year or t\u2026 [+2936 chars]"}]}, "2021-12-17": {"status": "ok", "totalResults": 137, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "CDC panel recommends Pfizer, Moderna over J&J shot - Reuters", "description": "A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccines over Johnson & Johnson's shot, due to rare but sometimes fatal case\u2026", "url": "https://www.reuters.com/video/watch/idPBOo?now=true", "urlToImage": "https://ajo.prod.reuters.tv/api/v2/img/61bbd0a4e4b09631b0e445ba-1639698596092?location=LANDSCAPE", "publishedAt": "2021-12-17T00:11:20Z", "content": "Posted \r\nA panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccine\u2026 [+92 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Pfizer says vaccine data for younger children delayed - Reuters", "description": "Pfizer on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2-4 year olds generated a weaker immune response than expected, potentially delaying authorization.", "url": "https://www.reuters.com/video/watch/idPBG6?now=true", "urlToImage": "https://ajo.prod.reuters.tv/api/v2/img/61bcfe7fe4b09631b0e4463a-1639775871185?location=LANDSCAPE", "publishedAt": "2021-12-17T22:52:14Z", "content": "Posted \r\nPfizer on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its vaccine for 2-4 year olds generated a weaker immune response than \u2026 [+44 chars]"}, {"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "Pfizer (PFE) COVID Pill Paxlovid Gets CHMP Support in Europe", "description": "The CHMP supports the use of Pfizer's (PFE) oral COVID-19 drug, Paxlovid, to treat high-risk patients even though it has not received conditional authorization from the European Commission.", "url": "http://www.zacks.com/stock/news/1840655/pfizer-pfe-covid-pill-paxlovid-gets-chmp-support-in-europe?cid=CS-ENTREPRENEUR-FT-analyst_blog|company_news_-_medical_sector-1840655", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-403463.jpeg", "publishedAt": "2021-12-17T15:43:00Z", "content": "Pfizer PFE announced that the Committee for Medicinal Products for Human Use (\"CHMP\") of the European Medicines Agency (\"EMA\") has advised the use of its oral COVID-19 drug, Paxlovid. The drug can be\u2026 [+5089 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "EU to place order with Pfizer for COVID shots adapted to Omicron - Reuters", "description": "European Union governments have agreed to order over 180 million doses of an adapted version against Omicron of the COVID-19 vaccine developed by BioNTech <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> and Pfizer <a href=\"\u2026", "url": "https://www.reuters.com/world/europe/eu-place-order-with-pfizer-covid-shots-adapted-omicron-2021-12-17/", "urlToImage": "https://www.reuters.com/resizer/fFoeyW05UVpMCcBqIXpYU3vyX-s=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/U27WJ3QH6FO2JOJJK456YGVODI.jpg", "publishedAt": "2021-12-17T10:25:00Z", "content": "People pose with syringe with needle in front of displayed Pfizer logo in this illustration taken, December 11, 2021. REUTERS/Dado RuvicBRUSSELS, Dec 17 (Reuters) - European Union governments have ag\u2026 [+846 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Japan PM Kishida speaks with Pfizer CEO on speeding vaccine boosters - media - Reuters", "description": "Japanese Prime Minister Fumio Kishida on Friday spoke with the country's biggest supplier of COVID-19 vaccines amid media reports he will seek to speed up the booster shot programme.", "url": "https://www.reuters.com/markets/asia/japan-pm-kishida-speaks-with-pfizer-ceo-speeding-vaccine-boosters-media-2021-12-17/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=66", "publishedAt": "2021-12-17T07:15:00Z", "content": "TOKYO, Dec 17 (Reuters) - Japanese Prime Minister Fumio Kishida on Friday spoke with the country's biggest supplier of COVID-19 vaccines amid media reports he will seek to speed up the booster shot p\u2026 [+1450 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "CDC recommends Moderna, Pfizer COVID-19 vaccines over J&J's - Reuters", "description": "The U.S. Centers for Disease Control and Prevention on Thursday recommended Americans choose to receive one of two other authorised COVID-19 vaccines over Johnson & Johnson's <a href=\"https://www.reuters.com/companies/JNJ.N\" target=\"_blank\">(JNJ.N)</a> shot, \u2026", "url": "https://www.reuters.com/markets/stocks/cdc-recommends-moderna-pfizer-covid-19-vaccines-over-jjs-2021-12-17/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=66", "publishedAt": "2021-12-17T15:36:00Z", "content": "Dec 17 (Reuters) - The U.S. Centers for Disease Control and Prevention on Thursday recommended Americans choose to receive one of two other authorised COVID-19 vaccines over Johnson &amp; Johnson's (\u2026 [+3206 chars]"}, {"source": {"id": null, "name": "NPR"}, "author": "Scott Neuman", "title": "Pfizer plan to test a third dose of its COVID vaccine on infants and young children", "description": "Pfizer and BioNTech, which produced the first COVID-19 vaccine authorized in the U.S., say they will expand ongoing trials to include a third dose for children as young as 6 months old.", "url": "https://www.npr.org/sections/coronavirus-live-updates/2021/12/17/1065200225/pfizer-third-dose-covid-vaccine-infants-young-children", "urlToImage": "https://media.npr.org/assets/img/2021/12/17/ap21336608878733_wide-aeb3401da28bfdc580b68efa00815e55e2735760.jpg?s=1400", "publishedAt": "2021-12-17T18:32:19Z", "content": "An information sign is displayed as a child arrives with her parent to receive the Pfizer COVID-19 vaccine for children 5 to 11-years-old at London Middle School in Wheeling, Ill., last month.\r\nNam Y\u2026 [+2190 chars]"}, {"source": {"id": "time", "name": "Time"}, "author": "LAURAN NEERGAARD and MIKE STOBBE / AP", "title": "U.S. Government Recommends Americans Get the Pfizer-BioNTech or Moderna COVID-19 Shots Instead of J&J\u2019s", "description": "Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday. The strange clotting problem has caused nine confirmed deaths after J&J\u2026", "url": "https://time.com/6129590/pfizer-moderna-vs-jandj/", "urlToImage": "https://api.time.com/wp-content/uploads/2021/12/jj-vaccine-2021.jpg?quality=85&w=1024&h=628&crop=1", "publishedAt": "2021-12-17T00:16:42Z", "content": "Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson &amp; Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday.\r\nThe st\u2026 [+5364 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": null, "title": "CDC Backs Pfizer, Moderna Covid Vaccines (Podcast)", "description": "Understand every aspect of the global economy \u2013 and know how to make your next move.", "url": "https://www.bloomberg.com/news/audio/2021-12-17/cdc-backs-pfizer-moderna-covid-vaccines-podcast", "urlToImage": null, "publishedAt": "2021-12-17T02:27:40Z", "content": "Rachel Chang, Bloomberg's team leader for Asia consumer and healthcare, discusses the CDC's backing for Pfizer and Moderna's vaccines over J&amp;J's with Ed Baxter on Bloomberg Daybreak Asia.\r\nDec 17\u2026 [+5 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Isabel Reynolds", "title": "Japan's Kishida Presses Pfizer CEO for Vaccines as Omicron Looms", "description": "Japanese Prime Minister Fumio Kishida called the CEO of Pfizer Inc. to seek faster delivery of coronavirus vaccines, TV Asahi reported Friday, as the country braces for the spread of the omicron variant.", "url": "https://www.bloomberg.com/news/articles/2021-12-17/japan-s-kishida-presses-pfizer-ceo-for-vaccines-as-omicron-looms", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i_.rCmyoAky8/v1/1200x800.jpg", "publishedAt": "2021-12-17T00:59:13Z", "content": "Japanese Prime Minister Fumio Kishida called the CEO of \r\nPfizer Inc. to seek faster delivery of coronavirus vaccines, TV Asahi reported Friday, as the country braces for the spread of the omicron va\u2026 [+1904 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "Pfizer COVID Vaccine for Younger Children Hits Snag", "description": "Pfizer\u2019s COVID-19 vaccine for children ages 2 to 5 years old fizzled in clinical trials, the company said on Friday, signaling a further delay in getting a vaccine to preschoolers just as Omicron bears down on the U.S.", "url": "https://www.webmd.com/vaccines/covid-19-vaccine/news/20211217/pfizer-covid-vaccine-younger-children-snag", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/other/vaccine_covid19_other/1800x1200_vaccine_1_other.jpg", "publishedAt": "2021-12-17T21:44:14Z", "content": "[MUSIC PLAYING]\r\nSPEAKER: How does a COVID-19\r\nmRNA vaccine work?\r\nCOVID vaccines are now\r\navailable.\r\nSome of the COVID-19 vaccines\r\nare mRNA vaccines, but what does\r\nthis mean?\r\nmRNA vaccines are\r\n\u2026 [+2094 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Eric Volkman)", "title": "Why Pfizer and Johnson & Johnson Fell on Friday", "description": "One prominent investment bank expressed a distinct lack of enthusiasm for the two stocks.", "url": "https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/", "urlToImage": "https://g.foolcdn.com/editorial/images/658036/elderly-customer-at-a-pharmacy.jpg", "publishedAt": "2021-12-17T23:40:50Z", "content": "What happened\r\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer(NYSE:PFE) and Johnson &amp; Johnson(NYSE:JNJ) both fell on the day by nearly 3%. This followed a prominent i\u2026 [+1822 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Riley Griffin", "title": "When Can Kids Under 5 Get Vaccinated? Pfizer Shifts Trial to Three Doses", "description": "Pfizer Inc. and BioNTech SE plan to study a three-dose regimen of their Covid-19 vaccine in young children 6 months to 4 years old, the companies said in a statement.", "url": "https://www.bloomberg.com/news/articles/2021-12-17/pfizer-to-study-three-shot-regimen-in-kids-6-months-to-4-years", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i8Ge1i0Puxd0/v1/1200x800.jpg", "publishedAt": "2021-12-17T14:18:57Z", "content": "Pfizer Inc. and \r\nBioNTech SE plan to study a three-dose regimen of their Covid-19 vaccine in young children 6 months to 4 years old, the companies said in a statement.\u00a0\r\nThe vaccine partners amended\u2026 [+1264 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (George Budwell)", "title": "Here's Why Shares of Bristol Myers Squibb, Eli Lilly, and Pfizer Rocketed Higher This Week", "description": "These three big-pharma stocks exploded higher this week.", "url": "https://www.fool.com/investing/2021/12/17/heres-why-shares-of-bristol-myers-squibb-eli-lilly/", "urlToImage": "https://g.foolcdn.com/editorial/images/657887/toy-rocket.jpg", "publishedAt": "2021-12-17T11:44:00Z", "content": "What happened\r\nBig-pharma stocks have generally had an outstanding week thus far. Through Thursday's closing bell, Bristol Myers Squibb(NYSE:BMY) shares have tracked higher by a respectable 8.2%, Pfi\u2026 [+2372 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "SA Transcripts", "title": "Pfizer (PFE) Investor Presentation - Slideshow", "description": "The following slide deck was published by Pfizer Inc.", "url": "https://seekingalpha.com/article/4475801-pfizer-pfe-investor-presentation-slideshow", "urlToImage": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png", "publishedAt": "2021-12-17T22:15:48Z", "content": "The following slide deck was published by Pfizer Inc. in conjunction with this event.\r\n\n\r\nView as PDF\r\nClick to Enlarge\r\n117"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "AP", "title": "US CDC recommends Pfizer, Moderna COVID-19 shots over J&J's", "description": "Until now the U.S. has treated all three COVID-19 vaccines available to Americans as an equal choice, since large studies found they all offered strong protection and early supplies were limited. J&J's vaccine initially was welcomed as a single-dose option th\u2026", "url": "https://economictimes.indiatimes.com/news/international/world-news/us-cdc-recommend-pfizer-moderna-covid-19-shots-over-jjs/articleshow/88329758.cms", "urlToImage": "https://img.etimg.com/thumb/msid-88329797,width-1070,height-580,imgsize-45344,overlay-economictimes/photo.jpg", "publishedAt": "2021-12-17T01:16:04Z", "content": "Most Americans should be given the or Moderna vaccines instead of the Johnson &amp; Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday.\r\nThe strange clottin\u2026 [+5388 chars]"}, {"source": {"id": null, "name": "The Guardian"}, "author": "Peter Beaumont", "title": "T-cells in people who have had Pfizer Covid jab stay robust against severe illness", "description": "Research in South Africa raises hopes that similar responses may be present with other vaccines<ul><li>Coronavirus \u2013 latest updates</li><li>See all our coronavirus coverage</li></ul>South African researchers examining how the body\u2019s immune system responds to \u2026", "url": "https://amp.theguardian.com/world/2021/dec/17/t-cells-pfizer-covid-jab-robust-against-severe-illness-south-africa-research", "urlToImage": "https://i.guim.co.uk/img/media/96c6408976ab22b83ab5a503af13e81237f5262f/0_236_3543_2126/master/3543.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=d03c866375bd163b14d25a0c6193b2d4", "publishedAt": "2021-12-17T16:50:57Z", "content": "South African researchers examining how the bodys immune system responds to the Omicron variant have identified that T-cells in people who have had the Pfizer vaccine continue to be robust in potenti\u2026 [+4000 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Trefis Team, Contributor, \n Trefis Team, Contributor\n https://www.forbes.com/sites/greatspeculations/people/trefis/", "title": "Will Pfizer Stock See Higher Levels After A Large 18% Rise In A Month?", "description": "The stock price of Pfizer (NYSE: PFE) has outperformed the broader indices. While the S&P500 index has seen a rise of 1% over the last month or so, PFE stock is up a solid 19%. This also compares with -10% returns for its peer \u2013 Merck, and 5% growth for Johns\u2026", "url": "https://www.forbes.com/sites/greatspeculations/2021/12/17/will-pfizer-stock-see-higher-levels-after-a-large-18-rise-in-a-month/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F5fc9f88165fd2c07cd02256e%2F0x0.jpg", "publishedAt": "2021-12-17T12:00:35Z", "content": "The logo of US multinational pharmaceutical company Pfizer, is pictured at a factory in Puurs, where ... [+] Covid-19 vaccines are being produced for Britain, on December 3, 2020. - Britain on Decemb\u2026 [+12559 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Mason Bissada, Forbes Staff, \n Mason Bissada, Forbes Staff\n https://www.forbes.com/sites/masonbissada/", "title": "Pfizer Requests Full Approval For Covid-19 Vaccine For 12- To 15-Year-Olds", "description": "The pharmaceutical company said in November its vaccine gave the age group 100% long-term protection against the virus.", "url": "https://www.forbes.com/sites/masonbissada/2021/12/16/pfizer-requests-full-approval-for-covid-19-vaccine-for-12to-15-year-olds/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61bbeb234f4c89e82741ffb0%2F0x0.jpg", "publishedAt": "2021-12-17T01:43:52Z", "content": "Pfizer and BioNTech announced Thursday they have asked the Food and Drug Administration to fully approve their Covid-19 vaccine for children ages 12 to 15, citing data that showed the shot gave 100% \u2026 [+3059 chars]"}, {"source": {"id": null, "name": "Snopes.com"}, "author": "Dan Evon", "title": "Did Pfizer CEO Say COVID-19 Vaccines Contain Microchips?", "description": "A 2018 video featuring Albert Bourla had nothing to do with COVID-19 or vaccines.", "url": "https://www.snopes.com/fact-check/pfizer-bourla-vaccine-microchip/", "urlToImage": "https://www.snopes.com/tachyon/2021/12/world-economic-forum.jpg", "publishedAt": "2021-12-17T18:24:00Z", "content": "Snopes is still fighting an infodemic of rumors and misinformation surrounding the COVID-19 pandemic, and you can help. Find out what weve learned and how to inoculate yourself against COVID-19 misin\u2026 [+6107 chars]"}]}, "2021-12-16": {"status": "ok", "totalResults": 98, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "New Zealand approves Pfizer vaccine for children aged 5-11 years - Reuters", "description": "New Zealand's health regulator Medsafe has granted provisional approval for the Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> COVID-19 vaccine for children aged 5 to 11 years old, the health ministry said in a statem\u2026", "url": "https://www.reuters.com/world/asia-pacific/new-zealand-approves-pfizer-vaccine-children-aged-5-11-years-2021-12-16/", "urlToImage": "https://www.reuters.com/resizer/pySIyOfuU2gCA_JQhapeN-v53DU=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/LIIKYWVBYVILXMO7PE3OIDLKBA.jpg", "publishedAt": "2021-12-16T00:21:00Z", "content": "A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/IllustrationWELLINGTON, Dec 16 (Reuters) \u2026 [+661 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer files for full FDA approval of COVID-19 vaccine in adolescents - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and its German partner BioNTech SE  said on Thursday they have filed for full approval of their COVID-19 vaccine with the U.S. Food and Drug Administration to include ado\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-files-full-fda-approval-covid-19-vaccine-adolescents-2021-12-16/", "urlToImage": "https://www.reuters.com/resizer/cwGkwK-smqTh4lr2uCTbyuSdIHw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/YMX4DCRRGRNANNKVGSPMYL3K6U.jpg", "publishedAt": "2021-12-16T22:54:00Z", "content": "Dec 16 (Reuters) - Pfizer Inc (PFE.N) and its German partner BioNTech SE said on Thursday they have filed for full approval of their COVID-19 vaccine with the U.S. Food and Drug Administration to inc\u2026 [+1165 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Japan adds Moderna shot to COVID vaccine booster arsenal, joining Pfizer - Reuters", "description": "Japan on Thursday officially approved Moderna Inc's <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> COVID-19 vaccine for its booster shot programme that began this month.", "url": "https://www.reuters.com/world/asia-pacific/japan-adds-moderna-shot-covid-vaccine-booster-arsenal-joining-pfizer-2021-12-16/", "urlToImage": "https://www.reuters.com/resizer/DNWCKjP-UTc21x4Fij5lqVdfy-U=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/LXZ7Q7HUERO4LJ6MQSEN5X7GLE.jpg", "publishedAt": "2021-12-16T03:19:00Z", "content": "TOKYO, Dec 16 (Reuters) - Japan on Thursday officially approved Moderna Inc's (MRNA.O) COVID-19 vaccine for its booster shot programme that began this month.\r\nThe move followed a recommendation from \u2026 [+1316 chars]"}, {"source": {"id": null, "name": "CP24 Toronto's Breaking News"}, "author": "Lauran Neergaard And Mike Stobbe", "title": "CDC panel recommends Pfizer, Moderna vaccines over Johnson & Johnson shot - CP24 Toronto's Breaking News", "description": "<ol><li>CDC panel recommends Pfizer, Moderna vaccines over Johnson & Johnson shot\u00a0\u00a0CP24 Toronto's Breaking News\r\n</li><li>CDC recommends Moderna, Pfizer COVID-19 vaccines over J&J's\u00a0\u00a0National Post\r\n</li><li>Pfizer, Moderna Covid Shots Preferred Over J&J's, CD\u2026", "url": "https://www.cp24.com/world/cdc-panel-recommends-pfizer-moderna-vaccines-over-johnson-johnson-shot-1.5710521", "urlToImage": "https://www.cp24.com/polopoly_fs/1.5704853.1639399008!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-16T20:56:47Z", "content": "Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson &amp; Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday.\r\nThe strange \u2026 [+5281 chars]"}, {"source": {"id": null, "name": "HuffPost"}, "author": "AP", "title": "CDC Panel Recommends Pfizer, Moderna Vaccines Over J&J Shot", "description": "U.S. health advisers are recommending that most Americans get the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot.", "url": "https://www.huffpost.com/entry/cdc-johnson-johnson-pfizer_n_61bbb1cfe4b0bf370338955c", "urlToImage": "https://img.huffingtonpost.com/asset/61bbb1d1280000b98d7ece6f.jpeg?ops=1778_1000", "publishedAt": "2021-12-16T21:43:20Z", "content": "Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson &amp; Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday.\r\nThe st\u2026 [+3898 chars]"}, {"source": {"id": "abc-news", "name": "ABC News"}, "author": "Cheyenne Haslett", "title": "CDC committee recommends opting for Pfizer or Moderna over J&J when there's a choice", "description": "The rare blood clots are not a new safety concern, and the vaccine has already become far less common in the US.", "url": "https://abcnews.go.com/Politics/cdc-committee-recommends-opting-pfizer-moderna-jj-choice/story?id=81797560", "urlToImage": "https://s.abcnews.com/images/Health/connecticut-covid-01-gty-llr-211207_1638927273426_hpMain_16x9_992.jpg", "publishedAt": "2021-12-16T21:15:53Z", "content": "The CDC's advisory committee recommended Thursday that people who have a choice should get an mRNA vaccine, either Pfizer or Moderna, over the single-shot Johnson &amp; Johnson vaccine after a review\u2026 [+5774 chars]"}, {"source": {"id": "usa-today", "name": "USA Today"}, "author": "USA TODAY, Elizabeth Weise, USA TODAY", "title": "CDC panel recommends Pfizer, Moderna COVID vaccines over Johnson & Johnson for people 18 and older", "description": "A CDC panel recommended the Pfizer and Moderna\u00a0COVID-19 vaccines be preferred over J&J's due to the chance of rare but dangerous blood clots.", "url": "https://www.usatoday.com/story/news/health/2021/12/16/cdc-panel-recommends-pfizer-moderna-covid-vaccines-over-johnson-johnson/8929073002/", "urlToImage": "https://www.gannett-cdn.com/-mm-/b2b05a4ab25f4fca0316459e1c7404c537a89702/c=0-0-1365-768/local/-/media/2021/12/14/USATODAY/usatsports/imageForEntry27-1pA.jpg?auto=webp&format=pjpg&width=1200", "publishedAt": "2021-12-16T20:43:10Z", "content": "A CDC panel voted Thursday to\u00a0recommend the Pfizer and Moderna\u00a0COVID-19 vaccines be preferred for adults\u00a0over the Johnson &amp; Johnson vaccine due to a small number of very rare but dangerous blood \u2026 [+1368 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Jessica Rendall", "title": "CDC committee recommends Moderna, Pfizer vaccines over Johnson & Johnson's - CNET", "description": "A panel that advises the CDC says the agency should adopt the recommendation because of a rare but dangerous blood-clotting disorder that's been linked to the J&J vaccine.", "url": "https://www.cnet.com/health/medical/cdc-committee-recommends-moderna-pfizer-vaccines-over-johnson-johnsons/", "urlToImage": "https://www.cnet.com/a/img/DIokPAs8y4IzuE2lt70Pd09OPeg=/1200x630/2021/12/16/e86b83cb-e165-43a8-8b87-d4e55ca8a78e/gettyimages-1312932254-1.jpg", "publishedAt": "2021-12-16T23:03:01Z", "content": "Getty Images\r\nA committee of scientists and doctors that give guidance to the US Centers for Disease Control and Prevention voted Thursday to recommend Pfizer's and Moderna's COVID-19 vaccines over J\u2026 [+2860 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Tracy Withers", "title": "New Zealand Provisionally Approves Pfizer Vaccine for Ages 5-11", "description": "New Zealand\u2019s medicines regulator has provisionally approved the use of the Pfizer Covid-19 vaccine for children aged five to 11.", "url": "https://www.bloomberg.com/news/articles/2021-12-16/new-zealand-provisionally-approves-pfizer-vaccine-for-ages-5-11", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iN8.lELke3bU/v0/1200x800.jpg", "publishedAt": "2021-12-16T00:28:00Z", "content": "New Zealands medicines regulator has provisionally approved the use of the Pfizer Covid-19 vaccine for children aged five to 11.\r\nThe provisional approval is for two doses of the pediatric vaccine gi\u2026 [+162 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Eric Volkman)", "title": "Why Moderna and Pfizer Beat the Market Today", "description": "An influential advisory committee burnishes the reputations of the two companies' coronavirus vaccines, while one gets a glowing write-up about its COVID-19 pill.", "url": "https://www.fool.com/investing/2021/12/16/why-moderna-and-pfizer-beat-the-market-today/", "urlToImage": "https://g.foolcdn.com/editorial/images/657886/pregnant-woman-receiving-a-vaccine-jab.jpg", "publishedAt": "2021-12-16T23:10:00Z", "content": "What happened\r\nModerna(NASDAQ:MRNA) and Pfizer(NYSE:PFE), makers of two of the three coronavirus vaccines authorized for use in the U.S., both outpaced the sagging S&amp;P 500 index on Thursday. Mode\u2026 [+1957 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Corinne Gretler, Naomi Kresge", "title": "Pfizer Covid Pill Can Be Used to Treat Adults, EU Regulator Says", "description": "A European Union advisory committee said Pfizer Inc.\u2019s experimental antiviral pill against Covid-19 can be used to treat adults, opening up another potential tool as the region prepares for the possibility of a wave of infections from the omicron variant.", "url": "https://www.bloomberg.com/news/articles/2021-12-16/pfizer-covid-pill-can-be-used-to-treat-adults-eu-regulator-says", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ilD.HvfJkruY/v0/1200x801.jpg", "publishedAt": "2021-12-16T15:55:13Z", "content": "A European Union advisory committee said \r\nPfizer Inc.s experimental antiviral pill against Covid-19 can be used to treat adults, opening up another potential tool as the region prepares for the poss\u2026 [+476 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "James Paton", "title": "Pfizer Will Dominate $20 Billion Covid-Pill Market in 2022, Analysis Shows", "description": "Large-scale generic-drug production\u00a0likely won\u2019t come until 2023, data firm says", "url": "https://www.bloomberg.com/news/articles/2021-12-16/pfizer-pfe-will-dominate-20-billion-covid-pill-market-in-2022-analysis-shows", "urlToImage": "https://assets.bwbx.io/s3/javelin/public/javelin/images/social-default-a4f15fa7ee.jpg", "publishedAt": "2021-12-16T17:06:16Z", "content": "Pfizer Inc. is set to dominate a $20 billion market for Covid pills next year as richer nations rush to purchase supplies, while less affluent countries will have to wait until early 2023 for generic\u2026 [+6410 chars]"}, {"source": {"id": null, "name": "The Guardian"}, "author": "Guardian staff and agencies", "title": "CDC advisers recommend Pfizer and Moderna vaccines over Johnson & Johnson", "description": "The panel cited the risk of rare but sometimes fatal cases of blood clotting as well as a lower level of effectiveness against Covid in the J&J shotA panel of outside advisers to the Centers for Disease Control and Prevention (CDC) on Thursday voted to recomm\u2026", "url": "https://amp.theguardian.com/world/2021/dec/16/cdc-recommends-pfizer-moderna-covid-vaccines", "urlToImage": "https://i.guim.co.uk/img/media/6e3691e2c807c7d650dd1f54edf96269ad0905e9/0_138_5760_3456/master/5760.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=bb5c6f06e8e13f6fd5a6ee801e00be8a", "publishedAt": "2021-12-16T21:41:03Z", "content": "A panel of outside advisers to the Centers for Disease Control and Prevention (CDC) on Thursday voted to recommend directing Americans towards the mRNA vaccines for protection against Covid-19 meanin\u2026 [+2256 chars]"}, {"source": {"id": null, "name": "SlashGear"}, "author": "Brittany A. Roston", "title": "CDC advisers recommend Pfizer, Moderna vaccines over Johnson & Johnson", "description": "When possible, advisers with the US Centers for Disease Control and Prevention say the public should choose Pfizer or Moderna\u2019s COVID-19 vaccines over the Johnson & Johnson version. The agency has published a lengthy presentation from the Advisory Committee o\u2026", "url": "https://www.slashgear.com/cdc-advisers-recommend-pfizer-moderna-vaccines-over-johnson-johnson-16702992/", "urlToImage": "https://cdn.slashgear.com/wp-content/uploads/2021/12/CDC-johnson-covid-vaccine-change-recommendation.jpg", "publishedAt": "2021-12-16T22:26:33Z", "content": "When possible, advisers with the US Centers for Disease Control and Prevention say the public should choose Pfizer or Moderna\u2019s COVID-19 vaccines over the Johnson &amp; Johnson version. The agency ha\u2026 [+3830 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "Reuters", "title": "Covid-19: New Zealand approves Pfizer vaccine for children aged 5-11 years", "description": "The provisional approval is for two doses of the paediatric Pfizer Covid-19 vaccine, given at least 21 days apart, New Zealand\u2019s health regulator  said.", "url": "https://indianexpress.com/article/world/new-zealand-approves-pfizer-vaccine-for-children-aged-5-11-years-7675416/", "urlToImage": "https://images.indianexpress.com/2021/11/2021-11-01T011127Z_871970238_RC2A7O9F52KN_RTRMADP_3_PFIZER-RESULTS.jpg", "publishedAt": "2021-12-16T03:54:13Z", "content": "New Zealands health regulator Medsafe has granted provisional approval for the Pfizer Inc Covid-19 vaccine for children aged 5 to 11 years old, the health ministry said in a statement.The provisional\u2026 [+280 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Marisa Dellatto, Forbes Staff, \n Marisa Dellatto, Forbes Staff\n https://www.forbes.com/sites/marisadellatto/", "title": "Moderna, Pfizer Covid Vaccines Should Be Given Over Johnson & Johnson\u2019s, CDC Advisory Board Says", "description": "The CDC has not yet decided if it will accept the recommendation and remove the shot from the market.", "url": "https://www.forbes.com/sites/marisadellatto/2021/12/16/moderna-pfizer-covid-vaccines-should-be-given-over-johnson--johnsons-cdc-advisory-board-says/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61bbc1c67f7a2a18cd91fb68%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D3244%26cropY1%3D0%26cropY2%3D1825", "publishedAt": "2021-12-16T22:49:31Z", "content": "A Centers For Disease Control and Prevention advisory board recommended Thursday that Moderna and Pfizers Covid-19 vaccines should be administered rather than Johnson &amp; Johnsons one-dose shot, ci\u2026 [+2152 chars]"}, {"source": {"id": null, "name": "Designtaxi.com"}, "author": "Alexa Heah", "title": "Pfizer Says New COVID-19 Pill Could Help Treat Rapidly-Spreading Omicron", "description": "Image ID 210332358 \u00a9 via Esther19775 | Dreamstime.com\n\nIn mid-November, Pfizer announced it was seeking approval from the US Food and Drug Administration (FDA) for its COVID-19 treatment pill, which could potentially help treat patients at a higher risk of de\u2026", "url": "https://designtaxi.com/news/417049/Pfizer-Says-New-COVID-19-Pill-Could-Help-Treat-Rapidly-Spreading-Omicron/", "urlToImage": "https://editorial.designtaxi.com/editorial-images/news-PfizerPillVariant161221/Pfizer-Pill-Variant-1.jpeg", "publishedAt": "2021-12-16T05:10:10Z", "content": "Image ID 210332358 \u00a9 via Esther19775 | Dreamstime.comIn mid-November, Pfizer announced it was seeking approval from the US Food and Drug Administration (FDA) for its COVID-19 treatment pill, which co\u2026 [+2547 chars]"}, {"source": {"id": null, "name": "Fox Business"}, "author": "Paul Best", "title": "CDC recommends Pfizer and Moderna vaccines over Johnson & Johnson due to rare blood clotting issue - Fox Business", "description": "The CDC now recommends that Americans take the mRNA vaccines made by Pfizer and Moderna instead of the one-shot Johnson & Johnson vaccine due to\u00a0rare but serious blood clots.", "url": "https://www.foxbusiness.com/economy/cdc-advisory-panel-recommends-pfizer-and-modern-vaccines-over-johnson-johnson", "urlToImage": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2021/07/0/0/Johnson-Johnson-Vaccine-Delta.jpg?ve=1&tl=1", "publishedAt": "2021-12-16T20:59:28Z", "content": "The CDC now recommends that Americans take the mRNA vaccines made by Pfizer and Moderna instead of the one-shot Johnson &amp; Johnson vaccine due to\u00a0rare but serious blood clots.\r\nThe agency's Adviso\u2026 [+3870 chars]"}, {"source": {"id": "national-review", "name": "National Review"}, "author": "Brittany Bernstein, Brittany Bernstein", "title": "CDC Panel Recommends Pfizer, Moderna Vaccines over J&J Due to Rare Blood Clot Cases", "description": "The vote serves to discourage vaccine providers and American adults from using the one-dose vaccine.", "url": "https://www.nationalreview.com/news/cdc-panel-recommends-pfizer-moderna-vaccines-over-jj-due-to-rare-blood-clot-cases/", "urlToImage": "https://www.nationalreview.com/wp-content/uploads/2021/05/vaccine.jpg?fit=2057%2C1200", "publishedAt": "2021-12-16T22:11:15Z", "content": "A healthcare worker prepares a dose of the Johnson &amp; Johnson vaccine in New York, May 12, 2021.(Carlo Allegri/Reuters)\r\nA CDC advisory panel on Thursday voted to recommend that adults 18 and over\u2026 [+2344 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "Alexander Alexander", "title": "CDC advisers recommend Pfizer or Moderna over J&J's COVID vaccine", "description": "A rare side effect is linked to nine deaths out of more than 16 million people vaccinated with the J&J shot.", "url": "https://www.cbsnews.com/news/covid-19-vaccine-johnson-and-johnson-cdc-blood-clots/", "urlToImage": "https://cbsnews1.cbsistatic.com/hub/i/r/2021/06/30/2af201f1-bcb0-4519-aaa6-248a8560db92/thumbnail/1200x630/bce167e7be958e871ec5050979cf38c7/gettyimages-1232542683.jpg", "publishedAt": "2021-12-16T21:13:05Z", "content": "A panel of the CDC's outside vaccine advisers voted unanimously Thursday to back recommendations preferring Pfizer and Moderna's COVID-19 vaccines over Johnson &amp; Johnson's, in light of new data p\u2026 [+5024 chars]"}]}, "2021-12-15": {"status": "ok", "totalResults": 58, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations - Reuters", "description": "Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and BioNtech <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> are set to displace AstraZeneca <a href=\"https://www.reuters.com/companies/AZ\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-set-oust-astrazeneca-top-supplier-covid-19-shots-poor-nations-2021-12-15/", "urlToImage": "https://www.reuters.com/resizer/zqVKXHnosclneKBBNjva9dTGYBU=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/RVB4EWSAT5PKHCFJME7AYIOIOQ.jpg", "publishedAt": "2021-12-15T06:03:00Z", "content": "BRUSSELS, Dec 15 (Reuters) - Pfizer (PFE.N) and BioNtech (22UAy.DE) are set to displace AstraZeneca (AZN.L) as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 20\u2026 [+4223 chars]"}, {"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "The Zacks Analyst Blog Highlights: Pfizer, Arena Pharma, Merck, Jazz Pharm and Sanofi", "description": "The Zacks Analyst Blog Highlights: Pfizer, Arena Pharma, Merck, Jazz Pharm and Sanofi", "url": "http://www.zacks.com/stock/news/1839444/the-zacks-analyst-blog-highlights-pfizer-arena-pharma-merck-jazz-pharm-and-sanofi?cid=CS-ENTREPRENEUR-FT-press_releases-1839444", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-402829.jpeg", "publishedAt": "2021-12-15T10:00:00Z", "content": "For Immediate Release\r\nChicago, IL December 15, 2021 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and even\u2026 [+6118 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "The Hill", "title": "Pfizer requests EMERGENCY authorization for 'effective' Covid antiviral pill as deaths near 800,000", "description": "Ryan Grim and Robby Soave weigh in on the Senate debt ceiling vote, as well as Pfizer's efforts to earn FDA approval for their antiviral Covid treatment...", "url": "https://news.yahoo.com/pfizer-requests-emergency-authorization-effective-134000505.html", "urlToImage": "https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/15/61b9f2d124ffa931eb944a22/61b9f2d124ffa931eb944a23_o_U_v2.jpg", "publishedAt": "2021-12-15T13:40:00Z", "content": "The study, published in the Nature Medicine journal, compared the risks of myocarditis, pericarditis and cardiac arrhythmia following a first and second dose of COVID-19 vaccines from AstraZeneca-Oxf\u2026 [+309 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "CBS News Videos", "title": "South African study says two doses of Pfizer vaccine 70% effective against Omicron hospitalization", "description": "A new study out of South Africa claims that two doses of Pfizer's COVID vaccine give up to 70% protection against hospitalization from the Omicron variant...", "url": "https://news.yahoo.com/south-african-study-says-double-131839618.html", "urlToImage": "https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/15/61b9eddb24ffa931eb94386e/61b9eddb24ffa931eb94386f_o_U_v2.jpg", "publishedAt": "2021-12-15T13:18:39Z", "content": "Scientists say they finally have an explanation for a mystifying, bright blue light that came from deep in space. Three years ago, astronomers were stunned to see a bright blue flash that came out of\u2026 [+360 chars]"}, {"source": {"id": null, "name": "Theonion.com"}, "author": "ji39f8deollek3", "title": "Pfizer Granted Emergency Use For Pill That Kills You Before Covid Can", "description": "WASHINGTON\u2014Stressing that the \u201crevolutionary treatment\u201d could change the way we fight the novel coronavirus, drug manufacturer Pfizer was granted emergency use authorization Wednesday for a pill that kills you before Covid can. \u201cAfter several months of testin\u2026", "url": "https://www.theonion.com/pfizer-granted-emergency-use-for-pill-that-kills-you-be-1848214138", "urlToImage": "https://i.kinja-img.com/gawker-media/image/upload/c_fill,f_auto,fl_progressive,g_center,h_675,pg_1,q_80,w_1200/fee9c5e72e74900965511976af843be8.jpg", "publishedAt": "2021-12-15T15:55:00Z", "content": "WASHINGTONStressing that the revolutionary treatment could change the way we fight the novel coronavirus, drug manufacturer Pfizer was granted emergency use authorization Wednesday for a pill that ki\u2026 [+1086 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Joe Tenebruso)", "title": "Why Pfizer Stock Jumped Today", "description": "Even more gains could lie ahead for the vaccine maker's investors.", "url": "https://www.fool.com/investing/2021/12/15/why-pfizer-stock-jumped-today/", "urlToImage": "https://g.foolcdn.com/editorial/images/657690/buy-gettyimages-986757634.jpg", "publishedAt": "2021-12-15T21:04:47Z", "content": "What happened\r\nShares of\u00a0Pfizer(NYSE:PFE) rose on Wednesday, following positive analyst commentary.\r\nAs of 3:30 p.m. ET, the drugmaker's stock price was up more than 5%.\u00a0\r\nSo what\u00a0\r\nOn Monday, UBS an\u2026 [+1600 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Janice Kew, Antony Sguazzin", "title": "Pfizer Shots And Prior Infection May Protect Better Against Omicron, South African Scientists Say", "description": "A two dose course of Pfizer Inc. and BioNTech SE\u2019s Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from South Africa\u2019s Africa Health Research Institute said.", "url": "https://www.bloomberg.com/news/articles/2021-12-15/pfizer-prior-infection-may-see-better-covid-shield-ahri-says", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ime4J9y9QFxg/v0/1200x800.jpg", "publishedAt": "2021-12-15T18:14:20Z", "content": "A two dose course of \r\nPfizer Inc. and \r\nBioNTech SEs Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from South Af\u2026 [+759 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Robert Hart, Forbes Staff, \n Robert Hart, Forbes Staff\n https://www.forbes.com/sites/roberthart/", "title": "Pfizer, Moderna Vaccines Less Effective Against Delta In Elderly And Protection Wanes Rapidly Four Months After Second Covid Shot, Study Finds", "description": "The mRNA shots were around 20% effective at preventing infection with delta in males over age 65 months five through seven after completing vaccination.", "url": "https://www.forbes.com/sites/roberthart/2021/12/15/pfizer-moderna-vaccines-less-effective-against-delta-in-elderly-and-protection-wanes-rapidly-four-months-after-second-covid-shot-study-finds/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61ba13a4011ae60a27cce11f%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D5524%26cropY1%3D229%26cropY2%3D3337", "publishedAt": "2021-12-15T16:17:31Z", "content": "Pfizer and Modernas Covid-19 vaccines are much less effective at preventing infection of senior citizens with the delta coronavirus variant and protection fades rapidly four months after the final ja\u2026 [+2824 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Francesco Guarascio", "title": "Pfizer set to oust AstraZeneca as top supplier of Covid-19 shots to poor nations", "description": "UNICEF and WHO warn about insufficient supply of auto-disable syringes", "url": "https://www.independent.co.uk/news/health/pfizer-astrazeneca-supplier-covid19-poor-b1976406.html", "urlToImage": "https://static.independent.co.uk/2021/12/14/16/6d8dd759c7035de31ae7c5577063190dY29udGVudHNlYXJjaGFwaSwxNjM5NTgzNzYx-2.64080164.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-15T14:01:12Z", "content": "Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of Covid-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows the increasing importance of thei\u2026 [+3890 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "CBS News", "title": "South African study says two doses of Pfizer vaccine 70% effective against Omicron hospitalization", "description": "A new study out of South Africa claims that two doses of Pfizer's COVID vaccine give up to 70% protection against hospitalization from the Omicron variant, despite an increase in children being hospitalized by the new variant. Debora Patta speaks with a pedia\u2026", "url": "https://www.cbsnews.com/video/south-african-study-says-two-doses-of-pfizer-vaccine-70-effective-against-omicron-hospitalization/", "urlToImage": "https://cbsnews2.cbsistatic.com/hub/i/r/2021/12/15/0c14c571-9409-4358-9342-a0986f2f4f8a/thumbnail/1200x630/1c7a68f2c92000536bb1c8e91795df07/1215-ctm-southafricaomicronvaxkids-patta-856412-640x360.jpg", "publishedAt": "2021-12-15T13:27:34Z", "content": "Watch CBSN Live\r\nCopyright \u00a9 2021 CBS Interactive Inc. All rights reserved.\r\nGet browser notifications for breaking news, live events, and exclusive reporting.\r\nNot NowTurn On"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Francesco Guarascio", "title": "Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations", "description": "Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 2022, a shift...", "url": "https://news.yahoo.com/pfizer-set-oust-astrazeneca-top-060325628.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/LvRqFqTnSbDXOXMO9IqPmA--~B/aD00OTQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/16d1e69b70a7746388246ff8d1255535", "publishedAt": "2021-12-15T06:03:25Z", "content": "By Francesco Guarascio\r\nBRUSSELS (Reuters) - Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 2022, a shift\u2026 [+4039 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Ya\u0451l Bizouati-Kennedy", "title": "Pfizer Stock Rises as Study Links COVID Pill to 89% Reduction of Hospitalization, Death", "description": "Pfizer released results of a recent study on Dec. 14, stating that its COVID-19 oral antiviral pill -- Paxlovid -- reduced risk of hospitalization or death...", "url": "https://finance.yahoo.com/news/pfizer-stock-rises-study-links-163125739.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/vcWWs8ULpWOYoSCj6_eICA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/uu/api/res/1.2/SBgxV33XseCek_XNCVPPSA--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/gobankingrates_644/5d2e7dc9f73c16aaf68a844c68dab3ce", "publishedAt": "2021-12-15T16:31:25Z", "content": "Spencer Platt / Getty Images\r\nPfizer released results of a recent study on Dec. 14, stating that its COVID-19 oral antiviral pill Paxlovid reduced risk of hospitalization or death by 89% within three\u2026 [+3499 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Research and Markets", "title": "European Drug Discovery Industry to 2030 - Featuring Bayer, Novartis and Pfizer Among Others", "description": "Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The \"Europe Drug Discovery Market 2020-2030 by Drug Type, Service, Process, Technology, Therapeutic Area, End User,...", "url": "https://finance.yahoo.com/news/european-drug-discovery-industry-2030-091300201.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/HP.E8HUfnyGeLtMAKwLgAQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "publishedAt": "2021-12-15T09:13:00Z", "content": "Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The \"Europe Drug Discovery Market 2020-2030 by Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Op\u2026 [+7547 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations", "description": "The expected change comes with headaches for receiving countries that lack sufficient cold storage capacity to handle the Pfizer vaccine, and amid risks of a shortage of syringes needed to administer that shot.", "url": "https://www.moneycontrol.com/news/trends/health-trends/pfizer-set-to-oust-astrazeneca-as-top-supplier-of-covid-19-shots-to-poor-nations-7827751.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/12/pfizer-astrazeneca-770x433.png", "publishedAt": "2021-12-15T06:23:52Z", "content": "Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of COVID-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows the increasing importance of thei\u2026 [+3812 chars]"}, {"source": {"id": null, "name": "AllAfrica - Top Africa News"}, "author": "VOA", "title": "South Africa: Pfizer Vaccine Provides Protection Against Hospitalisation in Omicron Patients - New Studies", "description": "[VOA] A new study out of South Africa shows that Pfizer's two-dose COVID-19 vaccine provides a high degree of protection against hospitalization from the fast-spreading omicron variant.", "url": "https://allafrica.com/stories/202112150036.html", "urlToImage": "https://cdn08.allafrica.com/download/pic/main/main/csiid/00591463:1339f9991956e22b0818911cd9097902:arc614x376:w1200.jpg", "publishedAt": "2021-12-15T05:57:35Z", "content": "A new study out of South Africa shows that Pfizer's two-dose COVID-19 vaccine provides a high degree of protection against hospitalization from the fast-spreading omicron variant.\r\nThe real-world stu\u2026 [+4168 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Global Targeted Therapeutics Market Report 2021-2026 Featuring Major Players - Amgen, AstraZeneca, Boehringer Ingelheim, BMS, F. Hoffmann-La Roche, Pfizer, Novartis, Merck & Co., and Takeda", "description": "The \"Global Targeted Therapeutics Market 2021-2026\" report has been added to ResearchAndMarkets.com's offering.", "url": "https://finance.yahoo.com/news/global-targeted-therapeutics-market-report-170000380.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/wDGPSO44TROYKbQSONxNmQ--~B/aD00Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/e75ef6f3096d7cb6f5dd43ba82eca2fe", "publishedAt": "2021-12-15T17:00:00Z", "content": "DUBLIN, Dec. 15, 2021 /PRNewswire/ -- The \"Global Targeted Therapeutics Market 2021-2026\" report has been added to ResearchAndMarkets.com's offering.\r\nResearch and Markets Logo\r\nThe global market for\u2026 [+6228 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Research and Markets", "title": "Insights on the Over-The-Counter Consumer Health Products Global Market to 2026 - Featuring Abbott Laboratories, Bayer and Pfizer Among Others", "description": "Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The \"Over- The -Counter Consumer Health Products Market Research Report by Indications, Distribution Channel, and...", "url": "https://finance.yahoo.com/news/insights-over-counter-consumer-health-112800409.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/HP.E8HUfnyGeLtMAKwLgAQ--~B/aD01ODt3PTQ4MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/93d5b27580f67db722dd7c112e43e8bc", "publishedAt": "2021-12-15T11:28:00Z", "content": "Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The \"Over- The -Counter Consumer Health Products Market Research Report by Indications, Distribution Channel, and Region - Global Forecast to 2026 - Cumulati\u2026 [+8612 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Global Inflammatory Bowel Disease (IBD) Market 2021-2026 Featuring Johnson & Johnson, AbbVie, Takeda, Pfizer, Roche, Celgene, GlaxoSmithKline, Novartis, UCB and Eli Lilly & Co", "description": "The \"Global Inflammatory Bowel Disease (IBD) Market - Analysis By Disease Indication (Crohn's Disease, Ulcerative Colitis), Drug Class, Distribution Channel,...", "url": "https://finance.yahoo.com/news/global-inflammatory-bowel-disease-ibd-213000545.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/wDGPSO44TROYKbQSONxNmQ--~B/aD00Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/e75ef6f3096d7cb6f5dd43ba82eca2fe", "publishedAt": "2021-12-15T21:30:00Z", "content": "DUBLIN, Dec. 15, 2021 /PRNewswire/ -- The \"Global Inflammatory Bowel Disease (IBD) Market - Analysis By Disease Indication (Crohn's Disease, Ulcerative Colitis), Drug Class, Distribution Channel, By \u2026 [+4803 chars]"}, {"source": {"id": null, "name": "BloombergQuint"}, "author": "Janice Kew, Antony Sguazzin", "title": "Pfizer Shots And Prior Infection May Protect Better Against Omicron, South African Scientists Say - BloombergQuint", "description": "<ol><li>Pfizer Shots And Prior Infection May Protect Better Against Omicron, South African Scientists Say\u00a0\u00a0BloombergQuint\r\n</li><li>US study suggests Covid-19 vaccines may be ineffective against Omicron without booster\u00a0\u00a0Times of India\r\n</li><li>Omicron Is Mil\u2026", "url": "https://www.bloombergquint.com/business/pfizer-prior-infection-may-see-better-covid-shield-ahri-says", "urlToImage": "https://gumlet.assettype.com/bloombergquint%2F2018-08%2F3a8e2237-2edb-4494-bcf2-231993fb6108%2FBLOOMBERG_LOGO.png?rect=0%2C56%2C1920%2C1008&w=1200&auto=format%2Ccompress&ogImage=true", "publishedAt": "2021-12-15T18:44:08Z", "content": "(Bloomberg) -- A two-dose course of Pfizer Inc. and BioNTech SEs Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists fr\u2026 [+2142 chars]"}, {"source": {"id": null, "name": "Newkerala.com"}, "author": "Naveen", "title": "Pfizer, Moderna, J and Js Covid vax less effective against Omicron: Study - newkerala.com - New Kerala", "description": "<ol><li>Pfizer, Moderna, J and Js Covid vax less effective against Omicron: Study - newkerala.com\u00a0\u00a0New Kerala\r\n</li><li>J&J Shot Loses Antibody Protection Against Omicron In Study\u00a0\u00a0NDTV\r\n</li><li>Matter of time before Omicron variant becomes dominant strain i\u2026", "url": "https://www.newkerala.com/news/2021/176522.htm", "urlToImage": null, "publishedAt": "2021-12-15T21:25:12Z", "content": "New York, Dec 15: Vaccines developed by US drugmakers Pfizer, Moderna, Johnson and Johnson against Covid-19 have proved to be less effective against the new super mutant Omicron variant that has now \u2026 [+2686 chars]"}]}, "2021-12-14": {"status": "ok", "totalResults": 189, "articles": [{"source": {"id": null, "name": "New York Times"}, "author": "Remy Tumin", "title": "Pfizer, Antarctica, James Webb Telescope: Your Tuesday Evening Briefing", "description": "Here\u2019s what you need to know at the end of the day.", "url": "https://www.nytimes.com/2021/12/14/briefing/pfizer-antarctica-james-webb-telescope.html", "urlToImage": "https://static01.nyt.com/images/2021/12/14/multimedia/14evening-briefing-01-promo/14evening-briefing-01-facebookJumbo.jpg", "publishedAt": "2021-12-14T23:07:44Z", "content": "10. And finally, hot ho-ho-home markets.\r\nPartly because of the pandemic, partly because of the small-town appeal (and prices) and partly because of the vibe, real estate in Santa-centric towns is bo\u2026 [+755 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "The New York Times", "title": "Pfizer Pill Protects Against Severe Disease, Including From Omicron, Study Says", "description": "The company said the pill reduced the risk of hospitalization and death by 89 percent if given within three days of the onset of symptoms. It\u2019s been one year since the first vaccine dose in the U.S.", "url": "https://www.nytimes.com/live/2021/12/14/world/covid-omicron-vaccines", "urlToImage": "https://static01.nyt.com/images/2021/12/14/us/14virus-brief-vaccination-promo/14virus-brief-vaccination-promo-facebookJumbo.jpg", "publishedAt": "2021-12-14T12:00:59Z", "content": "A highly anticipated study of Pfizers Covid pill confirmed that it helps stave off severe disease, the company announced on Tuesday.\r\nPfizer also said its antiviral pill worked in laboratory studies \u2026 [+4003 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Pfizer vaccine less effective against hospitalization: study - Reuters", "description": "Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70% protection against hospitalization in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant. Soraya Ali repor\u2026", "url": "https://www.reuters.com/video/watch/idOVF80NJ3N", "urlToImage": "https://static.reuters.com/resources/r/?d=20211214&i=OVF80NJ3N&r=OVF80NJ3N&t=2", "publishedAt": "2021-12-14T17:51:52Z", "content": "Posted \r\nTwo doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70% protection against hospitalization in South Africa in recent weeks, according to a major real-world study which sugge\u2026 [+71 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer vaccine protecting against hospitalisation during Omicron wave - study - Reuters", "description": "Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70% protection against hospitalisation in South Africa in recent weeks, a major real-world study on the potential impact of Omicron showed on Tuesday, as the country battles a spike in infec\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-vaccine-protecting-against-hospitalisation-during-omicron-wave-study-2021-12-14/", "urlToImage": "https://www.reuters.com/resizer/0o67-UJ5isqUSocj2LzQrtgmFHU=/728x381/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZGQTHP6LK5OBJGQQ3OEWNLNXTY.jpg", "publishedAt": "2021-12-14T09:14:00Z", "content": "JOHANNESBURG, Dec 14 (Reuters) - Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70% protection against hospitalisation in South Africa in recent weeks, a major real-world study \u2026 [+2466 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Swiss to start Pfizer/BioNTech jab for children aged 5-11 in January - Reuters", "description": "Swiss health authorities will start administering the COVID-19 vaccination from Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and BioNTech <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</\u2026", "url": "https://www.reuters.com/world/europe/swiss-start-pfizerbiontech-jab-children-aged-5-11-january-2021-12-14/", "urlToImage": "https://www.reuters.com/resizer/qW0LWALO_2OCSHBEdLMCzbbHMdw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/CBK2MELTPNJ7JJUIUGWP2A7564.jpg", "publishedAt": "2021-12-14T13:28:00Z", "content": "Shoppers are seen under Christmas illuminations, amid the spread of the coronavirus disease (COVID-19), on the Bahnhofstrasse street in Zurich, Switzerland December 11, 2021. REUTERS/Arnd WiegmannZUR\u2026 [+1086 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer says COVID-19 pill near 90% effective in final analysis - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent l\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-says-covid-19-pill-near-90-effective-final-analysis-2021-12-14/", "urlToImage": "https://www.reuters.com/resizer/6ajCUtrS6UDOyJ4bG5tJuu6YRLg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/QDROFKF225L55I36I7TMPUEFZA.jpg", "publishedAt": "2021-12-14T11:54:00Z", "content": "NEW YORK, Dec 14 (Reuters) - Pfizer Inc (PFE.N) on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk pat\u2026 [+3516 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Biden: U.S. has ordered enough Pfizer anti-viral pills to treat 10 million Americans - Reuters", "description": "U.S. President Joe Biden said on Tuesday he is encouraged by data released by Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> on its COVID-19 anti-viral medicine and his administration has ordered enough of the pills t\u2026", "url": "https://www.reuters.com/world/us/biden-us-has-ordered-enough-pfizer-anti-viral-pills-treat-10-million-americans-2021-12-14/", "urlToImage": "https://www.reuters.com/resizer/xo2BngNMVGyDfM3L-IaQeQ8APVE=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/2MGQF64MONKWBBDTYJHGC4OKGM.jpg", "publishedAt": "2021-12-14T20:46:00Z", "content": "U.S. President Joe Biden speaks prior to signing an executive order intended to reduce bureaucracy around government services for the public, in the Oval Office at the White House in Washington, U.S.\u2026 [+748 chars]"}, {"source": {"id": null, "name": "The Guardian"}, "author": "Richard Luscombe", "title": "Pfizer says pill is effective in protecting against severe disease from Covid", "description": "Experimental antiviral pill Paxlovid is also effective against the Omicron variant, company announcesA pill manufactured by the prominent Covid-19 vaccine provider Pfizer is highly effective in protecting against severe disease from coronavirus, the company s\u2026", "url": "https://amp.theguardian.com/world/2021/dec/14/pfizer-covid-pill-effective-protecting-against-severe-disease-omicron", "urlToImage": "https://i.guim.co.uk/img/media/9e4197db69f2ccb31b06e256d6efbba16a3689f6/0_0_2200_1321/master/2200.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=20c118090d0e6d3ba936c2a6a2d941e6", "publishedAt": "2021-12-14T15:22:23Z", "content": "A pill manufactured by the prominent Covid-19 vaccine provider Pfizer is highly effective in protecting against severe disease from coronavirus, the company said on Tuesday.\r\nThe experimental antivir\u2026 [+3333 chars]"}, {"source": {"id": null, "name": "Healthday.com"}, "author": "Robert Preidt", "title": "Omicron Resists Pfizer Vaccine But Causes Less Severe Disease: Study - The Suburban Newspaper", "description": "<ol><li>Omicron Resists Pfizer Vaccine But Causes Less Severe Disease: Study\u00a0\u00a0The Suburban Newspaper\r\n</li><li>Data indicates Omicron is milder, better at evading vaccines\u00a0\u00a0CTV News\r\n</li><li>Why omicron is overtaking delta \u2014 and what that means for our fight\u2026", "url": "https://consumer.healthday.com/b-12-14-omicron-resists-vaccines-more-but-causes-less-severe-disease-study-2656024787.html", "urlToImage": "https://bloximages.newyork1.vip.townnews.com/thesuburban.com/content/tncms/assets/v3/editorial/9/cb/9cb8ecd0-4148-58de-971a-1905816207c3/61b8ca3538e2e.image.jpg?crop=600%2C315%2C0%2C15&resize=600%2C315&order=crop%2Cresize", "publishedAt": "2021-12-14T15:43:15Z", "content": "TUESDAY, Dec. 14, 2021 (HealthDay News) -- Compared to previous coronavirus variants, Omicron appears to cause less severe illness, but is more resistant to the Pfizer vaccine, researchers at South A\u2026 [+2331 chars]"}, {"source": {"id": null, "name": "CP24 Toronto's Breaking News"}, "author": "Andrew Meldrum", "title": "Pfizer coronavirus vaccine provides 70 per cent protection against hospitalization by Omicron variant - CP24 Toronto's Breaking News", "description": "<ol><li>Pfizer coronavirus vaccine provides 70 per cent protection against hospitalization by Omicron variant\u00a0\u00a0CP24 Toronto's Breaking News\r\n</li><li>LIVE: The WHO gives an update as Omicron variant spreads\u00a0\u00a0Reuters\r\n</li><li>Why omicron is overtaking delta \u2014\u2026", "url": "https://www.cp24.com/world/pfizer-vaccine-protects-70-per-cent-against-hospitalization-from-omicron-1.5706309", "urlToImage": "https://www.cp24.com/polopoly_fs/1.5478753.1624274569!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-14T11:24:00Z", "content": "JOHANNESBURG (AP) -- The omicron variant appears to cause less severe disease than previous versions of the coronavirus, and the Pfizer vaccine seems to offer less defense against infection from it b\u2026 [+4586 chars]"}, {"source": {"id": null, "name": "Marginalrevolution.com"}, "author": "Tyler Cowen", "title": "Will China ever get Pfizer?", "description": "As Covid-19 started spreading in Wuhan early last year, Chinese billionaire Guo Guangchang\u2019s drugmaker appeared to have scored a big win: A partnership with Germany\u2019s\u00a0BioNTech SE, which went on to produce with\u00a0Pfizer Inc.\u00a0one of the world\u2019s most successful va\u2026", "url": "https://marginalrevolution.com/marginalrevolution/2021/12/will-china-ever-get-pfizer.html", "urlToImage": "https://marginalrevolution.com/wp-content/uploads/2016/10/MR-logo-thumbnail.png", "publishedAt": "2021-12-14T18:35:00Z", "content": "As Covid-19 started spreading in Wuhan early last year, Chinese billionaire Guo Guangchangs drugmaker appeared to have scored a big win: A partnership with Germanys\u00a0BioNTech SE, which went on to prod\u2026 [+691 chars]"}, {"source": {"id": "associated-press", "name": "Associated Press"}, "author": "Matthew Perrone", "title": "Pfizer Confirms COVID Pill's Results, Potency Versus Omicron", "description": "WASHINGTON (AP) \u2014 Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant.  The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug red\u2026", "url": "https://apnews.com/article/coronavirus-pandemic-science-business-health-1662719827498fa2b1a4f168c7723688", "urlToImage": "https://storage.googleapis.com/afs-prod/media/d7cf4607f2e74468a1fee27fb57f1560/2000.jpeg", "publishedAt": "2021-12-14T12:35:58Z", "content": "WASHINGTON (AP) Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. \r\nThe company also said full results of its 2,250-person study confirmed the pil\u2026 [+3249 chars]"}, {"source": {"id": null, "name": "NPR"}, "author": "Scott Hensley", "title": "Pfizer data shows that its COVID-19 pill is effective against severe disease", "description": "The research finds that the medicine, called Paxlovid, was effective in preventing hospitalization and death when taken by people with mild to moderate illness within a few days of symptoms.", "url": "https://www.npr.org/sections/health-shots/2021/12/14/1064030639/pfizer-covid-19-pill-paxlovid-data", "urlToImage": "https://media.npr.org/assets/img/2021/12/14/gettyimages-1349260353_wide-32fb9407b30bce6e04eba60d86fb13f4234e774d.jpg?s=1400", "publishedAt": "2021-12-14T12:41:01Z", "content": "A COVID-19 pop-up testing sits stands on a Manhattan street in October in New York City. On Tuesday, Pfizer released promising data about a pill to treat COVID-19.\r\nSpencer Platt/Getty Images\r\nPfizer\u2026 [+1595 chars]"}, {"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Pfizer jab protects against hospitalisation with Omicron: Study", "description": "South Africa study finds two doses of Pfizer's COVID shot appear to provide 70% protection against hospitalisation.", "url": "https://www.aljazeera.com/news/2021/12/14/pfizer-jab-protecting-against-hospitalisation-during-omicron-wave", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2021/12/2021-11-25T112539Z_665301519_RC2N1R9ISHXV_RTRMADP_3_HEALTH-CORONAVIRUS-AFRICA.jpg?resize=1200%2C630", "publishedAt": "2021-12-14T12:08:25Z", "content": "Two doses of Pfizer-BioNTechs COVID-19 vaccine appear to provide 70 percent protection against hospitalisation from the Omicron coronavirus variant, according to an extensive real-world study in Sout\u2026 [+3070 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Janice Kew", "title": "Pfizer Stops 70% Omicron Hospitalizations in S. Africa Study", "description": "A two-shot course of Pfizer Inc.\u2019s vaccination may offer 70% protection against being hospitalized with the Covid-19 omicron variant, South Africa\u2019s largest medical-insurance provider Discovery Ltd. said.", "url": "https://www.bloomberg.com/news/articles/2021-12-14/pfizer-stops-70-omicron-hospitalizations-in-south-african-study", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/isTZdmqb_XQI/v1/1200x800.jpg", "publishedAt": "2021-12-14T09:44:04Z", "content": "A two-shot course of \r\nPfizer Inc.s vaccination may offer 70% protection against being hospitalized with the Covid-19 omicron variant, South Africas largest medical-insurance provider \r\nDiscovery Ltd\u2026 [+1224 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Robert Langreth", "title": "Pfizer Covid Pill Stops Hospitalizations, Not Milder Symptoms", "description": "New study data showed Pfizer Inc.\u2019s experimental Covid-19 pill was highly effective at keeping patients out of the hospital, but less adept at erasing milder symptoms often associated with breakthrough infections.", "url": "https://www.bloomberg.com/news/articles/2021-12-14/pfizer-covid-pill-stops-hospitalizations-not-milder-symptoms", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iZ.dsa1OA.ZE/v1/1200x801.jpg", "publishedAt": "2021-12-14T11:45:00Z", "content": "New study data showed \r\nPfizer Inc.s experimental Covid-19 pill was highly effective at keeping patients out of the hospital, but less adept at erasing milder symptoms often associated with breakthro\u2026 [+338 chars]"}, {"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Pfizer says its COVID pill near 90% effective in clinical trials", "description": "Company says it can have 180,000 treatment courses ready to ship this year.", "url": "https://www.aljazeera.com/news/2021/12/14/pfizer-covid-19-pill-near-90-percent-effective-in-clinical-trial", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2021/12/000_9RR8X8.jpg?resize=1024%2C630", "publishedAt": "2021-12-14T14:18:08Z", "content": "Pfizer Inc has said the final analysis of its antiviral COVID-19 pill showed close to 90 percent efficacy in preventing hospitalisations and deaths in high-risk patients with recent lab data suggesti\u2026 [+2719 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "HealthDay", "title": "Pfizer: Final Data Shows COVID Pill Stays Strong Against Severe Illness", "description": "The latest results reinforce earlier reports that Pfizer\u2019s drug cuts hospitalizations and deaths when taken within three to five days of the start of symptoms.", "url": "https://www.webmd.com/lung/news/20211214/pfizer-says-final-data-shows-covid-pill-stays-strong-against-severe-illness", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/other/pharmacist_filling_prescription_pill_bottle_other/1800x1200_pharmacist_filling_prescription_pill_bottle_other.jpg", "publishedAt": "2021-12-14T15:05:44Z", "content": "TUESDAY, Dec. 14, 2021 (HealthDay News) -- Pfizer Inc. announced Tuesday that a final analysis shows its experimental antiviral pill Paxlovid sharply reduced hospitalizations and deaths among people \u2026 [+2663 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "Carl Zimmer and Rebecca Robbins", "title": "Pfizer Says Its Covid Pill Will Protect Against Severe Disease, Even From Omicron", "description": "The company said the pill, Paxlovid, reduced the risk of hospitalization and death by 89 percent if given within three days of the onset of symptoms.", "url": "https://www.nytimes.com/2021/12/14/health/pfizer-covid-pill-paxlovid.html", "urlToImage": "https://static01.nyt.com/images/2021/12/03/14virus-briefing-Pfizer/14virus-briefing-Pfizer-facebookJumbo-v2.jpg", "publishedAt": "2021-12-14T11:45:03Z", "content": "Mikael Dolsten, the chief scientific officer of Pfizer, was exuberant about the results after having overseen the development of the drug since the spring of 2020, with more than 200 company scientis\u2026 [+2361 chars]"}, {"source": {"id": "axios", "name": "Axios"}, "author": "Tina Reed", "title": "Pfizer says new data confirms COVID pill efficacy", "description": "Pfizer released new data Tuesday morning confirming Paxlovid, its oral antiviral pill for COVID, reduced the risk of hospitalization or death by 89% in high-risk adults.Driving the news: The company said it shared the Phase 2/3 data with the FDA as part of it\u2026", "url": "https://www.axios.com/pfizer-covid-pill-paxlovid-efficacy-22730d78-9587-4586-9cc8-8431c4cc0880.html", "urlToImage": "https://images.axios.com/-E8bGeWgXtUvV_BPiHyl91Doovo=/0x185:6048x3587/1366x768/2021/12/14/1639483422553.jpg", "publishedAt": "2021-12-14T12:06:48Z", "content": "Pfizer released new data Tuesday morning confirming Paxlovid, its oral antiviral pill for COVID, reduced the risk of hospitalization or death by 89% in high-risk adults.\r\nDriving the news: The compan\u2026 [+1010 chars]"}]}, "2021-12-13": {"status": "ok", "totalResults": 55, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer to acquire Arena Pharmaceuticals in $6.7 bln deal - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> has agreed to acquire Arena Pharmaceuticals <a href=\"https://www.reuters.com/companies/ARNA.O\" target=\"_blank\">(ARNA.O)</a> in a $6.7 billion all-cash deal to expand its \u2026", "url": "https://www.reuters.com/markets/deals/pfizer-acquire-arena-pharmaceuticals-67-bln-deal-2021-12-13/", "urlToImage": "https://www.reuters.com/resizer/KgX0WtFBM-zpivynlZiuO-HO5qg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/HLQD2IA4QBJSVG5SMQV3K4RARU.jpg", "publishedAt": "2021-12-13T11:20:00Z", "content": "Pfizer logo seen outside their building in Manhattan, New York City, New York, U.S., March 2, 2021. REUTERS/Carlo AllegriDec 13 (Reuters) - Pfizer Inc (PFE.N) has agreed to acquire Arena Pharmaceutic\u2026 [+889 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "insider@insider.com (Carla Moz\u00e9e)", "title": "Arena Pharmaceuticals soars 97% as Pfizer to spend $6.7 billion to buy ulcerative colitis drug developer", "description": "Arena's stock surge comes after the price this year had dropped by 35%.", "url": "https://markets.businessinsider.com/news/stocks/arena-pharmaceuticals-stock-price-pfizer-purchase-acquisition-plan-arna-2021-12", "urlToImage": "https://images2.markets.businessinsider.com/619f6d74ee9795001883e392?format=jpeg", "publishedAt": "2021-12-13T14:31:13Z", "content": "Carlo Allegri/Reuters\r\nShares of Arena Pharmaceuticals almost doubled in price Monday after Pfizer said it's reached a $6.7 billion deal to buy the Boston-based developer of medicines targeting immun\u2026 [+1497 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "James Paton", "title": "Pfizer to Purchase Arena at 100% Premium in $6.7 Billion Deal", "description": "Pfizer Inc. agreed to buy Arena Pharmaceuticals Inc. in a deal valued at about $6.7 billion, gaining potential therapies targeting immuno-inflammatory diseases.", "url": "https://www.bloomberg.com/news/articles/2021-12-13/pfizer-to-acquire-arena-in-deal-valued-at-6-7-billion", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/imFZGzAOhrFE/v0/1200x800.jpg", "publishedAt": "2021-12-13T12:07:46Z", "content": "Pfizer Inc. agreed to buy \r\nArena Pharmaceuticals Inc. in a deal valued at about $6.7 billion, gaining potential therapies targeting immuno-inflammatory diseases.\r\nThe U.S. drugmaker will pay $100 a \u2026 [+941 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Keith Speights)", "title": "How Much Will COVID Boosters for Teens Impact Pfizer and BioNTech?", "description": "Probably not very much.", "url": "https://www.fool.com/investing/2021/12/13/how-much-will-covid-boosters-for-teens-impact-pfiz/", "urlToImage": "https://g.foolcdn.com/editorial/images/656787/gettyimages-1307014774.jpg", "publishedAt": "2021-12-13T16:45:00Z", "content": "Pfizer( PFE 5.14% ) and BioNTech( BNTX 4.99% ) received expanded U.S. Emergency Use Authorization (EUA) of booster doses of their COVID-19 vaccine to teens ages 16 and 17 last week. In this Motley Fo\u2026 [+1866 chars]"}, {"source": {"id": null, "name": "TheStreet"}, "author": "Scott Rutt", "title": "Cramer's Mad Money Recap 12/13: Bank of America, Ford, Pfizer", "description": "Jim Cramer says a strong, diversified portfolio will serve you well into 2022.", "url": "https://www.thestreet.com/jim-cramer/cramers-mad-money-recap-dec-13-2021", "urlToImage": "https://www.thestreet.com/.image/t_share/MTY4NjQ5NTQ2OTI3Nzc3Njg3/not-all-low-volatility-funds-equal-says-intech-ceo.jpg", "publishedAt": "2021-12-13T19:27:00Z", "content": "Don't stray too far from the beaten path, Jim Cramer told his Mad Money viewers Monday. There may not be very many winners in this market, but the winners are likely to keep on winning.\r\nTypically, a\u2026 [+6612 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Nina Massey", "title": "Pfizer and AstraZeneca jabs \u2018induce fewer antibodies against Omicron\u2019", "description": "Researchers have said there is currently no evidence of increased potential to cause severe disease.", "url": "https://www.independent.co.uk/news/uk/astrazeneca-pfizer-omicron-antibodies-university-of-oxford-b1974976.html", "urlToImage": "https://static.independent.co.uk/2021/12/13/11/94dfc158cbf1416e55209f325a153386Y29udGVudHNlYXJjaGFwaSwxNjM5NDgwODg5-2.63932995.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-13T13:15:30Z", "content": "Two doses of the Pfizer and AstraZeneca Covid-19 vaccines induce lower levels of antibodies against Omicron a new study suggests.\r\nResearchers said the findings indicate the new variant has the poten\u2026 [+3175 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer to buy Arena Pharmaceuticals for $6.7 billion", "description": "Pfizer will take over all outstanding shares of Arena for $100 per share, representing a 100.2% premium to Arena's last closing price.  Arena is developing...", "url": "https://finance.yahoo.com/news/pfizer-buy-arena-pharmaceuticals-6-112905695.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/Kmx3htSmvM9TgCW63cvjEw--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters-finance.com/b850f0d83569433c9aa21c77674829fa", "publishedAt": "2021-12-13T11:29:05Z", "content": "(Reuters) - Pfizer Inc has agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline, the companies said on Monday.\r\nPfi\u2026 [+637 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer to Acquire Arena Pharmaceuticals", "description": "NEW YORK & PARK CITY, Utah--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Arena, a clinical stage company dev\u2026", "url": "https://www.businesswire.com/news/home/20211213005204/en/Pfizer-to-Acquire-Arena-Pharmaceuticals", "urlToImage": "https://mms.businesswire.com/media/20211213005204/en/1045874/23/Pfizer_Logo_Color_RGB_APPROVED.jpg", "publishedAt": "2021-12-13T11:50:35Z", "content": "NEW YORK &amp; PARK CITY, Utah--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the companies have entered into a definitive agreement und\u2026 [+14110 chars]"}, {"source": {"id": null, "name": "Investor's Business Daily"}, "author": "Investor's Business Daily", "title": "Pfizer Stock Up, Arena Stock Soars On Merger - Investor's Business Daily", "description": "<ol><li>Pfizer Stock Up, Arena Stock Soars On Merger\u00a0\u00a0Investor's Business Daily\r\n</li><li>Pfizer bets on Arena Pharmaceuticals' promising bowel disease treatment in $6.7 billion deal\u00a0\u00a0CNBC\r\n</li><li>Pfizer to acquire Arena Pharmaceuticals for $6.7 billion\u00a0\u00a0Ya\u2026", "url": "https://www.investors.com/news/technology/pfizer-stock-up-arena-stock-soars-on-merger/", "urlToImage": "https://www.investors.com/wp-content/uploads/2021/12/IT01-arenapharma-01-news.jpg", "publishedAt": "2021-12-13T15:56:00Z", "content": "Covid vaccine maker Pfizer (PFE) said Monday it plans to acquire Arena Pharmaceuticals (ARNA) for $100 a share, in a deal worth an estimated $6.7 billion. The news sent Arena stock rocketing and gave\u2026 [+2145 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "Vaccines and omicron: What we know about how variant responds to Pfizer, AstraZeneca and Moderna jabs", "description": "New jabs to target latest strain could be produced by March 2022", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-jab-pfizer-astrazeneca-moderna-b1974863.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-13T09:48:27Z", "content": "The omicron variant of Covid-19 has begun to spread in the UK, with Boris Johnson warning of a tidal wave of infections hitting these shores if the public do not observe social restrictions and get t\u2026 [+7169 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "James Paton and Riley Griffin", "title": "Pfizer to Purchase Arena at 100% Premium in $6.7 Billion Deal", "description": "(Bloomberg) -- Pfizer Inc. agreed to buy Arena Pharmaceuticals Inc. in a deal valued at about $6.7 billion that brings potential therapies targeting immuno...", "url": "https://finance.yahoo.com/news/pfizer-purchase-arena-100-premium-120746456.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/KYbPCc_2pDZKU55Re0BLiw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/uu/api/res/1.2/1yeqk97B_8wqhnzOeFKooQ--~B/aD0xMzM0O3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_markets_842/e3aa4001712ff1a45b601607745d6d2c", "publishedAt": "2021-12-13T12:07:46Z", "content": "(Bloomberg) -- Pfizer Inc. agreed to buy Arena Pharmaceuticals Inc. in a deal valued at about $6.7 billion that brings potential therapies targeting immuno-inflammatory diseases.\r\nMost Read from Bloo\u2026 [+1988 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "John Csiszar", "title": "How Pfizer and Moderna Are Faring a Year Into Mass COVID-19 Vaccinations", "description": "Pfizer and Moderna were the first two companies to get emergency approval for COVID-19 vaccinations, which they began distributing in earnest at the...", "url": "https://finance.yahoo.com/news/pfizer-moderna-faring-mass-covid-233127713.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/jFPIwkxajTME43xlgmSv_g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/uu/api/res/1.2/jvbWsRItuvYnIOej7VAmtw--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/gobankingrates_644/4c92cd07b99923bc023b257c9096e377", "publishedAt": "2021-12-13T23:31:27Z", "content": "Spencer Platt / Getty Images\r\nPfizer and Moderna were the first two companies to get emergency approval for COVID-19 vaccinations, which they began distributing in earnest at the beginning of 2021. A\u2026 [+3381 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Shareholder Alert: Ademi LLP investigates whether Arena Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Pfizer Inc.", "description": "Ademi LLP is investigating Arena (Nasdaq: ARNA), for possible breaches of fiduciary duty and other violations of law in its transaction Pfizer.", "url": "https://finance.yahoo.com/news/shareholder-alert-ademi-llp-investigates-222200944.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/aNtqK.M_4mlFIhoU1.T7bA--~B/aD0xNTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/47b59738751d31639b8bc7e27514ae1e", "publishedAt": "2021-12-13T22:22:00Z", "content": "MILWAUKEE, Dec. 13, 2021 /PRNewswire/ -- Ademi LLP is investigating Arena (Nasdaq: ARNA), for possible breaches of fiduciary duty and other violations of law in its transaction Pfizer.\r\nAdemiLogo (PR\u2026 [+1691 chars]"}, {"source": {"id": null, "name": "FierceBiotech"}, "author": "Annalee Armstrong", "title": "UPDATE: Pfizer books Arena for immuno-inflammatory portfolio in $6.7B deal", "description": "Arena Pharmaceuticals has been in need of a new R&D show since a phase 2 pain drug flopped earlier this year, and, now, the biotech has landed the biggest ticket in town: Pfizer. The Big Pharma will add Arena to its bill in a deal valued at $6.7 billion, brin\u2026", "url": "https://www.fiercebiotech.com/biotech/pfizer-books-arena-for-immuno-inflammatory-portfolio-6-7b-deal", "urlToImage": "https://qtxasset.com/fiercebiotech/1639404752/PfizerHQsignone.jpg/PfizerHQsignone.jpg?VersionId=BIDLjv1NUH1fwnsUt_Se17qfoQybA9ED", "publishedAt": "2021-12-13T14:12:49Z", "content": "Arena Pharmaceuticals has been in need of a new R&amp;D show since a phase 2 pain drug flopped earlier this year, and, now, the biotech has landed the biggest ticket in town: Pfizer.\r\nThe Big Pharma \u2026 [+5867 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Omicron Strain Could Reduce Effectiveness of Pfizer Shots by More Than 30 Times - Study", "description": "BEIJING (Sputnik) - The Pfizer/BioNTech vaccine could be over 30 times less effective against the Omicron strain of the coronavirus than other variants, a new study reveals.", "url": "https://sputniknews.com/20211213/omicron-strain-could-reduce-effectiveness-of-pfizer-shots-by-more-than-30-times---study-1091473377.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091473377.jpg?10911336251639360501", "publishedAt": "2021-12-13T01:55:00Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nThe new COVID variant was initially detected in South Africa and Botswana and sparked major concerns due to its high number\u2026 [+4176 chars]"}, {"source": {"id": null, "name": "Shtfplan.com"}, "author": "Mac Slavo", "title": "Pfizer Documents Reveal A Whole SLEW Of Side Effects From The COVID Shot", "description": "Documents released by the Food and Drug Administration (FDA) reveal that drugmaker Pfizer recorded nearly 160,000 adverse reactions to its Covid-19 vaccine in the initial months of its rollout. And the FDA still went ahead and authorized the drug for use.\nThe\u2026", "url": "https://www.shtfplan.com/headline-news/pfizer-documents-reveal-a-whole-slew-of-side-effects-from-the-covid-shot", "urlToImage": "https://www.shtfplan.com/wp-content/uploads/2021/07/covidvaccine-e1626440798888.jpg", "publishedAt": "2021-12-13T18:30:22Z", "content": "Documents released by the Food and Drug Administration (FDA) reveal that drugmaker Pfizer recorded nearly 160,000 adverse reactions to its Covid-19 vaccine in the initial months of its rollout. And t\u2026 [+2713 chars]"}, {"source": {"id": null, "name": "Boston Herald"}, "author": "Associated Press", "title": "Pfizer to pay $6.7B in cash for Arena Pharmaceuticals", "description": "NEW YORK (AP) \u2014 Pfizer is spending $6.7 billion to buy a drugmaker that is developing treatments for inflammatory conditions like Chrohn\u2019s disease but has no products on the market.", "url": "https://www.bostonherald.com/2021/12/13/pfizer-to-pay-6-7b-in-cash-for-arena-pharmaceuticals/", "urlToImage": "https://www.bostonherald.com/wp-content/uploads/2021/12/Pfizer_Results_51310.jpg?w=1024&h=682", "publishedAt": "2021-12-13T14:13:30Z", "content": "The Associated Press\r\nNEW YORK (AP) Pfizer is spending $6.7 billion to buy a drugmaker that is developing treatments for inflammatory conditions like Chrohns disease but has no products on the market\u2026 [+917 chars]"}, {"source": {"id": null, "name": "CNBC"}, "author": "Reuters", "title": "Pfizer to acquire Arena Pharmaceuticals in $6.7 billion deal", "description": "Pfizer has entered into a definitive agreement to acquire Arena Pharmaceuticals in a $6.7 billion deal, a regulatory filing showed on Monday.", "url": "https://www.cnbc.com/2021/12/13/pfizer-to-acquire-arena-pharmaceuticals-in-6point7-billion-deal-.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/106788033-16049416212020-11-09t165323z_136326159_rc2szj9nfzx8_rtrmadp_0_health-coronavirus-vaccines-pfizer.jpeg?v=1604941677", "publishedAt": "2021-12-13T11:45:00Z", "content": "Pfizer has entered into a definitive agreement to acquire Arena Pharmaceuticals in a $6.7 billion deal, a regulatory filing showed on Monday.\r\nPfizer will take over all outstanding shares of Arena fo\u2026 [+562 chars]"}, {"source": {"id": null, "name": "Barron's"}, "author": "Joe Woelfel", "title": "Buy Pfizer Stock Because Its Covid Pill Will Be a Big Seller, UBS Says", "description": "UBS expects antiviral pill Paxlovid to reach sales of at least $14 billion next year.", "url": "https://www.barrons.com/articles/pfizer-stock-price-upgrade-buy-covid-antirviral-pill-51639395479", "urlToImage": "https://images.barrons.com/im-427528/social", "publishedAt": "2021-12-13T14:46:00Z", "content": "Shares of \r\nPfizer\r\nwere upgraded to Buy from Neutral at UBS, with the firm writing that it expects antiviral pill Paxlovid to reach sales of at least $14 billion next year, or 40% above Wall Street \u2026 [+1139 chars]"}, {"source": {"id": null, "name": "Barron's"}, "author": "Callum Keown", "title": "Pfizer to Buy Arena Pharmaceuticals in $6.7 Billion Deal. Arena Stock Soars.", "description": "Pfizer agrees to buy U.S. biotech company Arena Pharmaceuticals in a deal valued at about $6.7 billion.", "url": "https://www.barrons.com/articles/pfizer-pfe-arena-pharmaceuticals-arna-acquisition-stock-51639396154", "urlToImage": "https://images.barrons.com/im-334275/social", "publishedAt": "2021-12-13T11:50:00Z", "content": "The U.S. pharma giant said the acquisition would expand its cancer and inflammatory disease drug pipeline.Shares in Arena Pharmaceuticals (ticker: ARNA) surged 93% to $96.45 in premarket trading, whi\u2026 [+973 chars]"}]}, "2021-12-12": {"status": "ok", "totalResults": 27, "articles": [{"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": "Dov Lieber", "title": "Pfizer Booster Shots Are Effective Against Omicron Variant, Israeli Study Says - The Wall Street Journal", "description": "<ol><li>Pfizer Booster Shots Are Effective Against Omicron Variant, Israeli Study Says\u00a0\u00a0The Wall Street Journal\r\n</li><li>'Three shots of Pfizer COVID vaccine 4x less effective against Omicron'\u00a0\u00a0The Jerusalem Post\r\n</li><li>Booster shots up to 75% effective a\u2026", "url": "https://www.wsj.com/articles/pfizer-booster-shots-are-effective-against-omicron-variant-israeli-study-says-11639317136", "urlToImage": "https://images.wsj.net/im-450677/social", "publishedAt": "2021-12-12T13:52:00Z", "content": "TEL AVIVA booster shot of Pfizer Inc. and BioNTech SE s Covid-19 vaccine provides good protection against severe illness from the Omicron variant, while those without a third shot are highly vulnerab\u2026 [+222 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Pfizer documents reveal variety of vaccine side effects", "description": "Documents released by the Food and Drug Administration (FDA) reveal that drugmaker Pfizer recorded nearly 160,000 adverse reactions to its Covid-19 vaccine in the initial months of its rollout. Read Full Article at RT.com", "url": "https://www.rt.com/usa/543001-pfizer-vaccine-side-effects/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61b661c585f54071355978bd.JPG", "publishedAt": "2021-12-12T21:17:07Z", "content": "The documents were obtained by a group of doctors, professors, and journalists calling themselves Public Health and Medical Professionals for Transparency, who filed a Freedom of Information Act (FOI\u2026 [+2269 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "David Averre, Reuters", "title": "Three shots of Pfizer vaccine DOES protect against Omicron, Israeli study shows", "description": "Gili Regev-Yochay, director of the Infectious Diseases Unit at Sheba Medical Centre which conducted the research, said a booster provides 'significant protection' against Omicron.", "url": "https://www.dailymail.co.uk/news/article-10302089/Three-shots-Pfizer-vaccine-DOES-protect-against-Omicron-Israeli-study-shows.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/12/20/51699021-0-image-a-6_1639339536399.jpg", "publishedAt": "2021-12-12T20:16:23Z", "content": "Israeli researchers have found that a three-shot course of the Pfizer/BioNTech COVID-19 vaccine provides significant protection against the new Omicron variant.\r\nThe study, carried out by Sheba Medic\u2026 [+5473 chars]"}, {"source": {"id": null, "name": "CNBC"}, "author": "Reuters", "title": "Israeli study finds Pfizer Covid booster protects against omicron variant", "description": "Israeli researchers said they found that a three-shot course of the Pfizer-BioNTech vaccine provided significant protection against the new omicron variant.", "url": "https://www.cnbc.com/2021/12/12/israeli-study-finds-pfizer-covid-booster-protects-against-omicron-variant.html", "urlToImage": "https://image.cnbcfm.com/api/v1/image/106984847-16387957942021-12-05t225115z_715541588_rc2g8r9ppg6q_rtrmadp_0_health-coronavirus-usa-children.jpeg?v=1638795846", "publishedAt": "2021-12-12T13:37:00Z", "content": "Israeli researchers said on Saturday they found that a three-shot course of the Pfizer-BioNTech Covid-19 vaccine provided significant protection against the new omicron variant.\r\nThe findings were si\u2026 [+1260 chars]"}, {"source": {"id": "newsweek", "name": "Newsweek"}, "author": "Thomas Kika", "title": "Protection From Omicron Jumps 100-Fold With Pfizer Booster Shot: Israeli Researchers", "description": "Compared to a two-dose track with the Pfizer vaccine, researchers found that getting a third booster reduces the chance of infection from Omicron significantly.", "url": "https://www.newsweek.com/protection-omicron-jumps-100-fold-pfizer-booster-shot-israeli-researchers-1658584", "urlToImage": "https://d.newsweek.com/en/full/1949929/israeli-research-omicron-vaccine-booster.jpg", "publishedAt": "2021-12-12T20:35:14Z", "content": "As the international medical community continues to study the Omicron variant, new research out of Israel suggests that available vaccines may be helpful.\r\nThe findings of a study carried out by Isra\u2026 [+2822 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "Reuters", "title": "Israeli study finds Pfizer Covid-19 booster protects against Omicron", "description": "The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identified variant.", "url": "https://indianexpress.com/article/world/israeli-study-finds-pfizer-covid-19-booster-protects-against-omicron-7668554/", "urlToImage": "https://images.indianexpress.com/2021/12/Pfizer-1.jpg", "publishedAt": "2021-12-12T04:25:37Z", "content": "The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identif\u2026 [+1082 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia A Gene Therapy", "description": "NEW YORK & BRISBANE, Calif.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec, an investiga\u2026", "url": "https://www.businesswire.com/news/home/20211212005051/en/Pfizer-and-Sangamo-Announce-Updated-Phase-12-Results-Showing-Sustained-Bleeding-Control-in-Highest-Dose-Cohort-Through-Two-Years-Following-Hemophilia-A-Gene-Therapy", "urlToImage": "https://mms.businesswire.com/media/20211212005051/en/736004/23/Sangamo_logoTM.jpg", "publishedAt": "2021-12-12T21:39:20Z", "content": "NEW YORK &amp; BRISBANE, Calif.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) andSangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Ph\u2026 [+15109 chars]"}, {"source": {"id": null, "name": "New York Post"}, "author": "Sam Raskin", "title": "Pfizer booster provides \u2018significant protection\u2019 against Omicron, study says", "description": "A third dose of Pfizer's COVID-19 vaccine provides \"significant protection\" against the Omicron variant of COVID-19, Israel researchers said Saturday.", "url": "https://nypost.com/2021/12/12/pfizer-covid-19-booster-protects-against-omicron-variant-study/", "urlToImage": "https://nypost.com/wp-content/uploads/sites/2/2021/12/ca-vaccination-168.jpg?quality=90&strip=all&w=1024", "publishedAt": "2021-12-12T14:06:58Z", "content": "A third dose of Pfizer\u2019s COVID-19 vaccine provides \u201csignificant protection\u201d against the Omicron variant of COVID-19, Israel researchers said Saturday. \r\nThe study, conducted by Sheba Medical Center a\u2026 [+2209 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Jonathan M Block", "title": "Israeli study bolsters efficacy of Pfizer/BioNTech COVID booster against Omicron", "description": "Three doses of the Pfizer/BioNTech COVID-19 provides protection against the Omicron variant, according to a new study from Israel.", "url": "https://seekingalpha.com/news/3779360-israeli-study-bolsters-effiicacy-of-pfizerbiontech-covid-booster-against-omicron", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304330723/large_image_1304330723.jpg", "publishedAt": "2021-12-12T17:23:25Z", "content": "narvikk/iStock via Getty Images"}, {"source": {"id": null, "name": "The Punch"}, "author": "Godfrey George", "title": "Omicron: Fourth dose needed to deal with new strain, says Pfizer", "description": "The Chief Executive of pharmaceutical giant, Pfizer, Dr Albert Bourla, has confirmed that a fourth COVID-19 jab will be needed to deal with Omicron. He warned that it would likely be required within a matter of months. Bourla has for weeks been floating the i\u2026", "url": "https://punchng.com/omicron-fourth-dose-needed-to-deal-with-new-strain-says-pfizer/", "urlToImage": "https://cdn.punchng.com/wp-content/uploads/2019/06/17163448/pfizer-logo.jpg", "publishedAt": "2021-12-12T00:03:24Z", "content": "The Chief Executive of pharmaceutical giant, Pfizer, Dr Albert Bourla, has confirmed that a fourth COVID-19 jab will be needed to deal with Omicron.\r\nHe warned that it would likely be required within\u2026 [+2321 chars]"}, {"source": {"id": null, "name": "Cracknewz.com"}, "author": "Neha", "title": "Pfizer CEO says fourth vaccine dose might be needed sooner than expected", "description": "", "url": "https://www.cracknewz.com/2021/12/pfizer-ceo-says-fourth-vaccine-dose.html", "urlToImage": null, "publishedAt": "2021-12-12T14:59:31Z", "content": "As people around the world line up to get their third-dose \u201cbooster\u201d shot of mRNA vaccines against COVID-19 due to waning protection from the first round, the CEO of Pfizer, Albert Bourla, has alread\u2026 [+3275 chars]"}, {"source": {"id": null, "name": "Cracknewz.com"}, "author": "Neha", "title": "Japan Health Ministry issues HEART WARNING for Pfizer and Moderna covid vaccines", "description": "", "url": "https://www.cracknewz.com/2021/12/japan-health-ministry-issues-heart.html", "urlToImage": null, "publishedAt": "2021-12-12T13:51:25Z", "content": "The Japan Health Ministry has been receiving several reports of\u00a0young people developing severe heart inflammation\u00a0after taking the Pfizer or Modern mRNA vaccines. The public health officials recently\u2026 [+3714 chars]"}, {"source": {"id": null, "name": "Zerohedge.com"}, "author": "Mike Rivero", "title": "Pfizer Jab Is Only 23% Effective Against Omicron, South African Study Finds", "description": "A few days ago, researchers in South Africa shared data from a preliminary study showing that the Pfizer vaccine is less effective at blocking the omicron variant than earlier variants like beta and delta. Now, the team is telling us exactly how much less eff\u2026", "url": "https://www.zerohedge.com/covid-19/pfizer-jab-only-23-against-omicron-south-african-study-finds", "urlToImage": "https://assets.zerohedge.com/s3fs-public/styles/16_9_max_700/public/2021-12/pfizer15.jpg?itok=YtSrbZHa", "publishedAt": "2021-12-12T13:34:33Z", "content": "A few days ago, researchers in South Africa shared data from a preliminary study showing that the Pfizer vaccine is less effective at blocking the omicron variant than earlier variants like beta and \u2026 [+3514 chars]"}, {"source": {"id": null, "name": "Cracknewz.com"}, "author": "Neha", "title": "BioNTech says three additional Pfizer covid vaccine doses needed to fight Omicron: total of SIX to be required for \u201cfull\u201d vaccination", "description": "", "url": "https://www.cracknewz.com/2021/12/biontech-says-three-additional-pfizer.html", "urlToImage": null, "publishedAt": "2021-12-12T14:12:58Z", "content": "Ugur Sahin, the CEO of BioNTech (Pfizer\u2019s \u201cvaccine\u201d partner), has\u00a0announced plans\u00a0to start selling a three-dose injection regimen specifically for the \u201cOmicron\u201d (Moronic) variant of the Wuhan coronav\u2026 [+3353 chars]"}, {"source": {"id": null, "name": "The Star Online"}, "author": "The Star Online", "title": "Israeli study finds Pfizer Covid-19 booster protects against Omicron", "description": "JERUSALEM (Reuters): Israeli researchers said on Saturday (Dec 12) that they found that a three-shot course of the Pfizer / BioNTech Covid-19 vaccine provided significant protection against the new Omicron variant. Read full story", "url": "https://www.thestar.com.my/news/world/2021/12/12/israeli-study-finds-pfizer-covid-19-booster-protects-against-omicron", "urlToImage": "https://apicms.thestar.com.my/uploads/images/2021/12/12/1403154.jpg", "publishedAt": "2021-12-12T02:57:00Z", "content": "JERUSALEM (Reuters): Israeli researchers said on Saturday (Dec 12) that they found that a three-shot course of the Pfizer / BioNTech Covid-19 vaccine provided significant protection against the new O\u2026 [+1317 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Israeli study finds Pfizer COVID-19 booster protects against omicron", "description": "Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech, COVID-19 vaccine provided significant protection against the new omicron variant.", "url": "https://bdnews24.com/coronavirus-pandemic/2021/12/12/israeli-study-finds-pfizer-covid-19-booster-protects-against-omicron", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/09/21/pfizer-vaccine-kids-smr-210921-01.jpg/BINARY/pfizer-vaccine-kids-smr-210921-01.jpg", "publishedAt": "2021-12-12T03:17:05Z", "content": "The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identif\u2026 [+1081 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Time", "title": "Pfizer Course Has 23% Efficacy Vs. Omicron in South African Study", "description": "A two-shot course of Pfizer Inc.\u2019s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South Africa.", "url": "https://freerepublic.com/focus/f-news/4020441/posts", "urlToImage": null, "publishedAt": "2021-12-12T03:34:36Z", "content": "Skip to comments.\r\nPfizer Course Has 23% Efficacy Vs. Omicron in South African StudyTime ^\r\n | 12/11/21\r\nPosted on 12/11/2021 7:34:36 PM PST by BusterDog\r\nA two-shot course of Pfizer Inc.s vaccine ha\u2026 [+1901 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Nation and State", "title": "Pfizer Jab Is Only 23% Effective Against Omicron, South African Study Finds", "description": "A few days ago, researchers in South Africa shared data from a preliminary study showing that the Pfizer vaccine is less effective at blocking the omicron variant than earlier variants like beta and delta. Now, the team is telling us exactly how much less eff\u2026", "url": "https://freerepublic.com/focus/f-chat/4020458/posts", "urlToImage": null, "publishedAt": "2021-12-12T05:32:44Z", "content": "Skip to comments.\r\nPfizer Jab Is Only 23% Effective Against Omicron, South African Study FindsNation and State ^\r\n | 12/11/2021\r\n | Tyler Durden\r\nPosted on 12/11/2021 9:32:44 PM PST by SeekAndFind\r\nA\u2026 [+4336 chars]"}, {"source": {"id": "the-hill", "name": "The Hill"}, "author": "Caroline Vakil", "title": "Israeli study supports Pfizer findings that booster provides strong protection against omicron", "description": "An Israeli study appears to support findings from Pfizer and BioNTech that\u00a0three doses of their vaccine, including a booster as well as\u00a0an initial two-shot regimen, provide\u00a0strong protection against the omicron vari...", "url": "https://thehill.com/policy/healthcare/585443-israeli-study-supports-pfizer-findings-that-booster-provides-strong", "urlToImage": "https://thehill.com/sites/default/files/article_images/coronavirus_vaccine_092421getty_companies.jpg", "publishedAt": "2021-12-12T01:19:30Z", "content": "An Israeli study appears to support findings from Pfizer and BioNTech that\u00a0three doses of their vaccine, including a booster as well as\u00a0an initial two-shot regimen, provide\u00a0strong protection against \u2026 [+2142 chars]"}, {"source": {"id": null, "name": "The Times of Israel"}, "author": null, "title": "Israeli study finds 2 Pfizer shots fail to neutralize Omicron, but booster effective", "description": "This data is \u2018very worrisome,' says study head, but those who received a third dose of the vaccine have cause for \u2018optimism'", "url": "https://www.timesofisrael.com/israeli-study-finds-2-pfizer-shots-fail-to-neutralize-omicron-but-booster-effective/", "urlToImage": "https://static.timesofisrael.com/www/uploads/2021/12/F211129DC02-1-1024x640.jpg", "publishedAt": "2021-12-12T08:17:29Z", "content": "People who were vaccinated with Pfizer shots six months ago or more have almost no neutralizing ability against the Omicron variant, while those who received boosters are in reasonably good shape, an\u2026 [+2730 chars]"}]}, "2021-12-11": {"status": "ok", "totalResults": 13, "articles": [{"source": {"id": null, "name": "Ctvnews.ca"}, "author": null, "title": "Pfizer booster shot protects against Omicron: Israeli study - CTV News", "description": "<ol><li>Pfizer booster shot protects against Omicron: Israeli study\u00a0\u00a0CTV News\r\n</li><li>Boosters give up to 75 percent protection from mild Omicron: UK\u00a0\u00a0Al Jazeera English\r\n</li><li>Pfizer Course Has 23% Efficacy Vs. Omicron in South African Study\u00a0\u00a0TIME\r\n</li\u2026", "url": "https://www.ctvnews.ca/health/coronavirus/israeli-study-finds-pfizer-covid-19-booster-protects-against-omicron-1.5703809", "urlToImage": "https://www.ctvnews.ca/polopoly_fs/1.5703811.1639255201!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-11T20:40:30Z", "content": "JERUSALEM -- \r\nIsraeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech COVID-19 vaccine provided significant protection against the new Omicron variant.\r\nThe f\u2026 [+1276 chars]"}, {"source": {"id": "time", "name": "Time"}, "author": "Antony Sguazzin / Bloomberg", "title": "Pfizer Course Has 23% Efficacy Vs. Omicron in South African Study", "description": "The research considered blood plasma samples from 12 participants", "url": "https://time.com/6127710/omicron-pfizer/", "urlToImage": "https://api.time.com/wp-content/uploads/2021/12/Pfizer.jpg?quality=85&w=1024&h=628&crop=1", "publishedAt": "2021-12-11T17:58:51Z", "content": "Bloomberg \u2014 A two-shot course of Pfizer Inc.\u2019s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experimen\u2026 [+1307 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Antony Sguazzin", "title": "Pfizer Course Has 23% Efficacy Vs. Omicron in S. African Study", "description": "A two-shot course of Pfizer Inc.\u2019s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South Africa.", "url": "https://www.bloomberg.com/news/articles/2021-12-11/pfizer-course-has-23-efficacy-vs-omicron-in-s-african-study", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iR1WCOedPmAo/v0/1200x738.jpg", "publishedAt": "2021-12-11T16:41:24Z", "content": "A two-shot course of \r\nPfizer Inc.s vaccine has just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South\u2026 [+138 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "CBS News", "title": "One year after first Pfizer vaccination, COVID case continue to rise", "description": "It has been exactly one year since the Food and Drug Administration authorized the Pfizer vaccine -- the first of three COVID-19 vaccines now in use in the United States. During that time, more than 480 million shots have been administered. But even with thos\u2026", "url": "https://www.cbsnews.com/video/one-year-after-first-pfizer-vaccination-covid-case-continue-to-rise/", "urlToImage": "https://cbsnews3.cbsistatic.com/hub/i/r/2021/12/11/f559d80a-0d64-4aab-9d0b-c1c7b21f4638/thumbnail/1200x630/e67d99bc6094ad80dcdc0393a3aa33b1/1211-satmo-covidlatest-853661-640x360.jpg", "publishedAt": "2021-12-11T13:32:38Z", "content": "Watch CBSN Live\r\nCopyright \u00a9 2021 CBS Interactive Inc. All rights reserved.\r\nGet browser notifications for breaking news, live events, and exclusive reporting.\r\nNot NowTurn On"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Pfizer Booster Gives Some Protection Against Omicron, Two Shots Not Enough - Study", "description": "TEL AVIV (Sputnik) - Two shots of the Pfizer vaccine against COVID-19 are not enough to protect people against the Omicron strain, while the booster shot's protection is much lower than with respect to other variants, a new study conducted at Israel\u2019s Sheba M\u2026", "url": "https://sputniknews.com/20211211/pfizer-booster-gives-some-protection-against-omicron-two-shots-not-enough---study-1091449420.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091449420.jpg?10913416961639261802", "publishedAt": "2021-12-11T22:30:00Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nhttps://sputniknews.com/20211211/pfizer-booster-gives-some-protection-against-omicron-two-shots-not-enough---study-10914494\u2026 [+3038 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ANI", "title": "Swiss medical agency approves Pfizer vaccine for children over 5", "description": "Europe News: ZURICH: The Swiss Agency for Therapeutic Products, Swissmedic on Friday approved the use of the Pfizer vaccine for children aged 5-11.", "url": "https://timesofindia.indiatimes.com/world/europe/swiss-medical-agency-approves-pfizer-vaccine-for-children-over-5/articleshow/88219632.cms", "urlToImage": "https://static.toiimg.com/thumb/msid-88219657,width-1070,height-580,imgsize-22902,resizemode-75,overlay-toi_sw,pt-32,y_pad-40/photo.jpg", "publishedAt": "2021-12-11T04:56:41Z", "content": "Swiss medical agency approves Pfizer vaccine for children over 5"}, {"source": {"id": null, "name": "Scoopyweb.com"}, "author": "unewsy", "title": "Vast majority of Britons have NO PROTECTION against Omicron: After 100 days two AstraZeneca doses offer virtually zero defence while two Pfizer jabs provide just 37% protection against new variant \u2013 but boosters cut risk of falling ill by 75%", "description": "Millions of Britons have effectively no protection against the Omicron Covid variant, health experts have warned as the public was urged to get their booster jabs - despite chaos on the NHS booking site meaning some can't get jabs until Christmas Eve.", "url": "http://www.scoopyweb.com/2021/12/vast-majority-of-britons-have-no.html", "urlToImage": "https://lh5.googleusercontent.com/proxy/7HVZkb3pPM9s5TfIFsXL4fDgb2SzXevFD5ceVvCWgJTL5WJ-bkjVecOOJCg4xr90jCJ-QRd4Skp4WRI5kGAIqitm4nv6GeOrVniblXA7akYBOb-k18QQ5Yxh8GKIW8wJ4bWqIGbO=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-11T12:55:15Z", "content": "Millions of Britons have effectively no protection against the\u00a0Omicron\u00a0Covid variant, health experts have warned as the public was urged to get their booster jabs - despite chaos on the NHS booking s\u2026 [+28397 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "IBT Times", "title": "552 Fully Vaccinated Oregon Residents Died Of COVID-19, Half Received Pfizer Vaccine", "description": "More than 500 residents in Oregon have now died of COVID-19 despite being fully vaccinated against the virus as health officials continue to report over 2,000 new infections daily. Since the beginning of the pandemic, health authorities in Oregon have recorde\u2026", "url": "https://freerepublic.com/focus/f-chat/4020313/posts", "urlToImage": null, "publishedAt": "2021-12-11T15:46:04Z", "content": "Skip to comments.\r\n552 Fully Vaccinated Oregon Residents Died Of COVID-19, Half Received Pfizer VaccineIBT Times ^\r\n | 12/06/2021\r\n | Danielle Ong\r\nPosted on 12/11/2021 7:46:04 AM PST by Jan_Sobieski\u2026 [+2192 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "NWT", "title": "33-Year-Old New Zealand Nurse Diagnosed With Pericarditis Following Pfizer COVID-19 Jab; 7th Person Admitted in One Day Suffering Heart Problem After Shot", "description": "We\u2019re told by pharmaceutical companies, mainstream media, and politicians on both sides of the aisle that adverse reactions to the COVID-19 injections are rare. But anyone with common sense knows that\u2019s a lie. Serious medical complications, such as myocarditi\u2026", "url": "https://freerepublic.com/focus/f-news/4020197/posts", "urlToImage": null, "publishedAt": "2021-12-11T02:36:17Z", "content": "Skip to comments.\r\n33-Year-Old New Zealand Nurse Diagnosed With Pericarditis Following Pfizer COVID-19 Jab; 7th Person Admitted in One Day Suffering Heart Problem After Shot\r\nNWT ^\r\n | 12/10/2021\r\nPo\u2026 [+2685 chars]"}, {"source": {"id": null, "name": "Ynetnews"}, "author": "Reuters", "title": "Israeli study finds Pfizer COVID-19 booster protects against Omicron", "description": "Joint study conducted by Sheba Medical Center, Health Ministry adds credence to Pfizer research proving that the booster could be key to protecting against newly identified Omicron variant", "url": "https://www.ynetnews.com/health_science/article/bk28kqm5t", "urlToImage": "https://ynet-images1.yit.co.il/picserver5/crop_images/2021/11/27/ryorNmxKF/ryorNmxKF_0_170_3000_1688_0_large.jpg", "publishedAt": "2021-12-11T21:03:46Z", "content": "<ul><li>facebook</li><li>print</li><li>send to friend</li><li>comment</li></ul>\r\nIsraeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech COVID-19 vaccine provi\u2026 [+1420 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Israeli study finds Pfizer COVID-19 booster protects against Omicron - Reuters", "description": "Israeli study finds Pfizer COVID-19 booster protects against OmicronReuters 'Three shots of Pfizer COVID vaccine 4x less effective against Omicron'The Jerusalem Post Omicron Cases, Vaccines and Boosters News: Covid-19 Live UpdatesThe New York Times Booster sh\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156420875", "urlToImage": null, "publishedAt": "2021-12-11T23:12:57Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": "the-irish-times", "name": "The Irish Times"}, "author": null, "title": "Pfizer booster provides significant protection against Omicron variant \u2013 study", "description": "Israeli research compared blood samples between two-dose group and booster group", "url": "https://www.irishtimes.com/news/world/pfizer-booster-provides-significant-protection-against-omicron-variant-study-1.4753298", "urlToImage": "https://www.irishtimes.com/image-creator/?id=1.4753297&origw=960", "publishedAt": "2021-12-11T20:44:10Z", "content": "Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech Covid-19 vaccine provided significant protection against the new Omicron variant.\r\nThe findings were si\u2026 [+190 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Israeli study finds Pfizer COVID-19 booster protects against Omicron", "description": "Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a>, <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> \u2026", "url": "https://www.reuters.com/world/middle-east/israeli-study-finds-pfizer-covid-19-booster-protects-against-omicron-2021-12-11/", "urlToImage": "https://www.reuters.com/resizer/_PpvTEOu1ldeGiWGRMkDndiUy5g=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/GZ24RWTXMZNJRBJFMYXAJDC2S4.jpg", "publishedAt": "2021-12-11T20:42:00Z", "content": "JERUSALEM, Dec 11 (Reuters) - Israeli researchers said on Saturday they found that a three-shot course of the Pfizer/BioNTech (PFE.N), (22UAy.DE) COVID-19 vaccine provided significant protection agai\u2026 [+1529 chars]"}]}, "2021-12-10": {"status": "ok", "totalResults": 43, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "South Africa to offer Pfizer and J&J vaccine booster doses - Reuters", "description": "South Africa is preparing to offer people booster doses of the Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and Johnson & Johnson <a href=\"https://www.reuters.com/companies/JNJ.N\" target=\"_blank\">(JNJ.N)</a> COVID-19 va\u2026", "url": "https://www.reuters.com/world/africa/south-africa-offer-pfizer-jj-vaccine-booster-doses-2021-12-10/", "urlToImage": "https://www.reuters.com/resizer/BFOBNMhYnz9KGAb-ldlOoIsXYRk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/6BVOZWSNURNNLFN7XWB75LZTDA.jpg", "publishedAt": "2021-12-10T07:20:00Z", "content": "A healthcare worker administers the Pfizer coronavirus disease (COVID-19) vaccine to a man, amidst the spread of the SARS-CoV-2 variant Omicron, in Johannesburg, South Africa, December 9, 2021. REUTE\u2026 [+645 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "The Conversation", "title": "Safety, side effects, allergies and doses. Pfizer vaccine for 5-11 year olds explained", "description": "Meanwhile, more than five million US children aged five-11 have had one dose and more than two million have had a second dose.", "url": "https://indianexpress.com/article/world/australia-pfizer-vaccine-children-safety-side-effects-allergies-7666018/", "urlToImage": "https://images.indianexpress.com/2021/12/vaccine-1200-1.jpg", "publishedAt": "2021-12-10T10:18:29Z", "content": "Australian children aged five-11 will start to receive the PfizerCovid-19 vaccine from January 10, after it cleared the final regulatory step and was recommended for use in this age group by the Aust\u2026 [+5226 chars]"}, {"source": {"id": null, "name": "SlashGear"}, "author": "Brittany A. Roston", "title": "FDA and CDC green light Pfizer COVID-19 booster for older teenagers", "description": "Teenagers ages 16 and 17 in the United States are now eligible for the Pfizer COVID-19 booster shot, the US FDA and CDC have announced. The FDA revealed its Emergency Use Authorization (EUA) expansion on December 9, noting that eligible teenagers must have re\u2026", "url": "https://www.slashgear.com/fda-and-cdc-green-light-pfizer-covid-19-booster-for-older-teenagers-09701744/", "urlToImage": "https://cdn.slashgear.com/wp-content/uploads/2021/12/FDA-CDC-Pfizer-Booster-Teens.jpg", "publishedAt": "2021-12-10T00:10:19Z", "content": "Teenagers ages 16 and 17 in the United States are now eligible for the Pfizer COVID-19 booster shot, the US FDA and CDC have announced. The FDA revealed its Emergency Use Authorization (EUA) expansio\u2026 [+4169 chars]"}, {"source": {"id": null, "name": "TheBlaze"}, "author": "Alex Nitzberg", "title": "US expands Pfizer COVID-19 vaccine booster eligibility to include 16- and 17-year-olds", "description": "The U.S. has given the green light for 16- and 17-year-olds to get a booster dose of the Pfizer-BioNTech COVID-19 vaccine.The U.S. Food and Drug Administration expanded the emergency use authorization for the vaccine to allow a booster shot for 16- and 17-yea\u2026", "url": "https://www.theblaze.com/news/us-expands-pfizer-covid-19-vaccine-booster-eligibility-to-include-those-ages-16-and-17", "urlToImage": "https://assets.rebelmouse.io/eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJpbWFnZSI6Imh0dHBzOi8vYXNzZXRzLnJibC5tcy8yODIwMDExOS9vcmlnaW4uanBnIiwiZXhwaXJlc19hdCI6MTY4NzQxNjMzNH0.RgLc_K_lmYwk98rmO4loa8Q1GojZX3NFCAbCvoGooaQ/img.jpg?width=1200&coordinates=0%2C85%2C0%2C86&height=600", "publishedAt": "2021-12-10T04:35:22Z", "content": "The U.S. has given the green light for 16- and 17-year-olds to get a booster dose of the Pfizer-BioNTech COVID-19 vaccine.\r\nThe U.S. Food and Drug Administration expanded the emergency use authorizat\u2026 [+1856 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "AFP Videographics", "title": "Biden: 'Encouraging news from Pfizer' over Omicron variant", "description": "Ahead of a meeting with his White House Covid-19 Response Team, US President Joe Biden says that preliminary lab data shows that three doses of the Pfizer...", "url": "https://news.yahoo.com/biden-encouraging-news-pfizer-over-043757765.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/skK8vojxolOkV2yH3Fq2qw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/10/61b2dacecec8b12ed24ff843/61b2dacecec8b12ed24ff844_o_U_v2.jpg", "publishedAt": "2021-12-10T04:37:57Z", "content": "A Los Angeles-bound flight from Washington, D.C. was diverted to Oklahoma City after a\"combative passenger\" assaulted a flight attendant and an air marshal aboard the plane Thursday evening, local po\u2026 [+299 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer Declares First-Quarter 2022 Dividend", "description": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the company\u2019s common stock to $0.40 for the first-quarter 2022 dividend, payable March 4, 2022, to holders of\u2026", "url": "https://www.businesswire.com/news/home/20211210005405/en/Pfizer-Declares-First-Quarter-2022-Dividend", "urlToImage": "https://mms.businesswire.com/media/20211210005405/en/1045874/23/Pfizer_Logo_Color_RGB_APPROVED.jpg", "publishedAt": "2021-12-10T17:07:48Z", "content": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on the companys common stock to $0.40 for the first-\u2026 [+3186 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "Booster shot of Pfizer COVID vaccine can cut mortality from Delta variant by 90%: Study", "description": "The research, published in The New England Journal of Medicine on Thursday, included data from participants 50 years of age or older who had received two doses of Pfizer vaccine at least five months earlier.", "url": "https://www.moneycontrol.com/news/trends/health-trends/booster-shot-of-pfizer-covid-vaccine-can-cut-mortality-from-delta-variant-by-90-study-7812411.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/09/pfizer-770x433.jpg", "publishedAt": "2021-12-10T10:45:22Z", "content": "The third dose of the Pfizer COVID-19 vaccine can reduce mortality due to the Delta variant of the SARS-CoV-2 virus by 90 per cent, according to a study conducted in Israel.\r\nThe research, published \u2026 [+1992 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Emily Mangiaracina", "title": "\u2018Unbiased\u2019 News Source? Reuters Chairman Is Top Investor and Board Member of Pfizer", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version). To receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here. Visit and follow\u2026", "url": "https://www.globalresearch.ca/unbiased-news-source-reuters-chairman-top-investor-board-member-pfizer/5764305", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/James-Smith-Reuters-1-810x500.jpg", "publishedAt": "2021-12-10T15:20:28Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+3587 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Arvinas Inc.", "title": "Arvinas and Pfizer Announce PROTAC\u00ae Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer", "description": "\u2013 ARV-471 continues to show a favorable tolerability profile and robust ER degradation in updated phase 1 dose escalation data presented at San Antonio...", "url": "https://finance.yahoo.com/news/arvinas-pfizer-announce-protac-protein-131000635.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/THk8GpbFdRBalzjrkr1Fkw--~B/aD0yNTI7dz02OTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/92323019a5a4213cf6ded7f6af366081", "publishedAt": "2021-12-10T13:10:00Z", "content": "ARV-471 continues to show a favorable tolerability profile and robust ER degradation in updated phase 1 dose escalation data presented at San Antonio Breast Cancer Symposium \r\n ARV-471 is expected to\u2026 [+22042 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Ethan Huff", "title": "Beyond Belief: FDA Adds Another 20 Years to Timeline for Full Release of Pfizer COVID Vaccine Data \u2013 Not Until 2096 Now", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/fda-adds-another-20-years-timeline-full-release-pfizer-covid-vaccine-data-not-until-2096-now/5764309", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/Coronavirus-Covid-19-Pfizer-Vaccine-Syringe-Vial.jpg", "publishedAt": "2021-12-10T15:23:56Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+3971 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Guy Hatchard", "title": "New Zealand: Pfizer \u201cConfidential Document\u201d Concedes that There Is a Large Increase in Types of Adverse Event Reaction to Its Vaccine", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/pfizer-document-concedes-large-increase-types-adverse-event-reaction-vaccine/5764294", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2020/12/allergic-reactions-Pfizer-vaccine-feature-800x417.jpg", "publishedAt": "2021-12-10T15:22:50Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+14591 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Singapore approves Pfizer-BioNTech COVID-19 vaccine for children aged 5 to 11; first shots by end-2021", "description": "SINGAPORE: The Health Sciences Authority (HSA) has extended the authorisation of the Pfizer-BioNTech/Comirnaty COVID-19 vaccine for use in children aged between five and 11, with inoculations set to begin before the end of the year.\r\n\r\n\u201cThe vaccination regime\u2026", "url": "https://www.channelnewsasia.com/singapore/moh-covid-19-vaccination-children-singapore-2372631", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--NjGSjPaw--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:afp_watermark%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/33bac94ffa8cc3f4612e21b6bc7170888ac8a2bc.jpg?itok=FOKCPTSV", "publishedAt": "2021-12-10T16:14:00Z", "content": "SINGAPORE: The Health Sciences Authority (HSA) has extended the authorisation of the Pfizer-BioNTech/Comirnaty COVID-19 vaccine for use in children aged between five and 11, with inoculations set to \u2026 [+1852 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Pfizer wins European approval for Cibinqo in atopic dermatitis", "description": "Pfizer (PFE) announced that the European Commission ((EC)) approved its Janus kinase 1 (JAK1) inhibitor Cibinqo (abrocitinib) for patients with moderate-to-severe atopic...", "url": "https://seekingalpha.com/news/3779174-pfizer-wins-european-approval-for-cibinqo-in-atopic-dermatitis", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1227739745/large_image_1227739745.jpg", "publishedAt": "2021-12-10T14:46:02Z", "content": "Jeenah Moon/Getty Images News"}, {"source": {"id": "news24", "name": "News24"}, "author": "Zakiyah Ebrahim", "title": "News24.com | Covid-19 vaccines: Latest on when Pfizer and J&J booster shots will likely be rolled out", "description": "The rollout of booster shots of the Pfizer and J&J vaccines is expected to kick off within a couple of weeks, the department of health said on Friday.", "url": "https://www.news24.com/health24/Medical/Infectious-diseases/Coronavirus/covid-19-vaccines-latest-on-when-pfizer-and-jj-booster-shots-will-likely-be-rolled-out-20211210", "urlToImage": "https://cdn.24.co.za/files/Cms/General/d/411/6b7f635b5e814377aa83a58f803c0d70.jpg", "publishedAt": "2021-12-10T10:09:46Z", "content": "<ul><li>Booster doses for adults who received the two-dose Pfizer vaccine have been approved.</li><li>This will likely become available to people in the new year.</li><li>Those who received the J&amp\u2026 [+4449 chars]"}, {"source": {"id": null, "name": "The Punch"}, "author": "Ademola Olonilua", "title": "Pfizer partners American Cancer Society to subsidise medication cost by 50%", "description": "Pharmaceutical company, Pfizer, has partnered with the American Cancer Society, as well as the Clinton Health Access Initiative to close the patient affordability gap and increase patient access to oncology treatments. In a statement signed by the Country Man\u2026", "url": "https://punchng.com/pfizer-partners-american-cancer-society-to-subsidise-medication-cost-by-50/", "urlToImage": "https://cdn.punchng.com/wp-content/uploads/2019/06/17163448/pfizer-logo.jpg", "publishedAt": "2021-12-10T20:58:46Z", "content": "Pharmaceutical company, Pfizer, has partnered with the American Cancer Society, as well as the Clinton Health Access Initiative to close the patient affordability gap and increase patient access to o\u2026 [+2498 chars]"}, {"source": {"id": null, "name": "Stationgossip.com"}, "author": "orraz", "title": "FDA Authorizes Pfizer Covid Booster Shot For 16 and 17 Year Olds One Day After Pfizer Pushes Third Jab as Protection Against Omicron Variant", "description": "Your Daily Station of Entertainment !!", "url": "http://www.stationgossip.com/2021/12/fda-authorizes-pfizer-covid-booster.html", "urlToImage": "https://lh3.googleusercontent.com/proxy/N5QFM8pujPkrlwd-mcPVvNszJztfw_pAuHa5OHhhPu6Sjj6C34dBMyEyx7IaD3G_rc_ZL7XI03PzlsozLpncpf1sxEV8q-taPfSarcDN0N0fPXchXyiw2CVkdjv2V9khGYu2g3sk3kzUkYpIbn5P0ozMxAuXmiHpIQ=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-10T16:20:10Z", "content": "The FDA on Thursday authorized the Pfizer Covid booster shot for 16 and 17 year olds just in time for the Omicron variant.\r\nThe announcement comes just one day after Pfizer said protection against th\u2026 [+787 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Mamta Mayani", "title": "Pfizer, Arvinas' ARV-471 shows encouraging clinical benefit rate in breast cancer patients", "description": "Arvinas (ARVN) and Pfizer (PFE) announce an update on Phase 1 dose escalation data of ARV-471, a PROTAC estrogen receptor ((ER)) degrader, being co-developed for the treatment of...", "url": "https://seekingalpha.com/news/3779116-pfizer-arvinas-arv-471-shows-encouraging-clinical-benefit-rate-in-breast-cancer-patients", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/897593850/large_image_897593850.jpg", "publishedAt": "2021-12-10T13:23:24Z", "content": "Vasyl Dolmatov/iStock via Getty Images"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "FOIA Release of Pfizer Vax Data Pushed Back from 2076 to 2096", "description": null, "url": "https://www.investmentwatchblog.com/foia-release-of-pfizer-vax-data-pushed-back-from-2076-to-2096/", "urlToImage": null, "publishedAt": "2021-12-10T14:02:13Z", "content": "by Chris Black\r\nThese people are mocking you.\r\nThe vaccines are safe and effective, Pfizer is a legit good-company, and the government has nothing to hide, right?\r\nWrong.\r\nAnyway, you will have to wa\u2026 [+461 chars]"}, {"source": {"id": null, "name": "Jamaica Observer"}, "author": null, "title": "US expands Pfizer COVID boosters for children", "description": "WASHINGTON, United States (AP) - United States health authorities said yesterday that 16 and 17 year olds should get a booster dose of Pfizer's COVID-19 vaccine once they're six months past their last shot.The US and many other nations already were urging adu\u2026", "url": "https://www.jamaicaobserver.com/international/us-expands-pfizer-covid-boosters-for-children_238531?profile=1470", "urlToImage": "https://www.jamaicaobserver.com/apps/pbcsi.dll/storyimage/JO/20211210/ARTICLE/312109958/AR/0/AR-312109958.jpg", "publishedAt": "2021-12-10T06:21:37Z", "content": "WASHINGTON, United States (AP) \u2014 United States health authorities said yesterday that 16 and 17 year olds should get a booster dose of Pfizer's COVID-19 vaccine once they're six months past their las\u2026 [+3212 chars]"}, {"source": {"id": null, "name": "Americanthinker.com"}, "author": null, "title": "Why does Pfizer want its vaccine research protected?", "description": "Go look at the VAERS COVID Vaccine Mortality Report to know why Pfizer wants FDA protection for its vaccine research along with 75 years of document secrecy. While there are all sorts of ways to interpret the VAERS data, and it\u2019s entirely possi...", "url": "https://www.americanthinker.com/blog/2021/12/why_does_pfizer_want_its_vaccine_research_protected.html", "urlToImage": "https://www.americanthinker.com/images/bucket/2021-12/234401.jpg", "publishedAt": "2021-12-10T06:00:00Z", "content": "Go look at the VAERS COVID Vaccine Mortality Report to know why Pfizer wants FDA protection for its vaccine research along with 75 years of document secrecy. While there are all sorts of ways to inte\u2026 [+3769 chars]"}]}, "2021-12-09": {"status": "ok", "totalResults": 154, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "U.S. FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-olds - Reuters", "description": "The U.S. Food and Drug Administration on Thursday authorized booster shots of the COVID-19 vaccine from Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and BioNTech SE  those aged 16 and 17, as public health officials \u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-authorizes-pfizerbiontech-booster-16-17-year-olds-2021-12-09/", "urlToImage": "https://www.reuters.com/resizer/bkUwY5mw95BseoxbGI5hQWv6hk4=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/QECPI4VTXNLM7AYMJK7B3PPZ4Q.jpg", "publishedAt": "2021-12-09T16:45:00Z", "content": "Dec 9 (Reuters) - The U.S. Food and Drug Administration on Thursday authorized booster shots of the COVID-19 vaccine from Pfizer Inc (PFE.N) and BioNTech SE those aged 16 and 17, as public health off\u2026 [+1888 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Jessica Rendall", "title": "FDA authorizes Pfizer boosters for 16- and 17-year-olds - CNET", "description": "The CDC still needs to sign off on the boosters for teens.", "url": "https://www.cnet.com/health/medical/fda-authorizes-pfizer-boosters-for-16-and-17-year-olds/", "urlToImage": "https://www.cnet.com/a/img/uHrXnopQHI-c7JDO-hz2calChRE=/1200x630/2021/11/24/646991f4-5a1a-4e6d-83ea-cc96bc1948fc/covid-19-vaccines-3rd-booster-shot-syringes-winter-2021-cnet-025.jpg", "publishedAt": "2021-12-09T17:49:00Z", "content": "Sarah Tew/CNET\r\nThe US Food and Drug Administration on Thursday\u00a0authorized boosters of Pfizer's COVID-19 vaccine for teens ages 16 and 17\u00a0at least six months after their second dose of Pfizer.\u00a0\r\nThe \u2026 [+1365 chars]"}, {"source": {"id": null, "name": "National Post"}, "author": "Bloomberg News", "title": "Pfizer CEO sees need for fourth shot faster than expected to protect against Omicron - National Post", "description": "<ol><li>Pfizer CEO sees need for fourth shot faster than expected to protect against Omicron\u00a0\u00a0National Post\r\n</li><li>Global National: Dec. 8, 2021 | Pfizer says 3rd vaccine dose raises defence against Omicron variant\u00a0\u00a0Global News\r\n</li><li>Pfizer-BioNTech pu\u2026", "url": "https://nationalpost.com/news/pfizer-ceo-recommends-four-shots-of-vaccine-to-boost-immunity-against-omicron", "urlToImage": "https://smartcdn.prod.postmedia.digital/nationalpost/wp-content/uploads/2021/11/vaccine.jpg", "publishedAt": "2021-12-09T17:50:34Z", "content": "Albert Bourla had said a fourth shot would be needed a year after the third dose, but 'we may need it faster' \r\nBoxes of the Pfizer Covid-19 vaccine to be administered to children from 5-11 years old\u2026 [+8952 chars]"}, {"source": {"id": null, "name": "Calgary Herald"}, "author": "Newsroom Staff", "title": "COVID-19 Update: 333 new cases, one death | Pfizer working on Omicron shot | Quebec to send rapid tests home with students - Calgary Herald", "description": "<ol><li>COVID-19 Update: 333 new cases, one death | Pfizer working on Omicron shot | Quebec to send rapid tests home with students\u00a0\u00a0Calgary Herald\r\n</li><li>COVID-19: Alberta reports six new cases of Omicron variant\u00a0\u00a0Edmonton Journal\r\n</li><li>COVID-19 in Alb\u2026", "url": "https://calgaryherald.com/news/local-news/covid-19-update-alberta-now-at-17-omicron-cases-10-in-calgary-zone-province-to-expand-monitoring-of-wastewater", "urlToImage": "https://smartcdn.prod.postmedia.digital/calgaryherald/wp-content/uploads/2021/12/Snowblast024.jpg", "publishedAt": "2021-12-09T23:15:00Z", "content": "Watch this page throughout the day for updates on COVID-19 in Calgary \r\nNewsroom Staff\r\nDowntown Calgary got a blast of snow sending commuters and maintence workers scrambling in Calgary on Wednesday\u2026 [+16488 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "Sharon LaFraniere", "title": "Pfizer Says Its Booster Is Effective Against Omicron", "description": "The company\u2019s finding is based on only a small study of blood samples in a laboratory, but others are sure to follow.", "url": "https://www.nytimes.com/2021/12/08/health/pfizer-booster-omicron.html", "urlToImage": "https://static01.nyt.com/images/2021/12/08/us/politics/08DC-PFIZER-1/08DC-PFIZER-1-facebookJumbo.jpg", "publishedAt": "2021-12-09T00:17:06Z", "content": "You have to start somewhere, said Kathrin U. Jansen, a senior vice president and the head of vaccine research and development at Pfizer, while awaiting the results of more complex studies and real-wo\u2026 [+2150 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": null, "title": "Third Pfizer-BioNTech Dose Is Key to Fight Omicron (Podcast)", "description": "Understand every aspect of the global economy \u2013 and know how to make your next move.", "url": "https://www.bloomberg.com/news/audio/2021-12-09/third-pfizer-biontech-dose-is-key-to-fight-omicron-podcast", "urlToImage": null, "publishedAt": "2021-12-09T03:19:01Z", "content": "Jason Gale, Bloomberg's Senior Editor, discusses the latest on the omicron variant and vaccines' impact with Bryan Curtis and Rishaad Salamat on Bloomberg Daybreak Asia.\r\nDec 09, 2021"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "FDA Authorizes Pfizer Boosters for 16 and 17 year-olds", "description": "The FDA said it was basing its emergency authorization of boosters for 16 and 17 year olds on data from 200 individuals who were ages 18 to 55 years of age when they received a booster dose.  They are requiring Pfizer to collect data on safety in post-authori\u2026", "url": "https://www.webmd.com/vaccines/covid-19-vaccine/news/20211209/fda-oks-boosters-for-teens", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/reference_guide/meningitis_vaccination_ref_guide/650x350_meningitis_vaccination_ref_guide.jpg", "publishedAt": "2021-12-09T18:37:17Z", "content": "Dec. 9, 2021 -- The FDA has authorized booster doses of Pfizers COVID-19 vaccine, clearing the way for millions of teenagers to get a third dose of vaccine starting 6 months after their second dose.\r\u2026 [+2087 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "Sharon LaFraniere and Noah Weiland", "title": "F.D.A. Authorizes Pfizer Boosters for 16- and 17-Year-Olds", "description": "The move clears the way for millions of teenagers to receive an additional shot, with a top regulator citing evidence that the effectiveness of two doses is waning in the age group.", "url": "https://www.nytimes.com/2021/12/09/us/politics/pfizer-boosters-16-17-year-olds.html", "urlToImage": "https://static01.nyt.com/images/2021/12/09/us/politics/09dc-pfizer-1/09dc-pfizer-1-facebookJumbo.jpg", "publishedAt": "2021-12-09T23:34:10Z", "content": "According to federal data, about 5.5 million 16- and 17-year-olds two-thirds of that age group have received at least one dose of Pfizers vaccine. More than 4.7 million have received two doses. Rough\u2026 [+2301 chars]"}, {"source": {"id": null, "name": "Quartz India"}, "author": "Annalisa Merelli", "title": "Should we trust what Pfizer tells us about its vaccine and omicron?", "description": "Relying on drugmakers' data on efficacy risks compromising the public trust in official approvals", "url": "https://qz.com/2100229/how-to-evaluate-pfizers-claim-its-booster-works-against-omicron/", "urlToImage": "https://cms.qz.com/wp-content/uploads/2021/12/2021-12-02T212845Z_590510391_RC243R9VECCC_RTRMADP_3_HEALTH-CORONAVIRUS-VARIANT-USA-e1639008963140.jpg?quality=75&strip=all&w=1200&h=630&crop=1", "publishedAt": "2021-12-09T18:53:24Z", "content": "As the world continues to gather information about covid-19s omicron variant, Pfizer has some good news: Early evidence indicates three doses of vaccine show significantly more\u00a0protection against omi\u2026 [+2959 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "jepstein@insider.com (Jake Epstein,Andrew Dunn)", "title": "The FDA says 16- and 17-year-olds can now get a Pfizer vaccine booster shot", "description": "The FDA authorized the Pfizer COVID-19 booster shot for all adults in the United States in November.", "url": "https://www.businessinsider.com/fda-authorizes-pfizer-booster-coronavirus-shot-teenagers-2021-12", "urlToImage": "https://i.insider.com/604276ca44d8e300117b9541?width=1200&format=jpeg", "publishedAt": "2021-12-09T16:37:07Z", "content": "The US Food &amp; Drug Administration on Thursday said it is authorizing Pfizer's COVID-19 booster shot for 16- and 17-year-olds.\r\nThis story is developing. Please check back for updates."}, {"source": {"id": null, "name": "The Indian Express"}, "author": "AP", "title": "FDA expands Pfizer COVID booster, opens extra dose to age 16", "description": "The Pfizer vaccine is the only option in the US for anyone younger than 18, either for initial vaccination or for use as a booster.", "url": "https://indianexpress.com/article/world/fda-expands-pfizer-covid-booster-opens-extra-dose-to-age-16-7664828/", "urlToImage": "https://images.indianexpress.com/2021/12/Pfizer-1.jpg", "publishedAt": "2021-12-09T16:54:17Z", "content": "The US is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer\u2019s vaccine.The US and many other nations already were urging adults to get booster shots to pump \u2026 [+1996 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Reuters", "title": "U.S. FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-olds", "description": "Regulators from the U.S. Centers for Disease Control and Prevention (CDC) likely need to sign off on the shots before the teenagers can begin receiving the doses. Around 4.7 million 16- and 17-year-olds in the United States are fully vaccinated and more than \u2026", "url": "https://economictimes.indiatimes.com/news/international/world-news/u-s-fda-authorizes-pfizer/biontech-booster-for-16-and-17-year-olds/articleshow/88193500.cms", "urlToImage": "https://img.etimg.com/thumb/msid-88193494,width-1070,height-580,imgsize-794879,overlay-economictimes/photo.jpg", "publishedAt": "2021-12-09T17:26:37Z", "content": "The U.S. Food and Drug Administration on Thursday authorized booster shots of the COVID-19 vaccine from Inc and BioNTech SE those aged 16 and 17, as public health officials have urged Americans to ge\u2026 [+1575 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Alex Knapp, Forbes Staff, \n Alex Knapp, Forbes Staff\n https://www.forbes.com/sites/alexknapp/", "title": "FDA Greenlights Booster Shots Of Pfizer/BioNTech\u2019s Covid Vaccine For 16 And 17-Year-Olds", "description": "Pfizer and BioNTech will also apply to the FDA to expand the approval of their companies' vaccine to include the third dose.", "url": "https://www.forbes.com/sites/alexknapp/2021/12/09/fda-greenlights-booster-shots-of-pfizerbiontechs-covid-vaccine-for-16-and-17-year-olds/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61b16a0ac42674add98fdd64%2F0x0.jpg", "publishedAt": "2021-12-09T16:31:54Z", "content": "AFP via Getty Images\r\nOn Thursday, the FDA announced that it is expanding the emergency use authorization of the Covid vaccine developed by Pfizer &amp; BioNTech to allow for booster shots in 16 and \u2026 [+1269 chars]"}, {"source": {"id": "axios", "name": "Axios"}, "author": "Rebecca Falconer", "title": "FDA authorizes Pfizer COVID booster for teens ages 16 to 17", "description": "The Food and Drug Administration expanded its emergency use authorization for Pfizer-BioNTech's COVID-19 vaccine booster shots to include those aged 16 and 17.Why it matters: The move could expand access to the boosters at a time when there's increasing conce\u2026", "url": "https://www.axios.com/fda-authorizes-pfizer-covid-vaccine-booster-teens-00358128-bf37-452f-9239-1cb0602e2db9.html", "urlToImage": "https://images.axios.com/YNJ-9A2lBfdt7iReP0eli76gYUg=/0x0:7642x4299/1366x768/2021/12/09/1639037834230.jpg", "publishedAt": "2021-12-09T16:22:33Z", "content": "The Food and Drug Administration on Thursday expanded its emergency use authorization for Pfizer-BioNTech's COVID-19 vaccine booster shots to include those aged 16 and 17.\r\nWhy it matters: The move c\u2026 [+1743 chars]"}, {"source": {"id": null, "name": "WBAL TV Baltimore"}, "author": null, "title": "FDA expands Pfizer COVID-19 booster to 16 and 17 year olds - WBAL Baltimore", "description": "<ol><li>FDA expands Pfizer COVID-19 booster to 16 and 17 year olds\u00a0\u00a0WBAL Baltimore\r\n</li><li>FDA authorizes Pfizer's COVID-19 booster for teens age 16 and up\u00a0\u00a0CBS News\r\n</li><li>CDC study: Veterans with two mRNA doses saw dip in antibody response after four m\u2026", "url": "https://www.wbaltv.com/article/fda-expands-pfizer-covid-19-booster-16-and-17-year-olds/38473671", "urlToImage": "https://kubrick.htvapps.com/htv-prod-media.s3.amazonaws.com/images/covid-19-vaccine-1622285336.jpg?crop=1.00xw:0.824xh;0,0.0258xh&resize=1200:*", "publishedAt": "2021-12-09T16:54:00Z", "content": "U.S. health authorities said Thursday that 16- and 17-year-olds should get a booster dose of Pfizer's COVID-19 vaccine once they're six months past their last shot.\r\nThe U.S. and many other nations a\u2026 [+3293 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Disclosing Pfizer vaccine data \u2018may now take until 2096\u2019", "description": "The US Food and Drug Administration is cooperating with a Freedom of Information Act request for clinical data associated with Pfizer\u2019s Covid-19 vaccine, but may require 75 years to do so \u2013 even longer than a prior estimate. Read Full Article at RT.com", "url": "https://www.rt.com/usa/542616-fda-years-declassify-pfizer/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61b14d542030273c932a422c.JPG", "publishedAt": "2021-12-09T01:59:49Z", "content": "The FDA has insisted it cannot commit to a faster release of the medical data associated with the approval of the Pfizer-BioNTech coronavirus vaccine, according to a legal brief filed on Tuesday in r\u2026 [+1640 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "BioNTech, Pfizer vaccine neutralises Omicron with three shots", "description": "In the first official statement from vaccine manufacturers on the likely efficacy of their shot against Omicron, BioNTech and Pfizer said that two vaccine doses resulted in significantly lower neutralising antibodies but that a third dose of their vaccine inc\u2026", "url": "https://www.moneycontrol.com/news/world/biontech-pfizer-vaccine-neutralises-omicron-with-three-shots-7806111.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/09/pfizer-770x433.jpg", "publishedAt": "2021-12-09T03:15:49Z", "content": "BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test and they could deliver an Omicron-based vaccine\u2026 [+1220 chars]"}, {"source": {"id": null, "name": "fox8.com"}, "author": "Peter Sullivan, The Hill via Nexstar Media Wire", "title": "Pfizer CEO says fourth vaccine shot may eventually be needed - WJW FOX 8 News Cleveland", "description": "<ol><li>Pfizer CEO says fourth vaccine shot may eventually be needed\u00a0\u00a0WJW FOX 8 News Cleveland\r\n</li><li>Coronavirus live updates: Omicron variant could require fourth vaccine dose\u00a0\u00a0The Washington Post\r\n</li><li>Mounting evidence highlights the importance of \u2026", "url": "https://fox8.com/news/coronavirus/pfizer-ceo-says-fourth-vaccine-shot-may-eventually-be-needed/", "urlToImage": "https://fox8.com/wp-content/uploads/sites/12/2021/12/AP21253766386353.jpg?w=1280", "publishedAt": "2021-12-09T15:36:10Z", "content": "(The Hill) \u2014 Pfizer CEO Albert Bourla\u00a0on Wednesday said that a fourth\u00a0dose of the COVID-19 vaccine may eventually be needed amid concerns about the omicron variant.\r\nBourla\u00a0told CNBC\u00a0that he previous\u2026 [+1464 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Eleanor Sly", "title": "Vaccines and omicron: What we know about how variant responds to Pfizer, AstraZeneca and Moderna jabs", "description": "Vaccines to target omicron could be produced by March 2022", "url": "https://www.independent.co.uk/news/health/omicron-vaccine-jab-pfizer-astrazeneca-moderna-b1973045.html", "urlToImage": "https://static.independent.co.uk/2021/12/09/16/GettyImages-89747046%20%281%29.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-09T19:52:06Z", "content": "The latest variant of Covid-19 has begun to spread in the UK, with the number of confirmed cases nearly doubling between Wednesday and Thursday.\r\nA total of 817 cases of the omicron variant of Covid \u2026 [+6288 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "Alexander Alexander", "title": "FDA greenlights Pfizer booster shots for Americans as young as 16", "description": "Less than a third of Americans 16 to 17 years old will initially be eligible to receive the additional dose.", "url": "https://www.cbsnews.com/news/fda-pfizer-covid-vaccine-booster-shots-age-16/", "urlToImage": "https://cbsnews1.cbsistatic.com/hub/i/r/2021/09/23/8c128fec-6552-4f8b-a085-937fee43742f/thumbnail/1200x630g8/2cf7af29f4cb588cdd9a5c62eba09987/2021-09-23t095602z-1017402233-rc2lvp9taqdy-rtrmadp-3-health-coronavirus-eu-pfizer.jpg", "publishedAt": "2021-12-09T16:26:48Z", "content": "The Food and Drug Administration has greenlighted a request from Pfizer and BioNTech to allow Americans as young as 16 to get a booster shot of their COVID-19 vaccine, the agency announced on Thursda\u2026 [+5488 chars]"}]}, "2021-12-08": {"status": "ok", "totalResults": 231, "articles": [{"source": {"id": null, "name": "New York Times"}, "author": "The New York Times", "title": "Early Study Shows Pfizer Vaccine Gives Some Protection Against Omicron", "description": "A South African lab experiment found the variant may dull the power of vaccines but hinted that booster shots might help. Here\u2019s the latest.", "url": "https://www.nytimes.com/live/2021/12/08/world/omicron-variant-covid", "urlToImage": "https://static01.nyt.com/images/2021/12/07/multimedia/07virus-briefing-pfizer/07virus-briefing-pfizer-facebookJumbo-v3.jpg", "publishedAt": "2021-12-08T10:14:29Z", "content": "A report out of South Africa offered a first glimpse at how vaccinated people might fare against the fast-spreading Omicron variant of the coronavirus.\r\nLaboratory experiments found that Omicron seem\u2026 [+5189 chars]"}, {"source": {"id": "bbc-news", "name": "BBC News"}, "author": "https://www.facebook.com/bbcnews", "title": "Covid: Pfizer says booster shot promising against Omicron", "description": "The company says a third dose of its vaccine could improve protection against the new variant.", "url": "https://www.bbc.co.uk/news/world-59582006", "urlToImage": "https://ichef.bbci.co.uk/news/1024/branded_news/537B/production/_122017312_072023140-1.jpg", "publishedAt": "2021-12-08T13:42:27Z", "content": "Three doses provide a similar level of antibodies against Omicron to that of two doses with other variants, the companies said after a small study."}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Booster works against Omicron - Pfizer/BioNTech - Reuters.com", "description": "BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and they could deliver an Omicron-based vaccine in March 2022 if needed.", "url": "https://www.reuters.com/video/watch/idPEoc?now=true", "urlToImage": "https://ajo.prod.reuters.tv/api/v2/img/61b0d22de4b09631b0e441d2-1638978093385?location=LANDSCAPE", "publishedAt": "2021-12-08T16:40:09Z", "content": "Posted \r\nBioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and they could deliver an Omicron-base\u2026 [+33 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Booster works against Omicron - Pfizer/BioNTech - Reuters.com", "description": "BioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and they could deliver a vaccine targeted at it in March 2022 if needed. Francis Maguire reports.", "url": "https://www.reuters.com/video/watch/idOVF76N0JV", "urlToImage": "https://static.reuters.com/resources/r/?d=20211208&i=OVF76N0JV&r=OVF76N0JV&t=2", "publishedAt": "2021-12-08T16:09:37Z", "content": "Posted \r\nBioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralize the new Omicron variant in a laboratory test and they could deliver a vaccine targe\u2026 [+58 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Futures rise after positive vaccine update from Pfizer - Reuters", "description": "U.S. stock index futures rose on Wednesday after drugmakers Pfizer and BioNTech said a three-shot course of their COVID-19 vaccine was shown to have a neutralizing effect against the new Omicron coronavirus variant in a laboratory test.", "url": "https://www.reuters.com/markets/europe/futures-rise-after-positive-vaccine-update-pfizer-2021-12-08/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=60", "publishedAt": "2021-12-08T12:23:00Z", "content": "Dec 8 (Reuters) - U.S. stock index futures rose on Wednesday after drugmakers Pfizer and BioNTech said a three-shot course of their COVID-19 vaccine was shown to have a neutralizing effect against th\u2026 [+1778 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Britain marks one year since giving first Pfizer COVID-19 shot - Reuters UK", "description": "Britain on Wednesday marked a year since the first person in the world was given a Pfizer-BioNTech COVID-19 vaccine outside of clinical trials, calling for people to receive booster shots as soon as they are eligible.", "url": "https://www.reuters.com/world/uk/britain-marks-one-year-since-giving-first-pfizer-covid-19-shot-2021-12-08/", "urlToImage": "https://www.reuters.com/resizer/bigXgSIWMWvkrxpvYXYK-eQZA40=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/2O7FXQ5ZVZP4LH3ONE64IMCCZA.jpg", "publishedAt": "2021-12-08T00:16:00Z", "content": "LONDON, Dec 8 (Reuters) - Britain on Wednesday marked a year since the first person in the world was given a Pfizer-BioNTech COVID-19 vaccine outside of clinical trials, calling for people to receive\u2026 [+1920 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "BioNTech, Pfizer say test shows 3 doses of vaccine neutralise Omicron - Reuters", "description": "BioNTech  and Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> said on Wednesday a three-shot course of their COVID-19 vaccine was shown to generate a neutralising effect against the new Omicron variant in a laboratory test.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/biontech-pfizer-say-test-shows-3-doses-vaccine-neutralise-omicron-2021-12-08/", "urlToImage": "https://www.reuters.com/resizer/AO74kgZXcbvT_EDNQsnkti5YS3Y=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/6AE3OV5UEFIMVKNGINVA5YXYEM.jpg", "publishedAt": "2021-12-08T12:16:00Z", "content": "A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado RuvicDec 8 (Reuters) - BioNTech and Pfizer (PFE\u2026 [+746 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": "Chuck Mikolajczak", "title": "TREASURIES-U.S. yields rise as Pfizer vaccine update dents Omicron worry - Reuters.com", "description": "The benchmark U.S. 10-year Treasury yield rose for a third straight day on Wednesday, as drugmakers Pfizer and BioNtech announced positive results for their COVID-19 vaccine in a laboratory test against the new Omicron variant.", "url": "https://www.reuters.com/article/usa-bonds-idUSL1N2ST19S", "urlToImage": "https://s1.reutersmedia.net/resources_v2/images/rcom-default.png?w=800", "publishedAt": "2021-12-08T15:36:00Z", "content": "NEW YORK, Dec 8 (Reuters) - The benchmark U.S. 10-year Treasury yield rose for a third straight day on Wednesday, as drugmakers Pfizer and BioNtech announced positive results for their COVID-19 vacci\u2026 [+2789 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "sbaker@businessinsider.com (Sin\u00e9ad Baker)", "title": "Pfizer says 3 of its shots work against Omicron, but that 2 are significantly less effective", "description": "Pfizer and BioNTech observed a 25-fold reduction in neutralizing antibodies after two doses of vaccine, but those levels were restored after three.", "url": "https://www.businessinsider.com/omicron-variant-pfizer-says-3-shots-work-2-less-effective-2021-12", "urlToImage": "https://i.insider.com/61b0a1b606b6770018c48883?width=1200&format=jpeg", "publishedAt": "2021-12-08T12:19:58Z", "content": "Although there is a marked reduction in the level of protective antibodies against Omicron after two doses of vaccine, a third dose seems to bring those levels back up, Pfizer and BioNTech said on We\u2026 [+1863 chars]"}, {"source": {"id": null, "name": "CP24 Toronto's Breaking News"}, "author": "Lauran Neergaard", "title": "Pfizer says COVID-19 vaccine booster offers protection against Omicron - CP24 Toronto's Breaking News", "description": "<ol><li>Pfizer says COVID-19 vaccine booster offers protection against Omicron\u00a0\u00a0CP24 Toronto's Breaking News\r\n</li><li>Global National: Dec. 8, 2021 | Pfizer says 3rd vaccine dose raises defence against Omicron variant\u00a0\u00a0Global News\r\n</li><li>Pfizer-BioNTech p\u2026", "url": "https://www.cp24.com/world/pfizer-says-covid-19-vaccine-booster-offers-protection-against-omicron-1.5699039", "urlToImage": "https://www.cp24.com/polopoly_fs/1.5699040.1638992621!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-08T19:44:26Z", "content": "Pfizer said Wednesday that a booster of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective.\r\nPfi\u2026 [+5034 chars]"}, {"source": {"id": null, "name": "Toronto Sun"}, "author": "Reuters", "title": "Study suggests Pfizer COVID-19 vaccine only partially protects against Omicron - Toronto Sun", "description": "The Omicron variant of the coronavirus can partially evade the protection from two doses of Pfizer Inc and partner BioNTech\u2019s COVID-19 vaccine, the research\u2026", "url": "https://torontosun.com/health/pfizer-covid-19-vaccine-partially-protective-against-omicron-reports", "urlToImage": "https://smartcdn.prod.postmedia.digital/torontosun/wp-content/uploads/2021/11/HEALTH-CORONAVIRUS_USA-CDC-scaled-e1637532679997.jpg?quality=100&strip=all", "publishedAt": "2021-12-08T00:45:00Z", "content": "A syringe is filled with a dose of Pfizer's COVID-19 vaccine at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., Feb. 23, 2021. Photo by B\u2026 [+5767 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "The Canadian Press", "title": "Pfizer says COVID booster offers protection against omicron - Yahoo Canada Finance", "description": "<ol><li>Pfizer says COVID booster offers protection against omicron\u00a0\u00a0Yahoo Canada Finance\r\n</li><li>Global National: Dec. 8, 2021 | Pfizer says 3rd vaccine dose raises defence against Omicron variant\u00a0\u00a0Global News\r\n</li><li>Pfizer-BioNTech pushing 3-dose COVID\u2026", "url": "https://ca.finance.yahoo.com/news/pfizer-says-covid-booster-offers-123554063.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/EoJy2kgFXtceMWqaBaeYRg--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cp.org/5bf690d418027fbc086d9fbfe2809df5", "publishedAt": "2021-12-08T17:29:00Z", "content": "Pfizer said Wednesday that a booster of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective.\r\nPfi\u2026 [+5265 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "CBS News Videos", "title": "Pfizer says 3 doses of coronavirus vaccine can neutralize Omicron variant", "description": "Pfizer says preliminary research shows that a booster dose of its existing COVID-19 vaccine raises effectiveness when battling the Omicron variant. CBS News'...", "url": "https://news.yahoo.com/pfizer-says-3-doses-coronavirus-142639490.html", "urlToImage": "https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/08/61b0c5a378856f75e6010885/61b0c5a378856f75e6010886_o_U_v2.jpg", "publishedAt": "2021-12-08T14:26:39Z", "content": "Entertainment Tonight Videos\r\nFormer 'Real Housewives' stars Tamra Judge and Teddi Mellencamp chat with ET's Denny Directo at iHeartRadio 102.7 KIIS FM's Jingle Ball 2021. The ladies dish all about t\u2026 [+320 chars]"}, {"source": {"id": null, "name": "MarketWatch"}, "author": "Mark DeCambre", "title": "Bond Report: U.S. Treasury yields steady after Pfizer/BioNTech omicron report", "description": "Yields for U.S. government debt on Wednesday were trading mixed as investors digested news suggesting the omicron variant of coronavirus that causes COVID-19 may not impact the economy as much as feared.", "url": "https://www.marketwatch.com/story/u-s-treasury-yields-steady-after-pfizer-biontech-omicron-report-11638967792", "urlToImage": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "publishedAt": "2021-12-08T12:49:00Z", "content": "Yields for U.S. government debt on Wednesday were trading mixed as investors digested news suggesting the omicron variant of coronavirus that causes COVID-19 may not impact the economy as much as fea\u2026 [+1892 chars]"}, {"source": {"id": "al-jazeera-english", "name": "Al Jazeera English"}, "author": "Al Jazeera", "title": "Pfizer says COVID booster \u2018effective\u2019 against Omicron variant", "description": "Lab tests show three-shot course of Pfizer-BioNTech vaccine neutralises Omicron, while two shots appear less effective.", "url": "https://www.aljazeera.com/news/2021/12/8/pfizer-booster-covid-vaccine-omicron-effective", "urlToImage": "https://www.aljazeera.com/wp-content/uploads/2021/12/AP21342448804833.jpg?resize=1200%2C630", "publishedAt": "2021-12-08T14:55:31Z", "content": "Pfizer has said a booster dose of its COVID-19 vaccine was able to neutralise the new Omicron variant in lab studies,\u00a0even though the initial two doses appear significantly less effective.\r\nThe annou\u2026 [+2430 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": null, "title": "Third Dose of Pfizer-BioNTech Key to Omicron (Audio)", "description": "Understand every aspect of the global economy \u2013 and know how to make your next move.", "url": "https://www.bloomberg.com/news/audio/2021-12-08/third-dose-of-pfizer-biontech-key-to-omicron-audio", "urlToImage": null, "publishedAt": "2021-12-08T19:36:44Z", "content": "Dr. Anthony Harris, Chief Innovation Officer at WorkCare, discusses vaccine efficacy for the omicron variant with Carol Massar and Tim Stenovec. \r\nDec 08, 2021"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Fiona Rutherford", "title": "Pfizer Booster for More Teens Moves Closer to FDA Clearance", "description": "", "url": "https://www.bloomberg.com/news/articles/2021-12-08/pfizer-booster-for-more-teens-moves-closer-to-fda-clearance", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ir06zuCPMEjo/v0/1200x800.jpg", "publishedAt": "2021-12-08T22:04:46Z", "content": "Food and Drug Administration authorization of \r\nPfizer Inc. \u00a0booster vaccines for more teens took a step forward when the agency said further study by an advisory committee wasnt necessary.\u00a0\r\nThird d\u2026 [+1423 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "Pfizer Says Vaccine Booster Should Protect Against Omicron", "description": "Blood samples obtained from people a month after they'd gotten their booster shots showed a level of antibodies against Omicron that were equal to those seen against other variants after two doses.", "url": "https://www.webmd.com/vaccines/covid-19-vaccine/news/20211208/pfizer-covid-booster-omicron", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/news/2020/12_2020/pfizer_vaccine/1800x1200_pfizer_vaccine.jpg", "publishedAt": "2021-12-08T22:46:15Z", "content": "[MUSIC PLAYING]\r\nSPEAKER: How does a COVID-19\r\nmRNA vaccine work?\r\nCOVID vaccines are now\r\navailable.\r\nSome of the COVID-19 vaccines\r\nare mRNA vaccines, but what does\r\nthis mean?\r\nmRNA vaccines are\r\n\u2026 [+2094 chars]"}, {"source": {"id": null, "name": "Pfizer.com"}, "author": null, "title": "Pfizer and BioNTech Provide Update on Omicron Variant - Pfizer", "description": "Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers Data indicate that a third dose of BNT162b2\u2026", "url": "https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provide-update-omicron-variant", "urlToImage": null, "publishedAt": "2021-12-08T11:58:10Z", "content": "<ul><li>Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduc\u2026 [+27774 chars]"}, {"source": {"id": null, "name": "Telegraph.co.uk"}, "author": "Joe Pinkstone", "title": "Omicron significantly reduces Covid antibodies generated by Pfizer vaccine, study finds", "description": "First data from very small research group suggests people who have had coronavirus would have more protection", "url": "https://www.telegraph.co.uk/news/2021/12/08/omicron-significantly-reduces-covid-antibodies-generated-pfizer/", "urlToImage": "https://www.telegraph.co.uk/content/dam/news/2021/12/07/TELEMMGLPICT000280034471_trans_NvBQzQNjv4Bq1EFwp94ofGImOIvvi5f16fcd23UqRwUae9Ng8w1oDOQ.jpeg?impolicy=logo-overlay", "publishedAt": "2021-12-08T00:16:21Z", "content": "People who have previously had Covid or been vaccinated have far less protection against omicron than they do for other variants, according to the first data of its kind.\r\nScientists from South Afric\u2026 [+1782 chars]"}]}, "2021-12-07": {"status": "ok", "totalResults": 51, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer, ex-employee reach accord over COVID-19 vaccine secrets - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> has reached a truce with a former longtime employee it sued two weeks ago for allegedly stealing confidential documents related to its COVID-19 vaccine and other drugs.", "url": "https://www.reuters.com/legal/government/pfizer-ex-employee-reach-accord-over-covid-19-vaccine-secrets-2021-12-07/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=60", "publishedAt": "2021-12-07T22:14:00Z", "content": "The company and law firm names shown above are generated automatically based on the text of the article. We are improving this feature as we continue to test and develop in beta. We welcome feedback,\u2026 [+1483 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer COVID-19 vaccine partially protective against Omicron - Bloomberg News - Reuters", "description": "The Omicron variant of the coronavirus can partially evade the protection from Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and partner BioNTech's  COVID-19 vaccine, Bloomberg News reported on Tuesday, citing the re\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-covid-19-vaccine-partially-protective-against-omicron-bloomberg-news-2021-12-07/", "urlToImage": "https://www.reuters.com/resizer/hV4nC8d2xxB4F9E_FL0qk50pvJg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/R3VFM7EHYRP3VONKX5CMDLSMTU.jpg", "publishedAt": "2021-12-07T21:07:00Z", "content": "Vials of the Pfizer-BioNTech vaccine are pictured in a vaccination centre in Geneva, Switzerland, February 3, 2021. REUTERS/Denis BalibouseDec 7 (Reuters) - The Omicron variant of the coronavirus can\u2026 [+1071 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Joe Pinkstone", "title": "Omicron significantly reduces Covid antibodies generated by Pfizer vaccine, study finds", "description": "People who have previously had Covid or been vaccinated have far less protection against omicron than they do for other variants, according to the first data...", "url": "https://news.yahoo.com/omicron-significantly-reduces-covid-antibodies-235058967.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/K3_zcYDmldSBW5SydoXrhQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://s.yimg.com/uu/api/res/1.2/FDLMucLiIEvb4MLexZrN4w--~B/aD0xNDM3O3c9MjMwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/the_telegraph_258/7d9890d6008c634d18c8e701dfdb766a", "publishedAt": "2021-12-07T23:50:58Z", "content": "Health workers giving out Covid vaccines in Gaza on Tuesday - BLOOMBERG\r\nPeople who have previously had Covid or been vaccinated have far less protection against omicron than they do for other varian\u2026 [+3384 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Kody Kester)", "title": "What This Label Expansion Means for Pfizer", "description": "The European Commission recently approved Pfizer's Xeljanz to treat patients with ankylosing spondylitis.", "url": "https://www.fool.com/investing/2021/12/07/what-this-label-expansion-means-for-pfizer/", "urlToImage": "https://g.foolcdn.com/editorial/images/655523/a-senior-woman-receives-a-vaccination-to-protect-against-covid-19.jpg", "publishedAt": "2021-12-07T16:50:00Z", "content": "Last month, Pfizer(NYSE:PFE) announced that the European Commission (E.C.) had authorized the company's Xeljanz immunology drug to treat adult ankylosing spondylitis -- a kind of arthritis affecting \u2026 [+4091 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "Reuters", "title": "Mixing Pfizer, AstraZ Covid-19 shots with Moderna gives better immune response: UK study", "description": "If the AstraZeneca-Oxford vaccine is followed by a Moderna or Novavax shot, higher antibodies and T-cell responses were induced versus two doses of AstraZeneca-Oxford, according to researchers at the University of Oxford.", "url": "https://indianexpress.com/article/world/mixing-pfizer-astrazeneca-moderna-covid-19-vaccine-immune-response-study-7660092/", "urlToImage": "https://images.indianexpress.com/2021/12/2021-12-06T065942Z_1051280657_RC2S7R9118QG_RTRMADP_3_HEALTH-CORONAVIRUS-VARIANT-HOTSPOT.jpg", "publishedAt": "2021-12-07T04:19:07Z", "content": "A major British study into mixing Covid-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine\u2026 [+3085 chars]"}, {"source": {"id": null, "name": "Democracy Now!"}, "author": "webdev@democracynow.org (Democracy Now!)", "title": "As World Confronts Omicron Variant, Top 8 Pfizer & Moderna Investors Make $10 Billion in a Week", "description": "The eight top Pfizer and Moderna shareholders made over $10 billion last week when  their stock holdings skyrocketed after the discovery of the new Omicron variant. This comes as global public health advocates warn the world will keep seeing more coronavirus \u2026", "url": "https://www.democracynow.org/2021/12/7/pfizer_and_moderna_shareholders_profit", "urlToImage": "https://www.democracynow.org/images/story/49/60649/full_hd/SEG2-PandemicProfits-2.jpg", "publishedAt": "2021-12-07T13:13:38Z", "content": "Dear Friend,\r\n This year Democracy Now! is celebrating our 25th anniversarythats 25 years of bringing you fearless, independent journalism. Since our first broadcast in 1996, Democracy Now! has refus\u2026 [+1184 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "Aria Bendix, Andrew Dunn", "title": "Omicron may resist Pfizer vaccine more than other variants: preprint - Business Insider", "description": "Two small studies that have yet to be published give the first look at how Omicron may impact immunity.", "url": "https://www.businessinsider.com/omicron-resist-pfizer-vaccine-lab-data-2021-12", "urlToImage": "https://i.insider.com/61afd0666531110019cf03a5?width=1200&format=jpeg", "publishedAt": "2021-12-07T14:52:36Z", "content": "The Omicron variant substantially reduced antibody levels generated by the Pfizer-BioNTech COVID-19 vaccine, according to preliminary results from a South African study that's still awaiting peer rev\u2026 [+5177 chars]"}, {"source": {"id": "cbs-news", "name": "CBS News"}, "author": "CBS News", "title": "Pfizer shot offers partial protection against Omicron variant, study finds", "description": "Pfizer's COVID-19 vaccine offers some protection against the Omicron variant \"but not complete\" protection, according to an early study by South African scientists. Nikki Battiste shares the latest.", "url": "https://www.cbsnews.com/video/pfizer-shot-offers-partial-protection-against-omicron-variant-study-finds/", "urlToImage": "https://cbsnews2.cbsistatic.com/hub/i/r/2021/12/07/5bde9754-daae-4969-bb72-0f9122ffc986/thumbnail/1200x630/3425d1b5d7a4a924a7fe3fd0a390b2d1/cbsn-fusion-pfizer-shot-offers-partial-protection-against-omicron-variant-study-finds-thumbnail-850947-640x360.jpg", "publishedAt": "2021-12-07T23:48:52Z", "content": "Watch CBSN Live\r\nCopyright \u00a9 2021 CBS Interactive Inc. All rights reserved.\r\nGet browser notifications for breaking news, live events, and exclusive reporting.\r\nNot NowTurn On"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer COVID-19 vaccine partially protective against Omicron - Bloomberg News", "description": "Its evasion is not complete and a booster shot could provide additional protection, according to the report, citing Alex Sigal, head of the lab.  The Omicron...", "url": "https://news.yahoo.com/pfizer-covid-19-vaccine-partially-210542703.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/TIRPiLeEc5I5b0f04rTOEA--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/60f78910457d169469367d728f3c8f79", "publishedAt": "2021-12-07T21:05:42Z", "content": "(Reuters) - The Omicron variant of the coronavirus can partially evade the protection from Pfizer Inc and partner BioNTech's COVID-19 vaccine, Bloomberg News reported on Tuesday, citing the research \u2026 [+800 chars]"}, {"source": {"id": null, "name": "MMA Mania"}, "author": "Jesse Holland", "title": "Rogan Calls CNN \u2018The Right Arm Of Pfizer\u2019", "description": "UFC mouthpiece and Spotify podcaster Joe Rogan slams CNN for its propaganda and biased ideology following the exit of Chris Cuomo.", "url": "https://www.mmamania.com/2021/12/7/22822188/ufc-joe-rogan-calls-cnn-the-right-arm-pfizer-slams-propagandists-following-chris-cuomo-exit", "urlToImage": "https://cdn.vox-cdn.com/thumbor/mKAiIZa5yzgEkl0N3R4LbyJN8o0=/0x0:3000x1688/1600x900/cdn.vox-cdn.com/uploads/chorus_image/image/70239570/1233899520.0.jpg", "publishedAt": "2021-12-07T15:23:07Z", "content": "Photo by Louis Grasse/PxImages/Icon Sportswire via Getty Images\r\n\n \n\n UFC color commentator and podcasting dynamo Joe Rogan misses the old days of CNN, back when the cable news network delivered obje\u2026 [+2021 chars]"}, {"source": {"id": "abc-news-au", "name": "ABC News (AU)"}, "author": "Dan Conifer", "title": "Emails reveal Pfizer was 'enthusiastic' to engage with Australia about COVID-19 vaccine", "description": "Documents obtained\u00a0under freedom of information laws shed new light on Pfizer\u00a0and the government's dealings at a critical time for negotiations last year.", "url": "https://www.abc.net.au/news/2021-12-07/new-emails-reveal-how-enthusiastic-pfizer-to-engage-australia/100680842", "urlToImage": "https://live-production.wcms.abc-cdn.net.au/04f0a5a4f816c350327fc9168bd61cb8?impolicy=wcms_crop_resize&cropH=2813&cropW=5000&xPos=0&yPos=23&width=862&height=485", "publishedAt": "2021-12-07T11:57:05Z", "content": "New emails reveal how \"enthusiastic\" Pfizer was to engage with Australia about its COVID-19 vaccine, months before the federal government agreed to buy any doses.\r\nKey points:\r\n<ul><li>In late June 2\u2026 [+5446 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Pfizer Invites Public to Register for Webcast of Analyst and Investor Call to Discuss Pfizer-BioNTech COVID-19 Vaccine and Pfizer\u2019s Novel COVID-19 Oral Antiviral Treatment Candidate", "description": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live webcast of a presentation and conference call with investment analysts at 8:30 a.m. EST on Friday, December 17, 2021. Pfizer Vaccines and Hospital lea\u2026", "url": "https://www.businesswire.com/news/home/20211207005083/en/Pfizer-Invites-Public-to-Register-for-Webcast-of-Analyst-and-Investor-Call-to-Discuss-Pfizer-BioNTech-COVID-19-Vaccine-and-Pfizer%E2%80%99s-Novel-COVID-19-Oral-Antiviral-Treatment-Candidate", "urlToImage": "https://mms.businesswire.com/media/20211207005083/en/1045874/23/Pfizer_Logo_Color_RGB_APPROVED.jpg", "publishedAt": "2021-12-07T15:09:16Z", "content": "NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to access a live webcast of a presentation and conference call with investment analysts at 8:30 a.m. EST on\u2026 [+3713 chars]"}, {"source": {"id": "cnn", "name": "CNN"}, "author": "Maggie Fox, CNN", "title": "Omicron coronavirus variant partly evades Pfizer vaccine's protection, study shows", "description": "The Omicron coronavirus variant partly escapes the protection offered by the Pfizer vaccine, but people who have been previously infected and then vaccinated are likely to be well protected, researchers working in South Africa reported Tuesday.", "url": "https://www.cnn.com/2021/12/07/health/omicron-variant-pfizer-vaccine-south-africa-study/index.html", "urlToImage": "https://cdn.cnn.com/cnnnext/dam/assets/211207174255-pfizer-vaccine-south-africa-113021-restricted-super-tease.jpg", "publishedAt": "2021-12-07T23:22:06Z", "content": "(CNN)The Omicron coronavirus variant partly escapes the protection offered by the Pfizer vaccine, but people who have been previously infected and then vaccinated are likely to be well protected, res\u2026 [+4043 chars]"}, {"source": {"id": null, "name": "ZDNet"}, "author": "Aimee Chanthadavong", "title": "AWS and Pfizer team up to develop cloud solutions to speed up medical development", "description": "Pfizer is developing prototype solutions that incorporate a slew of AWS capabilities including machine learning, analytics, data warehousing, storage, and security.", "url": "https://www.zdnet.com/article/aws-and-pfizer-team-up-to-develop-cloud-solutions-to-speed-up-medical-development/", "urlToImage": "https://www.zdnet.com/a/img/resize/b8d18eab920a4ee336bf0de05c2550b2bc2353a6/2013/08/26/77b82875-0e21-11e3-90a0-0291187ef9b6/drugs-innovation-research-pfizer-news-co_fENM2.jpg?width=770&height=578&fit=crop&auto=webp", "publishedAt": "2021-12-07T23:53:11Z", "content": "Amazon Web Services (AWS) and Pfizer have joined forces to create cloud-based solutions to speed up how new medicines are developed, manufactured, and distributed for testing in clinical trials.\r\nThe\u2026 [+4108 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Megan Redshaw", "title": "120 Teens Hospitalized, 3 Dead Following Pfizer Vaccine Rollout for 15- to 17-Year-Olds in Vietnam", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/120-teens-hospitalized-3-dead-following-pfizer-vaccine-rollout-15-17-year-olds-vietnam/5763913", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/Covid-vaccine-Vietnam-teen-deaths-feature-800x417.jpg", "publishedAt": "2021-12-07T16:02:58Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+3592 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Mixing Pfizer, AstraZeneca COVID-19 shots with Moderna gives better immune response: UK study", "description": "LONDON: A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday (De\u2026", "url": "https://www.channelnewsasia.com/world/mixing-pfizer-astrazeneca-covid-19-shots-moderna-gives-better-immune-response-uk-study-2362776", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--lO9NJAbQ--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2021-12-06t235303z_2_lynxmpehb512y_rtroptp_3_health-coronavirus-vaccine.jpg?itok=n11J8aZF", "publishedAt": "2021-12-07T00:27:15Z", "content": "LONDON: A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Mode\u2026 [+2100 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Study suggests Pfizer COVID-19 vaccine only partially protects against Omicron", "description": "DURBAN: The Omicron variant of the coronavirus can partially evade the protection from Pfizer and partner BioNTech's COVID-19 vaccine, the research head of a laboratory at Africa Health Research Institute in South Africa said on Tuesday (Dec 7).\r\n\r\nAlex Sigal\u2026", "url": "https://www.channelnewsasia.com/world/study-suggests-pfizer-covid-19-vaccine-only-partially-protects-against-omicron-2365041", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--bZy-tf8M--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2021-12-07t220933z_4_lynxmpehb6155_rtroptp_3_health-coronavirus-newzealand.jpg?itok=jXCLy9Gd", "publishedAt": "2021-12-07T22:51:00Z", "content": "DURBAN: The Omicron variant of the coronavirus can partially evade the protection from Pfizer and partner BioNTech's COVID-19 vaccine, the research head of a laboratory at Africa Health Research Inst\u2026 [+854 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "insider@insider.com (Allana Akhtar)", "title": "Pfizer should have helped low-income countries better distribute COVID-19 vaccines, CEO said", "description": "Albert Bourla told The Wall Street Journal he would have worked with low-income countries to improve infrastructure and better distribute doses.", "url": "https://www.businessinsider.com/pfizer-could-have-improved-vaccine-distribution-equity-ceo-said-2021-12", "urlToImage": "https://i.insider.com/61af76e16531110019cee136?width=1200&format=jpeg", "publishedAt": "2021-12-07T16:28:33Z", "content": "Pfizer CEO Albert Bourla acknowledged the pharmaceutical giant could have worked better to ensure low-income countries got enough COVID-19 vaccines.\r\nBourla said low-income countries have asked Pfize\u2026 [+2260 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Psoriatic Arthritis Treatment Global Market Report 2021 Featuring AbbVie, Amgen, J&J, BMS, Celgene, Novartis, Eli Lilly And Co, Pfizer, UCB Biosciences, and Hoffmann La Roche - ResearchAndMarkets.com", "description": "DUBLIN--(BUSINESS WIRE)--The \"Psoriatic Arthritis Treatment Global Market Report 2021: COVID-19 Growth and Change to 2030\" report has been added to ResearchAndMarkets.com's offering. The global psoriatic arthritis treatment market is expected to grow from $7.\u2026", "url": "https://www.businesswire.com/news/home/20211207005933/en/Psoriatic-Arthritis-Treatment-Global-Market-Report-2021-Featuring-AbbVie-Amgen-JJ-BMS-Celgene-Novartis-Eli-Lilly-And-Co-Pfizer-UCB-Biosciences-and-Hoffmann-La-Roche---ResearchAndMarkets.com", "urlToImage": "http://www.businesswire.com/images/bwlogo_square.png", "publishedAt": "2021-12-07T17:55:38Z", "content": "DUBLIN--(BUSINESS WIRE)--The \"Psoriatic Arthritis Treatment Global Market Report 2021: COVID-19 Growth and Change to 2030\" report has been added to ResearchAndMarkets.com's offering.\r\nThe global psor\u2026 [+5464 chars]"}, {"source": {"id": null, "name": "PharmaLive"}, "author": "Pushkala Aripaka", "title": "Mixing Pfizer, AstraZeneca COVID-19 shots with Moderna gives better immune response \u2013 UK study - PharmaLive", "description": "<ol><li>Mixing Pfizer, AstraZeneca COVID-19 shots with Moderna gives better immune response \u2013 UK study\u00a0\u00a0PharmaLive\r\n</li><li>Moderna or Novavax after AstraZeneca jab confers high Covid immunity, study finds\u00a0\u00a0The Guardian\r\n</li><li>Study: Mixing J&J Booster Ra\u2026", "url": "https://www.pharmalive.com/mixing-pfizer-astrazeneca-covid-19-shots-with-moderna-gives-better-immune-response-uk-study/", "urlToImage": "https://www.pharmalive.com/wp-content/uploads/2021/12/Mixing-Pfizer-AstraZ-COVID-19-shots-with-Moderna-gives-better-immune-response-UK-study-Reuters-12-6-21.jpg", "publishedAt": "2021-12-07T07:33:24Z", "content": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response UK study(Reuters) \u2013 A major British study into mixing COVID-19 vaccines has found that people had a better immune respon\u2026 [+3578 chars]"}]}, "2021-12-06": {"status": "ok", "totalResults": 56, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK study - Reuters", "description": "A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/mixing-pfizer-astraz-covid-19-shots-with-moderna-gives-better-immune-response-uk-2021-12-06/", "urlToImage": "https://www.reuters.com/resizer/2hWWuQQtDAfsE2_em2jdEEeltMw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/P3XCTOZZEJKGRERRQ6XNXOCXUU.jpg", "publishedAt": "2021-12-06T23:40:00Z", "content": "Dec 6 (Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots follow\u2026 [+3422 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022 - exec - Reuters", "description": "South Africa's Biovac Institute will start making Pfizer-BioNTech's <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a>, <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> COVID-19 vaccine early next \u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/south-africas-biovac-start-making-pfizer-biontech-covid-19-vaccine-early-2022-2021-12-06/", "urlToImage": "https://www.reuters.com/resizer/1cSn2jGxJGJONEa4AmZW9bIygxI=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/WTRFASBFQFOYDJKN4755OTK5KY.jpg", "publishedAt": "2021-12-06T13:59:00Z", "content": "KIGALI, Dec 6 (Reuters) - South Africa's Biovac Institute will start making Pfizer-BioNTech's (PFE.N), (22UAy.DE) COVID-19 vaccine early next year after receiving the drug substance from facilities i\u2026 [+1633 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Irina Anghel", "title": "Mixing Covid Vaccines Is Effective in Study on Pfizer, Astra", "description": "Mixing other vaccines with those from AstraZeneca Plc or Pfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a U.K. study found.", "url": "https://www.bloomberg.com/news/articles/2021-12-06/mixing-covid-vaccines-is-effective-in-study-on-pfizer-astra", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/i9O8xVfPiHs8/v0/1200x800.jpg", "publishedAt": "2021-12-06T23:30:00Z", "content": "Mixing other vaccines with those from \r\nAstraZeneca Plc or \r\nPfizer Inc. offers at least as effective protection against Covid-19 as giving two doses of the same shots, a U.K. study found.\u00a0\r\nThe Univ\u2026 [+2114 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (George Budwell)", "title": "Why Shares of Pfizer, Ocugen, and Vaxart Are Losing Ground Today", "description": "The initial data on omicron suggests that the pandemic has entered a new, less deadly phase.", "url": "https://www.fool.com/investing/2021/12/06/why-shares-of-pfizer-ocugen-and-vaxart-are-losing/", "urlToImage": "https://g.foolcdn.com/editorial/images/656256/covid-vax.jpg", "publishedAt": "2021-12-06T18:45:40Z", "content": "What happened\r\nShares of the COVID-19 vaccine makers Pfizer(NYSE:PFE), Ocugen(NASDAQ:OCGN), and Vaxart(NASDAQ:VXRT) are all moving in the wrong direction today. Specifically, Pfizer's stock is down b\u2026 [+2263 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Pfizer accused of \u2018sabotaging\u2019 AstraZeneca jab", "description": "US drugmaker Pfizer is denying any wrongdoing after a British TV documentary showed a presentation on its behalf had criticized the rival Covid-19 vaccine AstraZeneca as potentially dangerous and unsafe. Read Full Article at RT.com", "url": "https://www.rt.com/uk/542389-pfizer-astrazeneca-undermine-documentary/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61ae8cb585f5404afe76c337.JPG", "publishedAt": "2021-12-06T22:31:21Z", "content": "Teasers for a Channel 4 Dispatches investigative report, shown Monday, say that a Pfizer presentation described AstraZeneca\u2019s vaccine against Covid-19 as unsafe for patients with compromised immune s\u2026 [+1693 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Pushkala Aripaka and Lucy Marks", "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study - Yahoo News", "description": "<ol><li>Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study\u00a0\u00a0Yahoo News\r\n</li><li>Mix-and-match J&J Covid booster raised immune response after Pfizer vaccine, study finds\u00a0\u00a0CNN\r\n</li><li>Researchers say any approved vaccin\u2026", "url": "https://uk.news.yahoo.com/mixing-pfizer-astraz-covid-19-234026305.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/f4FnVunWZPfnoeUaEHGIyg--~B/aD01MTE7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/ea129a6d834bdf23e30712a3ac307f4c", "publishedAt": "2021-12-06T23:40:26Z", "content": "By Pushkala Aripaka and Lucy Marks\r\n(Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca o\u2026 [+3234 chars]"}, {"source": {"id": "the-wall-street-journal", "name": "The Wall Street Journal"}, "author": null, "title": "WSJ CEO Council: Leaders from Tesla, Intel, Reddit, Pfizer and More Discuss Challenges Facing Business - The Wall Street Journal", "description": "The Wall Street Journal is gathering prominent leaders in business and politics to discuss how CEOs can best navigate the current political and economic climate.", "url": "https://www.wsj.com/livecoverage/wsj-ceo-council-tesla-intel-reddit-pfizer", "urlToImage": "https://images.wsj.net/im-446301/social", "publishedAt": "2021-12-06T10:37:00Z", "content": "The Wall Street Journal is gathering prominent leaders in business and politics, including several members of President Bidens cabinet, at its CEO Council summit on Monday and Tuesday for discussions\u2026 [+1537 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Pushkala Aripaka and Lucy Marks", "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study", "description": "A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or...", "url": "https://news.yahoo.com/mixing-pfizer-astraz-covid-19-234026305.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/vIfC1kmKmg2Aubar6WYayg--~B/aD01MTE7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/e4b1ef0bc078f01a9ebe28e90aaf929c", "publishedAt": "2021-12-06T23:40:26Z", "content": "By Pushkala Aripaka and Lucy Marks\r\n(Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca o\u2026 [+3234 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Worldwide Benign Prostatic Hyperplasia Treatment Industry to 2026 - Featuring GlaxoSmithKline, Pfizer and Sanofi Among Others", "description": "The \"Benign Prostatic Hyperplasia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026\" report has been added to...", "url": "https://finance.yahoo.com/news/worldwide-benign-prostatic-hyperplasia-treatment-214500039.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/wDGPSO44TROYKbQSONxNmQ--~B/aD00Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/e75ef6f3096d7cb6f5dd43ba82eca2fe", "publishedAt": "2021-12-06T21:45:00Z", "content": "DUBLIN, Dec. 6, 2021 /PRNewswire/ -- The \"Benign Prostatic Hyperplasia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026\" report has been added to Rese\u2026 [+6531 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "PR Newswire", "title": "Worldwide Liposomal Doxorubicin Industry to 2026 - Featuring Baxter International, Cipla and Pfizer Among Others", "description": "The \"Liposomal Doxorubicin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026\" report has been added to...", "url": "https://finance.yahoo.com/news/worldwide-liposomal-doxorubicin-industry-2026-191500819.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/wDGPSO44TROYKbQSONxNmQ--~B/aD00Mjt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/e75ef6f3096d7cb6f5dd43ba82eca2fe", "publishedAt": "2021-12-06T19:15:00Z", "content": "DUBLIN, Dec. 6, 2021 /PRNewswire/ -- The \"Liposomal Doxorubicin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026\" report has been added to ResearchAndMarkets.co\u2026 [+5691 chars]"}, {"source": {"id": null, "name": "CNET"}, "author": "Jessica Dolcourt", "title": "Where can I get a booster shot? Quickly find Moderna and Pfizer vaccines near you - CNET", "description": "Texting a single number can save you a ton of time and hassle -- and you might even get a free Lyft or Uber ride in the process.", "url": "https://www.cnet.com/health/where-can-i-get-a-booster-shot-quickly-find-moderna-and-pfizer-vaccines-near-you/", "urlToImage": "https://www.cnet.com/a/img/fy-bL2dzhG4DqpoY_-Q7S38Gqi4=/1200x630/2021/11/24/5def0981-0b4a-497f-91d7-65d0323be6e8/covid-19-masks-n95-cnet-2021-012.jpg", "publishedAt": "2021-12-06T21:35:02Z", "content": "COVID-19 vaccine booster shots are available in 80,000 locations.\r\nSarah Tew/CNET\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites.\r\nBringi\u2026 [+4373 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": null, "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study - Yahoo News UK", "description": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response - UK study\u00a0\u00a0Yahoo News UKView Full Coverage on Google News", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_e79d32e6-cec9-4add-a94f-8e7d751d3fb9", "urlToImage": null, "publishedAt": "2021-12-06T23:40:26Z", "content": "Yahoo is part of the Yahoo family of brands.\r\nBy clicking \"Accept all\" you agree that Yahoo and our partners will store and/or access information on your device through the use of cookies and similar\u2026 [+689 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Carl Zimmer", "title": "J&J booster works well for people who had Pfizer originally, study finds", "description": "People who received Pfizer-BioNTech vaccines may get as much benefit from a Johnson & Johnson booster shot as a Pfizer one. That\u2019s the finding of a small study released Sunday.", "url": "https://www.bostonglobe.com/2021/12/05/nation/jj-booster-works-well-people-who-had-pfizer-originally-study-finds/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/TaTn3qJJm7G4hq0qE94vGHOsNBA=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/PFIVB7OKCHVYHYSDRTATW6C3RU.jpg", "publishedAt": "2021-12-06T02:23:06Z", "content": "People who received Pfizer-BioNTech vaccines may get as much benefit from a Johnson &amp; Johnson booster shot as a Pfizer one. Thats the finding of a small study released Sunday.\r\nResearchers at the\u2026 [+2289 chars]"}, {"source": {"id": null, "name": "Sputnik International"}, "author": "Sputnik International", "title": "Two Infants Hospitalised in Brazil After Getting Pfizer Shots by Mistake, Reports Say", "description": "BUENOS AIRES (Sputnik) - Two newborns in Brazil were given coronavirus vaccine shots by mistake and had to be hospitalised, the Brazilian media reports.", "url": "https://sputniknews.com/20211206/two-infants-hospitalised-in-brazil-after-getting-pfizer-shots-by-mistake-reports-say-1091272174.html", "urlToImage": "https://cdnn1.img.sputniknews.com/images/sharing/article/eng/1091272174.jpg?10902672951638765315", "publishedAt": "2021-12-06T04:34:07Z", "content": "Registration was successful!Please follow the link from the email sent to \r\nhttps://sputniknews.com/20211206/two-infants-hospitalised-in-brazil-after-getting-pfizer-shots-by-mistake-reports-say-10912\u2026 [+2144 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Megan Redshaw", "title": "5-Year-Old Died 4 Days after Pfizer Shot, CDC VAERS Data Show", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version). To receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here. Visit and follow\u2026", "url": "https://www.globalresearch.ca/5-year-old-died-4-days-pfizer-shot-cdc-vaers-data-show/5763620", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/Covid-vaccine-VAERS-120321-feature-800x417.jpg", "publishedAt": "2021-12-06T05:14:46Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+9952 chars]"}, {"source": {"id": null, "name": "Trust.org"}, "author": "Thomson Reuters Foundation", "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives ... - Thomson Reuters Foundation", "description": "<ol><li>Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives ...\u00a0\u00a0Thomson Reuters Foundation\r\n</li><li>Researchers say any approved vaccine will work as booster\u00a0\u00a0KRIS 6 News\r\n</li><li>Study shows COVID booster shots work\u00a0\u00a0News-Medical.net\r\n</li><li>Moderna\u2026", "url": "https://news.trust.org/item/20211206232742-o7inz/", "urlToImage": "https://d8zcwdvc14g2e.cloudfront.net/contentAsset/image/b8c49d62-dcf2-4d21-8e51-cd450b89fcc5/image/byInode/1/filter/Resize,Jpeg/jpeg_q/70/resize_w/1100", "publishedAt": "2021-12-06T23:30:00Z", "content": "By Pushkala Aripaka and Lucy Marks\r\nDec 6 (Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZe\u2026 [+3512 chars]"}, {"source": {"id": null, "name": "Devdiscourse"}, "author": "Reuters", "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK study - Devdiscourse", "description": "A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.  \"We found\u2026", "url": "https://www.devdiscourse.com/article/health/1837011-mixing-pfizer-astraz-covid-19-shots-with-moderna-gives-better-immune-response--uk-study", "urlToImage": "https://www.devdiscourse.com/remote.axd?https://devdiscourse.blob.core.windows.net/imagegallery/27_06_2019_18_22_44_8556925.png?width=920&format=jpeg", "publishedAt": "2021-12-06T23:30:42Z", "content": "A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine\u2026 [+3408 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "Seth Hancock", "title": "Congressman Introduces Bill to Force FDA to Release Pfizer Documents Within 100 Days, Instead of 55 Years", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version).\nTo receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here.\nVisit \u2026\nThe post\u2026", "url": "https://www.globalresearch.ca/congressman-introduces-bill-force-fda-release-pfizer-documents-100-days-instead-55-years/5763710", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/12/Rep-Norman-demands-FDA-Pfizer-data-feature-800x417.jpg", "publishedAt": "2021-12-06T14:38:37Z", "content": "All Global Research articles\u00a0can be read in 51 languages by activating the Translate Website\u00a0drop down menu on the top banner of our home page (Desktop version).\r\nTo receive Global Researchs Daily Ne\u2026 [+6768 chars]"}, {"source": {"id": "cnn", "name": "CNN"}, "author": "Maggie Fox, CNN", "title": "Mix-and-match J&J Covid booster raised immune response after Pfizer vaccine, study finds", "description": "Using the Johnson & Johnson vaccine as a booster for people initially immunized with the Pfizer/BioNTech vaccine produces a strong immune response and may do more to elicit protection against severe disease, researchers reported Sunday.", "url": "https://www.cnn.com/2021/12/05/health/covid-vaccine-johnson-pfizer-booster-mix/index.html", "urlToImage": "https://cdn.cnn.com/cnnnext/dam/assets/211111052048-johnson--johnson-janssen-covid-19-vaccine-california-032521-file-super-tease.jpg", "publishedAt": "2021-12-06T03:16:55Z", "content": "(CNN)Using the Johnson &amp; Johnson vaccine as a booster for people initially immunized with the Pfizer/BioNTech vaccine produces a strong immune response and may do more to elicit protection agains\u2026 [+2171 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "South Africa's Biovac to start making Pfizer-BioNTech COVID-19 vaccine in early 2022", "description": "KIGALI: South Africa's Biovac Institute will start making Pfizer-BioNTech's COVID-19 vaccine early next year after receiving the drug substance from facilities in Europe, a Pfizer executive said on Monday (Dec 6).\r\n\r\nThat earlier than the forecast start at ar\u2026", "url": "https://www.channelnewsasia.com/business/south-africas-biovac-start-making-pfizer-biontech-covid-19-vaccine-early-2022-2361996", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--BMeg4VXM--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2021-12-06t135809z_1_lynxmpehb50la_rtroptp_3_health-coronavirus-usa-children.jpg?itok=1spx8HWR", "publishedAt": "2021-12-06T13:59:00Z", "content": "KIGALI: South Africa's Biovac Institute will start making Pfizer-BioNTech's COVID-19 vaccine early next year after receiving the drug substance from facilities in Europe, a Pfizer executive said on M\u2026 [+1301 chars]"}]}, "2021-12-05": {"status": "ok", "totalResults": 22, "articles": [{"source": {"id": null, "name": "The Guardian"}, "author": "Jon Ungoed-Thomas", "title": "\u2018Wall of secrecy\u2019 in Pfizer contracts as company accused of profiteering", "description": "US company faces scrutiny over Covid profits after UK agrees to secrecy clause<ul><li>Coronavirus \u2013 latest updates</li><li>See all our coronavirus coverage</li></ul>Ministers have agreed a secrecy clause in any dispute with the drugs manufacturer Pfizer over \u2026", "url": "https://amp.theguardian.com/uk-news/2021/dec/05/wall-of-secrecy-in-pfizer-contracts-as-company-accused-of-profiteering", "urlToImage": "https://i.guim.co.uk/img/media/f48fdea9871e0b96394a999a0bd48e3b49971b44/0_118_5483_3290/master/5483.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdG8tZGVmYXVsdC5wbmc&enable=upscale&s=eb3b4edcf499e6758ace0de6e27423df", "publishedAt": "2021-12-05T06:30:47Z", "content": "Ministers have agreed a secrecy clause in any dispute with the drugs manufacturer Pfizer over Britains Covid vaccine supply. Large portions of the governments contracts with the company over the supp\u2026 [+4720 chars]"}, {"source": {"id": null, "name": "New York Times"}, "author": "Carl Zimmer", "title": "J.&J. Booster Worked for People Who Got Pfizer Shots in Study", "description": "", "url": "https://www.nytimes.com/2021/12/05/health/jj-booster-pfizer-study.html", "urlToImage": "https://static01.nyt.com/images/2021/12/05/multimedia/05virus-briefing-JJ-boosters-alt/05virus-briefing-JJ-boosters-alt-facebookJumbo.jpg", "publishedAt": "2021-12-05T22:55:16Z", "content": "People who received Pfizer-BioNTech vaccines may get as much benefit from a Johnson &amp; Johnson booster shot as a Pfizer one. Thats the finding of a small study released on Sunday.\r\nResearchers at \u2026 [+1288 chars]"}, {"source": {"id": null, "name": "The Guardian"}, "author": "Paul Karp", "title": "\u2018Provisional approval\u2019: Australian children aged five to 11 set to receive Pfizer Covid vaccine from mid-January", "description": "Subject to final approvals, 2.3 million children in age cohort could have first jab before school returns in 2022<ul><li>Get our free news app; get our morning email briefing</li></ul>Australian children aged five to 11 could receive the Pfizer vaccine agains\u2026", "url": "https://amp.theguardian.com/society/2021/dec/05/australian-children-aged-five-to-11-set-to-receive-pfizer-covid-vaccine-from-mid-january", "urlToImage": "https://i.guim.co.uk/img/media/8de38ca47901c8114400d7067e2d8ce32c30e4b6/0_64_4915_2949/master/4915.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctZGVmYXVsdC5wbmc&enable=upscale&s=e6218722ff3080965f87ac32156b8c56", "publishedAt": "2021-12-05T00:17:06Z", "content": "Australian children aged five to 11 could receive the Pfizer vaccine against Covid as soon as 10 January, following provisional approval by the countrys drugs regulator.\r\nThe Therapeutic Goods Admini\u2026 [+2606 chars]"}, {"source": {"id": null, "name": "WWLP.com"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - WWLP.com", "description": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say\u00a0\u00a0WWLP.comView Full Coverage on Google News", "url": "https://www.wwlp.com/news/health/coronavirus/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://www.wwlp.com/wp-content/uploads/sites/26/2021/12/ModernaPfizerGettyImages-1234603091.jpg?w=1280", "publishedAt": "2021-12-05T17:36:15Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1852 chars]"}, {"source": {"id": null, "name": "Globalresearch.ca"}, "author": "The Election Wizard", "title": "Bombshell Document Dump on Pfizer Vaccine Data", "description": "All Global Research articles\u00a0can be read in 51 languages by activating the \u201cTranslate Website\u201d\u00a0drop down menu on the top banner of our home page (Desktop version). To receive Global Research\u2019s Daily Newsletter (selected articles),\u00a0click here. Visit and follow\u2026", "url": "https://www.globalresearch.ca/bombshell-document-dump-pfizer-vaccine-data/5763397", "urlToImage": "https://www.globalresearch.ca/wp-content/uploads/2021/11/Covid-19-Coronavirus-Pfizer-Syringe-Vaccine-Vial.jpg", "publishedAt": "2021-12-05T23:03:53Z", "content": "This document provides an integrated analysis of the cumulative post-authorization safety data, including U.S. and foreign post-authorization adverse event reports received through 28 February 2021.\r\u2026 [+1114 chars]"}, {"source": {"id": null, "name": "RochesterFirst"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - RochesterFirst", "description": "<ol><li>Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say\u00a0\u00a0RochesterFirst\r\n</li><li>Mix-and-match J&J Covid booster raised immune response after Pfizer vaccine, study finds\u00a0\u00a0CNN\r\n</li><li>Researchers say any a\u2026", "url": "https://www.rochesterfirst.com/coronavirus/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://www.rochesterfirst.com/wp-content/uploads/sites/66/2021/12/GettyImages-1231116335.jpg?w=1280", "publishedAt": "2021-12-05T00:06:20Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1851 chars]"}, {"source": {"id": null, "name": "Israelnationalnews.com"}, "author": "Arutz Sheva Staff", "title": "Pfizer CEO: Israel is a beacon of hope in this pandemic", "description": "Albert Bourla talks about his good relations with Netanyahu and Bennett and answers parents who are worried over the COVID vaccine.", "url": "https://www.israelnationalnews.com/News/News.aspx/318091", "urlToImage": "https://u.a7.org/pictures/1040/1040424.jpg", "publishedAt": "2021-12-05T01:55:00Z", "content": "Albert Bourla, CEO of Pfizer, is not alarmed by the new Omicron variant of COVID-19 and reveals what he thinks about the way Israel is handling the crisis.\r\nIn an interview with the Yediot Aharonot n\u2026 [+3164 chars]"}, {"source": {"id": null, "name": "Cracknewz.com"}, "author": "Neha", "title": "3 children dead, 120 hospitalized\u2026 Pfizer Vaccine batch suspended\u2026", "description": "", "url": "https://www.cracknewz.com/2021/12/ghislaine-maxwell-kept-degrading-58.html", "urlToImage": null, "publishedAt": "2021-12-05T12:54:00Z", "content": "Since November 30, the central province has been vaccinating children aged 15-17 with the Pfizer Covid-19 vaccine. However, over 120 of the children were admitted to hospitals after exhibiting sympto\u2026 [+1431 chars]"}, {"source": {"id": null, "name": "ArkLaTexHomepage"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - ArkLaTexHomepage", "description": "<ol><li>Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say\u00a0\u00a0ArkLaTexHomepage\r\n</li><li>COVID-19: Study suggests mixing and matching vaccine boosters proves effective\u00a0\u00a0Global News\r\n</li><li>Study Finds Most Covi\u2026", "url": "https://www.arklatexhomepage.com/health/coronavirus/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://www.arklatexhomepage.com/wp-content/uploads/sites/5/2021/12/ModernaPfizerGettyImages-1234603091.jpg?w=1280", "publishedAt": "2021-12-05T03:19:53Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1970 chars]"}, {"source": {"id": null, "name": "TheJournal.ie"}, "author": "AFP", "title": "Australia approves Pfizer Covid-19 vaccine for children aged 5-11", "description": "\u201cIt is about keeping our kids safe, keeping our families safe, keeping all Australians safe,\u201d Australia\u2019s Health Minister said.", "url": "https://www.thejournal.ie/australia-covid-vaccines-pfizer-5620841-Dec2021/", "urlToImage": "https://img2.thejournal.ie/article/5620841/river/?height=400&version=5620874", "publishedAt": "2021-12-05T12:40:51Z", "content": "AUSTRALIA HAS CLEARED the first Covid-19 vaccine for children aged five to 11, with the next stage of its vaccine rollout expected to start in early 2022.\r\nHealth Minister Greg Hunt said medical regu\u2026 [+1600 chars]"}, {"source": {"id": null, "name": "City A.M."}, "author": "Amy O'Brien", "title": "Pfizer accused of funding anti-AstraZeneca information", "description": "US drugmaker Pfizer, the world\u2019s dominant Covid vaccine maker, has been accused of funding educational presentations that said its UK rival AstraZeneca was ineffective and even dangerous for some members of the population. A Channel 4 Dispatches investigation\u2026", "url": "https://www.cityam.com/pfizer-accused-of-funding-anti-astrazeneca-information/", "urlToImage": "https://www.cityam.com/wp-content/uploads/2021/10/City-AM-OG-1.jpg", "publishedAt": "2021-12-05T13:42:08Z", "content": "Sunday 05 December 2021 1:42 pm\r\nPfizer CEO Albert Bourla talks during a press conference after a visit at Pfizer vaccine plant in Puurs\r\nUS drugmaker Pfizer, the world\u2019s dominant Covid vaccine maker\u2026 [+2871 chars]"}, {"source": {"id": null, "name": "Vaccineimpact.com"}, "author": "Mike Rivero", "title": "2,809 Dead Babies in VAERS Following COVID Shots as New Documents Prove Pfizer, the FDA, and the CDC Knew the Shots Were Not Safe for Pregnant Women", "description": "The latest data dump into the U.S. Government\u2019s Vaccine Adverse Events Reporting System (VAERS) happened yesterday (12/3/21) and covers data through 11/26/2021. There are now 927,740 cases reported to VAERS following COVID-19 shots for the past 11 months, out\u2026", "url": "https://vaccineimpact.com/2021/2809-dead-babies-in-vaers-following-covid-shots-as-new-documents-prove-pfizer-the-fda-and-the-cdc-knew-the-shots-were-not-safe-for-pregnant-women/", "urlToImage": null, "publishedAt": "2021-12-05T14:23:19Z", "content": "by Brian ShilhavyEditor, Health Impact News\r\nThe latest data dump into the U.S. Governments\u00a0Vaccine Adverse Events Reporting System\u00a0(VAERS) happened yesterday (12/3/21) and covers data through 11/26/\u2026 [+18642 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "The National Pulse", "title": "CONFLICT: Reuters Chairman is Pfizer Investor and Board Member.", "description": "The chairman and former Chief Executive Officer (CEO) of the Reuters news agency \u2013 James C. Smith \u2013 is a top investor and board member for pharmaceuticals giant Pfizer. He was elected to the board in 2014, as well as joining Pfizer\u2019s Corporate Governance and \u2026", "url": "https://freerepublic.com/focus/f-bloggers/4018528/posts", "urlToImage": null, "publishedAt": "2021-12-05T21:38:19Z", "content": "Skip to comments.\r\nCONFLICT: Reuters Chairman is Pfizer Investor and Board Member.The National Pulse ^\r\n | 12/1/21\r\n | Kay Smythe\r\nPosted on 12/05/2021 1:38:19 PM PST by Roman_War_Criminal\r\nThe chair\u2026 [+2107 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Australia regulator approves Pfizer vaccine for children 5-11", "description": "Australia's medicine regulator on Sunday provisionally approved the Pfizer Inc coronavirus vaccine for children between the ages of 5 and 11, with the health minister saying the rollout could begin from Jan10.", "url": "https://bdnews24.com/world/asia-pacific/2021/12/05/australia-regulator-approves-pfizer-vaccine-for-children-5-11", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/10/29/australia-vaccine-291021-smr.jpg/BINARY/australia-vaccine-291021-smr.jpg", "publishedAt": "2021-12-05T04:40:06Z", "content": "The Therapeutics Goods Administration \"have made a careful, thorough assessment, determined that it is safe and effective and that it is in the interests of children and Australians for children 5 to\u2026 [+2086 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "IANS", "title": "Pfizer faces scrutiny over scale of its Covid profits, says report", "description": "Pfizer has to date pledged 40m doses out of global production to Covax", "url": "https://www.business-standard.com/article/international/pfizer-faces-scrutiny-over-scale-of-its-covid-profits-says-report-121120500724_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-02/25/full/1614255646-8333.jpg", "publishedAt": "2021-12-05T15:14:00Z", "content": "Pfizer has won plaudits for its Covid vaccine delivery programme, but the US multinational faces growing scrutiny over the scale of its profits and the proportion of doses it has delivered to low-inc\u2026 [+4581 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "CNN", "title": "Pfizer revenue and profits soar on its Covid vaccine business: Vaccine business alone was responsible for more than 60% of the company's sales", "description": "New York (CNN Business): Pfizer reported that earnings and sales more than doubled in the past quarter, and it raised its outlook for results the full year, thanks greatly to its Covid-19 vaccine. The company reported adjusted earnings of $7.7 billion, up 133\u2026", "url": "https://freerepublic.com/focus/f-chat/4018478/posts", "urlToImage": null, "publishedAt": "2021-12-05T17:41:07Z", "content": "Skip to comments.\r\nPfizer revenue and profits soar on its Covid vaccine business: Vaccine business alone was responsible for more than 60% of the company's salesCNN ^\r\n | November 2021\r\n | Chris Isid\u2026 [+3467 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Omicron and COVID booster shot: Find out fast if your pharmacy has Pfizer or Moderna - CNET", "description": "Omicron and COVID booster shot: Find out fast if your pharmacy has Pfizer or ModernaCNET COVID-19 Booster Vaccine: A Timeline for Third Dose Effectiveness and ImmunityGoodHousekeeping.com What to expect from booster reactionsKOLD COVID booster shot and omicro\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156240673", "urlToImage": null, "publishedAt": "2021-12-05T05:32:13Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "Anonymous Coward", "title": "Over 42,000 Adverse Reaction Reports Revealed In First Batch Of Pfizer Vax Docs", "description": "As first reported by Kyle Becker, there were a total of 42,086 case reports for adverse reactions (25,379 medically confirmed, 16,707 non-medically confirmed), spanning 158,893 total events. More than 25,000 of the events were classified as \"Nervous system di\u2026", "url": "https://slashdot.org/submission/15085467/over-42000-adverse-reaction-reports-revealed-in-first-batch-of-pfizer-vax-docs", "urlToImage": null, "publishedAt": "2021-12-05T02:35:52Z", "content": "As first reported by Kyle Becker, there were a total of 42,086 case reports for adverse reactions (25,379 medically confirmed, 16,707 non-medically confirmed), spanning 158,893 total events. More tha\u2026 [+222 chars]"}, {"source": {"id": "the-irish-times", "name": "The Irish Times"}, "author": null, "title": "Australian regulator approves Pfizer vaccine for children aged 5-11", "description": "Rollout of Covid jabs for children could begin in early January, health minister says", "url": "https://www.irishtimes.com/news/world/asia-pacific/australian-regulator-approves-pfizer-vaccine-for-children-aged-5-11-1.4747183", "urlToImage": "https://www.irishtimes.com/image-creator/?id=1.4747182&origw=1440", "publishedAt": "2021-12-05T08:59:30Z", "content": "Australias medicine regulator on Sunday provisionally approved the Pfizer coronavirus vaccine for children between the ages of five and 11, with the health minister saying the rollout could begin fro\u2026 [+282 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - fox4kc.com", "description": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers sayfox4kc.com...", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156240009", "urlToImage": null, "publishedAt": "2021-12-05T04:12:10Z", "content": "Thus mathematics may be defined as the subject in which we never know\r\nwhat we are talking about, nor whether what we are saying is true.\r\n-- Bertrand Russell"}]}, "2021-12-04": {"status": "ok", "totalResults": 14, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Australia's medicine regulator approves Pfizer vaccine for children 5-11 - Reuters", "description": "Australia's medicine regulator provisionally approved on Sunday the Pfizer Inc  coronavirus vaccine for children between the ages of 5 and 11, with the health minister saying the rollout could begin from Jan. 10.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/australias-medicine-regulator-approves-pfizer-vaccine-children-5-11-2021-12-04/", "urlToImage": "https://www.reuters.com/resizer/RvUfhvsalZtMT3LGTX3k_lkNOOg=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/S35QHTUSCBPIDBFCGZBRGOZUM4.jpg", "publishedAt": "2021-12-04T23:07:00Z", "content": "MELBOURNE, Dec 5 (Reuters) - Australia's medicine regulator provisionally approved on Sunday the Pfizer Inc coronavirus vaccine for children between the ages of 5 and 11, with the health minister say\u2026 [+2016 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "ydzhanova@businessinsider.com (Yelena Dzhanova)", "title": "Pfizer said it expects to have more data by end of year on whether COVID-19 vaccine can be administered to children under 5", "description": "Dr. Anthony Fauci has predicted that parents won't have to wait much longer for kids under 5\u00a0to receive a vaccine.", "url": "https://www.businessinsider.com/pfizer-vaccine-data-kids-under-5-years-end-2021-12", "urlToImage": "https://i.insider.com/619f6d74ee9795001883e392?width=1200&format=jpeg", "publishedAt": "2021-12-04T15:40:56Z", "content": "Pfizer CEO Albert Bourla on Friday said the company expects to know more about the effectiveness of its vaccines in children under 5\u00a0by the end of the year.\u00a0\r\n\"We have a study in children six months \u2026 [+2165 chars]"}, {"source": {"id": null, "name": "WDAF FOX4 Kansas City"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - fox4kc.com", "description": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say\u00a0\u00a0fox4kc.comView Full Coverage on Google News", "url": "https://fox4kc.com/news/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://fox4kc.com/wp-content/uploads/sites/16/2021/12/ModernaPfizerGettyImages-1234603091.jpg?w=1280", "publishedAt": "2021-12-04T22:06:58Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1874 chars]"}, {"source": {"id": "abc-news-au", "name": "ABC News (AU)"}, "author": "Michael Doyle", "title": "TGA approves Pfizer COVID-19 vaccine for 5-11-year-olds", "description": "The\u00a0Therapeutic Goods Administration provisionally approves the Pfizer vaccine for children aged between five and 11 years of age.", "url": "https://www.abc.net.au/news/2021-12-05/tga-approves-pfizer-covid-19-vaccine-for-5-11-year-olds/100675138", "urlToImage": "https://live-production.wcms.abc-cdn.net.au/761bdb8c386110a2b34083c817b0091f?impolicy=wcms_crop_resize&cropH=2813&cropW=5000&xPos=0&yPos=260&width=862&height=485", "publishedAt": "2021-12-04T21:16:56Z", "content": "Australia's Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer vaccine for children aged between five and 11 years of age.\u00a0\r\nFederal Health Minister Greg Hunt said the gover\u2026 [+672 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Australian Associated", "title": "Covid-19 Australia: Pfizer vaccines could be approved for children as young as five before Christmas", "description": "Federal Minister Greg Hunt has said the medical regulator should make the call on if Pifzer Covid-19 shots for children will get the go ahead before Christmas.", "url": "https://www.dailymail.co.uk/news/article-10274143/Covid-19-Australia-Pfizer-vaccines-approved-children-young-five-Christmas.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/04/05/51324773-0-image-a-53_1638596693919.jpg", "publishedAt": "2021-12-04T05:50:14Z", "content": "Federal Health Minister Greg Hunt said the Therapeutic Goods Administration and Australian Technical Advisory Group on Immunisation should make a call on Pfizer pediatric doses before year's end.\r\nIt\u2026 [+1614 chars]"}, {"source": {"id": null, "name": "FOX 31 Denver"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say - FOX31 Denver", "description": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say\u00a0\u00a0FOX31 DenverView Full Coverage on Google News", "url": "https://kdvr.com/news/coronavirus/covid-19-vaccine/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://kdvr.com/wp-content/uploads/sites/11/2021/12/ModernaPfizerGettyImages-1234603091.jpg?w=1280", "publishedAt": "2021-12-04T15:34:40Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1874 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "National File", "title": "Pfizer Documents Reveal Over 1,200 Vaccine Deaths Over 90-Day Trial Period", "description": "The Food and Drug Administration (FDA) has released the first batch of documents related to Pfizer\u2019s COVID-19 vaccine program after a federal judge ordered that they must comply with a massive FOIA request.The request was filed by the Public Health and Medica\u2026", "url": "https://freerepublic.com/focus/f-news/4018121/posts", "urlToImage": null, "publishedAt": "2021-12-04T01:23:19Z", "content": "Skip to comments.\r\nPfizer Documents Reveal Over 1,200 Vaccine Deaths Over 90-Day Trial PeriodNational File ^\r\n | 12/02/2021\r\n | Cullen McCue\r\nPosted on 12/03/2021 5:23:19 PM PST by Jan_Sobieski\r\nThe \u2026 [+2835 chars]"}, {"source": {"id": "the-hill", "name": "The Hill"}, "author": "Lexi Lonas", "title": "Pfizer CEO says vaccine data for those under 5 could be available by end of year", "description": "Pfizer's CEO on Friday said data about the effectiveness of its coronavirus vaccine in those under the age of five could be available by the end of\u00a0the year.CEO Albert Bourla ...", "url": "https://thehill.com/policy/healthcare/584322-pfizer-ceo-says-vaccine-data-for-those-under-5-could-be-available-by-end-of", "urlToImage": "https://thehill.com/sites/default/files/pfizervaccine_boosters_012621apmaryaltaffer.jpg", "publishedAt": "2021-12-04T03:47:20Z", "content": "Pfizer's CEO on Friday said data about the effectiveness of its coronavirus vaccine in those under the age of five could be available by the end of\u00a0the year.\r\nCEO Albert Bourla spoke with\u00a0NBC News ch\u2026 [+1164 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Kevin Airs", "title": "TGA gives provisional approval for the Pfizer vaccines for children aged 5-11", "description": "Jabs for children in 5-11 age group will now start to be rolled out by the government from January 10, subject to final approvals, with doses limited to just one-third of the adult dose.", "url": "https://www.dailymail.co.uk/news/article-10274569/TGA-gives-provisional-approval-Pfizer-vaccines-children-aged-5-11.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/04/05/51324773-0-image-a-53_1638596693919.jpg", "publishedAt": "2021-12-04T11:34:25Z", "content": "The Pfizer vaccine has been provisionally approved for use in children aged 5-11, the Therapeutic Goods Administration confirmed on Saturday.\r\nJabs for children in that age group will now start to be\u2026 [+2326 chars]"}, {"source": {"id": "nbc-news", "name": "NBC News"}, "author": "Berkeley Lovelace Jr.", "title": "Pfizer could have vaccine data for kids under age 5 by year-end, CEO says", "description": "Children under age 5 are the only group in the U.S. not eligible to get a shot.", "url": "https://www.nbcnews.com/health/health-news/pfizer-vaccine-data-kids-age-5-year-end-ceo-says-rcna7602", "urlToImage": "https://media-cldnry.s-nbcnews.com/image/upload/t_nbcnews-fp-1200-630,f_auto,q_auto:best/rockcms/2021-12/211203-pfizer-child-ac-633p-e0280e.jpg", "publishedAt": "2021-12-04T00:49:27Z", "content": "Pfizer could have data on how well its Covid-19 vaccine works in kids under age 5 by the end of the year, according to CEO Albert Bourla.\r\n\"We have a study in children 6 months to 2 years and then an\u2026 [+2465 chars]"}, {"source": {"id": "news-com-au", "name": "News.com.au"}, "author": "Sam Clench", "title": "Pfizer Covid vaccines for children aged 5-11 reportedly approved by TGA", "description": "<p>The Therapeutic Goods Administration (TGA) is expected to announce on Sunday that it has provisionally approved Pfizer&rsquo;s Covid-19 vaccine to be administered to children between the ages of five and eleven.</p>", "url": "https://www.news.com.au/lifestyle/health/pfizer-covid-vaccines-for-children-aged-511-reportedly-approved-by-tga/news-story/b18bfb577d6d19734ca8ee6cfedadd5f", "urlToImage": "https://content.api.news/v3/images/bin/dc8097dbee349d8445e44fd132ee25b4", "publishedAt": "2021-12-04T13:10:26Z", "content": "Children aged 5-11 could be vaccinated against Covid before school returns next year, with a key hurdle about to be cleared.The Therapeutic Goods Administration (TGA) is expected to announce on Sunda\u2026 [+3301 chars]"}, {"source": {"id": null, "name": "9News"}, "author": "9news Staff", "title": "TGA provisionally approves Pfizer COVID-19 vaccine for five to 11-year-old children", "description": "<p>The Therapeutic Goods Administration (TGA) has provisionally approved the <a href=\"https://www.9news.com.au/pfizer-vaccine\" target=\"\" rel=\"\" title=\"Pfizer\">Pfizer</a> vaccine as safe and effective for use among Australian children aged five to 11-years-old\u2026", "url": "https://www.9news.com.au/national/coronavirus-australia-updates-covid-19-vaccine-for-children-could-be-available-within-weeks/dfaba6ff-0007-4ad5-82b0-975d4e115b4c", "urlToImage": "https://imageresizer.static9.net.au/s7bjOy7-ar9rUkAEbJfIJkIQGNI=/1200x628/smart/https%3A%2F%2Fprod.static9.net.au%2Ffs%2F9669b5df-424a-4b4e-9910-5d343a0dadff", "publishedAt": "2021-12-04T21:22:12Z", "content": "Property News:\u00a0Music promoter Michael Coppel sells Toorak home for more than $30 million - domain.com.au"}, {"source": {"id": null, "name": "CNET"}, "author": "Jessica Dolcourt", "title": "Omicron and COVID booster shot: Find out fast if your pharmacy has Pfizer or Moderna", "description": "Texting a single number can save you a bundle of time and hassle -- and maybe get you a free Lyft or Uber ride in the process.", "url": "https://www.cnet.com/health/covid-booster-shot-and-omicron-find-out-fast-if-your-pharmacy-has-pfizer-or-moderna/", "urlToImage": "https://www.cnet.com/a/img/fy-bL2dzhG4DqpoY_-Q7S38Gqi4=/1200x630/2021/11/24/5def0981-0b4a-497f-91d7-65d0323be6e8/covid-19-masks-n95-cnet-2021-012.jpg", "publishedAt": "2021-12-04T19:00:51Z", "content": "COVID-19 vaccine booster shots are available in 80,000 locations.\r\nSarah Tew/CNET\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO and CDC websites.\r\nMore t\u2026 [+4283 chars]"}, {"source": {"id": null, "name": "KOLR - OzarksFirst.com"}, "author": "Michael Bartiromo, Nexstar Media Wire", "title": "Moderna or Pfizer? Head-to-head study finds one is slightly more effective, Harvard researchers say", "description": "The results of the study were published in the New England Journal of Medicine this week.", "url": "https://www.ozarksfirst.com/life-health/coronavirus/moderna-or-pfizer-head-to-head-study-finds-one-is-slightly-more-effective-harvard-researchers-say/", "urlToImage": "https://www.ozarksfirst.com/wp-content/uploads/sites/65/2021/12/ModernaPfizerGettyImages-1234603091.jpg?w=1280", "publishedAt": "2021-12-04T17:26:18Z", "content": "(NEXSTAR) A head-to-head study of the Moderna and Pfizer vaccines has determined the former to be slightly more effective against COVID-19, at least as far as the alpha and delta variants are concern\u2026 [+1852 chars]"}]}, "2021-12-03": {"status": "ok", "totalResults": 24, "articles": [{"source": {"id": "the-washington-post", "name": "The Washington Post"}, "author": "Amy Cheng, Adela Suliman, Hannah Knowles", "title": "Covid-19 live updates: Many vaccines offer protection as boosters; Pfizer and Moderna may work best - study - The Washington Post", "description": "<ol><li>Covid-19 live updates: Many vaccines offer protection as boosters; Pfizer and Moderna may work best - study\u00a0\u00a0The Washington Post\r\n</li><li>Most Covid Vaccines Will Work as Boosters, Study Suggests\u00a0\u00a0The New York Times\r\n</li><li>HealthWatch: Study Fins \u2026", "url": "https://www.washingtonpost.com/nation/2021/12/03/covid-omicron-variant-live-updates/", "urlToImage": "https://www.washingtonpost.com/wp-apps/imrs.php?src=https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/I5JJEBSUCMI6ZA6S3HNLBYR3PY.jpg&w=1440", "publishedAt": "2021-12-03T10:29:55Z", "content": "New York and Hawaii are the latest states to announce infections, and officials in both states said there is evidence of community spread. California, Minnesota and Colorado have also detected cases.\u2026 [+1539 chars]"}, {"source": {"id": "rt", "name": "RT"}, "author": "RT", "title": "Heart inflammation risk in Pfizer and Moderna jabs evaluated", "description": "The European Medicines Agency's safety committee has confirmed a \u201cvery rare\u201d risk of myocarditis and pericarditis in individuals who've had the Pfizer-BioNTech or Moderna Covid vaccines, having conducted large Europe-wide studies. Read Full Article at RT.com", "url": "https://www.rt.com/news/542126-pfizer-moderna-heart-inflammation/", "urlToImage": "https://cdni.rt.com/files/2021.12/article/61aa2b3d85f5405b6b033e41.JPG", "publishedAt": "2021-12-03T14:41:32Z", "content": "The data, released following the latest meeting of the European regulator\u2019s Pharmacovigilance Risk Assessment Committee (PRAC), backed up previous concerns about the potential risk posed by the Covid\u2026 [+1186 chars]"}, {"source": {"id": "bbc-news", "name": "BBC News"}, "author": "https://www.facebook.com/bbcnews", "title": "Covid: Pfizer and Moderna jabs give best overall boost, UK trial finds", "description": "Researchers also say there are signs the boosters would still offer protection against new variant Omicron.", "url": "https://www.bbc.co.uk/news/health-59489988", "urlToImage": "https://ichef.bbci.co.uk/news/1024/branded_news/127E8/production/_121925757_gettyimages-1236943038.jpg", "publishedAt": "2021-12-03T01:13:58Z", "content": "By Philippa RoxbyHealth reporter\r\nImage source, Getty Images\r\nThe Pfizer and Moderna vaccines being used in the UK as boosters give the best overall boost response, according to a UK trial of seven d\u2026 [+3782 chars]"}, {"source": {"id": null, "name": "NPR"}, "author": "Joe Palca", "title": "How Pfizer developed a COVID pill in record time", "description": "Pfizer researchers looking for a drug to treat SARS found clues that gave the company a head start in its quest for a pill to treat COVID-19, including the omicron variant.", "url": "https://www.npr.org/sections/health-shots/2021/12/03/1061060446/how-pfizer-developed-a-covid-pill-in-record-time", "urlToImage": "https://media.npr.org/assets/img/2021/12/02/pfe_ap_20204772081016_wide-699d5639de37fa5c7a9dd93135f716e52ebc2b71.jpg?s=1400", "publishedAt": "2021-12-03T10:05:37Z", "content": "Scientists at Pfizer's research and development laboratories in Groton, Conn., worked on the COVID-19 pill called Paxlovid.\r\nStew Milne/AP\r\nTwo new drugs are awaiting authorization from the Food and \u2026 [+4332 chars]"}, {"source": {"id": null, "name": "Shtfplan.com"}, "author": "Mac Slavo", "title": "Over 42,000 Adverse Reaction Reports Revealed In First Batch Of Pfizer Vax Docs", "description": "This article was originally published by Tyler Durden at ZeroHedge. The FDA\u2019s\u00a0excruciatingly slow\u00a0release of\u00a0data\u00a0related to Pfizer\u2019s COVID-19 vaccine has already borne fruit, and it\u2019s damning despite a trickle of just 500 pages per month out of 329,000 pages\u2026", "url": "https://www.shtfplan.com/headline-news/over-42000-adverse-reaction-reports-revealed-in-first-batch-of-pfizer-vax-docs", "urlToImage": "https://www.shtfplan.com/wp-content/uploads/2019/12/vaccines-e1575550979159.jpg", "publishedAt": "2021-12-03T23:30:43Z", "content": "This article was originally published by Tyler Durden at ZeroHedge.\r\nThe FDA\u2019s\u00a0excruciatingly slow\u00a0release of\u00a0data\u00a0related to Pfizer\u2019s COVID-19 vaccine has already borne fruit, and it\u2019s damning despi\u2026 [+2032 chars]"}, {"source": {"id": null, "name": "Ctvnews.ca"}, "author": null, "title": "Canada inks deals with Pfizer, Merck for COVID-19 antiviral drugs - CTV News", "description": "<ol><li>Canada inks deals with Pfizer, Merck for COVID-19 antiviral drugs\u00a0\u00a0CTV News\r\n</li><li>Canada secures orders of Merck, Pfizer COVID-19 antiviral pills\u00a0\u00a0Globalnews.ca\r\n</li><li>Canada buying up to 1.5 million courses of oral antiviral drugs to fight COV\u2026", "url": "https://www.ctvnews.ca/health/coronavirus/canada-inks-deals-with-pfizer-merck-for-covid-19-antiviral-drugs-1.5692723", "urlToImage": "https://www.ctvnews.ca/polopoly_fs/1.5692837.1638559830!/httpImage/image.jpg_gen/derivatives/landscape_620/image.jpg", "publishedAt": "2021-12-03T18:34:00Z", "content": "OTTAWA -- \r\nThe federal government has signed deals with Pfizer and Merck to purchase their antiviral medications, pending Health Canada approval of the products.\r\nPublic Services and Procurement Min\u2026 [+2848 chars]"}, {"source": {"id": null, "name": "LatestLY"}, "author": "Team Latestly", "title": "A New UK Study Has Found That COVID-19 Vaccines Made by Pfizer and Moderna That Use MRNA ... - Latest Tweet - LatestLY", "description": "<ol><li>A New UK Study Has Found That COVID-19 Vaccines Made by Pfizer and Moderna That Use MRNA ... - Latest Tweet\u00a0\u00a0LatestLY\r\n</li><li>6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna\u00a0\u00a0NDTV\r\n</li><li>Booster dose of 6 Covid vaccines is safe, in\u2026", "url": "https://www.latestly.com/socially/world/a-new-uk-study-has-found-that-covid-19-vaccines-made-by-pfizer-and-moderna-that-use-mrna-latest-tweet-by-reuters-3119683.html", "urlToImage": "https://st1.latestly.com/wp-content/uploads/2021/06/TW-Reuters-4-784x441.png", "publishedAt": "2021-12-03T20:46:39Z", "content": "A new UK study has found that COVID-19 vaccines made by Pfizer and Moderna that use mRNA technology provide the biggest booster impact https://t.co/ODGFdaQsbXpic.twitter.com/8H6ThuDr6X\u2014 Reuters (@Reu\u2026 [+532 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Pfizer, Merck in pact with Canada to deliver up to 1.5 million courses of COVID-19 pills", "description": "The Canadian government has inked purchase agreements with Pfizer (PFE) and Merck (MRK) to buy up to 1.5 million courses of their COVID-19 pills, Filomena Tassi, Canada\u2019s minister of...", "url": "https://seekingalpha.com/news/3777053-pfizer-merck-in-pact-with-canada-to-deliver-up-to-15-million-courses-of-covid-19-pills", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1207501947/large_image_1207501947.jpg", "publishedAt": "2021-12-03T19:32:12Z", "content": "sittithat tangwitthayaphum/iStock via Getty Images\r\n\n<ul>\n<li>The Canadian government has inked purchase agreements with Pfizer (NYSE:PFE) and Merck (NYSE:MRK) to buy up to 1.5 million courses of the\u2026 [+982 chars]"}, {"source": {"id": null, "name": "Lewrockwell.com"}, "author": "No Author", "title": "Federal Judge Rejects DOD Claim That Pfizer EUA and Comirnaty Vaccines Are \u2018Interchangeable\u2019", "description": "A federal district court judge has rejected a claim by the U.S. Department of Defense (DOD) that the Pfizer-BioNTech COVID-19 vaccine being administered under Emergency Use Authorization is interchangeable with Pfizer\u2019s Comirnaty vaccine, which in August was\u00a0\u2026", "url": "https://www.lewrockwell.com/2021/12/no_author/federal-judge-rejects-dod-claim-that-pfizer-eua-and-comirnaty-vaccines-are-interchangeable/", "urlToImage": "https://s3.amazonaws.com/lrc-cdn/assets/2021/02/LRC-share.jpg", "publishedAt": "2021-12-03T05:01:36Z", "content": "A federal district court judge has rejected a claim by the U.S. Department of Defense (DOD) that the Pfizer-BioNTech COVID-19 vaccine being administered under Emergency Use Authorization is interchan\u2026 [+11602 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "@ElectionWizard: \"Have you seen the document dump on the Pfizer vaccine data? It\u2019s a bombshell. No wonder the FDA fought to keep it hidden for 55 years.\"", "description": null, "url": "https://www.investmentwatchblog.com/have-you-seen-the-document-dump-on-the-pfizer-vaccine-data-its-a-bombshell-no-wonder-the-fda-fought-to-keep-it-hidden-for-55-years/", "urlToImage": null, "publishedAt": "2021-12-03T12:50:29Z", "content": "InvestmentWatchBlog.com \u00a9 2013-2021. All Rights Reserved."}, {"source": {"id": null, "name": "NDTV News"}, "author": null, "title": "6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna", "description": "A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.", "url": "https://www.ndtv.com/world-news/coronavirus-6-vaccines-show-promise-as-boosters-led-by-pfizer-and-moderna-2635139", "urlToImage": "https://c.ndtvimg.com/2021-12/91ruk77g_covid19-vaccine-generic-bloomberg_625x300_03_December_21.jpg", "publishedAt": "2021-12-03T03:31:41Z", "content": "Antibody levels were measured four weeks after the booster was given.\r\nA U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from\u2026 [+2925 chars]"}, {"source": {"id": null, "name": "Cracknewz.com"}, "author": "Neha", "title": "Smoking gun confidential Pfizer document exposes FDA criminal cover-up of VACCINE DEATHS\u2026 they knew the jab was killing people in early 2021\u2026 three times more WOMEN than MEN", "description": "", "url": "https://www.cracknewz.com/2021/12/smoking-gun-confidential-pfizer.html", "urlToImage": "https://lh3.googleusercontent.com/proxy/bxjrf-p8K90L5d4LnX2FsMzDvdnYDsMIf2gqySoqoq1mWfCh1I3BwmvSPDspnIuVa9FLvY6cm6GlCA_PajH-XaHk8XI-bGFHV-cWoVgTCoqOwA0nXlNc4IFXrxUj6sFYl3ekBf8QhFwe0bok4b0Z4IBNHQ=w1200-h630-p-k-no-nu", "publishedAt": "2021-12-03T18:47:34Z", "content": "Thanks to the efforts of a group called\u00a0Public Health and Medical Professionals for Transparency, we now have smoking gun confidential documents that show Pfizer and the FDA knew in early 2021 that\u00a0p\u2026 [+5434 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "USSA News", "title": "Over 42,000 Adverse Reaction Reports Revealed In First Batch Of Pfizer Vaccine Docs From FDA", "description": "The FDA's excruciatingly slow release of data related to Pfizer's COVID-19 vaccine has already borne fruit, and it's damning despite a trickle of just 500 pages per month out of 329,000 pages - which will take until 2076 to complete.As first reported by Kyle \u2026", "url": "https://freerepublic.com/focus/f-news/4017855/posts", "urlToImage": null, "publishedAt": "2021-12-03T06:09:25Z", "content": "Skip to comments.\r\nOver 42,000 Adverse Reaction Reports Revealed In First Batch Of Pfizer Vaccine Docs From FDAUSSA News ^\r\n | 12/02/2021\r\n | Tyler Durden\r\nPosted on 12/02/2021 10:09:25 PM PST by See\u2026 [+2155 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "theblaze.com", "title": "Horowitz: Pfizer vaccine injury data ordered released by judge shows shocking risk level", "description": "Any time one even mentions a story, data, or even VAERS numbers showing serious injury or death resulting from the vaccine, the bio-medical state lobby close their ears and shout while their censors in Big Tech label it as misinformation. But now we have it f\u2026", "url": "https://freerepublic.com/focus/f-chat/4018034/posts", "urlToImage": null, "publishedAt": "2021-12-03T20:05:27Z", "content": "Skip to comments.\r\nHorowitz: Pfizer vaccine injury data ordered released by judge shows shocking risk leveltheblaze.com ^\r\n | DECEMBER 2, 2021\r\n | DANIEL HOROWITZ\r\nPosted on 12/03/2021 12:05:27 PM PS\u2026 [+1858 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "GP", "title": "Court Orders FDA To Comply With FOIA and Release Information On Pfizer Vaccine \u2013 First Batch of Documents Shows Over 1,200 Vaccine Deaths WITHIN FIRST 90 DAYS", "description": "Meanwhile, the FDA still has to comply with the original order to begin turning over documents. Lo and behold, the first release is a bombshell. According to an official Pfizer document that is titled Cumulative Analysis of Post-Authorization Adverse Event Re\u2026", "url": "https://freerepublic.com/focus/f-news/4017786/posts", "urlToImage": null, "publishedAt": "2021-12-03T01:23:55Z", "content": "Skip to comments.\r\nCourt Orders FDA To Comply With FOIA and Release Information On Pfizer Vaccine First Batch of Documents Shows Over 1,200 Vaccine Deaths WITHIN FIRST 90 DAYSGP ^\r\n | December 2,2021\u2026 [+1405 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Joe Davies", "title": "Pfizer and Moderna shareholders pocket \u00a37.5bn in the week after Omicron was discovered", "description": "EXCLUSIVE: Moderna's CEO Stephane Bancel pocketed a cool \u00a3623million ($824million) in share growth alone - and sold 10,000 of his own stocks for $319 each on  November 26.", "url": "https://www.dailymail.co.uk/news/article-10272221/Pfizer-Moderna-shareholders-pocket-7-5bn-week-Omicron-discovered.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/03/18/51309791-0-image-a-26_1638555893217.jpg", "publishedAt": "2021-12-03T18:56:40Z", "content": "Top shareholders at Pfizer and Moderna made more than \u00a37.8billion ($10billion) in stocks growth in the week after the discovery of Omicron, MailOnline can reveal.\r\nShares in the pharmaceutical giants\u2026 [+7811 chars]"}, {"source": {"id": "the-washington-post", "name": "The Washington Post"}, "author": "Ellen Francis, Hannah Knowles", "title": "Most coronavirus vaccines work as boosters, with Pfizer and Moderna antibody levels high - study", "description": "Almost all the vaccines in a study of seven different shots appeared to boost the immune response when used as a third dose.", "url": "https://www.washingtonpost.com/health/2021/12/03/covid-vaccines-booster-combinations-study/", "urlToImage": "https://www.washingtonpost.com/wp-apps/imrs.php?src=https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/WCDZDECUDUI6ZA6S3HNLBYR3PY.jpg&w=1440", "publishedAt": "2021-12-03T15:34:03Z", "content": "The new research on safety and immune response, published Thursday in British journal the Lancet, looks at how to optimize selection of booster vaccines by examining people who initially took two dos\u2026 [+3071 chars]"}, {"source": {"id": null, "name": "BBC News"}, "author": "Bbc News", "title": "Covid: Pfizer and Moderna jabs give best overall boost, UK trial finds", "description": "Researchers say there are signs the boosters would still offer protection against new variant Omicron.", "url": "https://www.bbc.com/news/health-59489988", "urlToImage": "https://ichef.bbci.co.uk/news/1024/branded_news/127E8/production/_121925757_gettyimages-1236943038.jpg", "publishedAt": "2021-12-03T04:41:06Z", "content": "By Philippa RoxbyHealth reporter\r\nImage source, Getty Images\r\nThe Pfizer and Moderna vaccines being used in the UK as boosters give the best overall boost response, according to a UK trial of seven d\u2026 [+3782 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Most coronavirus vaccines work as boosters, with higher antibody levels from Pfizer and Moderna, study finds - The Washington Post", "description": "Most coronavirus vaccines work as boosters, with higher antibody levels from Pfizer and Moderna, study findsThe Washington Post Most Covid Vaccines Will Work as Boosters, Study SuggestsThe New York Times HealthWatch: Study Fins Moderna's COVID-19 Vaccine More\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156211840", "urlToImage": null, "publishedAt": "2021-12-03T17:33:13Z", "content": "\"I have more information in one place than anybody in the world.\" \r\n-- Jerry Pournelle, an absurd notion, apparently about the BIX BBS"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Covid-19 live updates: Many vaccines offer protection as boosters; Pfizer and Moderna may work best, study says - The Washington Post", "description": "Covid-19 live updates: Many vaccines offer protection as boosters; Pfizer and Moderna may work best, study saysThe Washington Post Most Covid Vaccines Will Work as Boosters, Study SuggestsThe New York Times HealthWatch: Study Fins Moderna's COVID-19 Vaccine M\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156205265", "urlToImage": null, "publishedAt": "2021-12-03T11:32:29Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}]}, "2021-12-02": {"status": "ok", "totalResults": 52, "articles": [{"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "The Hill", "title": "Pfizer lobbies to BLOCK anti-corporate fraud law after it cost them $2.3 BILLION in 2009", "description": "Team Rising discusses reporting from The Intercept about Pfizer's efforts to kill a law making it easier for corporate whistleblowers to come forward.", "url": "https://news.yahoo.com/pfizer-lobbies-block-anti-corporate-183300844.html", "urlToImage": "https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/02/61a91e904b8a6404eeb176cd/61a91e904b8a6404eeb176ce_o_U_v2.jpg", "publishedAt": "2021-12-02T18:33:00Z", "content": "Courtesy Mykayla BolieuThe family of Sativa Transue, a 26-year-old American woman from Spokane, Washington who was found dead in her Cancun hotel room while on vacation with her boyfriend, said she l\u2026 [+293 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Naomi Kresge, Anna Edwards, Mark Cudmore", "title": "Pfizer Executive Expects Vaccine to Hold Up to Omicron", "description": "Pfizer Inc. expects its Covid-19 vaccine to hold up against the omicron variant, an executive said, and data on how well it protects should be available within two to three weeks.", "url": "https://www.bloomberg.com/news/articles/2021-12-02/pfizer-executive-expects-vaccine-to-hold-up-in-tests-vs-omicron", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iXFn17L1VQgo/v0/1200x800.jpg", "publishedAt": "2021-12-02T09:13:54Z", "content": "Pfizer Inc. expects its Covid-19 vaccine to hold up against the omicron variant, an executive said, and data on how well it protects should be available within two to three weeks.\r\nWe dont expect tha\u2026 [+285 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "Pfizer or Moderna: Which COVID Vaccine Is Better?", "description": "While both vaccines were highly effective in preventing infection, hospitalization and death, data reveals one delivers better results.", "url": "https://www.webmd.com/vaccines/covid-19-vaccine/news/20211202/pfizer-or-moderna-head-to-head-study-shows-one-shot-has-an-edge", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/slideshows/covid19_myths_you_shouldnt_believe_slideshow/1800x1200_covid19_myths_you_shouldnt_believe_slideshow.jpg", "publishedAt": "2021-12-02T16:27:47Z", "content": "THURSDAY, Dec. 2, 2021 (HealthDay News) -- Which coronavirus vaccine is best at beating COVID-19 -- Moderna or Pfizer?\r\nNew research hands that honor to Moderna: In what is billed as the first head-t\u2026 [+1918 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Alexander Carchidi)", "title": "3 Hard Facts Moderna and Pfizer Investors Need to Know About the Omicron Variant", "description": "It's not all bad news.", "url": "https://www.fool.com/investing/2021/12/02/3-hard-facts-that-moderna-and-pfizer-investors-nee/", "urlToImage": "https://g.foolcdn.com/editorial/images/655304/nurse-vaccinates-senior-man.jpg", "publishedAt": "2021-12-02T11:40:00Z", "content": "As the leading coronavirus vaccine makers in the U.S., Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) will once again be put to the test by a new viral variant. So far, the market hasn't reacted favorab\u2026 [+5314 chars]"}, {"source": {"id": null, "name": "New Atlas"}, "author": "Rich Haridy", "title": "Pfizer vs Moderna: Harvard study compares the two mRNA COVID vaccines", "description": "A new study published in the New England Journal of Medicine (NEJM) is the first to pit Moderna and Pfizer\u2019s mRNA COVID-19 vaccines against each other in an efficacy face-off. The novel research compared health records from nearly half a million US veterans a\u2026", "url": "https://newatlas.com/health-wellbeing/pfizer-moderna-mrna-coronavirus-vaccines-compared/", "urlToImage": "https://assets.newatlas.com/dims4/default/c04949a/2147483647/strip/true/crop/5892x3093+0+537/resize/1200x630!/quality/90/?url=http%3A%2F%2Fnewatlas-brightspot.s3.amazonaws.com%2F16%2F13%2Fbf08566f49e8a8a977e17b2932e9%2Fdepositphotos-359669510-xl.jpg", "publishedAt": "2021-12-02T03:13:09Z", "content": "A new study published in the New England Journal of Medicine (NEJM) is the first to pit Moderna and Pfizers mRNA COVID-19 vaccines against each other in an efficacy face-off. The novel research compa\u2026 [+4550 chars]"}, {"source": {"id": "bbc-news", "name": "BBC News"}, "author": null, "title": "Pfizer CEO Albert Bourla: My wife's vaccine death is fake news", "description": "In an exclusive interview, Albert Bourla hits out at the \"rubbish\" that has been published about him.", "url": "https://www.bbc.co.uk/news/av/health-59490619", "urlToImage": "https://ichef.bbci.co.uk/news/1024/branded_news/14C27/production/_121913058_p0b7j77w.jpg", "publishedAt": "2021-12-02T06:11:32Z", "content": "Watch our exclusive interview with the CEO of Pfizer Albert Bourla, as he hits out at the \"rubbish\" that has been published about him and his wife - including a fake story that she had died from the \u2026 [+161 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "The Hill", "title": "NEW: 42% say Pfizer & Moderna 2 shot, J&J 1 shot regimen sufficient", "description": "On today's What America's Thinking, a new Hill-HarrisX poll reveals how Americans define \"fully vaccinated.\" The survey was conducted online within the...", "url": "https://news.yahoo.com/42-pfizer-moderna-2-shot-170500723.html", "urlToImage": "https://s.yimg.com/hd/cp-video-transcode/prod/2021-12/02/61a90e9bcf09e433d9a45e6b/61a90e9bcf09e433d9a45e6c_o_U_v2.jpg", "publishedAt": "2021-12-02T17:05:00Z", "content": "Courtesy Mykayla BolieuThe family of Sativa Transue, a 26-year-old American woman from Spokane, Washington who was found dead in her Cancun hotel room while on vacation with her boyfriend, said she l\u2026 [+293 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "AWS Helps Pfizer Accelerate Drug Development and Clinical Manufacturing", "description": "SEATTLE--(BUSINESS WIRE)--AWS and Pfizer are creating solutions with the potential to improve how medicines are developed, manufactured, and distributed for clinical trials.", "url": "https://www.businesswire.com/news/home/20211202005591/en/AWS-Helps-Pfizer-Accelerate-Drug-Development-and-Clinical-Manufacturing", "urlToImage": "https://mms.businesswire.com/media/20211202005591/en/841482/23/AWS_logo_RGB.jpg", "publishedAt": "2021-12-02T14:09:41Z", "content": "SEATTLE--(BUSINESS WIRE)--Today, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), announced that it is working with Pfizer to create innovative, cloud-based solutions with\u2026 [+9873 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "hbrueck@businessinsider.com (Hilary Brueck)", "title": "How to choose which booster shot is right for you, between Pfizer and Moderna", "description": "Some early studies suggest that Moderna's vaccine is slightly stronger than Pfizer's. Moderna's also comes with slightly heavier side effects.", "url": "https://www.businessinsider.com/covid-booster-how-to-choose-the-right-shot-pfizer-moderna-2021-11", "urlToImage": "https://i.insider.com/619e94f60fb6720018d66404?width=1200&format=jpeg", "publishedAt": "2021-12-02T19:44:05Z", "content": "Now that free booster shots are being offered to all adults in the US, many are wondering which is the best one to get.\r\nTruth is, all of the three authorized COVID-19 vaccines do a good job, and you\u2026 [+5796 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": null, "title": "Pfizer working on updated jab in response to Omicron variant: CEO", "description": "Pfizer\u00e2\u0080\u0099s chief executive Dr Albert Bourla told the BBC that he is of the view that annual vaccinations would be needed to maintain a \"very high level of protection\u00e2\u0080\u009d against the deadly disease that has claimed over five million lives across the world.", "url": "https://www.moneycontrol.com/news/trends/health-trends/pfizer-working-on-updated-jab-in-response-to-omicron-variant-ceo-7785351.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/02/Pfizer-770x433.jpg", "publishedAt": "2021-12-02T11:30:17Z", "content": "Pfizer is working on an updated jab in response to the Omicron variant that could be ready in 100 days, according to the head of American multinational pharmaceutical giant, who said that people may \u2026 [+2575 chars]"}, {"source": {"id": "independent", "name": "Independent"}, "author": "Arpan Rai,Rory Sullivan and Sam Hancock", "title": "Covid news \u2013 live: Omicron data expected \u2018in days\u2019 as UK buys millions more Pfizer and Moderna vaccines", "description": "Follow the latest developments and statistics", "url": "https://www.independent.co.uk/news/covid-omicron-variant-vaccines-lockdown-latest-b1968195.html", "urlToImage": "https://static.independent.co.uk/2021/12/01/14/PRI212902978.jpg?width=1200&auto=webp&quality=75", "publishedAt": "2021-12-02T03:02:04Z", "content": "Anger in Scotland amid confusion over booster jab advice\r\nMSPs have accused the Scottish government of sending out mixed messages on booster vaccine eligibility, which they say is leaving the public \u2026 [+1426 chars]"}, {"source": {"id": null, "name": "Umn.edu"}, "author": null, "title": "Moderna vaccine a bit better against COVID-19 than Pfizer, study finds - CIDRAP", "description": "<ol><li>Moderna vaccine a bit better against COVID-19 than Pfizer, study finds\u00a0\u00a0CIDRAP\r\n</li><li>Most Covid Vaccines Will Work as Boosters, Study Suggests\u00a0\u00a0The New York Times\r\n</li><li>HealthWatch: Study Fins Moderna's COVID-19 Vaccine More Effective Than Pfi\u2026", "url": "https://www.cidrap.umn.edu/news-perspective/2021/12/moderna-vaccine-bit-better-against-covid-19-pfizer-study-finds", "urlToImage": "https://www.cidrap.umn.edu/sites/default/files/public/styles/thumbnail/public/images/news/vials_of_moderna_and_pfizer_vaccine.jpg?itok=TzbF5BBi", "publishedAt": "2021-12-02T20:40:09Z", "content": "In the first head-to-head comparison of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines, Moderna edged out its competition with a 21% lower risk of infection and a 41% lower risk of hospitaliz\u2026 [+4315 chars]"}, {"source": {"id": null, "name": "BloombergQuint"}, "author": "Suzi Ring, Irina Anghel", "title": "Six Vaccines Show Promise as Boosters, Led by Pfizer and Moderna - BloombergQuint", "description": "Six Vaccines Show Promise as Boosters, Led by Pfizer and Moderna\u00a0\u00a0BloombergQuintView Full coverage on Google News", "url": "https://www.bloombergquint.com/coronavirus-outbreak/six-vaccines-show-promise-as-boosters-led-by-pfizer-and-moderna", "urlToImage": "https://gumlet.assettype.com/bloombergquint%2F2021-12%2F320568ea-6dce-461e-b035-1a1de976d525%2F381764853.jpg?w=1200&auto=format%2Ccompress&ogImage=true", "publishedAt": "2021-12-02T23:53:35Z", "content": "(Bloomberg) -- A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnershi\u2026 [+2856 chars]"}, {"source": {"id": null, "name": "The Federalist"}, "author": "Peter Navarro", "title": "Why Did Pfizer Delay Good Vaccine News Until After The 2020 Election?", "description": "CEO Albert Bourla\u2019s team stored, rather than immediately tested, the nasal swabs taken from participants Pfizer researchers suspected were infected.", "url": "https://thefederalist.com/2021/12/02/why-did-pfizer-delay-good-vaccine-news-until-after-the-2020-election/", "urlToImage": "https://thefederalist.com/wp-content/uploads/2021/11/50714715547_fe8b8b6926_k-e1637348174900.jpg", "publishedAt": "2021-12-02T10:10:11Z", "content": "As Pfizer positions itself to make billions from the pandemic misery of people around the world, Pfizer CEO Albert Bourla has recently branded those who question the Joe Biden universal vaccination d\u2026 [+6350 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Abi Moustafa, Monique Friedlander", "title": "Monique Morley attends an event in Sydney after experiencing an alleged Pfizer side effect", "description": "The blonde was spotted mingling with other guests at a swanky bar opening in Manly on Thursday.", "url": "https://www.dailymail.co.uk/tvshowbiz/article-10265853/Monique-Morley-attends-event-Sydney-experiencing-alleged-Pfizer-effect.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/02/04/51233947-0-image-a-9_1638420684539.jpg", "publishedAt": "2021-12-02T05:12:34Z", "content": "The Bachelor's Monique Morley is well and truly on the mend after revealing she was hospitalised and diagnosed with pericarditis, or inflammation of the sac-like tissue that surrounds the heart after\u2026 [+9959 chars]"}, {"source": {"id": null, "name": "BNNBloomberg.ca"}, "author": "Bloomberg News", "title": "Six Vaccines Show Promise as Boosters, Led by Pfizer and Moderna - BNN", "description": "<ol><li>Six Vaccines Show Promise as Boosters, Led by Pfizer and Moderna\u00a0\u00a0BNN\r\n</li><li>Seven vaccine makers' COVID-19 boosters raise immune response, British study says\u00a0\u00a0The Globe and Mail\r\n</li><li>Largest U.S. COVID-19 vaccine study shows continued protect\u2026", "url": "http://www.bnnbloomberg.ca/six-vaccines-show-promise-as-boosters-led-by-pfizer-and-moderna-1.1690472", "urlToImage": "http://www.bnnbloomberg.ca/polopoly_fs/1.1690473!/fileimage/httpImage/image.jpg_gen/derivatives/landscape_620/a-healthcare-worker-prepares-a-third-dose-of-the-pfizer-biontech-covid-19-vaccine-at-a-senior-living-facility-in-paris-france-on-thursday-sept-16-2021-france-is-on-the-forefront-of-a-carrot-and-stick-approach-that-seeks-to-maintain-a-high-level-of-vaccinations-photographer-nathan-laine-bloomberg.jpg", "publishedAt": "2021-12-02T23:48:49Z", "content": "(Bloomberg) -- A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnershi\u2026 [+2765 chars]"}, {"source": {"id": "the-irish-times", "name": "The Irish Times"}, "author": "The Irish Times", "title": "Covid vaccine boosters will likely be needed every year, Pfizer chief says", "description": "New jab for Omicron variant of coronavirus being developed, Dr Albert Bourla says", "url": "https://www.irishtimes.com/news/health/covid-vaccine-boosters-will-likely-be-needed-every-year-pfizer-chief-says-1.4744856", "urlToImage": "https://www.irishtimes.com/image-creator/?id=1.4744855&origw=1440", "publishedAt": "2021-12-02T08:44:46Z", "content": "Annual vaccines to tackle Covid-19 are likely to be needed, the boss of pharmaceutical giant Pfizer has said.\r\nDr Albert Bourla said yearly vaccinations could boost population immunity, adding that t\u2026 [+2230 chars]"}, {"source": {"id": null, "name": "SiliconANGLE News"}, "author": "Mike Wheatley", "title": "AWS partners with Pfizer and Rivian on drug discovery and autonomous vehicles", "description": "Amazon Web Services Inc.\u2019s customer acquisition spree continued apace today with the cloud computing giant announcing new arrangements with the pharmaceutical and biotech firm Pfizer Inc. and the electric vehicle manufacturer Rivian Automotive LLC. The partne\u2026", "url": "https://siliconangle.com/2021/12/02/aws-pfizer-partner-accelerate-drug-discovery-machine-learning/", "urlToImage": "https://d15shllkswkct0.cloudfront.net/wp-content/blogs.dir/1/files/2021/12/tablets-1001224_960_720.jpg", "publishedAt": "2021-12-02T14:00:33Z", "content": "Amazon Web Services Inc.s customer acquisition spree continued apace today with the cloud computing giant announcing new arrangements with the pharmaceutical and biotech firm Pfizer Inc. and the elec\u2026 [+4939 chars]"}, {"source": {"id": null, "name": "SiliconANGLE News"}, "author": "Mike Wheatley", "title": "AWS partners with Pfizer and Rivian on drug discovery and electric vehicles", "description": "Amazon Web Services Inc.\u2019s customer acquisition spree continued apace today with the cloud computing giant announcing new arrangements with the pharmaceutical and biotech firm Pfizer Inc. and the electric vehicle manufacturer Rivian Automotive LLC. The partne\u2026", "url": "https://siliconangle.com/2021/12/02/aws-partners-pfizer-rivian-drug-discovery-electric-vehicles/", "urlToImage": "https://d15shllkswkct0.cloudfront.net/wp-content/blogs.dir/1/files/2021/12/tablets-1001224_960_720.jpg", "publishedAt": "2021-12-02T14:00:33Z", "content": "Amazon Web Services Inc.s customer acquisition spree continued apace today with the cloud computing giant announcing new arrangements with the pharmaceutical and biotech firm Pfizer Inc. and the elec\u2026 [+4938 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Sushmi Dey", "title": "Covid-19: A wide range of vaccines act as booster to AstraZeneca, Pfizer shots, says study", "description": "Up to six different Covid-19 boosters were found to be safe, and provoked strong immune responses in people who have previously received a two-dose course of the Oxford-AstraZeneca-developed Covishield, or Pfizer-BioNTech\u2019s BNT162b2, the first randomised phas\u2026", "url": "https://timesofindia.indiatimes.com/india/covid-19-a-wide-range-of-vaccines-act-as-booster-to-astrazeneca-pfizer-shots-says-study/articleshow/88059696.cms", "urlToImage": "https://static.toiimg.com/thumb/msid-88059694,width-1070,height-580,imgsize-16086,resizemode-75,overlay-toi_sw,pt-32,y_pad-40/photo.jpg", "publishedAt": "2021-12-02T19:24:56Z", "content": "Covid-19: A wide range of vaccines act as booster to AstraZeneca, Pfizer shots, says study\r\n<ul><li>News</li>\r\n<li>India News</li>\r\n<li>Covid-19: A wide range of vaccines act as booster to AstraZenec\u2026 [+36 chars]"}]}, "2021-12-01": {"status": "ok", "totalResults": 34, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "EU launch of Pfizer/BioNTech COVID shot for younger children brought forward to Dec 13 - Reuters", "description": "The European Union-wide roll-out of Pfizer <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and BioNTech's <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> COVID-19 vaccine version for five- to 1\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eu-launch-pfizerbiontech-covid-shot-younger-children-brought-forward-dec-13-2021-12-01/", "urlToImage": "https://www.reuters.com/resizer/Zfn8JTmn0uGmFnGwWIkbwYpA0ow=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/IFS4SACF5NL67LEFDS2ZJBJIPY.jpg", "publishedAt": "2021-12-01T08:27:00Z", "content": "A medical worker prepares a dose of the \"Comirnaty\" Pfizer-BioNTech COVID-19 vaccine at a coronavirus disease (COVID-19) vaccination center in Madrid, Spain, November 24, 2021. REUTERS/Sergio Perez/F\u2026 [+791 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "UK agrees deals for 114 million more Moderna and Pfizer COVID-19 doses - Reuters", "description": "Britain said on Wednesday it had agreed deals to buy 114 million more Pfizer/BioNTech and Moderna COVID-19 vaccine shots, saying it had sped up signing the new contracts in light of the emergence of the new Omicron variant.", "url": "https://www.reuters.com/markets/europe/uk-agrees-deals-114-million-more-moderna-pfizer-covid-19-doses-2021-12-01/", "urlToImage": "https://www.reuters.com/resizer/eQve7PfcPfZ5i9ai0x_vwj8fh14=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/YZCWCNWWZZO6BOOXQNCQZ73S3U.jpg", "publishedAt": "2021-12-01T22:30:00Z", "content": "LONDON, Dec 1 (Reuters) - Britain said on Wednesday it had agreed deals to buy 114 million more Pfizer/BioNTech and Moderna COVID-19 vaccine shots, saying it had sped up signing the new contracts in \u2026 [+2469 chars]"}, {"source": {"id": null, "name": "NPR"}, "author": "Will Stone", "title": "Pfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot", "description": "Pfizer's CEO says the vaccine maker has asked federal regulators to authorize boosters for 16- and 17-year-olds. Currently, only people 18 and over are eligible for a booster in the U.S.", "url": "https://www.npr.org/sections/health-shots/2021/11/30/1060281550/pfizer-fda-covid-booster-16-and-17-year-olds", "urlToImage": "https://media.npr.org/assets/img/2021/11/30/teen-ap-pfizer-shot_wide-f05a8a5ea64eeb9be0a64aca76382002a492c5d1.jpg?s=1400", "publishedAt": "2021-12-01T01:58:34Z", "content": "Keidy Ventura, 17, receives her first dose of the Pfizer COVID-19 vaccine in West New York, N.J. Pfizer has asked federal regulators to expand the eligibility for booster shots to include 16- and 17-\u2026 [+1426 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Emily Ashton", "title": "U.K. Signs New Pfizer, Moderna Vaccine Deals to Counter Omicron", "description": "", "url": "https://www.bloomberg.com/news/articles/2021-12-01/u-k-signs-new-pfizer-moderna-vaccine-deals-to-counter-omicron", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iZZswS6DNmek/v0/1200x800.jpg", "publishedAt": "2021-12-01T22:30:00Z", "content": "The U.K. agreed to buy an additional 114 million Covid-19 vaccine doses from \r\nModerna Inc. and the partnership of \r\nPfizer Inc. and \r\nBioNTech SE to secure the countrys supplies following the emerge\u2026 [+1179 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Cory Renauer)", "title": "Exact Sciences Breaks Up With Pfizer -- Time to Buy?", "description": "The end of a co-promotion deal with Pfizer could work out well for Exact Sciences.", "url": "https://www.fool.com/investing/2021/12/01/exact-sciences-breaks-up-with-pfizer-time-to-buy/", "urlToImage": "https://g.foolcdn.com/editorial/images/655200/smart-investor-picking-stocks-to-buy.jpg", "publishedAt": "2021-12-01T10:35:00Z", "content": "Breaking up is hard to do, but not for Exact Sciences(NASDAQ:EXAS) and Pfizer(NYSE:PFE). Recently the partners let a partnership that was a lot more important to the diagnostics provider than the pha\u2026 [+3383 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Adria Cimino)", "title": "Is This Latecomer a Better Buy Than Moderna and Pfizer?", "description": "Its big moment may be only a few weeks away.", "url": "https://www.fool.com/investing/2021/12/01/is-this-latecomer-a-better-buy-than-moderna-pfizer/", "urlToImage": "https://g.foolcdn.com/editorial/images/655207/gettyimages-1266746458.jpg", "publishedAt": "2021-12-01T11:00:00Z", "content": "Moderna(NASDAQ:MRNA) and Pfizer(NYSE:PFE) dominate the coronavirus vaccine market. Each has generated quarterly vaccine revenue in the billions. And they expect to report annual vaccine revenue of as\u2026 [+4053 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Alessandro Speciale", "title": "Pfizer Vaccine Wins Approval in Italy for Kids Aged 5-11", "description": "", "url": "https://www.bloomberg.com/news/articles/2021-12-01/italy-s-drug-agency-approves-pfizer-vaccine-for-kids-aged-5-11", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iTCO_9Z_V4oE/v0/1200x728.png", "publishedAt": "2021-12-01T19:42:51Z", "content": "Italys medicines agency Aifa approved the use of the Covid-19 vaccine from \r\nPfizer Inc. and \r\nBioNTech SE for children aged 5-11.\r\nThe approval follows that of the \r\nEuropean Unions drugs regulator \u2026 [+1126 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (George Budwell)", "title": "3 Reasons Pfizer Stock Will Crush the Broader Market in 2022", "description": "This red-hot pharma is far from hitting a peak.", "url": "https://www.fool.com/investing/2021/12/01/3-reasons-pfizer-stock-will-crush-the-broader-mark/", "urlToImage": "https://g.foolcdn.com/editorial/images/655144/happy-investor.jpg", "publishedAt": "2021-12-01T15:00:00Z", "content": "Pfizer( PFE -1.30% ) has been the second-best-performing big pharma stock for the whole of 2021. As of the close of November, the shares were up by an astonishing 45.8% year to date, which is only sl\u2026 [+4076 chars]"}, {"source": {"id": null, "name": "MobiHealthNews"}, "author": null, "title": "Mental health app ThoughtFull, Pfizer to expand access to biopsychosocial care in Singapore", "description": "ThoughtFull is giving free three-month access to counsellor or psychologist support via its mobile app.", "url": "https://www.mobihealthnews.com/news/asia/mental-health-app-thoughtfull-pfizer-expand-access-biopsychosocial-care-singapore", "urlToImage": "https://www.mobihealthnews.com/sites/default/files/Person%20using%20TFC.jpg", "publishedAt": "2021-12-01T08:29:25Z", "content": "Digital mental health platform ThoughtFull and pharmaceutical firm Pfizer Singapore have signed an exclusive partnership to bring more access to biopsychosocial care to people in Singapore.\u00a0\r\nThe col\u2026 [+2086 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "EU launch of Pfizer-BioNTech COVID-19 shot for younger children brought forward to Dec 13", "description": "FRANKFURT: The European Union-wide roll-out of Pfizer and BioNTech's COVID-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week earlier than previously planned, Germany's health ministry said on Wednesday (Dec 1).\r\n\r\nGermany is due\u2026", "url": "https://www.channelnewsasia.com/world/covid-19-pfizer-vaccine-children-5-11-european-union-2350641", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--GvMlV94---/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2021-12-01t082706z_1_lynxmpehb01oi_rtroptp_3_health-coronavirus-biontech-ceo.jpg?itok=jnF7rq7s", "publishedAt": "2021-12-01T08:44:40Z", "content": "FRANKFURT: The European Union-wide roll-out of Pfizer and BioNTech's COVID-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week earlier than previously planned, Germany's \u2026 [+376 chars]"}, {"source": {"id": null, "name": "Harvard School of Engineering and Applied Sciences"}, "author": "Nicole Rura", "title": "Moderna vaccine slightly more effective than Pfizer", "description": "In a comparison study, the Moderna vaccine was slightly more effective than the Pfizer vaccine in preventing COVID-19 infection, hospitalization, and death.", "url": "https://news.harvard.edu/gazette/story/2021/12/moderna-vaccine-slightly-more-effective-than-pfizer/", "urlToImage": "https://news.harvard.edu/wp-content/uploads/2021/12/iStock-vaccine-card-1200x630.jpg", "publishedAt": "2021-12-01T22:00:33Z", "content": "Compared with the Pfizer COVID-19 vaccine, the Moderna COVID-19 vaccine has a slightly lower risk of COVID-19 outcomes, including documented SARS-CoV-2 infection, symptomatic COVID-19, and COVID-19-r\u2026 [+4483 chars]"}, {"source": {"id": null, "name": "Independent.ie"}, "author": "Eoghan Moloney", "title": "Children aged 5-11 can receive Pfizer vaccine from December 13, pending Niac approval", "description": "Children aged between five and 11 can begin to receive the Pfizer-BioNTech Covid-19 jab from December 13 in the EU, German health minister Jens Spahn confirmed today.", "url": "https://www.independent.ie/news/children-aged-5-11-can-receive-pfizer-vaccine-from-december-13-pending-niac-approval-41107139.html", "urlToImage": "https://www.independent.ie/news/70603/41107138.ece/AUTOCROP/w1240h700/COLOMBIA-HEALTHCORONAVIRUS.jfif", "publishedAt": "2021-12-01T11:21:58Z", "content": "Children aged between five and 11 can begin to receive the Pfizer-BioNTech Covid-19 jab from December 13 in the EU, German health minister Jens Spahn confirmed today.\r\nThis is one week earlier than t\u2026 [+1524 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Mamta Mayani", "title": "EU-wide roll out of Pfizer-BioNTech's COVID-19 vaccine for kids to commence on Dec. 13", "description": "The rollout of Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine in European Union ((EU)) for children aged 5 to 11 will begin December 13, Germany's health ministry said -...", "url": "https://seekingalpha.com/news/3775676-eu-wide-roll-out-of-pfizer-biontechs-covid-19-vaccine-for-kids-to-commence-on-dec-13", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293283810/large_image_1293283810.jpg", "publishedAt": "2021-12-01T10:51:02Z", "content": "Sean Gallup/Getty Images News\r\n\n<ul>\n<li>The rollout of Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) COVID-19 vaccine in European Union (EU) for children aged 5 to 11 will begin December 13, German\u2026 [+623 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Is Big Pharma Punishing South Africa? South Africa Denied Pfizer & Johnson And Johnson. 1 Day Later, Omicron Detected There And Country Blocked From The World.", "description": null, "url": "https://www.investmentwatchblog.com/is-big-pharma-punishing-south-africa-south-africa-denied-pfizer-johnson-and-johnson-1-day-later-omicron-detected-there-and-country-blocked-from-the-world/", "urlToImage": null, "publishedAt": "2021-12-01T16:18:00Z", "content": "by Martin Armstrong\r\nSouth Africa denied Pfizer and Johnson &amp; Johnson from delivering\u00a0additional vaccines.\u00a0A day later, on November 25, the omicron variant was detected in the country. Before the\u2026 [+1664 chars]"}, {"source": {"id": null, "name": "NDTV News"}, "author": null, "title": "Pfizer Seeks US Approval For Covid Boosters For Ages 16-17", "description": "Pfizer announced Tuesday it was seeking US authorization for Covid booster shots among adolescents aged 16 and 17, as concerns grow about the impact of the new Omicron variant.", "url": "https://www.ndtv.com/world-news/coronavirus-pfizer-seeks-us-approval-for-covid-boosters-for-ages-16-17-2631392", "urlToImage": "https://c.ndtvimg.com/2021-12/h2vt31vo_pfizer-afp_625x300_01_December_21.jpg", "publishedAt": "2021-12-01T01:35:25Z", "content": "US health authorities are urging all adults to get boosted when they are eligible.\r\nWashington, United States: Pfizer announced Tuesday it was seeking US authorization for Covid booster shots among a\u2026 [+1911 chars]"}, {"source": {"id": null, "name": "NDTV News"}, "author": null, "title": "Pfizer Covid Vaccine For Children In EU To Be Available In Two Weeks", "description": "The EU's main Covid vaccine provider, BioNTech/Pfizer, will have jabs available for children in the bloc in two weeks' time, European Commission chief Ursula von der Leyen said Wednesday.", "url": "https://www.ndtv.com/world-news/pfizer-covid-19-vaccine-for-children-in-european-union-to-be-available-in-two-weeks-2631933", "urlToImage": "https://c.ndtvimg.com/2021-08/7ekf01i8_pfizer-reuters_625x300_30_August_21.jpg", "publishedAt": "2021-12-01T12:06:30Z", "content": "BioNTech/Pfizer will have jabs available for EU children in the bloc in two weeks' time (File)\r\nBrussels: The EU's main Covid vaccine provider, BioNTech/Pfizer, will have jabs available for children \u2026 [+416 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Jonathan M Block", "title": "Pfizer begins filing for COVID antiviral Paxlovid in Canada", "description": "Pfizer said that it has begun a rolling submission of its COVID-19 antiviral Paxlovid (PF-07321332 and ritonavir) with Health Canada.", "url": "https://seekingalpha.com/news/3776166-pfizer-begins-filing-for-covid-antiviral-paxlovid-in-canada", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1207501947/large_image_1207501947.jpg", "publishedAt": "2021-12-01T21:12:13Z", "content": "sittithat tangwitthayaphum/iStock via Getty Images\r\n\n<ul>\n<li>Pfizer (NYSE:PFE) said that it has begun a rolling submission of its COVID-19 antiviral Paxlovid (PF-07321332 and ritonavir) with Health \u2026 [+398 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "WND", "title": "Pfizer whistleblower accused of lying fires back", "description": "A whistleblower charging that a contract research company helping to carry out Pfizer\u2019s COVID-19 vaccine trial last fall falsified data has responded to her former employer\u2019s accusation that she is lying.Brook Jackson\u2019s company, Ventavia Research Group, relea\u2026", "url": "https://freerepublic.com/focus/f-news/4017278/posts", "urlToImage": null, "publishedAt": "2021-12-01T15:39:40Z", "content": "A whistleblower charging that a contract research company helping to carry out Pfizers COVID-19 vaccine trial last fall falsified data has responded to her former employers accusation that she is lyi\u2026 [+4049 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "Reuters", "title": "Pfizer begins application for Canada's approval of Covid-19 pill", "description": "The country has identified seven people with the new variant as of Nov. 30.", "url": "https://www.business-standard.com/article/companies/pfizer-begins-application-for-canada-s-approval-of-covid-19-pill-121120200081_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2016-08/23/full/1471927210-791.jpg", "publishedAt": "2021-12-01T20:43:00Z", "content": "Pfizer Inc said on Wednesday it had started the real-time submission of its application seeking Health Canada's approval of its oral COVID-19 antiviral drug candidate.\r\nThe pill, PF-07321332, is desi\u2026 [+2055 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Levi Parsons", "title": "Sporty plumber, 26, DIES 12 days after getting the Pfizer Covid vaccine", "description": "Rory James Nairn, 26, experienced heart palpitations after receiving his first dose of the Pfizer vaccine and later collapsed on the floor of his Dunedin home in New Zealand.", "url": "https://www.dailymail.co.uk/news/article-10261605/Sporty-plumber-26-DIES-12-days-getting-Pfizer-Covid-vaccine.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/12/01/07/51186065-0-image-a-2_1638342279111.jpg", "publishedAt": "2021-12-01T07:57:13Z", "content": "A fit and active 26-year-old man has mysterious died with fears he may have suffered fatal side effects 12 days after receiving Pfizer's Covid vaccine.\r\nRory James Nairn, 26, had heart palpitations f\u2026 [+5534 chars]"}]}, "2021-11-30": {"status": "ok", "totalResults": 49, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer seeks U.S. authorization of COVID-19 booster shots for 16, 17 year olds - Reuters", "description": "Pfizer Inc's <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> Chief Executive Officer Albert Bourla <a href=\"https://twitter.com/AlbertBourla/status/1465804576372703241\" target=\"_blank\">said</a> on Tuesday the company has submitte\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-seeks-us-authorization-covid-19-booster-shots-16-17-year-olds-2021-11-30/", "urlToImage": "https://www.reuters.com/resizer/9d08ueSnFVl_SGOzkrl4lubpWvE=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/53XNUANG5ZIGPL5FDTP4AO37EQ.jpg", "publishedAt": "2021-11-30T23:09:00Z", "content": "A child reacts while receiving a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at Smoketown Family Wellness Center in Louisville, Kentucky, U.S., November 8, 2021. REUTERS/Jon Ch\u2026 [+1139 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "insider@insider.com (Allana Akhtar)", "title": "Pfizer CEO is 'very confident' the company's oral COVID-19 pill will be effective against the new variant", "description": "\"I'm very very confident that this drug works for all known mutations, including the Omicron one,\" Bourla told CNBC's Squawk Box.", "url": "https://www.businessinsider.com/pfizer-ceo-very-confident-antiviral-pill-works-against-omicron-2021-11", "urlToImage": "https://i.insider.com/61a636ba0ed48c0019e4ff52?width=1200&format=jpeg", "publishedAt": "2021-11-30T14:52:15Z", "content": "Pfizer CEO Albert Bourla said he believes his company's COVID-19 oral treatment will work in patients diagnosed with the Omicron variant.\r\n\"I'm very very confident that this drug works for all known \u2026 [+1403 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "James Paton", "title": "Glaxo Lures Top Pfizer Scientist to Lead Vaccines Research", "description": "", "url": "https://www.bloomberg.com/news/articles/2021-11-30/glaxo-lures-top-pfizer-scientist-to-lead-vaccines-research", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/irwsU_ZSYTKc/v0/1200x800.jpg", "publishedAt": "2021-11-30T13:00:00Z", "content": "GlaxoSmithKline Plc lured a senior \r\nPfizer Inc. scientist who helped develop the U.S. pharma companys Covid shot to oversee vaccines research and development as it takes on increased competition in \u2026 [+1829 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": "Timothy Annett", "title": "Pfizer Seeks U.S. Clearance for Covid Boosters for Older Teens", "description": "Pfizer Inc.\u2019s chief executive said the company has asked the U.S. to allow Covid-19 booster shots for people age 16-17, a move that would expand access to additional doses amid worry about the new omicron virus variant.", "url": "https://www.bloomberg.com/news/articles/2021-11-30/pfizer-seeks-u-s-clearance-for-covid-boosters-for-older-teens", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/ieCGF.eQH8Ng/v0/1200x801.jpg", "publishedAt": "2021-11-30T22:39:36Z", "content": "Pfizer Inc.s chief executive said the company has asked the U.S. to allow Covid-19 booster shots for people age 16-17, a move that would expand access to additional doses amid worry about the new omi\u2026 [+1269 chars]"}, {"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (Eric Volkman)", "title": "Why Novavax and Pfizer Are Trouncing the Market Today", "description": "But not all coronavirus stocks were on the rise.", "url": "https://www.fool.com/investing/2021/11/30/why-novavax-and-pfizer-are-trouncing-the-market-to/", "urlToImage": "https://g.foolcdn.com/editorial/images/655291/gloved-hand-filling-a-syringe-from-a-vial.jpg", "publishedAt": "2021-11-30T20:22:57Z", "content": "What happened\r\nOn yet more worrying news about the omicron variant of the coronavirus, the fortunes of coronavirus stocks were mixed on Tuesday. Some of the ones doing particularly well in midafterno\u2026 [+1770 chars]"}, {"source": {"id": null, "name": "WebMD"}, "author": "https://www.facebook.com/WebMD", "title": "Pfizer Plans to Seek Booster Approval for 16- and 17-Year-Olds", "description": "Pfizer and BioNTech plan to apply for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds.", "url": "https://www.webmd.com/vaccines/covid-19-vaccine/news/20211130/pfizer-booster-approval-16-17-year-olds", "urlToImage": "https://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/blog_posts/public-health/1800x1200_vaccine.jpg", "publishedAt": "2021-11-30T16:52:33Z", "content": "Nov. 30, 2021 -- Pfizer and BioNTech plan to apply for FDA authorization this week for a booster COVID-19 vaccine for 16- and 17-year-olds.\r\nWe expect to share updates on this soon, Kit Longley, a Pf\u2026 [+1683 chars]"}, {"source": {"id": null, "name": "Forbes"}, "author": "Mason Bissada, Forbes Staff, \n Mason Bissada, Forbes Staff\n https://www.forbes.com/sites/masonbissada/", "title": "Pfizer Reportedly Plans To Ask For Approval Of Covid Boosters For 16- And 17-Year-Olds", "description": "The report comes as public experts track the coronavirus\u2019 new omicron variant.", "url": "https://www.forbes.com/sites/masonbissada/2021/11/29/pfizer-reportedly-plans-to-ask-for-approval-of-covid-boosters-for-16and-17-year-olds/", "urlToImage": "https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F61a57e3e31e611d0b206c32e%2F0x0.jpg%3FcropX1%3D0%26cropX2%3D2339%26cropY1%3D2%26cropY2%3D1318", "publishedAt": "2021-11-30T01:29:32Z", "content": "Pfizer is expected to ask the Food and Drug Administration to authorize its Covid-19 vaccine booster shot for Americans ages 16 and 17, newsoutletsreported Monday, as public health experts track the \u2026 [+1777 chars]"}, {"source": {"id": null, "name": "Fox Business"}, "author": "Kyle Morris", "title": "Pfizer prepares shipments of antiviral pill for treating COVID-19 - Fox Business", "description": "Pfizer has prepared the first shipments of its COVID-19 antiviral pill PAXLOVID and sent them to the airport for distribution across Europe and America once it receives approval.", "url": "https://www.foxbusiness.com/politics/pfizer-prepares-shipments-of-antiviral-pill-for-treating-covid-19", "urlToImage": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2021/11/0/0/2021-11-16T211908Z_1648590397_RC2C8Q9M6KMN_RTRMADP_3_HEALTH-CORONAVIRUS-USA-PFIZER.jpg?ve=1&tl=1", "publishedAt": "2021-11-30T23:35:06Z", "content": "Pfizer announced Tuesday that it has prepared the first shipments of its COVID-19 antiviral pill PAXLOVID and sent them to the airport for distribution across Europe and America once the treatment re\u2026 [+1847 chars]"}, {"source": {"id": null, "name": "Designtaxi.com"}, "author": "Mikelle Leow", "title": "Pfizer Sends Drones To Rural Village To Display Light-Up Health PSAs", "description": "[Click here to view the video in this article] \nImage via F5 Shanghai\n\nEven with the internet within reach, citydwellers are subjected to a barrage of fake health news. Imagine what life\u2019s like for regions where access to health services and education is limi\u2026", "url": "https://designtaxi.com/news/416847/Pfizer-Sends-Drones-To-Rural-Village-To-Display-Light-Up-Health-PSAs/", "urlToImage": "https://editorial.designtaxi.com/editorial-images/news-Pfizer301121/Pfizer-Drone-Light-Show-China-1.jpg", "publishedAt": "2021-11-30T11:10:21Z", "content": "Image via F5 ShanghaiEven with the internet within reach, citydwellers are subjected to a barrage of fake health news. Imagine what life\u2019s like for regions where access to health services and educati\u2026 [+1655 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "GSK names Pfizer scientist Dormitzer as vaccines R&D head", "description": "\"The importance of vaccines has never been clearer, and the pace of technological innovation has rarely been greater ... Phil's scientific expertise and...", "url": "https://news.yahoo.com/gsk-names-pfizer-scientist-dormitzer-130323833.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/aYXbwakBIxOSagRHpnKQ.Q--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/78bc97d4af59a2fd630da4bce94540be", "publishedAt": "2021-11-30T13:03:23Z", "content": "(Reuters) - GSK has hired one of the scientists behind Pfizer's mRNA COVID-19 shot, Phil Dormitzer, as its global head of R&amp;D for vaccines and he will join the British drugmaker from Dec. 3, GSK \u2026 [+1387 chars]"}, {"source": {"id": "national-review", "name": "National Review"}, "author": "Zachary Evans, Zachary Evans", "title": "Pfizer to Seek FDA Approval for COVID Boosters for Ages 16\u201317", "description": "The FDA authorized Pfizer and Moderna boosters for all adults in mid November.", "url": "https://www.nationalreview.com/news/pfizer-to-seek-fda-approval-for-covid-boosters-for-ages-16-17/", "urlToImage": "https://www.nationalreview.com/wp-content/uploads/2021/08/vaccinations-august-2021-3.jpg?fit=2057%2C1200", "publishedAt": "2021-11-30T00:59:03Z", "content": "Caitlyn Jendrejas, 15, receives her second dose of the Pfizer vaccine from pharmacist Shane Dixon at the Watson Pharmacy in Fordyce, Ark., August 12, 2021. (Shannon Stapleton/Reuters)\r\nPfizer and Bio\u2026 [+1747 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Cristin Flanagan", "title": "Pfizer Poised for Best Month in 30 Years Amid Vaccine Race", "description": "(Bloomberg) -- Pfizer Inc. is poised to close out November with its best monthly advance in 30 years, as renewed virus fears revive the market\u2019s focus on...", "url": "https://finance.yahoo.com/news/pfizer-set-best-month-30-153850519.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/VIShTOOsfzOuxTMeO9ri3g--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/153b576137f43851d3629b55f1296791", "publishedAt": "2021-11-30T17:37:42Z", "content": "(Bloomberg) -- Pfizer Inc. is poised to close out November with its best monthly advance in 30 years, as renewed virus fears revive the markets focus on vaccine makers.\r\nMost Read from Bloomberg\r\nThe\u2026 [+1532 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Reuters", "title": "Pfizer seeks U.S. authorization of COVID-19 booster shots for 16, 17 year olds", "description": "Last week, U.S. regulators expanded the eligibility for a booster dose of Pfizer and partner BioNTech's vaccine to all adults 18 and over, to be given at...", "url": "https://news.yahoo.com/pfizer-seeks-u-authorization-covid-230944470.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/UZDnns8uldLomE2mB03wyg--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/fcc7ae91909bab697ed761d940b3b087", "publishedAt": "2021-11-30T23:09:44Z", "content": "(Reuters) - Pfizer Inc's Chief Executive Officer Albert Bourla said on Tuesday the company has submitted a request to the U.S. Food and Drug Administration seeking the authorization for its COVID-19 \u2026 [+792 chars]"}, {"source": {"id": null, "name": "FierceBiotech"}, "author": "Ben Adams", "title": "GlaxoSmithKline poaches Pfizer vax leader Dormitzer after hemorrhaging vaccine R&D talent", "description": "GlaxoSmithKline has seen a host of vaccine research staffers exit the Big Pharma over the past year, but it\u2019s hoping a big name can get its vaccine business back on track.", "url": "https://www.fiercebiotech.com/biotech/glaxosmithkline-poaches-pfizer-vax-leader-phil-dormitzer-after-hemorrhaging-vaccine-r-d", "urlToImage": "https://qtxasset.com/fiercebiotech/1638279998/22720111227_2a042d40c2_k.jpg/22720111227_2a042d40c2_k.jpg?VersionId=DbpOxuEzquotDvodoIedFTTBUGCDGfLd", "publishedAt": "2021-11-30T13:47:13Z", "content": "GlaxoSmithKline has seen a host of vaccine research staffers exit the Big Pharma over the past year, but its hoping a big name can get its vaccine business back on track. \r\nThat name is Phil Dormitze\u2026 [+2268 chars]"}, {"source": {"id": null, "name": "Daily Mail"}, "author": "Natasha Anderson, Rob Crilly, Geoff Earle", "title": "Pfizer to apply for FDA approval for first COVID vaccine booster shot for kids aged 16 and 17", "description": "The drug-maker is expected to apply for regulatory approval from the FDA for the booster shot of their vaccine this week. It would be the first booster shot available to anyone under 18.", "url": "https://www.dailymail.co.uk/news/article-10256751/Pfizer-apply-FDA-approval-COVID-vaccine-booster-shot-kids-aged-16-17.html", "urlToImage": "https://i.dailymail.co.uk/1s/2021/11/30/04/51128897-0-image-a-69_1638245357993.jpg", "publishedAt": "2021-11-30T04:14:28Z", "content": "Pfizer is seeking FDA approval for COVID-19 booster shots for older teens as the Omicron variant of the virus continues to spread worldwide.\r\nThe drug-maker is expected to apply for regulatory approv\u2026 [+9333 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Laurie McGinley, Tyler Pager", "title": "Pfizer set to request FDA authorization for coronavirus booster for 16- and 17-year-olds", "description": "The company is expected to ask the Food and Drug Administration in the coming days to authorize its booster shot for another age group.", "url": "https://www.bostonglobe.com/2021/11/29/nation/pfizer-set-request-fda-authorization-coronavirus-booster-16-17-year-olds/", "urlToImage": "https://bostonglobe-prod.cdn.arcpublishing.com/resizer/GhBGXu92J-XEhjV6ZSdvGcpdAQY=/506x0/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/HGFFAUBXQTCJY4VAECNCPP2XNE.jpg", "publishedAt": "2021-11-30T01:18:25Z", "content": "WASHINGTON - As President Joe Biden exhorts Americans to get coronavirus vaccines and booster shots to strengthen protections against the delta and omicron variants, another age group might soon beco\u2026 [+4132 chars]"}, {"source": {"id": null, "name": "Bangkok Post"}, "author": "Bangkok Post Public Company Limited", "title": "Pfizer already working on Covid vaccine targeting Omicron: CEO", "description": "NEW YORK: Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the new Omicron variant in case the current inoculation is not effective against the latest strain, the US drugmaker's CEO Albert Bourla said Monday.", "url": "https://www.bangkokpost.com/world/2224071/pfizer-already-working-on-covid-vaccine-targeting-omicron-ceo", "urlToImage": "https://static.bangkokpost.com/media/content/20211130/c1_4158623_700.jpg", "publishedAt": "2021-11-30T01:45:00Z", "content": "NEW YORK: Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the new Omicron variant in case the current inoculation is not effective against the latest st\u2026 [+1763 chars]"}, {"source": {"id": null, "name": "Hindustan Times"}, "author": "hindustantimes.com", "title": "From Pfizer to Moderna: What vaccine makers are saying about omicron jabs - Hindustan Times", "description": "<ol><li>From Pfizer to Moderna: What vaccine makers are saying about omicron jabs\u00a0\u00a0Hindustan Times\r\n</li><li>Omicron May Elude Current Vaccines, Says Moderna Expert\u00a0\u00a0NDTV\r\n</li><li>Explained: Will the vaccines stop Omicron? Scientists are racing to find out\u00a0\u00a0\u2026", "url": "https://www.hindustantimes.com/world-news/from-pfizer-to-moderna-what-vaccine-makers-are-saying-about-omicron-jabs-101638232110944.html", "urlToImage": "https://images.hindustantimes.com/img/2021/11/30/1600x900/omicron_covid_vaccine_1638232387548_1638232387782.jpg", "publishedAt": "2021-11-30T00:36:48Z", "content": "Omicron poses a \"very high\" risk globally, the World Health Organization (WHO) has warned even as the new variant of the coronavirus has raised concerns around the world, with countries implementing \u2026 [+4457 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "It\u2019s Time To Dump Pfizer", "description": null, "url": "https://www.investmentwatchblog.com/its-time-to-dump-pfizer/", "urlToImage": null, "publishedAt": "2021-11-30T13:22:23Z", "content": "by Ra\u00fal Ilargi Meijer\r\nIvan Kramskoy\u00a0Christ in the desert\u00a01920\r\n\u00a0\r\n\u00a0\r\nIts time for the world to come to its senses. Maybe Omicron is a good guide for doing that. Because it shows how something that i\u2026 [+13799 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "NiKang Therapeutics and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Novel Combination Therapies for the Treatment of Advanced Clear Cell Renal Cell Carcinoma", "description": "WILMINGTON, Del.--(BUSINESS WIRE)--NiKang Therapeutics Inc. (\u201cNiKang\u201d), a clinical stage biotech company focused on developing innovative small molecule oncology medicines to help patients with unmet medical needs, today announced that it has entered into a c\u2026", "url": "https://www.businesswire.com/news/home/20211130005397/en/NiKang-Therapeutics-and-Pfizer-Enter-Clinical-Trial-Collaboration-and-Supply-Agreement-to-Evaluate-Novel-Combination-Therapies-for-the-Treatment-of-Advanced-Clear-Cell-Renal-Cell-Carcinoma", "urlToImage": "https://mms.businesswire.com/media/20211130005397/en/1125458/23/NK-Logo-CMYK_-_v2.jpg", "publishedAt": "2021-11-30T13:08:52Z", "content": "WILMINGTON, Del.--(BUSINESS WIRE)--NiKang Therapeutics Inc. (NiKang), a clinical stage biotech company focused on developing innovative small molecule oncology medicines to help patients with unmet m\u2026 [+2520 chars]"}]}, "2021-11-29": {"status": "ok", "totalResults": 41, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Pfizer, BioNTech to seek FDA approval for booster shots for 16 and 17-year olds- Washington Post - Reuters", "description": "Pfizer Inc <a href=\"https://www.reuters.com/companies/PFE.N\" target=\"_blank\">(PFE.N)</a> and German partner BioNTech SE <a href=\"https://www.reuters.com/companies/22UAy.DE\" target=\"_blank\">(22UAy.DE)</a> are expected to ask the U.S. Food and Drug Administrati\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-biontech-seek-fda-approval-booster-shots-16-17-year-olds-washington-post-2021-11-29/", "urlToImage": "https://www.reuters.com/resizer/AmCAWWd_LA__ReVAhAZ7ABQg0q4=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/L5TW7LJS5RJVPL5F3DID3TSMWQ.jpg", "publishedAt": "2021-11-29T22:53:00Z", "content": "Dr. Sarah Linde with the Maryland Medical Reserve Corps gives Luca Starling, 10, his first COVID-19 vaccination at Eastern Middle School in Silver Spring, Maryland, U.S., November 6, 2021. Picture ta\u2026 [+552 chars]"}, {"source": {"id": null, "name": "Adsoftheworld.com"}, "author": "bob.nicholl", "title": "Pfizer China: Healthcare for All: Healthycopter", "description": "Drone shows have recently become a cliche. Every major city and event has mounted one. But what made this drone show by Pfizer and F5 Shanghai one to remember was the creative use of drone technology to spread healthcare to China\u2019s hard to reach mountainous r\u2026", "url": "https://www.adsoftheworld.com/media/experiential/pfizer_china_healthcare_for_all_healthycopter", "urlToImage": "https://d3nuqriibqh3vw.cloudfront.net/4_116.jpg?0dapow6AOwUfFSd3hNBsK4tauqgqVp7X", "publishedAt": "2021-11-29T14:29:48Z", "content": "Drone shows have recently become a cliche. Every major city and event has mounted one. But what made this drone show by Pfizer and F5 Shanghai one to remember was the creative use of drone technology\u2026 [+650 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": null, "title": "Balance of Power: Pfizer CEO on Omicron Vaccine (Radio)", "description": "Listen Balance of Power -Bloomberg", "url": "https://www.bloomberg.com/news/audio/2021-11-29/balance-of-power-pfizer-ceo-on-omicron-vaccine-radio", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iaLVV6Zri8mw/v0/955x500.jpg", "publishedAt": "2021-11-29T20:10:54Z", "content": "Bloomberg Balance of Power, where the world of politics meets the world of business. David Westin speaks with experts from Bloomberg News, Bloomberg Government, Bloomberg Tax and Bloomberg Law about \u2026 [+114 chars]"}, {"source": {"id": "bloomberg", "name": "Bloomberg"}, "author": null, "title": "Wall Street Covid Fears Ease, Retail Outlook, Pfizer (Podcast)", "description": "Guy Johnson and Alix Steel bring you the conversations dominating the trading desks at the City of London and the view from on Wall Street.", "url": "https://www.bloomberg.com/news/audio/2021-11-29/wall-street-covid-fears-ease-retail-outlook-pfizer-podcast", "urlToImage": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/isw9rluw5LUE/v0/955x500.png", "publishedAt": "2021-11-29T19:43:36Z", "content": "The Cable Podcast Browse all episodesHosts Alix Steel and Guy Johnson speak with Therese Raphael, Bloomberg Opinion Editor and Columnist, Kriti Gupta, Bloomberg Markets Correspondent, and Mary Lou Ga\u2026 [+112 chars]"}, {"source": {"id": null, "name": "The Intercept"}, "author": "Lee Fang", "title": "Pfizer Is Lobbying to Thwart Whistleblowers From Exposing Corporate Fraud", "description": "Pfizer is among the Big Pharma companies trying to block legislation strengthening whistleblowers' ability to report corporate fraud.\nThe post Pfizer Is Lobbying to Thwart Whistleblowers From Exposing Corporate Fraud appeared first on The Intercept.", "url": "https://theintercept.com/2021/11/29/pfizer-whistleblower-reform-corporate-fraud/", "urlToImage": "https://theintercept.imgix.net/wp-uploads/sites/1/2021/11/GettyImages-1292540635-crop.jpg?auto=compress%2Cformat&q=90&fit=crop&w=1200&h=800", "publishedAt": "2021-11-29T19:05:00Z", "content": "Pfizer and other\r\n large pharmaceutical\u00a0corporations are pushing to block legislation that would make it easier for whistleblowers to hold companies liable for corporate fraud.\r\nIn the midst of a diz\u2026 [+9776 chars]"}, {"source": {"id": null, "name": "Fox Business"}, "author": "Lucas Manfredi", "title": "Moderna, Pfizer, J&J talk omicron response - Fox Business", "description": "As COVID-19's new omicron variant has begun to emerge overseas, vaccine makers Moderna, Pfizer and Johnson & Johnson have outlined their respective strategies to tackle the new strain.", "url": "https://www.foxbusiness.com/markets/moderna-pfizer-jj-talk-omicron-response", "urlToImage": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2021/11/0/0/pfizer-vaccine.gif?ve=1&tl=1", "publishedAt": "2021-11-29T19:30:40Z", "content": "As COVID-19's new omicron variant has begun to emerge overseas, vaccine makers Moderna, Pfizer and Johnson &amp; Johnson have outlined their respective strategies to tackle the new strain.\r\nVARNEY: O\u2026 [+5461 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "AFP", "title": "Pfizer already working on Covid vaccine targeting Omicron: CEO", "description": "Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the Omicron variant in case the current inoculation is not...", "url": "https://news.yahoo.com/pfizer-already-working-covid-vaccine-153520887.html", "urlToImage": "https://s.yimg.com/uu/api/res/1.2/piHDiCFU.2q3hYq0qTDn8Q--~B/aD01MTI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/afp.com/28221ee021ec0255e5e9f90f6bdccab0", "publishedAt": "2021-11-29T15:35:20Z", "content": "Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the Omicron variant in case the current inoculation is not effective against the new strain, the US drug\u2026 [+1498 chars]"}, {"source": {"id": null, "name": "Yahoo Entertainment"}, "author": "Ya\u0451l Bizouati-Kennedy", "title": "Omicron Variant Sees Moderna, Pfizer Stocks Skyrocket as Companies Target 100-Day Vaccine Timeline", "description": "On Black Friday, Nov. 26, shares of the top COVID-19 vaccine developers Moderna, Pfizer and Novavax all vaulted higher, per The Motley Fool. See: How Will...", "url": "https://finance.yahoo.com/news/omicron-variant-sees-moderna-pfizer-194343694.html", "urlToImage": "https://s.yimg.com/ny/api/res/1.2/1WE95.JmEPvW3kSysinfGQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/uu/api/res/1.2/Ojm1vBC4KNElnN_GBr8xKQ--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/gobankingrates_644/9314dd541daf92049bf75dafcbf4e2b0", "publishedAt": "2021-11-29T19:43:43Z", "content": "solarseven / Getty Images/iStockphoto\r\nOn Black Friday, Nov. 26, shares of the top COVID-19 vaccine developers Moderna, Pfizer and Novavax all vaulted higher, per The Motley Fool.\r\nSee: How Will the \u2026 [+3249 chars]"}, {"source": {"id": null, "name": "Business Wire"}, "author": null, "title": "Ranok Therapeutics Announces Agreement with Pfizer on Targeted Protein Degradation", "description": "BOSTON & HANGZHOU, China--(BUSINESS WIRE)--Ranok Therapeutics (Hangzhou) Co. Ltd., an emerging biopharmaceutical company focused on developing breakthrough therapies for cancer and other serious diseases, today announced an agreement with Pfizer Inc. to apply\u2026", "url": "https://www.businesswire.com/news/home/20211129005350/en/Ranok-Therapeutics-Announces-Agreement-with-Pfizer-on-Targeted-Protein-Degradation", "urlToImage": "https://mms.businesswire.com/media/20211129005350/en/930753/23/Ranok_Tx_Logo.jpg", "publishedAt": "2021-11-29T13:09:37Z", "content": "BOSTON &amp; HANGZHOU, China--(BUSINESS WIRE)--Ranok Therapeutics (Hangzhou) Co. Ltd., an emerging biopharmaceutical company focused on developing breakthrough therapies for cancer and other serious \u2026 [+2740 chars]"}, {"source": {"id": null, "name": "The Times of Israel"}, "author": null, "title": "Pfizer CEO: We\u2019re working on COVID vaccine against Omicron", "description": "Albert Bourla says new shot may be needed if testing shows existing vaccine provides less protection against new coronavirus variant", "url": "https://www.timesofisrael.com/pfizer-ceo-were-working-on-covid-vaccine-against-omicron/", "urlToImage": "https://static.timesofisrael.com/www/uploads/2021/11/AP21323076051775-e1638206537739-1024x640.jpg", "publishedAt": "2021-11-29T18:11:54Z", "content": "NEW YORK \u2014 Pfizer has already started working on a version of its COVID-19 vaccine specifically targeting the Omicron variant in case the current inoculation is not effective against the new strain, \u2026 [+1619 chars]"}, {"source": {"id": null, "name": "Japan Today"}, "author": null, "title": "Pfizer already working on vaccine targeting Omicron: CEO", "description": "Pfizer has already started working on a version of its COVID-19 vaccine specifically targeting the new Omicron variant in case the current inoculation is not effective against the latest strain, the U.S. drugmaker's CEO Albert Bourla said Monday. Bourla told \u2026", "url": "https://japantoday.com/category/world/pfizer-already-working-on-covid-vaccine-targeting-omicron-ceo", "urlToImage": null, "publishedAt": "2021-11-29T22:03:06Z", "content": "Pfizer has already started working on a version of its COVID-19 vaccine specifically targeting the new Omicron variant in case the current inoculation is not effective against the latest strain, the \u2026 [+1767 chars]"}, {"source": {"id": null, "name": "The Boston Globe"}, "author": "Jonathan Saltzman", "title": "J&J joins Pfizer and Moderna in vowing to target Omicron variant", "description": "The company is working with scientists in South Africa to gauge its vaccine's real-world effectiveness against the new variant", "url": "https://www.bostonglobe.com/2021/11/29/nation/jj-joins-pfizer-moderna-vowing-target-omicron-variant/", "urlToImage": "https://www.bostonglobe.com/pf/resources/images/logo-bg.jpg?d=305", "publishedAt": "2021-11-29T16:10:35Z", "content": "Johnson &amp; Johnson joined Pfizer-BioNTech and Moderna on Monday in saying it will test how well its vaccine works against the worrisome variant that emerged in southern Africa and will develop a b\u2026 [+2396 chars]"}, {"source": {"id": null, "name": "AllAfrica - Top Africa News"}, "author": "Premium Times", "title": "Ghana: Pfizer Foundation Donates $6.4 Million for Infectious Disease Control in Nigeria, Ghana", "description": "[Premium Times] Ms Roan noted that globally, nearly eight million people lose their lives each year from infectious diseases that could be avoided with access to basic healthcare", "url": "https://allafrica.com/stories/202111290014.html", "urlToImage": "https://cdn08.allafrica.com/static/images/structure/aa-logo-rgba-no-text-square.png", "publishedAt": "2021-11-29T04:53:28Z", "content": "Ms Roan noted that globally, nearly eight million people lose their lives each year from infectious diseases that could be avoided with access to basic healthcare\r\nThe Pfizer Foundation, an instituti\u2026 [+4461 chars]"}, {"source": {"id": null, "name": "FiercePharma"}, "author": "Angus Liu", "title": "Pfizer boosts Paxlovid manufacturing capacity as Merck\u2019s rival COVID pill sees efficacy wane", "description": "The efficacy data for Pfizer\u2019s oral COVID-19 drug now look so appealing that the Big Pharma company is boosting manufacturing capacity even before an expected emergency use authorization.", "url": "https://www.fiercepharma.com/manufacturing/pfizer-boosts-paxlovid-manufacturing-capacity-as-merck-s-rival-covid-pill-sees", "urlToImage": "https://qtxasset.com/fiercepharma/1638203888/AlbertBourla.jpg/AlbertBourla.jpg?VersionId=7CmB1Jorc4BYucMs5odda1QkBG4Us6aw", "publishedAt": "2021-11-29T16:38:24Z", "content": "The efficacy data for Pfizers oral COVID-19 drug now look so appealing that the Big Pharma company is boosting manufacturing capacity even before an expected emergency use authorization from the FDA.\u2026 [+2399 chars]"}, {"source": {"id": "cnn", "name": "CNN"}, "author": "Kaitlan Collins, CNN", "title": "Pfizer expected to seek FDA authorization for boosters for those ages 16 and 17", "description": "Pfizer is expected to seek authorization from the US Food and Drug Administration for its vaccine booster shot for those who are ages 16 and 17, a source familiar with the plan told CNN on Monday.", "url": "https://www.cnn.com/2021/11/29/politics/pfizer-fda-authorization-boosters-ages-16-17/index.html", "urlToImage": "https://cdn.cnn.com/cnnnext/dam/assets/211008135959-pfizer-booster-vaccine-california-1001-super-tease.jpg", "publishedAt": "2021-11-29T23:21:35Z", "content": "(CNN)Pfizer is expected to seek authorization from the US Food and Drug Administration for its vaccine booster shot for those who are ages 16 and 17, a source familiar with the plan told CNN on Monda\u2026 [+932 chars]"}, {"source": {"id": "newsweek", "name": "Newsweek"}, "author": "Alexandra Hutzler", "title": "Pfizer CEO Says They've Started Developing New COVID Vaccine Amid Omicron Spread", "description": "Pfizer CEO Albert Bourla said his company could have a new vaccine available in less than 100 days, if necessary.", "url": "https://www.newsweek.com/pfizer-ceo-says-theyve-started-developing-new-covid-vaccine-amid-omicron-spread-1654037", "urlToImage": "https://d.newsweek.com/en/full/1941588/pfizer-starts-development-new-vaccine-omicron.jpg", "publishedAt": "2021-11-29T17:45:38Z", "content": "Pfizer CEO Albert Bourla said his company has already started to develop a new coronavirus vaccine amid the spread of the new variant Omicron.\r\nBourla made the remarks during an appearance on CNBC's \u2026 [+3792 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Dulan Lokuwithana", "title": "Exact Sciences ends co-promotion deal with Pfizer for Cologuard", "description": "Exact Sciences Corporation (EXAS) says that Pfizer (PFE) will no longer join the company from Nov", "url": "https://seekingalpha.com/news/3775121-exact-sciences-ends-co-promotion-deal-with-pfizer-for-cologuard", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/94113879/large_image_94113879.jpg", "publishedAt": "2021-11-29T21:59:23Z", "content": "Kuzma/iStock via Getty Images\r\n\n<ul>\n<li>Exact Sciences Corporation (NASDAQ:EXAS) says that Pfizer (NYSE:PFE) will no longer join the company from Nov. 30 in the promotion of its Cologuard colorectal\u2026 [+819 chars]"}, {"source": {"id": null, "name": "SoyaCincau.com"}, "author": "Alexander Wong", "title": "Khairy: Less than 0.001% of Pfizer booster vaccine recipients had serious side effects", "description": "Health Minister Khairy Jamaluddin has revealed that a very small number of individuals had experienced serious side effects after getting their COVID-19 booster vaccine jab. During an interview on Astro Awani yesterday evening, he said there are only 11 cases\u2026", "url": "https://soyacincau.com/2021/11/29/khairy-11-pfizer-covid-19-booster-vaccine-had-serious-side-effects-malaysia/", "urlToImage": "https://soyacincau.com/wp-content/uploads/2021/05/210519-covid-vaccination-WTC-KL-04.jpg", "publishedAt": "2021-11-29T09:54:58Z", "content": "Health Minister Khairy Jamaluddin has revealed that a very small number of individuals had experienced serious side effects after getting their COVID-19 booster vaccine jab. During an interview on As\u2026 [+2953 chars]"}, {"source": {"id": null, "name": "ValueWalk"}, "author": "Jacob Wolinsky", "title": "Albert Bourla: Pfizer Could Have A New Vaccine Against Omicron Covid Variant In Less Than 100 Days", "description": "Following is the unofficial transcript of a CNBC interview with Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla on CNBC\u2019s \u201cSquawk Box\u201d (M-F, 6AM-9AM ET) today, Monday, November 29th. Following is a link to video on CNBC.com: Q3 2021 hedge fund letters, \u2026", "url": "https://www.valuewalk.com/albert-bourla-pfizer-could-have-a-new-vaccine-against-omicron-covid-variant-in-less-than-100-days/", "urlToImage": "https://valuewalk.b-cdn.net/wp-content/uploads/2020/12/Pfizer-CEO-Albert-Bourla.jpg", "publishedAt": "2021-11-29T15:54:00Z", "content": "Following is the unofficial transcript of a CNBC interview with Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla on CNBCs Squawk Box (M-F, 6AM-9AM ET) today, Monday, November 29th. Following is \u2026 [+14902 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "PFIZER: \u2018Vaccine 100% Effective Against COVID-19 For Ages 12-15\u2019. But there is a catch.", "description": null, "url": "https://www.investmentwatchblog.com/pfizer-vaccine-100-effective-against-covid-19-for-ages-12-15-but-there-is-a-catch/", "urlToImage": null, "publishedAt": "2021-11-29T13:33:48Z", "content": "www.pfizer.com/news/press-release/press-release-detail/follow-data-phase-3-trial-pfizer-biontech-covid-19-vaccine\r\nA press release put out by Pfizer last Monday claimed strong results for the Pfizer-\u2026 [+961 chars]"}]}, "2021-11-28": {"status": "ok", "totalResults": 7, "articles": [{"source": {"id": null, "name": "Motley Fool"}, "author": "newsfeedback@fool.com (George Budwell)", "title": "Moderna, Pfizer, and Novavax Are Must-Own Stocks This Week", "description": "The omicron variant should gives these top vaccine stocks a healthy boost this week.", "url": "https://www.fool.com/investing/2021/11/28/moderna-pfizer-and-novavax-are-must-own-stocks-thi/", "urlToImage": "https://g.foolcdn.com/editorial/images/654907/omicrong.jpg", "publishedAt": "2021-11-28T15:30:00Z", "content": "The newly emerged omicron coronavirus variant sent shockwaves through U.S. stock markets last Friday. Omicron has the world on edge because of its unique combination of mutations that might significa\u2026 [+3625 chars]"}, {"source": {"id": null, "name": "CNA"}, "author": null, "title": "Philippines to buy extra 20 million doses of Pfizer-BioNTech's COVID-19 vaccine", "description": "MANILA: The\u00a0Philippines will buy an additional 20 million doses of the COVID-19 vaccine developed by Pfizer and BioNTech, seeking to fully inoculate more than 80 per cent of its population by mid-2022, a government official said on Sunday (Nov 28).\r\n\r\nA deal \u2026", "url": "https://www.channelnewsasia.com/asia/philippines-buy-20-million-pfizer-biontech-covid19-vaccine-2343486", "urlToImage": "https://onecms-res.cloudinary.com/image/upload/s--RtZgj6eP--/c_crop%2Ch_450%2Cw_800%2Cx_0%2Cy_0/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2021-11-28t083128z_1_lynxmpehar03o_rtroptp_3_health-coronavirus-philippines.jpg?itok=-v4oK-Fp", "publishedAt": "2021-11-28T09:08:58Z", "content": "The government's goal is to inoculate 54 million Filipinos by year-end, or 70 per cent of the targeted population, Galvez said.\r\nThe next goal is to hit the 77 million threshold by the end of March 2\u2026 [+526 chars]"}, {"source": {"id": null, "name": "Investmentwatchblog.com"}, "author": "alexmark", "title": "Pfizer CEO Warns New Vaccine To Combat Heavily-Mutated Coronavirus Could Take 100 Days", "description": null, "url": "https://www.investmentwatchblog.com/pfizer-ceo-warns-new-vaccine-to-combat-heavily-mutated-coronavirus-could-take-100-days/", "urlToImage": null, "publishedAt": "2021-11-28T00:31:48Z", "content": "Relax guys, Pfizer\u2019s got our back.\r\nThey just have to mix up a new batch, no reason to worry.\r\n\u2026Baum said the next few weeks of testing would be essential to determine whether Nu is more aggressive t\u2026 [+768 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Jim Hoft", "title": "VIDEO: Former Pfizer Employee Says COVID-19 Vaccine Causes Recipients to Become More Susceptible to the Virus", "description": "A former Pfizer employee, now working as a pharmaceutical marketing expert\u00a0and biotech analyst, has provided evidence in a public meeting in September suggesting that Pfizer is aware that these shots can cause those vaccinated to be more prone to contracting \u2026", "url": "https://www.thegatewaypundit.com/2021/11/video-former-pfizer-employee-says-covid-19-vaccine-causes-recipients-become-susceptible-virus/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/8DAD6101-1959-408B-9ED1-4742AB126C47.jpeg", "publishedAt": "2021-11-28T00:40:28Z", "content": "A former Pfizer employee, now working as a pharmaceutical marketing expert\u00a0and biotech analyst, has provided evidence in a public meeting in September suggesting that Pfizer is aware that these shots\u2026 [+2449 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Jim Hoft", "title": "Pfizer Says it can Tweak Current COVID Vaccine in 100 Days if Necessary in Response to Omicron Variant", "description": "Pfizer said on Friday that it could produce an improved version of its vaccine within 100 days if the new \u00a0\u2018Omicron\u2019 variant is resistant to the current vaccine. Pfizer told FOX Business in an email that they are \u201cremaining vigilant\u201d and \u201cconstantly conductin\u2026", "url": "https://www.thegatewaypundit.com/2021/11/pfizer-says-can-tweak-current-covid-vaccine-100-days-necessary/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/6A0830C8-FB69-4650-B7A8-690B091821E8.jpeg", "publishedAt": "2021-11-28T20:40:04Z", "content": "Pfizer said on Friday that it could produce an improved version of its vaccine within 100 days if the new \u00a0\u2018Omicron\u2019 variant is resistant to the current vaccine.\r\nPfizer told FOX Business in an email\u2026 [+1139 chars]"}, {"source": {"id": null, "name": "Slashdot.org"}, "author": "feedfeeder", "title": "Pfizer and Moderna set to adapt to Omicron COVID variant - New York Post", "description": "Pfizer and Moderna set to adapt to Omicron COVID variantNew York Post Pfizer said an updated version of its COVID-19 vaccine will be 'ready in 100 days' if the new Omicron variant is resistant to its current vaccineYahoo! Voices Pfizer/BioNTech seeking data o\u2026", "url": "https://slashdot.org/firehose.pl?op=view&amp;id=156034355", "urlToImage": null, "publishedAt": "2021-11-28T07:32:43Z", "content": "The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way."}, {"source": {"id": null, "name": "CNET"}, "author": "Clifford Colby", "title": "Pfizer COVID booster FAQ: New omicron variant, side effects, who's eligible and more", "description": "A new COVID-19 variant named 'omicron' is raising concerns. Here's what to know so far about Pfizer's vaccine and the mutated virus.", "url": "https://www.cnet.com/health/pfizer-covid-booster-faq-new-omicron-variant-side-effects-whos-eligible-and-more/", "urlToImage": "https://www.cnet.com/a/img/Uwm4LT69IJkLxAdtFtCqRJofu2k=/1200x630/2021/09/14/e835f0fa-2ca6-4702-a564-a7ca34f79b1b/gettyimages-1234837929.jpg", "publishedAt": "2021-11-28T15:44:12Z", "content": "Adults who received Pfizer's COVID-19 vaccine can get a booster after six months.\r\nRobyn Beck/Getty Images\r\nFor the most up-to-date news and information about the coronavirus pandemic, visit the WHO \u2026 [+5811 chars]"}]}, "2021-11-27": {"status": "ok", "totalResults": 32, "articles": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Pfizer/BioNTech seeking data on new COVID variant - Reuters", "description": "BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine whether its vaccine produced with partner Pfizer Inc would have to be reworked. Gloria Tso reports.", "url": "https://www.reuters.com/video/watch/idOVF5DPAWB", "urlToImage": "https://static.reuters.com/resources/r/?d=20211127&i=OVF5DPAWB&r=OVF5DPAWB&t=2", "publishedAt": "2021-11-27T07:17:33Z", "content": "Posted \r\nBioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine whether its vaccine produced with partner Pf\u2026 [+54 chars]"}, {"source": {"id": "business-insider", "name": "Business Insider"}, "author": "ydzhanova@businessinsider.com (Yelena Dzhanova)", "title": "Pfizer said an updated version of its COVID-19 vaccine will be 'ready in 100 days' if the new Omicron variant is resistant to its current vaccine", "description": "Pfizer expects to know within two weeks whether the variant is resistant to its current vaccine, a company spokesperson told Reuters.", "url": "https://www.businessinsider.com/pfizer-vaccine-update-100-days-omicron-variant-resistant-2021-11", "urlToImage": "https://i.insider.com/61a2477b1ca5280018117e17?width=1200&format=jpeg", "publishedAt": "2021-11-27T15:33:53Z", "content": "Pfizer said it will be able to manufacture and distribute an updated version of its COVID-19 vaccine within 100 days if the new variant Omicron is found to be resistant to its current vaccine.\u00a0\r\nScie\u2026 [+2367 chars]"}, {"source": {"id": null, "name": "The Indian Express"}, "author": "Reuters", "title": "Pfizer/BioNTech, Moderna expect data on shot\u2019s protection against new COVID-19 variant soon", "description": "\"We expect more data from the laboratory tests in two weeks at the latest. These data will provide more information about whether B.1.1.529 could be an escape variant that may require an adjustment of our vaccine if the variant spreads globally,\" it added.", "url": "https://indianexpress.com/article/world/pfizer-biontech-moderna-vaccine-new-omicron-variant-7644041/", "urlToImage": "https://images.indianexpress.com/2021/01/Sinovac-China.jpg", "publishedAt": "2021-11-27T05:57:08Z", "content": "BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine whether its vaccine produced with partner Pfizer Inc \u2026 [+2321 chars]"}, {"source": {"id": null, "name": "Seeking Alpha"}, "author": "Mark Bern", "title": "Pfizer Stock May Break Out On New COVID Variant", "description": "Pfizer is well positioned to benefit for many years to come with both effective vaccines and treatments. Read more on why it may be time to consider an investment.", "url": "https://seekingalpha.com/article/4472096-pfizer-ready-to-break-out", "urlToImage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/182745918/large_image_182745918.jpg", "publishedAt": "2021-11-27T02:49:11Z", "content": "ManoAfrica/E+ via Getty Images\r\nThis New Variant is Scary\r\n The latest new variant of COVID-19 originated in South Africa. The World Health Organization has designated this new variant, called B.1.1.\u2026 [+4479 chars]"}, {"source": {"id": null, "name": "9News.com KUSA"}, "author": "Travis Pittman", "title": "Pfizer: 'Tailor-made' vaccine against new variants in 100 days - 9News.com KUSA", "description": "<ol><li>Pfizer: 'Tailor-made' vaccine against new variants in 100 days\u00a0\u00a09News.com KUSA\r\n</li><li>Moderna says an omicron variant vaccine could be ready in early 2022\u00a0\u00a0CNBC\r\n</li><li>Will the Vaccines Stop Omicron? Scientists Are Racing to Find Out.\u00a0\u00a0The New Y\u2026", "url": "https://www.9news.com/article/news/nation-world/covid-19-vaccine-booster-omicron-pfizer-moderna/507-d0f54021-08dc-46f9-8f75-8bdcd92c00bd", "urlToImage": "https://media.9news.com/assets/WPMT/images/cc1cc8dc-f212-4d74-a4d4-be3a3f006c2d/cc1cc8dc-f212-4d74-a4d4-be3a3f006c2d_1140x641.jpg", "publishedAt": "2021-11-27T22:40:00Z", "content": "With the emergence of the omicron COVID-19 variant, which has now been detected in southern Africa, Europe, Israel and Hong Kong, a number of pharmaceutical firms are announcing they have plans in pl\u2026 [+4400 chars]"}, {"source": {"id": null, "name": "PJ Media"}, "author": "Glenn Reynolds", "title": "THE VACCINES ARE UNDERPERFORMING: Study: COVID-19 protection wanes after two doses of Pfizer vaccin\u2026", "description": "THE VACCINES ARE UNDERPERFORMING: Study: COVID-19 protection wanes after two doses of Pfizer vaccine.", "url": "https://pjmedia.com/instapundit/487740/", "urlToImage": null, "publishedAt": "2021-11-27T18:00:51Z", "content": "As an Amazon Associate,I earn from qualifying purchases."}, {"source": {"id": null, "name": "Zoom"}, "author": "Times Now Digital", "title": "Omicron Covid-19 variant: Pfizer, BioNTech unsure about vaccine efficacy against new coronavirus strain - Times Now", "description": "<ol><li>Omicron Covid-19 variant: Pfizer, BioNTech unsure about vaccine efficacy against new coronavirus strain\u00a0\u00a0Times Now\r\n</li><li>COVID-19: Not sure whether vaccine will work against \u2018Variant of Concern\u2019 Omicron, says Pfizer\u00a0\u00a0Livemint\r\n</li><li>Moderna Say\u2026", "url": "https://www.timesnownews.com/international/article/omicron-covid19-variant-pfizer-biontech-unsure-about-vaccine-efficacy-against-new-coronavirus-strain/835702", "urlToImage": "https://imgk.timesnownews.com/story/Pfizer_COVID-19_vaccine_syringes._AP_Photo.jpg?tr=w-560,h-292,fo-top", "publishedAt": "2021-11-27T05:20:44Z", "content": "<ul><li>Pfizer and BioNTech noted that the new variant significantly differs from previously observed ones</li></ul>\r\n<ul><li>India has increased its scrutiny level amid the new threat, and included \u2026 [+2050 chars]"}, {"source": {"id": null, "name": "India.com"}, "author": "ANI", "title": "Pfizer, BioNTech not sure on vaccine effectiveness on new Covid variant Omicron - Zee News", "description": "<ol><li>Pfizer, BioNTech not sure on vaccine effectiveness on new Covid variant Omicron\u00a0\u00a0Zee News\r\n</li><li>COVID-19: Not sure whether vaccine will work against \u2018Variant of Concern\u2019 Omicron, says Pfizer\u00a0\u00a0Livemint\r\n</li><li>Moderna Says It Will Develop Booster\u2026", "url": "https://zeenews.india.com/india/pfizer-biontech-not-sure-on-vaccine-effectiveness-on-new-covid-variant-omicron-2413921.html", "urlToImage": "https://english.cdn.zeenews.com/sites/default/files/2021/11/27/990949-hfgvbrty.jpg", "publishedAt": "2021-11-27T02:32:57Z", "content": "Washington: The pharmaceutical companies Pfizer and BioNTech on Saturday issued a statement stating that they are not sure whether their vaccines would be able to help in the treatment of the new COV\u2026 [+1751 chars]"}, {"source": {"id": null, "name": "Israelnationalnews.com"}, "author": "Arutz Sheva Staff", "title": "South African expert: Pfizer vaccine likely protects against severe illness", "description": "Prof. Barry Schoub, COVID-19 adviser to South Africa's Pres., says those vaccinated with Pfizer's COVID-19 vaccine likely protected from severe illness even if infected with Omicron.", "url": "https://www.israelnationalnews.com/News/News.aspx/317665", "urlToImage": "https://u.a7.org/pictures/1044/1044342.jpg", "publishedAt": "2021-11-27T18:55:30Z", "content": "Professor Barry Schoub, who advises South Africa's President on issues relating to COVID-19, on Friday said that he estimates those who have received the Pfizer-BioNTech vaccine will not suffer sever\u2026 [+1243 chars]"}, {"source": {"id": "newsweek", "name": "Newsweek"}, "author": "Brendan Cole", "title": "Pfizer in 100 day Race For Omicron Vaccine as World Seeks to Contain Variant", "description": "The U.S. is among countries that have imposed restrictions on travelers from southern Africa as the race is on for a vaccine against the new Covid variant.", "url": "https://www.newsweek.com/pfizer-omicron-vaccine-covid-19-1653668", "urlToImage": "https://d.newsweek.com/en/full/1941036/passenger-heathrow.jpg", "publishedAt": "2021-11-27T11:02:21Z", "content": "The Omicron variant of COVID-19 has spurred a number of countries to place restrictions on travelers from southern Africa as the race is on to develop a vaccine for the new form of the disease.\r\nThe \u2026 [+3614 chars]"}, {"source": {"id": null, "name": "Zerohedge.com"}, "author": "Mike Rivero", "title": "26 More Cases Of Heart Inflammation Linked To Pfizer Jab", "description": "Pfizer is already quietly scrambling Friday as the COVID \"variant of the moment\" raises new questions about the efficacy of its vaccine (while the latest \"data\" shows Merck may have oversold its mulnupiravir drug as a \"miracle cure\" for the virus), it appears\u2026", "url": "https://www.zerohedge.com/covid-19/26-more-cases-heart-inflammation-linked-pfizer-jab", "urlToImage": "https://assets.zerohedge.com/s3fs-public/styles/16_9_max_700/public/2021-11/pfizer3.jpeg?itok=VsyI4YNf", "publishedAt": "2021-11-27T15:41:48Z", "content": "Pfizer is already quietly scrambling Friday as the COVID \"variant of the moment\" raises new questions about the efficacy of its vaccine (while the latest \"data\" shows Merck may have oversold its muln\u2026 [+1585 chars]"}, {"source": {"id": null, "name": "New York Post"}, "author": "Rich Calder", "title": "Pfizer and Moderna set to adapt to Omicron COVID variant", "description": "The manufacturers of America\u2019s most used COVID-19 vaccines insist they have plans in place to quickly adapt to potential challenges presented by the new omicron variant.", "url": "https://nypost.com/2021/11/27/vaccine-makers-set-to-adapt-for-omicron-covid-variant/", "urlToImage": "https://nypost.com/wp-content/uploads/sites/2/2021/11/PfizerJab.jpg?quality=90&strip=all&w=1024", "publishedAt": "2021-11-27T20:59:22Z", "content": "The manufacturers of Americas most used COVID-19 vaccines insist they have plans in place to quickly adapt to potential challenges presented by the new omicron variant.\r\nBoth Pfizer and vaccine partn\u2026 [+1843 chars]"}, {"source": {"id": null, "name": "Zerohedge.com"}, "author": "Mike Rivero", "title": "Vaxx Trial Fraud: Pfizer Whistleblower Exposes How Your Government Is Captured By Multinational Corporations", "description": "If you had a nickel for every time some bureaucrat or corporate news actor promised the COVID \u201cvaccines\u201d* are \u201csafe and effective,\u201d you\u2019d have a lot of fiat currency (spend it while you still can before inflation renders it valueless \u2013 or, better, convert it \u2026", "url": "https://www.zerohedge.com/news/2021-11-26/vaxx-trial-fraud-pfizer-whistleblower-exposes-how-your-government-captured", "urlToImage": null, "publishedAt": "2021-11-27T15:48:49Z", "content": "By Ben Bartee via The Daily Bell\r\nThe Hound\r\nPolitical theory rarely, if ever, aligns with practice in the real world.\r\nHeres how the FDA sausage is really made, exemplified perfectly by the recent P\u2026 [+6374 chars]"}, {"source": {"id": null, "name": "Thegatewaypundit.com"}, "author": "Cristina Laila", "title": "More Shots? Pfizer/BioNTech Will Know Vaccine\u2019s Effectiveness Against \u2018Omicron\u2019 Variant Soon \u2013 Can Ship New Jab Tailored to Emerging Variant in 100 Days", "description": "Here we go. A new variant of the COVID virus identified in South Africa is \u201chighly transmissible and vaccine-resistant.\u201d BioNTech/Pfizer on Friday said it will know its vaccine effectiveness against the new \u2018Omicron\u2019 variant within a couple weeks. \u201cWe expect \u2026", "url": "https://www.thegatewaypundit.com/2021/11/shots-pfizer-biontech-will-know-vaccines-effectiveness-omicron-variant-soon-can-ship-new-jab-tailored-emerging-variant-100-days/", "urlToImage": "https://www.thegatewaypundit.com/wp-content/uploads/towfiqu-barbhuiya-FsVEqeiOtPo-unsplash-scaled.jpg", "publishedAt": "2021-11-27T03:34:02Z", "content": "Here we go.\r\nA new variant of the COVID virus identified in South Africa is highly transmissible and vaccine-resistant.\r\nBioNTech/Pfizer on Friday said it will know its vaccine effectiveness against \u2026 [+1298 chars]"}, {"source": {"id": null, "name": "Livemint"}, "author": "Livemint", "title": "COVID-19: Not sure whether vaccine will work against \u2018Variant of Concern\u2019 Omicron, says Pfizer", "description": "Pfizer promised to develop a new COVID-19 vaccine against the Omicron within 100 days.Moderna said it will develop a booster shot against the new Omicron variant of the coronavirus", "url": "https://www.livemint.com/companies/news/covid19-not-sure-whether-vaccine-will-work-against-variant-of-concern-omicron-says-pfizer-11637981656742.html", "urlToImage": "https://images.livemint.com/img/2021/11/27/600x338/Covid-19_vaccine_1637984914506_1637984914722.jpg", "publishedAt": "2021-11-27T03:50:07Z", "content": "Pfizer and BioNTech COVID-19 vaccine: Noting that they are not sure whether their vaccines would work against new COVID-19 variant 'Omicron, Pfizer and BioNTech promised to develop a new vaccine agai\u2026 [+1967 chars]"}, {"source": {"id": null, "name": "City A.M."}, "author": "Michiel Willems", "title": "Omicron: Pfizer, BioNTech and Moderna race to tweak Covid vaccines against new Coronavirus variant", "description": "Work is underway to look at tweaking vaccines against the new concerning strain of coronavirus that has sparked travel bans. The variant, named Omicron and designated a \u201cvariant of concern\u201d by the World Health Organisation (WHO), has reached Belgium after bei\u2026", "url": "https://www.cityam.com/omicron-pfizer-biontech-and-moderna-in-pharma-race-to-tweak-covid-vaccines-against-new-coronavirus-variant/", "urlToImage": "https://www.cityam.com/wp-content/uploads/2020/08/1227887339.jpg", "publishedAt": "2021-11-27T08:25:00Z", "content": "Saturday 27 November 2021 8:25 am\r\nWork is underway to look at tweaking vaccines against the new concerning strain of coronavirus that has sparked travel bans.\r\nThe variant, named Omicron and designa\u2026 [+4173 chars]"}, {"source": {"id": null, "name": "Business Standard"}, "author": "ANI", "title": "Pfizer, BioNTech unsure of vax effectiveness against new Covid variant", "description": "The companies also promised to develop a new vaccine against the variant in about 100 days", "url": "https://www.business-standard.com/article/news-ani/pfizer-biontech-not-sure-on-vaccines-effectiveness-on-new-covid-variant-omicron-121112700146_1.html", "urlToImage": "https://bsmedia.business-standard.com/_media/bs/img/article/2021-02/25/full/1614255646-8333.jpg", "publishedAt": "2021-11-27T02:21:00Z", "content": "The pharmaceutical companies Pfizer and BioNTech on Saturday issued a statement stating that they are not sure whether their vaccines would be able to help in the treatment of the new Coronavirus (CO\u2026 [+3080 chars]"}, {"source": {"id": null, "name": "Freerepublic.com"}, "author": "Reuters", "title": "Pfizer/BioNTech, Moderna expect data on shot's protection against new COVID-19 variant soon", "description": "BioNTech SE (22UAy.DE) said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine whether its vaccine produced with partner Pfizer Inc (PFE.N) would have to be reworked. Pfizer and Bio\u2026", "url": "https://freerepublic.com/focus/f-news/4016129/posts", "urlToImage": null, "publishedAt": "2021-11-27T13:25:55Z", "content": "Skip to comments.\r\nPfizer/BioNTech, Moderna expect data on shot's protection against new COVID-19 variant soonReuters ^\r\n | Ludwig Burger\r\nPosted on 11/27/2021 5:25:55 AM PST by BlackAdderess\r\nBioNTe\u2026 [+3549 chars]"}, {"source": {"id": null, "name": "bdnews24.com"}, "author": null, "title": "Pfizer/BioNTech, Moderna expect data on shot's protection against new COVID-19 variant soon", "description": "BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine whether its vaccine produced with partner Pfizer Inc would have to be reworked.", "url": "https://bdnews24.com/coronavirus-pandemic/2021/11/27/pfizerbiontech-moderna-expect-data-on-shot-s-protection-against-new-covid-19-variant-soon", "urlToImage": "https://d30fl32nd2baj9.cloudfront.net/media/2021/11/27/new-variant-data-27112021-01-smr.jpg/BINARY/new-variant-data-27112021-01-smr.jpg", "publishedAt": "2021-11-27T08:19:36Z", "content": "Pfizer and BioNTech said that if necessary they expect to be able to ship a new vaccine tailored to the emerging variant in approximately 100 days.\r\n\"We understand the concern of experts and have imm\u2026 [+2102 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "Gursharan Bhalla", "title": "Omicron COVID-19 Variant: Pfizer, BioNTech Unsure About Vaccine Efficacy Against New Variant", "description": "With the new COVID-19 variant that's deadlier than the previous delta variant, there are new challenges that the medical fraternity across the world is facing.Noting that they are not sure whether their vaccines would work against new COVID-19 variant 'Omicro\u2026", "url": "https://www.indiatimes.com/news/india/omicron-vaccine-efficacy-pfizer-biontech-555299.html", "urlToImage": "https://im.indiatimes.in/content/2021/Nov/53_61a1dd9855561.jpg", "publishedAt": "2021-11-27T07:17:52Z", "content": "With the new COVID-19 variant that's deadlier than the previous delta variant, there are new challenges that the medical fraternity across the world is facing.\r\nNoting that they are not sure whether \u2026 [+3004 chars]"}]}, "2021-11-26": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-26. You may need to upgrade to a paid plan."}, "2021-11-25": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-25. You may need to upgrade to a paid plan."}, "2021-11-24": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-24. You may need to upgrade to a paid plan."}, "2021-11-23": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-23. You may need to upgrade to a paid plan."}, "2021-11-22": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-22. You may need to upgrade to a paid plan."}, "2021-11-21": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-21. You may need to upgrade to a paid plan."}, "2021-11-20": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-20. You may need to upgrade to a paid plan."}, "2021-11-19": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-19. You may need to upgrade to a paid plan."}, "2021-11-18": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-18. You may need to upgrade to a paid plan."}, "2021-11-17": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-17. You may need to upgrade to a paid plan."}, "2021-11-16": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-16. You may need to upgrade to a paid plan."}, "2021-11-15": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-15. You may need to upgrade to a paid plan."}, "2021-11-14": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-14. You may need to upgrade to a paid plan."}, "2021-11-13": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-13. You may need to upgrade to a paid plan."}, "2021-11-12": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-12. You may need to upgrade to a paid plan."}, "2021-11-11": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-11. You may need to upgrade to a paid plan."}, "2021-11-10": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-10. You may need to upgrade to a paid plan."}, "2021-11-09": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-09. You may need to upgrade to a paid plan."}, "2021-11-08": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-08. You may need to upgrade to a paid plan."}, "2021-11-07": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-07. You may need to upgrade to a paid plan."}, "2021-11-06": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-06. You may need to upgrade to a paid plan."}, "2021-11-05": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-05. You may need to upgrade to a paid plan."}, "2021-11-04": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-04. You may need to upgrade to a paid plan."}, "2021-11-03": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-03. You may need to upgrade to a paid plan."}, "2021-11-02": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-02. You may need to upgrade to a paid plan."}, "2021-11-01": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-11-01. You may need to upgrade to a paid plan."}, "2021-10-31": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-31. You may need to upgrade to a paid plan."}, "2021-10-30": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-30. You may need to upgrade to a paid plan."}, "2021-10-29": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-29. You may need to upgrade to a paid plan."}, "2021-10-28": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-28. You may need to upgrade to a paid plan."}, "2021-10-27": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-27. You may need to upgrade to a paid plan."}, "2021-10-26": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-26. You may need to upgrade to a paid plan."}, "2021-10-25": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-25. You may need to upgrade to a paid plan."}, "2021-10-24": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-24. You may need to upgrade to a paid plan."}, "2021-10-23": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-23. You may need to upgrade to a paid plan."}, "2021-10-22": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-22. You may need to upgrade to a paid plan."}, "2021-10-21": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-21. You may need to upgrade to a paid plan."}, "2021-10-20": {"status": "error", "code": "parameterInvalid", "message": "You are trying to request results too far in the past. Your plan permits you to request articles as far back as 2021-11-26, but you have requested 2021-10-20. You may need to upgrade to a paid plan."}, "2021-10-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-17": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-16": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-10": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-06": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-03": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-02": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-10-01": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-30": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-29": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-26": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-25": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-24": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-23": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-22": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-21": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-20": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-17": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-16": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-10": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-06": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-03": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-02": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-09-01": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-31": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-30": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-29": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-26": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-25": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-24": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-23": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-22": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-21": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-20": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-17": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-16": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-10": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-06": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-03": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-02": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-08-01": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-31": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-30": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-29": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-26": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-25": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-24": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-23": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-22": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-21": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-20": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-17": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-16": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-10": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-06": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-03": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-02": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-07-01": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-30": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-29": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-26": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-25": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-24": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-23": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-22": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-21": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-20": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-17": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-16": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-10": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-06": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-03": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-02": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-06-01": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-31": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-30": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-29": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-26": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-25": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-24": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-23": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-22": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-21": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-20": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-17": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-16": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-10": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-06": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-03": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-02": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-05-01": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-30": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-29": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-26": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-25": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-24": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-23": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-22": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-21": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-20": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-17": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-16": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-10": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-06": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-03": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-02": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-04-01": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-31": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-30": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-29": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-26": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-25": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-24": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-23": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-22": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-21": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-20": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-17": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-16": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-10": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-06": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-03": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-02": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-03-01": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-26": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-25": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-24": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-23": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-22": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-21": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-20": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-17": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-16": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-10": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-06": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-03": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-02": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-02-01": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-31": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-30": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-29": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-26": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-25": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-24": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-23": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-22": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-21": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-20": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-19": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-18": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-17": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-16": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-15": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-14": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-13": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-12": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-11": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-10": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-09": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-08": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-07": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-06": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-05": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-04": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-03": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-02": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2021-01-01": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2020-12-31": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2020-12-30": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2020-12-29": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2020-12-28": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}, "2020-12-27": {"status": "error", "code": "rateLimited", "message": "You have made too many requests recently. Developer accounts are limited to 100 requests over a 24 hour period (50 requests available every 12 hours). Please upgrade to a paid plan if you need more requests."}}